dlb-20260925
00013085472026FYFALSEP3Y111http://fasb.org/us-gaap/2026#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2026#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2026#PrepaidExpenseAndOtherAssetsCurrenthttp://fasb.org/us-gaap/2026#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2026#AccruedLiabilitiesCurrenthttp://xbrl.sec.gov/country/2026#US11368iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesdlb:votexbrli:puredlb:countrydlb:segment00013085472025-09-272026-09-2500013085472026-03-270001308547us-gaap:CommonClassAMember2026-10-230001308547us-gaap:CommonClassBMember2026-10-2300013085472026-09-2500013085472025-09-260001308547us-gaap:CommonClassAMember2025-09-260001308547us-gaap:CommonClassAMember2026-09-250001308547us-gaap:CommonClassBMember2025-09-260001308547us-gaap:CommonClassBMember2026-09-250001308547dlb:TotalLicensingRevenueMember2025-09-272026-09-250001308547dlb:TotalLicensingRevenueMember2024-09-282025-09-260001308547dlb:TotalLicensingRevenueMember2023-09-302024-09-270001308547dlb:ProductsAndServicesMember2025-09-272026-09-250001308547dlb:ProductsAndServicesMember2024-09-282025-09-260001308547dlb:ProductsAndServicesMember2023-09-302024-09-2700013085472024-09-282025-09-2600013085472023-09-302024-09-270001308547us-gaap:NonrelatedPartyMember2025-09-272026-09-250001308547us-gaap:NonrelatedPartyMember2024-09-282025-09-260001308547us-gaap:NonrelatedPartyMember2023-09-302024-09-270001308547us-gaap:RelatedPartyMember2025-09-272026-09-250001308547us-gaap:RelatedPartyMember2024-09-282025-09-260001308547us-gaap:RelatedPartyMember2023-09-302024-09-270001308547us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-09-290001308547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-09-290001308547us-gaap:AdditionalPaidInCapitalMember2023-09-290001308547us-gaap:RetainedEarningsMember2023-09-290001308547us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-290001308547us-gaap:ParentMember2023-09-290001308547us-gaap:NoncontrollingInterestMember2023-09-2900013085472023-09-290001308547us-gaap:RetainedEarningsMember2023-09-302024-09-270001308547us-gaap:ParentMember2023-09-302024-09-270001308547us-gaap:NoncontrollingInterestMember2023-09-302024-09-270001308547us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-302024-09-270001308547us-gaap:AdditionalPaidInCapitalMember2023-09-302024-09-270001308547us-gaap:CommonClassAMemberus-gaap:CommonStockMember2023-09-302024-09-270001308547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2023-09-302024-09-270001308547us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-09-270001308547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-09-270001308547us-gaap:AdditionalPaidInCapitalMember2024-09-270001308547us-gaap:RetainedEarningsMember2024-09-270001308547us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-270001308547us-gaap:ParentMember2024-09-270001308547us-gaap:NoncontrollingInterestMember2024-09-2700013085472024-09-270001308547us-gaap:RetainedEarningsMember2024-09-282025-09-260001308547us-gaap:ParentMember2024-09-282025-09-260001308547us-gaap:NoncontrollingInterestMember2024-09-282025-09-260001308547us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-282025-09-260001308547us-gaap:AdditionalPaidInCapitalMember2024-09-282025-09-260001308547us-gaap:CommonClassAMemberus-gaap:CommonStockMember2024-09-282025-09-260001308547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2024-09-282025-09-260001308547us-gaap:CommonClassAMemberus-gaap:CommonStockMember2025-09-260001308547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-09-260001308547us-gaap:AdditionalPaidInCapitalMember2025-09-260001308547us-gaap:RetainedEarningsMember2025-09-260001308547us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-260001308547us-gaap:ParentMember2025-09-260001308547us-gaap:NoncontrollingInterestMember2025-09-260001308547us-gaap:RetainedEarningsMember2025-09-272026-09-250001308547us-gaap:ParentMember2025-09-272026-09-250001308547us-gaap:NoncontrollingInterestMember2025-09-272026-09-250001308547us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-272026-09-250001308547us-gaap:AdditionalPaidInCapitalMember2025-09-272026-09-250001308547us-gaap:CommonClassAMemberus-gaap:CommonStockMember2025-09-272026-09-250001308547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2025-09-272026-09-250001308547us-gaap:CommonClassAMemberus-gaap:CommonStockMember2026-09-250001308547us-gaap:CommonClassBMemberus-gaap:CommonStockMember2026-09-250001308547us-gaap:AdditionalPaidInCapitalMember2026-09-250001308547us-gaap:RetainedEarningsMember2026-09-250001308547us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-09-250001308547us-gaap:ParentMember2026-09-250001308547us-gaap:NoncontrollingInterestMember2026-09-250001308547srt:MinimumMemberdlb:SystemsAndSoftwareMember2026-09-250001308547srt:MaximumMemberdlb:SystemsAndSoftwareMember2026-09-250001308547srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2026-09-250001308547srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2026-09-250001308547srt:MinimumMemberus-gaap:FurnitureAndFixturesMember2026-09-250001308547srt:MaximumMemberus-gaap:FurnitureAndFixturesMember2026-09-250001308547srt:MaximumMemberdlb:LeasedEquipmentMember2026-09-250001308547srt:MinimumMemberus-gaap:BuildingMember2026-09-250001308547srt:MaximumMemberus-gaap:BuildingMember2026-09-250001308547srt:MinimumMemberus-gaap:SoftwareDevelopmentMember2026-09-250001308547srt:MinimumMember2026-09-250001308547srt:MaximumMember2026-09-250001308547us-gaap:ForeignExchangeForwardMember2026-09-250001308547us-gaap:ForeignExchangeForwardMember2025-09-260001308547us-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-09-250001308547us-gaap:ForeignExchangeForwardMemberus-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-09-260001308547us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-09-272026-09-250001308547us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-282025-09-2600013085472025-09-272025-12-2600013085472025-12-272026-03-2700013085472026-03-282026-06-2600013085472026-06-272026-09-2500013085472026-09-262026-09-2500013085472027-09-252026-09-2500013085472028-09-302026-09-250001308547dlb:LicensingBrodcastRevenueMember2025-09-272026-09-250001308547dlb:LicensingBrodcastRevenueMember2024-09-282025-09-260001308547dlb:LicensingBrodcastRevenueMember2023-09-302024-09-270001308547dlb:LicensingMobileRevenueMember2025-09-272026-09-250001308547dlb:LicensingMobileRevenueMember2024-09-282025-09-260001308547dlb:LicensingMobileRevenueMember2023-09-302024-09-270001308547dlb:LicensingCERevenueMember2025-09-272026-09-250001308547dlb:LicensingCERevenueMember2024-09-282025-09-260001308547dlb:LicensingCERevenueMember2023-09-302024-09-270001308547dlb:LicensingPCRevenueMember2025-09-272026-09-250001308547dlb:LicensingPCRevenueMember2024-09-282025-09-260001308547dlb:LicensingPCRevenueMember2023-09-302024-09-270001308547dlb:LicensingOtherRevenueMember2025-09-272026-09-250001308547dlb:LicensingOtherRevenueMember2024-09-282025-09-260001308547dlb:LicensingOtherRevenueMember2023-09-302024-09-270001308547country:US2025-09-272026-09-250001308547country:US2024-09-282025-09-260001308547country:US2023-09-302024-09-270001308547us-gaap:NonUsMember2025-09-272026-09-250001308547us-gaap:NonUsMember2024-09-282025-09-260001308547us-gaap:NonUsMember2023-09-302024-09-270001308547us-gaap:OtherAssetsNoncurrent2026-09-250001308547us-gaap:OtherAssetsNoncurrent2025-09-260001308547us-gaap:CashMember2026-09-250001308547us-gaap:CashMemberus-gaap:FairValueInputsLevel1Member2026-09-250001308547us-gaap:MoneyMarketFundsMember2026-09-250001308547us-gaap:MoneyMarketFundsMember2025-09-272026-09-250001308547us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2026-09-250001308547us-gaap:FairValueInputsLevel1Member2026-09-250001308547us-gaap:FairValueInputsLevel2Member2026-09-250001308547us-gaap:ShortTermInvestmentsMember2026-09-250001308547us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2026-09-250001308547us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel2Member2026-09-250001308547us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2026-09-250001308547us-gaap:FairValueInputsLevel3Member2026-09-250001308547us-gaap:OtherLongTermInvestmentsMember2026-09-250001308547us-gaap:OtherLongTermInvestmentsMember2025-09-272026-09-250001308547us-gaap:OtherLongTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2026-09-250001308547dlb:LongtermInvestmentsMember2026-09-250001308547dlb:LongtermInvestmentsMember2025-09-272026-09-250001308547dlb:InvestmentsHeldInSupplementalRetirementPlanMemberus-gaap:FairValueInputsLevel1Member2026-09-250001308547dlb:DerivativeFinancialInstrumentsAssetsCurrentMemberus-gaap:FairValueInputsLevel2Member2026-09-250001308547dlb:DerivativeFinancialInstrumentsAssetsCurrentMember2026-09-250001308547dlb:DerivativeFinancialInstrumentsAssetsCurrentMember2025-09-272026-09-250001308547us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2026-09-250001308547us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember2025-09-272026-09-250001308547us-gaap:CashMember2025-09-260001308547us-gaap:CashMemberus-gaap:FairValueInputsLevel1Member2025-09-260001308547us-gaap:MoneyMarketFundsMember2025-09-260001308547us-gaap:MoneyMarketFundsMember2024-09-282025-09-260001308547us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2025-09-260001308547us-gaap:FairValueInputsLevel1Member2025-09-260001308547us-gaap:FairValueInputsLevel2Member2025-09-260001308547us-gaap:ShortTermInvestmentsMember2025-09-260001308547us-gaap:ShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2025-09-260001308547us-gaap:OtherLongTermInvestmentsMember2025-09-260001308547us-gaap:OtherLongTermInvestmentsMember2024-09-282025-09-260001308547us-gaap:OtherLongTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2025-09-260001308547us-gaap:OtherLongTermInvestmentsMemberus-gaap:FairValueInputsLevel3Member2025-09-260001308547dlb:LongtermInvestmentsMember2025-09-260001308547dlb:LongtermInvestmentsMember2024-09-282025-09-260001308547us-gaap:FairValueInputsLevel3Member2025-09-260001308547dlb:InvestmentsHeldInSupplementalRetirementPlanMemberus-gaap:FairValueInputsLevel1Member2025-09-260001308547dlb:DerivativeFinancialInstrumentsAssetsCurrentMemberus-gaap:FairValueInputsLevel2Member2025-09-260001308547dlb:DerivativeFinancialInstrumentsAssetsCurrentMember2025-09-260001308547dlb:DerivativeFinancialInstrumentsAssetsCurrentMember2024-09-282025-09-260001308547us-gaap:DerivativeFinancialInstrumentsAssetsMember2025-09-260001308547us-gaap:DerivativeFinancialInstrumentsAssetsMember2024-09-282025-09-260001308547dlb:DerivativeFinancialInstrumentsLiabilitiesCurrentMember2025-09-260001308547dlb:DerivativeFinancialInstrumentsLiabilitiesCurrentMember2024-09-282025-09-260001308547us-gaap:LandMember2026-09-250001308547us-gaap:LandMember2025-09-260001308547us-gaap:BuildingMember2026-09-250001308547us-gaap:BuildingMember2025-09-260001308547us-gaap:LeaseholdImprovementsMember2026-09-250001308547us-gaap:LeaseholdImprovementsMember2025-09-260001308547us-gaap:MachineryAndEquipmentMember2026-09-250001308547us-gaap:MachineryAndEquipmentMember2025-09-260001308547dlb:ComputerSystemsandSoftwareMember2026-09-250001308547dlb:ComputerSystemsandSoftwareMember2025-09-260001308547us-gaap:FurnitureAndFixturesMember2026-09-250001308547us-gaap:FurnitureAndFixturesMember2025-09-260001308547dlb:LeasedEquipmentMember2026-09-250001308547dlb:LeasedEquipmentMember2025-09-260001308547us-gaap:ConstructionInProgressMember2026-09-250001308547us-gaap:ConstructionInProgressMember2025-09-260001308547dlb:AcquiredPatentsAndTechnologyMember2026-09-250001308547dlb:AcquiredPatentsAndTechnologyMember2025-09-260001308547us-gaap:CustomerRelationshipsMember2026-09-250001308547us-gaap:CustomerRelationshipsMember2025-09-260001308547us-gaap:OtherIntangibleAssetsMember2026-09-250001308547us-gaap:OtherIntangibleAssetsMember2025-09-260001308547dlb:ViaMemberdlb:AccessAdvanceMember2026-09-250001308547dlb:TwoThousandFiveStockPlanMemberus-gaap:CommonClassAMember2026-09-250001308547dlb:AwardsGrantedUnderTwoThousandFiveStockPlanFromFebruaryTwoThousandElevenMember2025-09-272026-09-250001308547dlb:A2026InducementStockPlanMemberus-gaap:CommonClassAMember2026-09-250001308547us-gaap:EmployeeStockOptionMemberdlb:OptionsGrantedFromJuneTwoThousandEightMember2025-09-272026-09-250001308547us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMemberdlb:OptionsGrantedFromJuneTwoThousandEightMember2025-09-272026-09-250001308547dlb:PerformanceBasedStockOptionsMembersrt:MinimumMember2025-09-272026-09-250001308547dlb:PerformanceBasedStockOptionsMembersrt:MaximumMember2025-09-272026-09-250001308547dlb:PerformanceBasedStockOptionsMember2025-09-272026-09-250001308547dlb:TwoThousandFiveStockPlanMemberus-gaap:CommonClassAMember2025-09-272026-09-250001308547us-gaap:RestrictedStockUnitsRSUMemberdlb:EmployeeandOfficerMember2025-09-272026-09-250001308547us-gaap:RestrictedStockUnitsRSUMemberdlb:AwardsGrantedPriortoNovember2010Membersrt:DirectorMember2010-11-012014-03-280001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:MinimumMember2025-09-272026-09-250001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:MaximumMember2025-09-272026-09-250001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2023-12-152023-12-150001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2024-12-162024-12-160001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2025-12-152025-12-150001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2020-12-150001308547us-gaap:PerformanceSharesMembersrt:ExecutiveOfficerMember2023-12-012023-12-310001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2021-12-150001308547us-gaap:PerformanceSharesMembersrt:ExecutiveOfficerMember2024-12-012024-12-310001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2022-12-150001308547us-gaap:PerformanceSharesMembersrt:ExecutiveOfficerMember2025-12-012025-12-310001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2025-12-310001308547dlb:PerformanceBasedRestrictedStockUnitsMemberdlb:VestingSharesAt200OfTheTargetAwardAmountMembersrt:ExecutiveOfficerMember2026-09-250001308547dlb:PerformanceBasedRestrictedStockUnitsMembersrt:ExecutiveOfficerMember2025-09-272026-09-250001308547dlb:PerformanceBasedRestrictedStockUnitsMember2025-09-272026-09-250001308547dlb:PerformanceBasedRestrictedStockUnitsMember2026-09-250001308547dlb:EmployeeStockPurchasePlanMember2025-09-272026-09-250001308547dlb:EmployeeStockPurchasePlanMemberus-gaap:CommonClassAMember2025-09-272026-09-250001308547dlb:EmployeeStockPurchasePlanMemberus-gaap:CommonClassAMember2026-09-250001308547us-gaap:StockOptionMember2025-09-272026-09-250001308547us-gaap:StockOptionMember2024-09-282025-09-260001308547us-gaap:StockOptionMember2023-09-302024-09-270001308547us-gaap:RestrictedStockUnitsRSUMember2025-09-272026-09-250001308547us-gaap:RestrictedStockUnitsRSUMember2024-09-282025-09-260001308547us-gaap:RestrictedStockUnitsRSUMember2023-09-302024-09-270001308547dlb:EmployeeStockPurchasePlanMember2025-09-272026-09-250001308547dlb:EmployeeStockPurchasePlanMember2024-09-282025-09-260001308547dlb:EmployeeStockPurchasePlanMember2023-09-302024-09-270001308547dlb:ModificationOfEquityAwardMember2025-09-272026-09-250001308547us-gaap:CostOfRevenue2025-09-272026-09-250001308547us-gaap:CostOfRevenue2024-09-282025-09-260001308547us-gaap:CostOfRevenue2023-09-302024-09-270001308547us-gaap:ResearchAndDevelopmentExpense2025-09-272026-09-250001308547us-gaap:ResearchAndDevelopmentExpense2024-09-282025-09-260001308547us-gaap:ResearchAndDevelopmentExpense2023-09-302024-09-270001308547us-gaap:SellingAndMarketingExpense2025-09-272026-09-250001308547us-gaap:SellingAndMarketingExpense2024-09-282025-09-260001308547us-gaap:SellingAndMarketingExpense2023-09-302024-09-270001308547us-gaap:GeneralAndAdministrativeExpense2025-09-272026-09-250001308547us-gaap:GeneralAndAdministrativeExpense2024-09-282025-09-260001308547us-gaap:GeneralAndAdministrativeExpense2023-09-302024-09-270001308547us-gaap:EmployeeStockMember2024-09-282025-09-260001308547us-gaap:EmployeeStockMember2025-09-272026-09-250001308547us-gaap:EmployeeStockOptionMember2026-09-250001308547us-gaap:EmployeeStockOptionMember2025-09-272026-09-250001308547us-gaap:RestrictedStockUnitsRSUMember2026-09-2500013085472009-11-300001308547dlb:AdditionalStockApprovedMember2010-07-310001308547dlb:AdditionalStockApprovedMember2011-07-310001308547dlb:AdditionalStockApprovedMember2012-02-290001308547dlb:AdditionalStockApprovedMember2014-10-310001308547dlb:AdditionalStockApprovedMember2017-01-250001308547dlb:AdditionalStockApprovedMember2018-07-250001308547dlb:AdditionalStockApprovedMember2019-07-310001308547dlb:AdditionalStockApprovedMember2021-07-290001308547dlb:AdditionalStockApprovedMember2022-02-280001308547dlb:AdditionalStockApprovedMember2022-08-310001308547dlb:AdditionalStockApprovedMember2024-08-3100013085472025-12-2600013085472026-06-260001308547us-gaap:SubsequentEventMember2026-11-172026-11-170001308547us-gaap:SubsequentEventMember2026-12-092026-12-090001308547us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-09-260001308547us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-09-260001308547us-gaap:AccumulatedTranslationAdjustmentMember2025-09-260001308547us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-270001308547us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-09-270001308547us-gaap:AccumulatedTranslationAdjustmentMember2024-09-270001308547us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2025-09-272026-09-250001308547us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-282025-09-260001308547us-gaap:AccumulatedTranslationAdjustmentMember2025-09-272026-09-250001308547us-gaap:AccumulatedTranslationAdjustmentMember2024-09-282025-09-260001308547us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2026-09-250001308547us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-09-250001308547us-gaap:AccumulatedTranslationAdjustmentMember2026-09-250001308547us-gaap:EmployeeStockOptionMember2024-09-282025-09-260001308547us-gaap:EmployeeStockOptionMember2023-09-302024-09-270001308547us-gaap:EmployeeStockMember2025-09-272026-09-250001308547us-gaap:EmployeeStockMember2024-09-282025-09-260001308547us-gaap:EmployeeStockMember2023-09-302024-09-270001308547dlb:ForeignTaxCreditCarryforwardMember2026-09-250001308547dlb:CaliforniaResearchTaxCreditCarryforwardMember2026-09-250001308547us-gaap:ResearchMember2026-09-250001308547country:IE2025-09-272026-09-250001308547country:CN2025-09-272026-09-250001308547country:TW2025-09-272026-09-250001308547country:JP2025-09-272026-09-250001308547country:AU2025-09-272026-09-250001308547us-gaap:ForeignTaxJurisdictionOtherMember2025-09-272026-09-250001308547dlb:June2026RestructuringPlanMemberus-gaap:EmployeeSeveranceMember2025-09-272026-09-250001308547dlb:June2026RestructuringPlanMembersrt:MaximumMember2025-09-272026-09-250001308547srt:ScenarioForecastMemberdlb:June2026RestructuringPlanMembersrt:MaximumMember2026-09-262027-09-240001308547dlb:September2025RestructuringPlanMemberus-gaap:EmployeeSeveranceMember2025-09-272026-09-250001308547dlb:September2025RestructuringPlanMemberus-gaap:EmployeeSeveranceMember2024-09-282025-09-260001308547dlb:September2025RestructuringPlanMembersrt:MaximumMember2025-09-272026-09-250001308547dlb:November2024RestructuringPlanMemberus-gaap:EmployeeSeveranceMember2024-09-282025-09-260001308547dlb:November2024RestructuringPlanMembersrt:MaximumMember2024-09-282025-09-260001308547dlb:April2024RestructuringPlanMemberus-gaap:EmployeeSeveranceMember2023-09-302024-09-270001308547dlb:April2024RestructuringPlanMembersrt:MinimumMember2023-09-302024-09-270001308547dlb:April2024RestructuringPlanMembersrt:MaximumMember2024-09-282025-09-260001308547dlb:September2023RestructuringPlanMemberus-gaap:EmployeeSeveranceMember2023-09-302024-09-270001308547dlb:September2023RestructuringPlanMembersrt:MaximumMember2023-09-302024-09-270001308547dlb:June2023RestructuringPlanMembersrt:MaximumMember2023-09-302024-09-270001308547us-gaap:EmployeeSeveranceMember2024-09-270001308547us-gaap:FacilityClosingMember2024-09-270001308547us-gaap:EmployeeSeveranceMember2024-09-282025-09-260001308547us-gaap:FacilityClosingMember2024-09-282025-09-260001308547us-gaap:EmployeeSeveranceMember2025-09-260001308547us-gaap:FacilityClosingMember2025-09-260001308547us-gaap:EmployeeSeveranceMember2025-09-272026-09-250001308547us-gaap:FacilityClosingMember2025-09-272026-09-250001308547us-gaap:EmployeeSeveranceMember2026-09-250001308547us-gaap:FacilityClosingMember2026-09-250001308547dlb:NamingRightsMember2025-09-272026-09-250001308547dlb:DonationCommitmentsMember2025-09-272026-09-250001308547dlb:GELicensingMember2024-08-190001308547dlb:GELicensingMember2024-08-192024-08-190001308547dlb:GELicensingMemberus-gaap:NoncontrollingInterestMember2024-09-282025-09-260001308547dlb:GELicensingMemberus-gaap:ParentMember2024-09-282025-09-260001308547dlb:GELicensingMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2024-08-190001308547dlb:GELicensingMember2025-09-260001308547us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberdlb:GELicensingMember2025-09-260001308547us-gaap:ShortTermInvestmentsdlb:GELicensingMember2025-09-260001308547dlb:GELicensingMemberdlb:PatentsAndTechnologyHEVCCodecsMemberdlb:AcquiredPatentsAndTechnologyMember2024-08-190001308547dlb:GELicensingMemberdlb:PatentsAndTechnologyHEVCCodecsMemberdlb:AcquiredPatentsAndTechnologyMember2024-08-192024-08-190001308547dlb:GELicensingMemberdlb:PatentsAndTechnologyNonHEVCCodecsMemberdlb:AcquiredPatentsAndTechnologyMember2024-08-190001308547dlb:GELicensingMemberdlb:PatentsAndTechnologyNonHEVCCodecsMemberdlb:AcquiredPatentsAndTechnologyMember2024-08-192024-08-190001308547dlb:GELicensingMember2023-09-302024-09-270001308547dlb:GELicensingMemberus-gaap:GeneralAndAdministrativeExpense2023-09-302024-09-270001308547dlb:GELicensingMemberus-gaap:SellingAndMarketingExpense2023-09-302024-09-270001308547dlb:THEOTechnologiesMember2022-01-312022-01-310001308547dlb:THEOTechnologiesMember2024-09-282025-09-260001308547dlb:THEOTechnologiesMembersrt:MinimumMember2022-01-312022-01-310001308547dlb:THEOTechnologiesMembersrt:MaximumMember2022-01-312022-01-310001308547dlb:THEOTechnologiesMember2022-01-310001308547dlb:ReportableSegmentMember2025-09-272026-09-250001308547dlb:ReportableSegmentMember2024-09-282025-09-260001308547dlb:ReportableSegmentMember2023-09-302024-09-270001308547dlb:ReportableSegmentMemberdlb:TotalLicensingRevenueMember2025-09-272026-09-250001308547dlb:ReportableSegmentMemberdlb:TotalLicensingRevenueMember2024-09-282025-09-260001308547dlb:ReportableSegmentMemberdlb:TotalLicensingRevenueMember2023-09-302024-09-270001308547dlb:ReportableSegmentMemberdlb:ProductsAndServicesMember2025-09-272026-09-250001308547dlb:ReportableSegmentMemberdlb:ProductsAndServicesMember2024-09-282025-09-260001308547dlb:ReportableSegmentMemberdlb:ProductsAndServicesMember2023-09-302024-09-270001308547dlb:ReportableSegmentMemberus-gaap:NonrelatedPartyMember2025-09-272026-09-250001308547dlb:ReportableSegmentMemberus-gaap:NonrelatedPartyMember2024-09-282025-09-260001308547dlb:ReportableSegmentMemberus-gaap:NonrelatedPartyMember2023-09-302024-09-270001308547country:KR2025-09-272026-09-250001308547country:KR2024-09-282025-09-260001308547country:KR2023-09-302024-09-270001308547country:CN2025-09-272026-09-250001308547country:CN2024-09-282025-09-260001308547country:CN2023-09-302024-09-270001308547country:JP2025-09-272026-09-250001308547country:JP2024-09-282025-09-260001308547country:JP2023-09-302024-09-270001308547srt:EuropeMember2025-09-272026-09-250001308547srt:EuropeMember2024-09-282025-09-260001308547srt:EuropeMember2023-09-302024-09-270001308547dlb:OtherGeographicLocationsMember2025-09-272026-09-250001308547dlb:OtherGeographicLocationsMember2024-09-282025-09-260001308547dlb:OtherGeographicLocationsMember2023-09-302024-09-270001308547country:US2026-09-250001308547country:US2025-09-260001308547us-gaap:NonUsMember2026-09-250001308547us-gaap:NonUsMember2025-09-260001308547dlb:DolbyPropertiesBurbankLlcMember2026-09-250001308547dlb:DolbyPropertiesLpMember2026-09-250001308547dlb:DolbyPropertiesBurbankLlcMember2025-09-272026-09-250001308547dlb:DolbyPropertiesBurbankLlcMember2024-09-282025-09-260001308547dlb:DolbyPropertiesBurbankLlcMember2023-09-302024-09-2700013085472024-09-282025-06-270001308547dlb:DagmarDolbyMember2026-06-272026-09-250001308547dlb:DagmarDolbyMember2026-09-25
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended September 25, 2026
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From              To             
Commission File Number: 001-32431
dlb_corp-newlogo.jpg
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware90-0199783
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
1275 Market StreetSan FranciscoCalifornia94103-1410
(Address of principal executive offices)(Zip Code)
(415) 558-0200
Registrant's telephone number, including area code
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, $0.001 par valueDLBThe New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act:
Title of each class
Class B common stock, $0.001 par value
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ý    No  ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ¨    No  ý
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý    No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  ý    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer☒Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements
of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  ☐    No  ☒
The aggregate market value of the voting common equity held by non-affiliates of the registrant as of March 27, 2026 was $2.4 billion. This calculation excludes the shares of Class A and Class B common stock held by executive officers, directors and stockholders whose combined
ownership of Class A and Class B common stock exceeds 5% of the shares of Class A common stock outstanding as of March 27, 2026. This calculation does not reflect a determination that such persons are affiliates for any other purposes.
On October 23, 2026, the registrant had 58,771,115 shares of Class A common stock, par value $0.001 per share, and 33,951,901 shares of Class B common stock, par value $0.001 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s Definitive Proxy Statement to be filed with the Commission pursuant to Regulation 14A in connection with the registrant’s 2027 Annual Meeting of Stockholders, to be filed subsequent to the date hereof, are incorporated by reference into Part III of this Report. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission not later than 120 days after the conclusion of the registrant’s fiscal year ended September 25, 2026. Except with respect to information specifically incorporated by reference in this Form 10-K, the Definitive Proxy Statement is not deemed to be filed as part of this Form 10-K.


Table of Contents

DOLBY LABORATORIES, INC.
FORM 10-K
For the Fiscal Year Ended September 25, 2026
TABLE OF CONTENTS
PART I
Item 1—
Item 1A—
Item 1B—
Item 1C—
Item 2—
Item 3—
Item 4—
PART II
Item 5—
Item 6—
Item 7—
Item 7A—
Item 8—
Item 9—
Item 9A—
Item 9B—
Item 9C—
PART III
Item 10—
Item 11—
Item 12—
Item 13—
Item 14—
PART IV
Item 15—
Item 16—

1

Table of Contents

GLOSSARY OF TERMS
The following table summarizes certain terms and abbreviations that may be used within the text of this report:
AbbreviationTerm
AACAdvanced Audio Coding
AFSAvailable-For-Sale (Securities)
AOCIAccumulated Other Comprehensive Income (Loss)
APICAdditional Paid In-Capital
ARPUAverage Revenue Per Unit
ASCAccounting Standards Codification
ASUAccounting Standards Update
AVCAdvanced Video Coding
AVRAudio/Video Receiver
CEConsumer Electronics
CODMChief Operating Decision Maker
COSOCommittee of Sponsoring Organizations (of the Treadway Commission)
DDDolby Digital®
DD+Dolby Digital Plus™
DMADigital Media Adapter
DVDDigital Versatile Disc
EPSEarnings Per Share
ESPEstimated Selling Price
ESPPEmployee Stock Purchase Plan
FASBFinancial Accounting Standards Board
FCPAForeign Corrupt Practices Act
G&AGeneral and Administrative
HDRHigh-Dynamic Range
HE-AACHigh Efficiency Advanced Audio Coding
HEVCHigh Efficiency Video Coding
ICIntegrated Circuit
IBRIncremental Borrowing Rate
IPIntellectual Property
LPLimited Partner/Partnership
NOLNet Operating Loss
OECDOrganization For Economic Co-Operation and Development
OEMOriginal Equipment Manufacturer
OTTOver-The-Top
PCPersonal Computer
PCSPost-Contract Support
PLFPremium Large Format
PP&EProperty, Plant, and Equipment
PSOPerformance-Based Stock Option
PSUPerformance-Based Restricted Stock Unit
R&DResearch and Development
ROURight-Of-Use
RSURestricted Stock Unit
S&MSales and Marketing
SECU.S. Securities and Exchange Commission
SERPSupplemental Executive Retirement Plan
STBSet-Top Box
TSRTotal Stockholder Return
U.S. GAAPGenerally Accepted Accounting Principles in the United States
VVCVersatile Video Coding
2

Table of Contents

FORWARD LOOKING STATEMENTS
This Annual Report on Form 10-K contains forward-looking statements reflecting our current expectations that are subject to risks and uncertainties, including, but not limited to statements regarding: operating results and underlying measures and the effect of acquisitions; demand and acceptance for our technologies and products; the effect of macroeconomic factors on our business; market growth opportunities and trends, including artificial intelligence and new technologies; the development and launch of new products, features, and platforms; our ability to maintain key partnership relationships; our plans, strategies and expected opportunities, including for our licensing business; future competition; our stock repurchase plan; and our dividend policy. Use of words such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," "intend," "could," "can," "would," "target," "goal," "outlook," "project," "contemplate," "future," or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions indicates a forward-looking statement. Such forward-looking statements are based on management's reasonable and current assumptions and expectations, but such statements inherently involve substantial risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including but not limited to the risks set forth in Part I, Item 1A, "Risk Factors" and key challenges set forth in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations." Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements.
In addition, statements that "we believe" and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Annual Report on Form 10-K, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. We disclaim any duty to update any of the forward-looking statements after the date of this Annual Report on Form 10-K to conform our prior statements to actual results.

3

Table of Contents

PART I

ITEM 1. BUSINESS
OVERVIEW
Founded in 1965, we are in the business of improving entertainment experiences by inventing and innovating technologies that advance audio and video capture, transmission, and playback. We enable highly compelling experiences for consumers of movies and TV shows, music, sports and more by meeting the needs of content creators, distributors, and consumer electronics manufacturers. We have been at the forefront of multiple audio and video revolutions over the last sixty years including the transitions from mono to stereo then surround, analog to digital, and terrestrial broadcasting to streaming. Our strength and durability stem from our ability to combine our expertise in signal processing with our close relationships with artists and other industry experts to continually bring to the creative community technology that allows them to express themselves in new and compelling ways.
Dolby provides technologies such as Dolby Vision and Dolby Atmos to support high-quality entertainment from a consumer perspective. Many of our technologies are fundamental to the creation and delivery of audio and video content. While some of our technology represents relatively elemental functions like audio signal compression that enable playback, we also offer technology that is innovating in personalized streaming video and intelligent picture optimization. We derive the majority of our revenue from licensing audio and video technology to electronics manufacturers, and a lesser portion of our revenue by offering premium audio and video technologies to cinema exhibitors and video streaming providers.
STRATEGY
Key elements of our strategy include:
Advancing the Science of Sight and Sound. We apply our understanding of the human senses, audio, and imaging engineering by collaborating with music, TV and movie creators, and innovating in emerging categories like user-generated content and live-streamed sports, to develop and update technologies aimed at enabling and improving how people experience and interact with entertainment content.
Delivering Superior Creative Experiences. We promote the use of our solutions as creative tools that allow filmmakers, musical artists, sound mixers, and other content creators and providers to fully express their creative intent to their audiences. Our technologies and solutions significantly improve delivery and playback so that consumers may enjoy richer, clearer, and immersive sound and sight experiences.
Building Ecosystems that Benefit from and Sustain Demand for our Solutions. We work closely with content creators, content distributors, and device manufacturers to enable them to deliver great experiences to their audiences, creating a virtuous cycle of product development, improved experiences, and sustained demand for our solutions. We also work closely with technology developers to create and promote standardized technologies that enable content to be enjoyed any place, any time on a broad range of devices.
Expanding the Reach of our Technologies. We look for new and innovative ways to apply our expertise in the science of sight and sound to expand the reach of our technologies to new content, media, devices, and audiences.
PRODUCTS AND REVENUE GENERATION
We generate most of our revenue by licensing technology, our brand, and patents to device manufacturers, and selling cinema hardware and services to movie exhibitors.
The following table presents a summary of the composition of our revenue for all periods presented. Refer to Note 2 "Summary of Significant Accounting Policies" and Note 3 "Revenue Recognition" to our consolidated financial statements for further detail.
Fiscal Year Ended
RevenueSeptember 25,
2026
September 26,
2025
September 27,
2024
   Licensing93%93%93%
   Products and services7%7%7%
Total100%100%100%
4

Table of Contents

Licensing
The two primary components of our licensing business are Branded Technologies which include Branded Audio Codecs, Dolby Atmos, and Dolby Vision, and Patents, which include Audio Patents and Imaging Patents.
We generated 93% of our total revenue in fiscal 2026 primarily from agreements to license branded technology and patents that enable approximately 1,000 device makers and implementation licensees to enable and enhance the audio and visual capabilities of their products by incorporating our technology.
Branded Technology Licensing
Dolby branded technologies offer enhanced audio and video experiences for consumers. Dolby branded technologies enjoy widespread adoption, are occasionally mandated as standards, and are frequently considered fundamental to a wide variety of devices and types of entertainment content, including movies, TV shows, sports, and music.
Our branded technology solutions are complete solutions. We provide licensees with software, patent rights, and know-how to enable and enhance content creation, delivery, and playback. Our branded offerings are designed to support ease of adoption and deployment. Additionally, our device partners derive value from the use of the Dolby brand, which is synonymous with high quality entertainment.
Dolby branded technologies are part of a unique and broad ecosystem that includes content creators, distributors (such as streaming media companies and broadcasters), and device manufacturers. Initial ecosystem adoption of these technologies yields a virtuous cycle. The more content made available using our branded technologies, the higher the likelihood that more devices embed our technology to facilitate the playback of that content. The more device manufacturers include our technology, the more content creators and distributors want to make content available in Dolby formats.
Branded Audio Codecs
A significant portion of our branded licensing is centered on audio codecs: compression and decompression technologies for audio. The most important of these are the following:
•Dolby Digital Plus ("DD+"). DD+ is an advanced surround sound audio codec technology that enables the Dolby audio experience across home theaters, smartphones, operating systems, and browsers. A versatile, bandwidth efficient, and scalable home theater grade audio codec for A/V content, DD+ is designed to deliver up to 7.1 channels of surround sound across multiple platforms and content types.
•Dolby AC-4. Dolby AC-4 is an audio codec that delivers equivalent experiences at half the bitrate of DD+, its predecessor. Dolby AC-4 matches the delivery method with the optimal configuration, enabling encodes tailored for broadcast or streaming and catering to headphone or speaker playback. It is also capable of delivering enhanced, user-configurable, and accessible experiences. The Dolby AC-4 coding system utilizes new aspects of object audio for features like dialogue enhancement or commentator substitution.
Dolby Atmos and Dolby Vision
Dolby Atmos and Dolby Vision are Dolby’s next generation of branded licensing products. They represent significant innovations, and enable consumers to enjoy increasingly immersive audio and video experiences. Dolby Atmos and Dolby Vision include encoding technologies that artists use to create more compelling and immersive audio and video experiences, as well as a set of decoding technologies that device manufacturers include on their devices to decode the content the artists have created.
•Dolby Atmos. Dolby Atmos is a three-dimensional audio experience with object-based sound technology using up to 128 audio objects that can be positioned anywhere to allow for precise placement and movement of sound in a three-dimensional space. This is achieved by adding height channels and spatially encoded digital signals. Dolby Atmos can adapt to varied playback environments and devices, including stereo headphones, speakers, TVs, soundbars, Audio/Video Receivers ("AVRs"), and automotive systems.
5

Table of Contents

•Dolby Vision. Dolby Vision is a visual technology that uses High-Dynamic Range ("HDR") to improve the quality of images in movies, TV shows, sports, games, UGC, and XR content. Dolby Vision is designed to make images appear more realistic by enhancing details in both dark and bright areas, and by increasing brightness, increasing the range of colors, and depicting deep blacks. It includes dynamic metadata that adjusts the picture based on a display's capabilities on a per-frame or per-shot basis. Dolby Vision 2, the next generation of Dolby Vision, expands our market opportunity by further enhancing picture quality and offering content intelligence and authentic motion with Dolby Vision 2 Max for premium televisions and Dolby Vision 2 for mainstream televisions.
A device must support Dolby Atmos and Dolby Vision to fully experience content in Dolby Atmos and Dolby Vision. Ecosystems for these products flourish because creatives appreciate that creating content using Dolby Atmos and Dolby Vision tools enables them to express their creativity in unique and compelling ways. Distributors see value in distributing this differentiated content. Device manufacturers understand that consumers want to enjoy content in the highest quality possible and will express a preference for devices with Dolby Atmos and Dolby Vision playback.
The volume of content available in Dolby Atmos and Dolby Vision formats has increased in recent periods. In addition to strong momentum in music, TV shows and movies, our technologies are gaining increased adoption in user-generated content, audiobooks, and live sports. The increasing availability of Dolby Atmos and Dolby Vision content provides device manufacturers with an incentive to license our technology in order to make it available to their customers.
Revenue Generation
We license our branded technologies via a direct sales force that works with approximately 1,000 device makers and implementation licensees all over the globe. Licensing usually occurs in two stages. First, we license to semiconductor manufacturers who incorporate our technologies in Integrated Circuits ("ICs") that they sell to Original Equipment Manufacturers ("OEMs") of consumer entertainment devices. These semiconductor licensees pay us a nominal initial fee for use of our technology and the services that we provide in their implementation process. Second, we license OEMs, who are then authorized to purchase chips from the chip makers, and incorporate those chips into Dolby-approved products. In addition to the two-stage model, we also license directly to integrated chip and device makers. 
Our branded licensing customers typically enter into a per unit royalty arrangement whereby they pay us for each unit they sell. In accordance with Generally Accepted Accounting Principles in the United States ("U.S. GAAP"), we estimate the number of units each customer sells every quarter and record it as revenue, and then true up that estimate when we get the actual unit sales data, typically one quarter in arrears. This method can lead to variability in revenue in any given quarter.
Some of our customers choose to enter into a minimum volume commitment where they commit to a certain minimum number of devices in exchange for a lower price per unit. If the customer sells more than the number of units they committed to, they pay a set per unit royalty for each incremental unit. These are annual and sometimes multiyear deals, where the value of the committed volume is generally recognized as revenue up front. These contract structures, as well as the occasional fixed fee contract whereby a licensee pays for unlimited units, are often selected by large customers and can also lead to variability in quarterly revenue.
We price our products based on value and volume, among other factors.
With respect to value, the advanced features of Dolby Atmos and Dolby Vision enhance the audio and video capabilities of our consumer electronics OEM partners' products and many of those partners can charge a premium for devices that include these technologies. Branded audio codecs can be implemented standalone but are necessary components for an effective Dolby Atmos implementation. Generally, the more technologies a customer licenses, the higher the total royalty per device.
Higher volumes generally equate to lower prices. This dynamic manifests at a market level for device families that represent significant volume. For example, in 2025, there were over one billion mobile devices, approximately 200 million TVs and, approximately 90 million cars sold. Accordingly, Average Revenue Per Unit ("ARPU") for cars is higher than ARPU for TVs, which is higher than ARPU for mobile phones.
6

Table of Contents

Patent Licensing
We generate patent licensing revenue primarily from licensing Dolby-owned patents essential to standardized audio and video technologies. These technologies are fundamental to the capture, storage, transmission and playback of audio and video, and are used across a broad range of products, devices, and services. These technologies are embedded in billions of products sold each year throughout the world, including streaming devices, televisions, gaming consoles, automotive media consoles, and security cameras. As the value created by the use of standardized audio and video technologies has extended beyond end-user devices, our patent pool partners have begun to expand their licensing activities and engagement models to include services that utilize these technologies, such as video distribution platforms and data center infrastructure.
Technology Standards
The standardized technologies at the core of our patent licenses are generally developed in an open, collaborative process under the auspices of international standard-setting organizations like ETSI, ISO, IEC and/or ITU. Active participants are leaders in the field, and often include businesses (large and small), research institutes, and universities. Participants, including Dolby, contribute specialized expertise and/or technology with the goal of creating common industry solutions to address technical challenges. Given the collaborative and meritocratic nature of the standardization process, the resulting technology solution is both state-of-the-art and designed to meet the requirements of the market, increasing the likelihood of industry adoption.
For audio and video codecs, the standardization process is centered on creating interoperable solutions that work in a uniform manner despite increasingly complex device requirements. The resulting standardized technologies are intended to connect billions of disparate devices worldwide in a way that allows for seamless communication. These technology standards have played an essential role in advancing the technology of media capture, storage, transmission, and playback through multiple generations of technological development. For example, the Advanced Video Coding ("AVC") codec helped enable standard-definition streaming over the internet, while the next-generation High Efficiency Video Coding ("HEVC") codec optimized streaming for higher-definition formats like 4K.
Looking forward, Dolby intends to continue to actively participate (both in standards bodies and independently) in the development of next-generation standardized audio and video technologies.
Key Current Programs
The majority of revenue from Dolby’s patent licensing comes from licensing standard essential patents associated with standardized Advanced Audio Coding ("AAC"), AVC, and HEVC codecs, each of which is described below.
• AAC, High Efficiency Advanced Audio Coding ("HE-AAC"), and Extended HE-AAC. The AAC family of audio codecs comprises some of the most efficient audio coding technologies available today. These codecs are designed to provide high quality audio at lower bitrates than prior coding formats. The AAC family of codecs is widely deployed across most consumer media playback devices.
• AVC. The AVC digital video codec is highly efficient and is widely implemented in video playback devices including Set-Top Boxes ("STBs"), mobile devices, cameras, and broadcast television services and other products. AVC is the most widely deployed video codec used by broadcasters and video streaming companies.
• HEVC. HEVC is a next-generation digital video codec that compresses video more efficiently than AVC, leading to an average bitrate reduction of up to 50%. HEVC enables the distribution of higher-quality video, such as 4K streaming. HEVC is especially useful for streaming video on mobile devices, where data usage and processing power are often limited.
In addition, we also license patents essential to other audio, video, and communications codec technologies, such as AV1, MPEG H, Opus, and Versatile Video Coding ("VVC"). These technologies and licensing programs are in earlier phases of technology adoption and licensing program maturity.
Revenue Generation
Given the collaborative nature of the standardization process, Dolby generally owns only a portion of the patent rights incorporated into a given technology standard. As such, patent licensing solutions are not Dolby-branded, and we can directly offer licensees only a portion of the rights necessary to practice the relevant standard.
7

Table of Contents

Our preferred solution to these ownership dynamics is the patent pool.
A patent pool is a collaborative structure administered by a patent pool administrator and comprised of multiple patent owners (referred to as licensors) who agree to jointly license their patents relevant to a particular technology. There can be dozens of licensors contributing intellectual property ("IP") to a patent pool for a standardized technology.
By bringing together multiple patent owners to offer a combined solution, pools offer a number of advantages over direct licensing, including the following:
•Pools dramatically decrease transaction costs for most licensees and, to a lesser extent, for most licensors;
•Pools offer licensees relatively simple access to fundamental technology in a simplified ‘one-stop shop,’ enabling licensees to focus their resources on developing their own products and technologies;
•Pools enable widespread, rapid adoption of a technology, which accelerates research into subsequent technologies and catalyzes downstream competition;
•Pools allow licensors like Dolby to focus on innovation rather than sales, marketing, and licensing activities; and
•The pool structure naturally leads to more transparent and consistent licensing terms.
Patent pools employ a variety of licensing revenue models, including per-unit, per-subscriber, and fixed-fee royalties, and sometimes include royalty caps or committed volume arrangements in exchange for a lower price per unit. The fees charged for licensing pooled patents are initially determined by market forces - a careful balance of the need to compensate innovators with the desire to develop an active licensee base. For example, Access Advance LLC’s ("Access Advance") Video Distribution Patent ("VDP") Pool adopted a service-based royalty model based on the recognition that social media and streaming platforms benefit from the VDP’s patented compression codec technologies that enable large-scale video distribution at manageable cost. The balance of licensor and licensee interests is also a core consideration in the development of non-fee licensing terms.
Licensing fees collected from companies implementing the technology are distributed to the licensors by the patent pool administrator after deducting an administration fee. Royalty share among the pool licensors is determined based on the value of the patents each licensor contributes to the pool, as governed by allocation rules negotiated among the pool licensors.
We operate as licensors in patent pools administered by several patent pool administrators including Access Advance, Sisvel, Via, and Vectis IP Ltd ("Vectis"). We are a majority stockholder and licensor in Via, which we co-own with Philips and Mitsubishi. We hold a minority ownership interest in Access Advance. Patent pool administration fees are paid as a percentage of royalties collected for services rendered by the pool administrator such as royalty collection, allocation and compliance, financial reporting, and tax planning and preparation.
The vast majority of our patent licensing revenue comes from patent pools in the form of royalties, and a minority of our patent licensing revenue is generated from bilateral licensing agreements between Dolby and licensees, with licensing fees negotiated directly with the licensee. We also generate revenue from Via administration fees.
Recoveries
We also generate licensing revenue via recoveries, which is revenue attributable to unlicensed or under-reported distribution of products incorporating our technologies in prior periods. Recoveries arise in the context of both branded technology licensing and patent licensing, and usually result from a settlement following a licensee audit under an existing license agreement, or as part of back-royalties paid in connection with a license agreement with a new licensee. Within the Results of Operations section of Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations," revenue attributable to previous periods' usage including settlements are collectively referred to as "recoveries." Recoveries are a recurring element of our business and are subject to fluctuation and unpredictability.
Dolby Cinema
Dolby Cinemas are Premium Large Format ("PLF") cinemas that deliver a Dolby branded premium cinema offering with Dolby Vision, Dolby Atmos, and a proprietary Dolby theater design. We typically provide Dolby Cinema
8

Table of Contents

exhibitors with the requisite Dolby technology at minimal or no upfront cost and generate revenue from these sites through a share of box office receipts, which we recognize as licensing revenue. We draw on the expertise of our creative and technical teams to deliver high quality and consistent experiences to our exhibitor partners. Dolby Cinemas deliver a unique, high-end theater experience. The proprietary theater design differentiates Dolby Cinema from competing PLFs as well as our exhibitor partner’s other theaters that use Dolby manufactured and distributed cinema hardware, including those that may utilize Dolby Atmos and/or Dolby Vision.
Products and Services
Cinema Products and Services
We design and manufacture audio, imaging, accessibility, and other hardware and software solutions primarily for the cinema, with occasional applications in the television, broadcast, and live entertainment industries.
Cinema Imaging Products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on cinema projectors. It also includes software used to encrypt, encode, and package digital media files for distribution.
Cinema Audio Products include cinema processors, amplifiers, and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos.
In addition, we offer various services to support theatrical and television production for cinema, broadcast, and home entertainment, including equipment training and maintenance, mixing room alignment, equalization, as well as audio, color, and light image calibration. We also provide Post-Contract Support ("PCS") for products sold and equipment installed at Dolby Cinema theaters operated by exhibitor partners, and we support the implementation of our technologies into products manufactured by our licensees.
Revenue Generation
We generate revenue from Dolby Cinema Products by selling and leasing products to exhibitors, excluding Dolby Cinemas, and offering PCS to exhibitors.
Dolby OptiView
Dolby OptiView is our proprietary content delivery system enabling immersive, interactive, and social experiences with real-time engagement for live events, such as live sports. Dolby OptiView comprises a number of products that work individually or together to optimize these experiences. Dolby OptiView is designed to provide a high-quality, synchronized viewer experience across the globe, with minimal delay – as low as sub-second. This enables our customers to engage viewers effectively with interaction tools that strengthen connections and drive participation. Dolby OptiView Ads is an advertisement delivery system that is designed to increase the impact of advertisements delivered with video services through just-in-time delivery, personalization, and customizable on-screen presentation. Dolby OptiView Ads integrates with advertising platforms like Google Ad Manager.
As the world of streaming audiovisual content continues to evolve, understanding and engaging viewers presents a challenge for content creators and distributors. We partner with our customers to innovate on the Dolby OptiView platform to increase audience engagement and deliver value to our enterprise customers.
Revenue Generation
Dolby OptiView is a software as a service (SaaS) product licensed directly to enterprises via a consumption-based revenue model.
SALES AND MARKETING
Our marketing efforts focus on cultivating strong relationships with consumers, creators and our partners in an effort to demonstrate how Dolby’s innovations in product and services transform entertainment experiences. We sell our solutions primarily using an internal sales organization to various customers in the markets where we operate. We also license our technologies and IP indirectly through patent pools, where owners of IP covering technology standards aggregate their patents and offer the pooled patents to implementers through patent pool licensing administrators who are responsible for the sales and marketing of the pooled patents. We maintain more than 20 sales offices in key regions around the globe.
9

Table of Contents

We promote our solutions and our brand through industry events such as tradeshows, film festivals, movie premieres, and product launches, as well as through our website, public relations, direct marketing, co-marketing programs, and social media. In addition, we hold the naming rights to the Dolby Theatre, home to the Academy Awards® in Hollywood, California, where we showcase our technology and host high-profile events. We also hold the naming rights to Dolby Live at the Park MGM in Las Vegas, Nevada. Dolby Live is a fully integrated performance venue offering live concerts in Dolby Atmos.
END MARKETS
We generated 93% of our revenues in fiscal 2026 by licensing technology, brand, and patents, primarily to device manufacturers. The following table presents the end market composition of revenue from our licensing business for all periods presented:

Fiscal Year Ended
MarketSeptember 25,
2026
September 26,
2025
September 27,
2024
Main Components of Each Category
Broadcast34%34%35%Televisions and STBs
Mobile21%22%20%Smartphones and Tablets
CE11%12%14%Digital Media Adapters ("DMAs"), Blu-ray Disc devices, AVRs, Soundbars, and Digital Versatile Disc ("DVDs")
PC11%12%12%Windows and macOS devices
Other23%20%19%Dolby Cinema, Gaming consoles, Automotive, Patent pool administrative fees, and VDP licensing revenue
Total100%100%100%
INTELLECTUAL PROPERTY
Our base of IP assets includes patents, trademarks, copyrights, and trade secrets developed based on our technical expertise.
As of September 25, 2026, we had approximately 32,000 issued and effective patents and approximately 7,000 pending patent applications in more than 200 jurisdictions throughout the world. In fiscal 2026, we were issued 2,805 new patents.
We pursue a general practice of filing patent applications for our technologies in the United States and foreign countries where our customers manufacture, distribute, or sell licensed products. We actively pursue new applications to expand our patent portfolio to address new technological innovations, and we also make strategic acquisitions of technology and patents from time to time. We have multiple patents covering aspects and improvements for many of our technologies.
Our issued patents expire at various times, ranging from 2026 through 2049. For a discussion of certain risks related to patent expiration, please refer to Part I, Item 1A “Risk Factors” in this annual report on Form 10-K, under the heading "Our revenue could decline if we are unable to maintain patent coverage for our technologies."
We have approximately 1,600 trademark registrations throughout the world for a variety of wordmarks, logos, and slogans. Our trademarks cover our various products, technologies, improvements, and features, as well as the services that we provide. These trademarks are an integral part of our technology licensing program as licensees typically place our branding on their products that incorporate our technologies to inform consumers that the products have met our quality specifications.
We protect our IP rights both domestically and internationally. From time to time, OEMs have failed to report or have underreported shipments of their products that incorporate our technologies. We anticipate that such issues will continue to occur. Accordingly, we have taken steps in the past to enforce our IP rights and expect to continue doing so in the future.
RESEARCH AND DEVELOPMENT
We conduct research and development activities at numerous locations in the United States ("U.S.") and internationally. Dolby’s history of innovation has resulted in many forms of IP. This IP generates licensing revenue that enables us to fund and pursue further innovation.
10

Table of Contents

Most of our research and development resources are focused on audio and video technologies for consumer entertainment. A significant portion of the research and development budget is dedicated to forward looking research because innovation is a core and critical function at Dolby. The goal of our research teams is to maintain leadership in all our current markets while simultaneously inventing new experiences. Our researchers work on every stage in the product development cycle because the end markets we serve are constantly evolving to take advantage of the latest innovations, and keeping our offerings on the cutting edge helps us keep our partnerships strong and productive.
PRODUCT MANUFACTURING
Our hardware product quality is enabled through the use of well-established, and in some cases, highly automated, assembly processes along with rigorous testing of our products. We rely primarily upon contract manufacturers for the majority of our production capacity. We purchase components and fabricated parts from multiple suppliers; however, we rely on sole source suppliers for certain components used to manufacture our products. We source components and fabricated parts both domestically and internationally.
COMPETITION
The entertainment industry is highly competitive, and we face aggressive competition in all areas of our business. Some of our current and future competitors may have significantly greater financial, technical, marketing, and other resources than we do, or may have more experience or advantages in the markets in which they compete. In addition, some of our current or potential competitors may be able to offer integrated systems in certain markets for entertainment technologies, including audio and imaging, which could make competing technologies that we develop or acquire obsolete. By offering an integrated system solution, these potential competitors may also be able to offer competing technologies at lower prices than we can, which could adversely affect our operating results.
Many end products that include our audio and video technologies also include technologies developed by our competitors. We believe that the principal competitive factors in our markets include some or all of the following:
•Degree of access and inclusion in industry standards;
•Technological performance, flexibility, and range of application;
•Brand recognition and reputation;
•Timeliness and relevance of new product introductions;
•Quality and reliability of products and services;
•Relationships with producers, directors, and distributors in the film and television industry, with television broadcast industry leaders, with Over-The-Top ("OTT") industry leaders, and with the management of semiconductor and Consumer Electronics ("CE") OEMs;
•Availability of compatible high quality audio and video content; and
•Price.
Certain foreign governments and industry participants have advanced arguments under competition laws that exert downward pressure on royalties for IP, which can impact the licensing fees that we are able to collect. The regulatory enforcement activities in such jurisdictions can be unpredictable.
Our technologies, products, and services span the audio and imaging sectors of several distinct and diverse industries, including the broadcast, mobile, consumer entertainment, Personal Computer ("PC"), gaming, automotive, cinema, and other industries. The lack of a clear definition of the markets in which our products, services, and technologies are sold or licensed, the nature of our technologies, their potential use for various commercial applications, and the diverse nature of and lack of detailed reporting by our competitors, make it impracticable to quantify our position.
HUMAN CAPITAL
At Dolby, we strive to act as a good partner to our customers, employees, shareholders, and communities. We are committed to fostering a workplace environment in which every employee can contribute their fullest potential and make a positive impact through their roles.
11

Table of Contents

Details of this work, along with our sustainability, social impact, employee wellbeing, and inclusion and belonging initiatives, are included in our Sustainability Report, and we encourage you to read it on our website to learn more. Nothing in our Sustainability Report shall be deemed incorporated by reference into this Annual Report on Form 10-K.
As of September 25, 2026, we had approximately 2,000 employees worldwide, of whom approximately 1,000 were based outside of the U.S. None of our employees are represented by a labor union, except to the extent certain employees outside the United States are represented by national trade unions or local works councils. We have not experienced any work stoppages, and we believe that our employee relations are strong.
Compensation and Benefits
We offer competitive compensation (including salary, incentive bonus, and equity) and benefits packages in each of our locations around the globe. In addition to comprehensive health benefits and the Employee Stock Purchase Plan ("ESPP"), depending on the location, employees may also enjoy free or subsidized fitness programs, commuter benefits, wellness credits, tuition reimbursement opportunities, and personal development courses, among other benefits.
Board Oversight of Human Capital Management
Through our Compensation Committee, our Board of Directors provides oversight of human capital matters. Our Nominating and Governance Committee works with the Board of Directors on management succession planning. The Board and Board committees are supported in these efforts by our management team and People, Legal and Compliance teams.
CORPORATE AND AVAILABLE INFORMATION
We were founded in London, England in 1965 and incorporated in the State of New York in 1967. We reincorporated in California in 1976 and reincorporated in Delaware in September 2004. Our principal corporate offices are located at 1275 Market Street, San Francisco, California 94103. Our telephone number is (415) 558-0200.
Our website is www.dolby.com. We make available on our website our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and any amendments to those reports, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the U.S. Securities and Exchange Commission ("SEC"). Our SEC reports can be accessed through the Investor Relations section of our website at www.investor.dolby.com. The information found on our website is not part of this or any other report we file with or furnish to the SEC. The SEC also maintains a website that contains our SEC filings at www.sec.gov.
12

Table of Contents

ITEM 1A. RISK FACTORS
The following risk factors and other information included in this Annual Report on Form 10-K should be carefully considered. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not currently known to us or that we currently deem less significant may also affect our business operations or financial results. If any of the following risks actually occur, our stock price, business, operating results and financial condition could be materially adversely affected.
REVENUE GENERATION
Markets We Target
Changing trends in content distribution and consumption may negatively impact our business. Changing trends in the way that content is distributed and consumed may impact our existing business and future opportunities for growth. One such trend has been the shift by consumers in certain markets away from subscription-based cable and satellite television providers toward streaming services, commonly referred to as "cord-cutting." While cable and satellite television often require a STB, consumers can also access streaming media through smart TVs or DMA devices. As consumers have trended toward canceling subscriptions to traditional cable and satellite providers in favor of streaming media, we have observed declines in demand for STBs in certain regions. While we adjust our strategy and offerings to respond to and anticipate changes to the way content is distributed and consumed, such as licensing our technology to streaming content providers, those efforts may not be successful and our licensing and other businesses may be impacted.
The mobile device market is concentrated and susceptible to competition and rapid change, which may negatively affect our penetration and pricing in that market. Successful penetration of the mobile device market is important to our future growth. The mobile device market, particularly smartphones and tablets, is characterized by rapidly changing market conditions, frequent product introductions and intense competition based on features and price. Our technologies usually are not mandated as an industry standard for mobile devices. We must continually convince mobile device OEMs and end users of mobile devices of the value of our technologies. With shorter product lifecycles, it is easier for mobile device OEMs to add or remove our technologies from mobile devices than it is for TV OEMs and other hardware OEMs. In addition, because the mobile industry is concentrated, we rely on a small number of partnerships with key participants in the mobile market. If we are unable to maintain these key relationships, we may experience a decline in mobile devices incorporating our technologies.
In order to increase the value of our technologies in the mobile market and increase OEM and software vendor demand for our decoding technologies, we have worked with online and mobile media content service providers to encode their content with our technologies. However, the online and mobile media content services markets are also characterized by intense competition, evolving industry standards and business and distribution models, disruptive software and hardware technology developments, frequent product and service introductions and short life cycles, and price sensitivity on the part of consumers, all of which may result in downward pressure on pricing or the removal of our technologies by these providers and may result in decreased revenue from our mobile market. Further, macroeconomic conditions such as inflation, trade barriers, international conflicts and geopolitical instability, global health risks, and other factors may adversely impact the ability of our partners to manufacture and distribute mobile devices and consumer demand for mobile devices.
Our revenue from the PC market is reliant on key partnerships and is vulnerable to macroeconomic risks. Our revenue from the PC market depends on several factors, including underlying PC unit shipments, the extent to which our technologies are included on computers, including through operating systems and various subsystems, and the terms of any royalties or other payments we receive. To the extent that PC manufacturers do not incorporate our technologies in current and future products, our revenue could be impacted. Further, we rely on a small number of partnerships with key participants in the PC market. If we are unable to maintain these key relationships, we may experience a decline in PCs incorporating our technologies. Demand for PCs has also fluctuated significantly in recent years. Macroeconomic conditions may also adversely impact PC manufacturing, supply chain and distribution, the timing of the adoption of our technologies into products by partners and licensees, and the timing of launches for new products.
The success of Dolby Cinema and cinema product sales are subject to a number of factors beyond our control, such as the production of films in Dolby formats and broader cinema industry conditions. Revenue from Dolby Cinema and cinema product sales is subject to our ability to develop and implement new technologies, the pace of construction or upgrade of screens, the financial stability of exhibitors, the advent of new or competing technologies, and the willingness of movie studios to produce films in our Dolby Atmos and Dolby Vision formats. Although we have
13

Table of Contents

invested a substantial amount of time and resources developing Dolby Cinema, and expect to continue to invest and build partnerships in connection with the launch of Dolby Cinema locations, we may not continue to recognize a meaningful amount of revenue from these efforts in the near future. Additionally, we collaborate with multiple exhibitors in foreign markets, including Asia, Europe, and the Middle East, and we may face a number of risks in expanding Dolby Cinema in these and other new international markets. The revenue we receive from Dolby Cinema exhibitors is based on a portion of box-office receipts from the installed theaters, and the timing of such theater installations is dependent upon a number of factors beyond our control. In addition, the success of our Dolby Cinema offering will be tied to the pipeline and success of motion pictures available at Dolby Cinema locations generally. The success of Dolby Cinema and cinema products depends in large part on our ability to differentiate our offering, deploy new sites and installations in accordance with plans, provide a compelling experience, and attract and retain a viewing audience. A decrease in our ability to develop and introduce new cinema products and services successfully could affect licensing of our consumer technologies, because the strength of our brand and our ability to leverage professional product developments to introduce new consumer technologies could be negatively impacted. To the extent that we do not make progress in these areas or are faced with pricing pressures or competing technologies, our revenue may be adversely impacted.
Our revenue and associated demand for Dolby Cinema and cinema products are affected by cinema industry and macroeconomic conditions, which are subject to risks including consumer trends and box office performance in general, delays in cinematic releases, the seasonality of film releases and associated moviegoing attendance, discretionary consumer spending, and other events or conditions in the cinema industry. For example, restrictions related to the COVID-19 pandemic and certain entertainment industry labor strikes resulted in reduced cinema attendance and box office receipts in the past. Such disruptions impacted, and potential similar disruptions in the future could potentially impact, revenue generated by Dolby Cinema theaters and exhibitors’ willingness and ability to invest in Dolby Cinema and cinema products. Consolidation among the major motion picture studios may impact the number of films released theatrically and could impart volatility into the timing and number of ticket sales. The trend towards shorter theatrical release windows may also impact ticket sales. Additionally, a portion of our opportunity lies in the China market, which is subject to unique economic and geopolitical risks, including risks posed by tariffs and other trade barriers. Furthermore, future growth of our cinema products offerings also depends upon new theater construction and entering into an equipment replacement cycle whereby previously purchased cinema products are upgraded or replaced. To the extent that such cinema industry and macroeconomic challenges constrain the growth of our Dolby Cinema and cinema products offerings, our revenue may be adversely impacted.
Customers
Our licensing business depends on the incorporation of our technologies into products and the sales of such products, which are, in large part, not within our control. Our licensing businesses depend on OEMs and other licensees to incorporate our technologies into their products. Our license agreements are typically non-exclusive, and frequently do not mandate use of our technologies. Additionally, a small number of our licensees or other customers may represent a significant percentage of our licensing, products, or services revenue. Customer demand for our technologies and products can shift quickly as many of our markets are rapidly evolving. In consumer electronic device markets, our technologies are not mandated and are subject to significant competition, so there is a risk that a large consumer electronic device licensee may reduce or eliminate its use of our technologies. Our revenue will decline if our licensees choose not to incorporate our technologies into their products or if they sell fewer products incorporating our technologies.
Our licensing business depends, in part, on semiconductor manufacturers and the availability of semiconductor components. Our licensing revenue from OEM system licensees depends in large part upon the availability of ICs that implement our technologies. IC manufacturers incorporate our technologies into these ICs, which are then incorporated in consumer entertainment products. We do not manufacture these ICs, but rather depend on IC manufacturers to develop, produce, and then sell them to system licensees in accordance with their agreements. We do not control the IC manufacturers’ decisions on whether or not to incorporate our technologies into their ICs, and we do not control their product development or commercialization efforts. More generally, demand levels and supply chain issues may result in shortages of semiconductor components and other key materials for IC production. Notably, the rapid expansion of data center and artificial intelligence infrastructure has placed pressure on global semiconductor and memory supply chains, leading to tighter capacity allocation, higher costs, and periodic availability constraints for certain electronic components, which has impacted the end markets we serve. Further, the IC manufacturing industry is geographically concentrated and thus can be particularly sensitive to regional and macroeconomic developments that create impediments to IC production. Obstacles to IC production and delivery may adversely impact the ability of our implementation and system licensees and other customers to meet product
14

Table of Contents

demand in a timely fashion and lead to other negative impacts for the technology industry, which is in large part dependent on the continued supply of ICs.
Consumer spending weakness may impact our licensees and licensing revenue generally. Our business consists, in large part, of licensing technology and IP into consumer electronic device markets and, as such, is subject to macroeconomic factors impacting those markets. Weakness in general economic conditions due to inflation, elevated interest rates, lower consumer confidence, tariffs and non-tariff trade barriers, a potential recession, pandemic or other adverse economic conditions and related uncertainty, may suppress consumer demand in our end markets and consumers going to the movies. Many of the products in which our technologies are incorporated are discretionary goods, such as PCs, TVs, STBs, video game consoles, AV Receivers, mobile devices, in-car entertainment systems, and home-theater systems, which makes revenue generated by such technologies vulnerable to weakness in consumer spending. Prolonged weakness in consumer spending may also lead to licensees and other customers becoming delinquent on their obligations to us or being unable to pay, resulting in a higher level of write-offs. Weakness in consumer spending may also increase underreporting and non-reporting of royalty-bearing revenue by our licensees as well as increase the unauthorized use of our technologies.
If we fail to promote and maintain the Dolby brand, our business will suffer. Maintaining and strengthening the Dolby brand is critical to maintaining and expanding our licensing, products, and services business, as well as our ability to offer technologies for new markets. Our continued success depends on our reputation for providing high quality technologies, products, and services across a wide range of entertainment markets, including the consumer electronics, PC, broadcast, and gaming markets. If we fail to promote and maintain the Dolby brand successfully in licensing, products or services, our business will suffer. Furthermore, we believe that the strength of our brand may affect the likelihood that our technologies are adopted as industry standards in various markets and for various applications. Our ability to maintain and strengthen our brand will depend heavily on our ability to develop innovative technologies for the entertainment industry, to enter into new markets successfully, and to provide high quality products and services in these new markets. In addition, our practices and public disclosures related to environmental, social and governance (ESG) matters could impact our brand and reputation. If our ESG practices do not meet evolving investor or other stakeholder expectations and societal and regulatory standards, or if we are unable to make progress on or achieve our goals and objectives in this area, then our reputation, our ability to attract or retain employees, and our attractiveness as an investment or business partner could be negatively impacted, which could adversely affect our operating results.
Technology Standards
Certain parts of our business are dependent on the inclusion of our technologies in technology standards, the adoption and development of which are not fully within our control. Standards-setting organizations establish technology standards for use in a wide range of products and solutions. The entertainment industry in particular has historically depended upon technology standards to ensure compatibility and interoperability across delivery platforms and a wide variety of consumer entertainment products. We make significant efforts to design our products and technologies to address capability, quality, and cost considerations so that they either meet or, more importantly, are adopted as industry standards across the broad range of entertainment industry markets in which we participate, as well as the markets in which we plan to compete in the future. We are also active in standards development where many contributing members work together to come up with next-generation technology standards in media, entertainment, and communications technologies. Nonetheless, it can be difficult to have our technologies and products adopted as technology standards. To do so, we must convince a broad spectrum of standards-setting organizations throughout the world, as well as our major customers and licensees who are members of such organizations, to adopt them as such. Multiple companies, including ones that typically compete against one another, are involved in the development of new technology standards for use in consumer products. Furthermore, some standards-setting organizations choose to adopt a set of optional standards or a combination of mandatory and optional standards; in such cases, our technologies may be adopted only as an optional standard and not a mandatory standard. Standards may also change in ways that are unfavorable to Dolby.
The market for broadcast technologies in particular has traditionally been heavily based on technology standards, in some cases mandated by governments choosing from among alternative standards. The continued advancement of OTT media delivery and consumption is altering the landscape for broadcast standards. The importance of broadcast standards in the entertainment technology ecosystem has been gradually diminishing over the recent years. This trend is reducing the importance of the inclusion of our technology in certain broadcast standards while increasing the importance of inclusion within internet and mobile technology standards. We cannot predict the extent to which this trend may impact our revenue.
15

Table of Contents

Participants may choose alternative technologies within standards. Even when a standards-setting organization incorporates our technologies in a technology standard for a particular market or geographic region, our technologies may not be the sole technologies adopted for that market. Furthermore, different standards may be adopted within a single market or region, and across different markets and regions. Our operating results depend upon participants in that market choosing to adopt our technologies instead of competitive technologies that also may be acceptable under such standard. For example, the continued growth of our revenue from the mobile device market will depend, in part, upon both the continued global adoption of the 3GPP telecommunications standards by the market generally and the choice to use the media codec standards in which we participate such as Extended HE-AAC, where they are one of several accepted industry standards.
Being part of a standard may limit our licensing practices. When a standards-setting organization mandates our technologies, we generally must agree to license such technologies on a fair, reasonable, and non-discriminatory basis, which could limit our control over the use of these technologies. In these situations, we must often limit the royalty rates we charge for these technologies, and we may be unable to limit to whom we license such technologies or to restrict many terms of the license. We have in the past, and may in the future, be subject to claims that our licensing of industry standard technologies may not conform to the requirements of the standards-setting organization. Allegations such as these could be asserted in private actions seeking monetary damages and injunctive relief, or in regulatory actions. Claimants in such cases could seek to restrict or change our licensing practices or our ability to license our technologies. Additionally, where our technologies are incorporated into a standard, our licensing practices may become subject to additional regulatory requirements.
Royalty Reporting
Reporting practices and uncertainty may result in fluctuations in our royalty revenue from period to period. We recognize a material portion of our licensing revenue based on our estimate of sales of royalty-bearing products. Upon receipt of actual reporting of sales-based royalties, we record a favorable or unfavorable adjustment based on the difference, if any, between estimated and actual sales. Our sales estimates may be based on reports or studies from third parties that may turn out to be inaccurate or incomplete, and that risk may increase when macroeconomic conditions are highly dynamic, which could result in significant variation in the amount of revenue we recognize in a quarter. Additionally, from time to time we reach agreements for retroactive royalties that cover extended periods in the past, such as when an audit of a licensee identifies under‑reporting of royalties or where we have reached a settlement relating to past unlicensed use of our technologies. In certain cases, applicable accounting standards require us to recognize all or a substantial portion of such retroactive royalties as revenue in the period in which the audit or settlement is resolved, which could cause our results of operations to vary materially from quarter to quarter and cause volatility in the price of our Class A common stock.
Royalty reporting by our licensees may be inaccurate or understated. We generate licensing revenue primarily from OEMs who license our technologies and incorporate those technologies into their products. Our license agreements generally obligate our licensees to pay us a specified royalty for every product they ship that incorporates our technologies, and we rely on our licensees to report their shipments accurately. However, it is inherently difficult to independently determine whether our licensees are reporting shipments accurately, particularly with respect to software incorporating our technologies because unauthorized copies of such software can be made relatively easily. A licensee may disagree with our interpretation of the terms of a license agreement or, as a result of an audit, a licensee could challenge the accuracy of our calculation. We are regularly involved in discussions with licensees regarding license terms. Most of our license agreements permit us to audit our licensees’ records, and we routinely exercise these rights, typically by using an independent third party auditor. Such audits are generally expensive, time-consuming, and potentially detrimental to our ongoing business relationships with our licensees. In the past, some licensees have understated or failed to report the number of products incorporating our technologies that they shipped, and we have not been able to collect and recognize revenue to which we were entitled. We expect that we will continue to experience understatement and non-reporting of royalties by our licensees. We have been able to obtain certain recovery payments from licensees (either in the form of back payments or settlements), and such recoveries have become a recurring element of our business; however, we are unable to predict with certainty the revenue that we may recover in the future or our ability to continue to obtain such recoveries at all.
The amount of royalties we owe others may be disputed. In some cases, the products we sell and the technologies we license include IP that we have licensed from third parties. Our agreements with these third parties generally require us to pay them royalties for that use, and to give the third parties the right to audit our calculation of those royalties. A third party may disagree with our interpretation of the terms of a license agreement or, as a result of an audit, a third party could challenge the accuracy of our calculation. A successful challenge by a third party could result in the termination of a license agreement or an increase in the amount of royalties we have to pay to the third
16

Table of Contents

party.
TECHNOLOGY TRENDS AND DEVELOPMENTS
Developing new and enhanced technologies is inherently difficult and our revenue growth may be impacted if we are unsuccessful in our efforts. Our revenue growth will depend upon our success in new and existing markets for our technologies, such as digital broadcast, mobile devices, online and mobile media distribution, cinema, and cloud services. The markets for our technologies and products are influenced by: 
•Rapid technological change;
•New and improved technology and frequent product introductions;
•Evolving consumer and licensee expectations with respect to features and capabilities;
•Evolving industry standards; and
•Technology and product obsolescence.
Our future success depends on our ability to enhance our technologies and products and to develop new technologies and products that address market needs in a timely manner, including the development of technologies and products that incorporate rapidly developing generative artificial intelligence and other artificial intelligence and machine learning technologies ("AI/ML"). Our use of AI/ML technologies in the technology development process is dependent, in part, on foundation models that are developed and provided by other companies. As a result, such models may not continue to be well-suited to our needs or to be available to us on commercially reasonable terms. Technology development is a complex, uncertain process requiring high levels of innovation, highly-skilled engineering and development personnel, and the accurate anticipation of technological and market trends. We may not be able to identify, develop, acquire, market, or support new or enhanced technologies or products on a timely basis, if at all. If we are unable to develop technologies and related intellectual property that are accepted into technology standards, or are unable to do so at the same rate as other technology developers, our royalty share within patent pools that we participate in may decline.
Our efforts to expand into new markets may not be successful. Our future growth will depend, in part, upon our continued expansion into areas beyond our established lines of business. As we enter into new markets, such as licensing our technology to streaming content providers, we will face new sources of competition, new business models, and new customer relationships. In order to be successful in these markets, we will need to cultivate new industry relationships and strengthen existing relationships to bring our products, services, and technologies to market. Our limited experience in new markets could limit our ability to successfully execute on our growth strategy.
The success of our existing products and newer initiatives is dependent on the use of Dolby formats in, and commercial success of, products and content. The success of many of our initiatives, such as Dolby Atmos, Dolby Vision, and Dolby Cinema, is dependent upon the availability and success of (i) products that incorporate Dolby formats and (ii) content produced in Dolby formats. However, there is no guarantee that device makers will continue to incorporate Dolby formats into their products, that content creators will continue to release content in Dolby formats, or that either those products or that content will be commercially successful.
For instance, to broaden adoption of Dolby Vision and Dolby Atmos, we will need to continue to expand the array of products and consumer devices that incorporate Dolby Atmos and Dolby Vision, expand the pipeline of Dolby Atmos and Dolby Vision content available from content creators, and encourage consumer adoption in the face of competing products and technologies. Similarly, the success of Dolby Cinema and cinema products is dependent on our ability to partner with movie theater exhibitors to launch new Dolby Cinema locations and screens using our cinema products and to deploy new sites in accordance with plans, and on the continued release and box-office success of new films in the Dolby Vision and Dolby Atmos formats.
Further, the commercial success of products incorporating Dolby formats, content released in Dolby formats, and Dolby Cinemas generally, depends upon a number of factors outside of our control, including, but not limited to, consumer preferences, critical reception, timing of release, marketing efforts of third parties, and general market conditions. Moreover, release and distribution of such products and content can be subject to delays in production or changes in release schedule, which can negatively impact the quantity, timing and quality of such products and content released in Dolby formats and available at Dolby Cinema theaters.
17

Table of Contents

INTELLECTUAL PROPERTY
Our business is dependent on protecting our intellectual property rights. Our business is dependent upon protecting our patents, trademarks, trade secrets, copyrights, and other IP rights, the loss or expiration of which may significantly impact our results of operations and financial condition. Effective IP rights protection, however, may not be available under the laws of every country in which our products and those of our licensees are distributed. The efforts we have taken to protect our proprietary rights may not be sufficient or effective. We also seek to maintain select IP as trade secrets, and third parties or our employees could intentionally or accidentally compromise the IP that we maintain as trade secrets. In addition, protecting our IP rights is costly and time consuming. We have taken steps in the past to enforce our IP rights and expect to do so in the future. However, it may not be practicable or cost effective for us to enforce our IP rights fully, particularly in some countries or where the initiation of a claim might harm our business relationships.
We seek patent protection for many of our innovations. However, our patent program faces a number of challenges, including:
•Possibility that innovations may not be protectable;
•Failure to protect innovations that later turn out to be important;
•Insufficient patent protection to prevent third parties from designing around our patent claims;
•Our pending patent applications may not be approved;
•Possibility that an issued patent may later be found to be invalid or unenforceable; and
•Patents eventually expire.
Our revenue could decline if we are unable to maintain patent coverage for our technologies. Many of the technologies that we license to our system licensees are covered by patents, and the licensing revenue that we receive from those licenses depends in part upon the life of such patents. In general, our agreements with our licensees require them to pay us a full royalty with respect to a particular technology only until there are no patents or, in some cases, no patent applications covering that technology in countries where applicable products are made and sold. As of September 25, 2026, we had approximately 32,000 issued patents in addition to approximately 7,000 pending patent applications in more than 200 jurisdictions throughout the world. Our currently issued patents expire at various times ranging from 2026 through 2049. If we are unable to refresh our technology with new patented inventions or expand our patent portfolio, our revenue could decline. In addition to patents covering technology we license directly, if patents we license through patent pool arrangements expire or we are otherwise unable to maintain our share of pool royalties, then our revenue could be impacted. Additionally, if the patents licensed through a patent pool arrangement are deemed not to be valuable in the aggregate by the licensees of such patent pool, they may not renew their licenses, which could impact our revenue.
We seek to mitigate this risk in a variety of ways. We regularly look for opportunities to expand our patent portfolio through organic development and acquisitions. We develop technologies to replace licensing revenue from technologies covered by expiring patents with licensing revenue supported by patents with a longer remaining life. And we develop and license our intellectual property in a manner designed to promote the continued use and licensing of our technology. The continued success of these risk mitigation strategies is not guaranteed, including the risk that such technologies will not achieve widespread adoption or be licensed at a rate sufficient to replace licensing revenue from technologies covered by expiring patents.
In the case of our patent coverage related to Dolby Digital ("DD") and DD+ audio codec technologies, some of our relevant patents have expired and will expire in the coming years, but others will continue to apply. We have continued to innovate and develop IP to support these standardized technologies and their various implementations, including generating patents associated with different or new features of the technologies and obtaining patents that generally expire later than those incorporated into the original standards. Our customers use our DD and DD+ implementation for quality, reliability, and performance and to take advantage of other elements of these offerings such as Dolby branding, even in locations where we have not had or no longer have applicable patent coverage. Nevertheless, revenue attributed to DD and DD+ technologies has declined and is expected to continue to decline due, in part, to expiration of relevant patents. Many of our partners have adopted newer generations of our offerings such as Dolby AC-4 technologies, the associated patents of which generally expire later than those associated with DD and DD+. We will continue to work to transition our DD and DD+ licensees to our newer technologies, but the success of such efforts is not guaranteed.
18

Table of Contents

Some of our patents incorporated into the AAC audio coding standard and the AVC digital video coding standard, from which we derive a significant portion of our licensing revenue, have expired and others will expire over the next several years. While there are alternative versions of these standards that offer different features and that incorporate patents that have later expirations, licensees may see less value in those alternative versions, resulting in a decrease in royalty revenue. A decrease in royalty revenue may also result in decreased revenue from patent pool administration fees. Our patents are incorporated into newer coding standards that represent successive generations of technology, such as, in the case of AAC, Extended HE-AAC and, in the case of AVC, HEVC whose patents generally expire later than the AAC and AVC patents and to which many of the AAC and AVC licensees have, are in the process of, or may in the future transition. However it is not certain that all or most licensees will transition to such newer technologies.
Unauthorized use of our intellectual property has occurred and will likely continue to occur. We have often experienced, and expect to continue to experience, problems with non-licensee OEMs and software vendors, particularly in certain emerging economies, incorporating our technologies and trademarks into their products without authorization and without paying licensing fees. Unauthorized IP use occurs in the context of both branded products and technology offered through open standards. Manufacturers of ICs containing our technologies occasionally sell these ICs to third parties who are not our system licensees. These sales, and the failure of such manufacturers to report the sales, facilitate the unauthorized use of our IP. As emerging economies have transitioned from analog to digital content, such as the transition from analog to digital broadcast, we have observed an increase in problems with this form of piracy.
Our business may be negatively impacted by intellectual property litigation. Companies in the technology and entertainment industries frequently engage in litigation based on allegations of infringement or other violations of IP rights. We have faced such claims in the past, and we expect to face similar claims in the future. The use of AI/ML technologies in our products and business operations may increase the risk that third-party intellectual property is inadvertently incorporated into our products or used within the company, which could result in infringement claims or other adverse actions. Any IP claims, with or without merit, could be time-consuming, expensive to litigate or settle, and could divert management resources and attention. In the past, we have settled claims relating to infringement allegations and agreed to make payments in connection with such settlements. An adverse determination in any IP claim could require that we pay damages or stop using technologies found to be in violation of a third party’s rights and could prevent us from offering our products and services to others. In order to avoid these restrictions, we may have to seek a license for the technology, which may not be available on reasonable terms or at all. Licensors could also require us to pay significant royalties. As a result, we may be required to develop alternative non-infringing technologies, which could require significant effort and expense. If we cannot license or develop technologies for any aspects of our business found to be infringing, we may be forced to limit our product and service offerings and may be unable to compete effectively.
In some instances, we have contractually agreed to provide indemnifications to licensees relating to our IP. Additionally, at times, when it is in our interests, we have chosen to defend our licensees from third party IP infringement claims even where such defense was not contractually required, and we may choose to take on such defense in the future.
Our business may be negatively impacted by disputes involving the licensing of our IP. At times, we are engaged in disputes regarding the licensing of our IP rights, including matters related to our royalty rates, whether products are royalty-bearing, and other terms of our licensing arrangements. These types of disputes can be asserted by our customers or prospective customers or by other third parties as part of negotiations with us or in private actions seeking monetary damages or injunctive relief, or in regulatory actions. In the past, licensees have threatened to initiate litigation against us based on potential antitrust claims or regarding our licensing royalty rate practices. Damages and requests for injunctive relief asserted in claims like these could be significant, and could be disruptive to our business.
Maintaining and enforcing our IP rights in the U.S. and abroad presents challenges to our business. Our licensing business depends in part on the uniform and consistent treatment of patent rights in the U.S. and abroad. Changes to the patent and intellectual property laws and regulations in the U.S. and abroad may limit our ability to obtain, license, and enforce our rights. Additionally, court and administrative rulings may interpret existing patent laws and regulations in ways that hurt our ability to obtain, license, and enforce our patents. We face challenges protecting our IP in foreign jurisdictions, including that our ability to enforce our contractual and IP rights, especially in countries that do not recognize and enforce IP rights to the same extent as the U.S., Japan, Korea, and European countries do, which increases the risk of unauthorized use of our technologies. Also, because of limitations in the legal systems in
19

Table of Contents

many countries, our ability to obtain and enforce patents in many countries is uncertain, and we must strengthen and develop relationships with entertainment industry participants worldwide to increase our ability to enforce our IP and contractual rights without relying solely on the legal systems in the countries in which we operate.
OPERATIONS
Production processes for our products and reliance on key suppliers present certain risks to our business, many of which are beyond our control. We rely on contract manufacturers to manufacture our products and such reliance involves risks, including limited control over timely delivery and quality of such products. We may be unable to quickly adapt manufacturing capacity to rapidly changing market conditions, such as fluctuations in customer demand. Supply chain disruptions, production interruptions, and shortages of manufacturing capacity could each lead to an inability to manufacture and deliver our products on a timely basis, which could negatively impact our operating results and damage our customer relationships.
Our reliance on suppliers for some of the key materials and components we use in manufacturing our products involves risks, including limited control over the price, timely delivery, and quality of such components, and supply chain interruptions resulting from military conflict, trade controls, and other geopolitical developments. Due to the relatively small volume of components we purchase for use in manufacturing, we purchase such components primarily through distributors. As such, we have relatively limited influence over the suppliers of such components to, for example, ensure continuity of supply. Although we have identified alternate suppliers for most of our key materials and components, any required changes in our suppliers could cause delays in our operations and increase our production costs. In addition, our suppliers may not be able to meet our production demands as to volume, quality, or timeliness. Our ability to source materials and components is also subject to risks from supply chain disruptions due to global shortages, such as those that impact the pricing and availability of memory components and ICs. Avoiding the potential inclusion of “conflict minerals” in the materials used in our products could also affect the sourcing, availability and pricing of such materials as well as the companies we use to manufacture our products.
Due to the bespoke nature of some of the components and products we purchase and relatively low quantities needed, sourcing multiple suppliers for every item we purchase is not practicable. Some of the components that we use to manufacture our products are sole-sourced. Also, the projectors offered as part of our cinema offerings are provided by a single supplier. These sole source suppliers may become unable or unwilling to deliver their products to us at an acceptable cost or at all, which could force us to redesign certain products or locate alternative suppliers. Our inability to obtain timely delivery of key components or projectors of acceptable quality, any significant increases in the prices of such products, or the redesign of our products could result in production delays, increased costs, and reductions in shipments of our offerings.
Ensuring the quality of our products and the products in which our technology is incorporated is inherently difficult, and product quality failures can be costly. While we conduct security testing prior to releasing new products or new versions of existing products, there are sometimes errors or vulnerabilities that are not detected during development or testing. We have limited control over manufacturing performed by contract manufacturers, which could result in quality problems. Furthermore, our products and technologies are sometimes combined with or incorporated into products from other vendors, sometimes making it difficult to identify the source of a problem or, in certain instances, making the quality of our implementation dependent in part upon the quality of such other vendors' products. While we have processes to remediate errors and vulnerabilities, we cannot guarantee that we will detect all issues or develop successful patches. If our products or technologies contain errors, we could be required to replace or reengineer them and, as with security vulnerabilities, we may rely upon parties who have incorporated our technologies into their products to implement updates to address such issues, which could leave any such errors or vulnerabilities unresolved. As an example of these types of risks, in October 2025, a team of security researchers announced a vulnerability related to a specific Dolby software module. We have developed a corrective software patch and made the patch, as well as other assistance, available to potentially impacted partners. While many of our partners have deployed the patch across their devices, the application of the patch across all affected devices will require the effort of our partners and, in some cases, the end users and other third parties, which we cannot guarantee. While there are technical impediments to exploiting unpatched devices, we cannot guarantee that malicious actors will not exploit unpatched vulnerabilities and damage or gain unauthorized access to affected products. Negative publicity or impact related to errors or vulnerabilities could affect the perception of our brand and market acceptance of our products or technologies. Moreover, if any errors or vulnerabilities cause unintended consequences, we could incur substantial costs in investigating and remediating those consequences, including defending and settling product liability claims. Although we generally attempt to contractually limit our liability, if these contract provisions are not enforced, or are unenforceable for any reason, or if liabilities arise that are not effectively
20

Table of Contents

limited, we could incur substantial costs in defending and settling product liability claims.
We face threats to the confidentiality, integrity, and availability of our information systems, which could result in disruption of our business, reputational damage, legal exposure, and financial losses. The number and sophistication of cyber attacks and disruptions that companies have experienced has increased in recent years, including computer viruses, malware, ransomware, cyber extortion, social engineering, denial of service, supply chain attacks, and other similar attacks and disruptions, often perpetrated by nation-states or sophisticated cyber criminals. These risks could be elevated in connection with geopolitical conflicts. Measures we have undertaken to protect our information systems may be unsuccessful in deterring or repelling malicious actors, many of whom are highly sophisticated and well-funded. Since techniques used by malicious actors to access or sabotage networks and computer systems, including the use of rapidly evolving AI/ML technology, change frequently and often are not recognized until after they are used, we may be unable to anticipate or immediately detect these techniques. This could delay our detection and response, or impede the effectiveness of our response, our operations and ability to limit our exposure to third party claims and other potential liability. Attacks on our systems have occurred in the past and may occur, and be successful, in the future. Such risks are also faced by our third party service providers and others, which forms another vector for malicious attacks on our systems and on information of ours stored on our vendors' networks and systems.
We also may suffer data security breaches and the unauthorized access to, misuse or acquisition of, our proprietary business information, personal data, trade secrets or other sensitive and confidential information as the result of intentional or inadvertent breaches or other compromises of our systems, including by our employees or service providers. We rely on information technology systems designed and managed by third parties and sensitive information could potentially be misappropriated by third party service providers or others who may inappropriately access or exfiltrate that information from a third party service provider's system. Increased use of AI/ML technologies and programs by our employees and service providers presents another potential vector for inadvertent disclosure or misappropriation of our sensitive information. Any data security breach or other incident, whether external or internal in origin, could compromise our networks and systems, create system disruptions or slowdowns and exploit security vulnerabilities of our products. Disruptions to our information technology systems, whether due to security breaches, network outages, or other causes, could also disrupt our work and ability to communicate. Furthermore, a data security breach or other incident can result in the information stored on our networks and systems, or our vendors' networks and systems, being improperly accessed or acquired, publicly disclosed, lost, stolen, modified, made unavailable, or otherwise processed without authorization. Any such breach or other incident, or the perception any has occurred, could subject us to demands, litigation, and liability to our customers, suppliers, business partners and others, as well as regulatory investigations and other proceedings, fines, penalties, and other liabilities, and brand and reputational damage. We make efforts to detect and investigate such attempts and incidents and to prevent their recurrence where practicable through changes to our internal processes and tools, but in some cases preventive and remedial action might not be sufficient or successful.
We must comply with a variety of data privacy regulations. Compliance with such regulations can be costly and failure to comply may affect our operations, financial performance, and business. A variety of provincial, state, national, and international laws and regulations apply to the collection, use, retention, protection, disclosure, transfer and other processing of personal data. These laws and regulations are evolving, including with respect to the development and use of AI/ML technologies, and may result in ever-increasing obligations and regulatory and public scrutiny and escalating levels of enforcement and sanctions. For example, the California Privacy Rights Act (CPRA), as well as obligations under other recently-enacted and forthcoming privacy laws, including those in other states, may require us to further modify certain of our information practices and could subject us to additional compliance costs and expenses. Our actual or perceived failure to adequately comply with applicable laws and regulations relating to privacy and data protection (including regimes such as the California Consumer Privacy Act, as amended and supplemented by the CPRA, and continuing developments in the European Union, United Kingdom ("U.K."), and U.S. data privacy frameworks that are rapidly evolving) could result in regulatory fines, investigations and other proceedings, penalties and other liabilities, claims for damages by affected individuals, and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance, and business. Our commercial and cybersecurity insurance policies may be insufficient to insure us against these risks, and future escalations in premiums and deductibles under these policies may render them uneconomical.
COMPETITION
The markets for our technologies are highly competitive. The markets for our technologies are highly competitive, and we face competitive threats and pricing pressure in our markets. Consumers may perceive the quality of the visual and audio experiences produced by some of our competitors’ technologies to be equivalent or
21

Table of Contents

superior to the sight and sound experiences produced by our technologies. Some of our current or future competitors may have significantly greater financial, technical, marketing, and other resources than we do, or may have more experience or advantages in the markets in which they compete. These competitors may also be able to offer integrated systems in markets for entertainment technologies on a royalty-free basis or at a lower price than our technologies, including audio, imaging, and other technologies, which could make competing technologies that we develop less attractive. Competitors may also be able to develop and market new technologies that render our existing or future products less competitive. For example, advances in AI/ML may enable competitors to develop competing technologies more rapidly and with fewer resources, or to develop products that incorporate AI/ML in a way that makes them more effective, than has historically been possible. Such use of disruptive technologies could significantly alter the market for our products in unpredictable ways.
Many of the markets for our products and for products in which our technologies are incorporated are price sensitive. The markets for the consumer entertainment products in which our technologies are incorporated are intensely competitive and price sensitive. We expect to face increased royalty pricing pressure for our technologies as we seek to increase the adoption of our technologies in online content and portable devices, such as tablets and smartphones. Such pricing pressures may be exacerbated by elevated rates of inflation, tariffs and other trade barriers, which may cause device manufacturers to take additional steps to limit costs. Retail prices for consumer entertainment products that include our audio technologies, such as home theater systems, have decreased significantly, and we expect prices to decrease for the foreseeable future. In response, OEMs have sought to reduce their product costs, which can result in additional downward pressure on the licensing fees we charge. Further, Dolby OptiView faces pricing pressure from other platforms offering similar solutions that may be able to offer competing services at lower prices.
We face competitive risks in situations where our customers are also current or potential competitors. We face competitive risks in situations where our customers are also current or potential competitors. For example, Samsung is a significant customer, but some of its technologies are competitive with some of our consumer and cinema technologies. Our customers may choose to use competing technologies they have developed or in which they have an interest rather than use our technologies. The existence of important customer relationships may influence which strategic opportunities we pursue, as we may forgo some opportunities in the interests of preserving a critical customer relationship.
We face competition from other audio formats, imaging solutions, and integrated system offerings. We believe that the success we have had licensing our audio and imaging technologies is due, in part, to the high quality of the solutions that our technologies provide, our success in fostering content and device ecosystems, and to the strength of our brand. However, both free and proprietary sound and imaging technologies are becoming increasingly prevalent, and we expect competitors to continue to enter these fields with other offerings. Furthermore, to the extent that customers perceive our competitors’ products or open source alternatives as providing the same or similar advantages as our technologies for free or at lower prices, there is a risk that these customers may treat sound and video encoding technologies as commodities, resulting in loss of status of our technologies, decline in their use, and significant pricing pressure. For example, we face competition with respect to our immersive audio technology, Dolby Atmos, from open source and proprietary alternatives. While Dolby Atmos provides certain advantages over the alternatives, consumers and device makers may prefer those alternatives, which would impact our revenue and results of operations.
In addition, some of our current or potential competitors may be able to offer integrated systems in certain markets for entertainment technologies, including audio and imaging, which could make competing technologies that we develop or acquire obsolete. By offering an integrated system solution, these potential competitors may also be able to offer competing technologies at lower prices than we can, which could adversely affect our operating results.
STRATEGIC ACTIVITIES
The success of our business depends on strong industry relationships. To be successful, we must maintain and grow our relationships with a broad range of industry participants, including:
•Content creators, such as film directors, movie and game studios, mobile and online content producers, and music producers;
•Content distributors, such as studios, film exhibitors, broadcasters, operators, live sports and other streaming content service providers, OTT video service providers and video game publishers;
•Device manufacturers; and
22

Table of Contents

•Standards-setting organizations and other participants in the development of industry standards.
Industry relationships have historically played an important role in the markets that we serve, particularly in the entertainment market. For example, sales of our products and services are particularly dependent upon our relationships with major film studios and broadcasters, and licensing of our technologies is particularly dependent upon our relationships with system licensees and IC manufacturers. Industry relationships also play an important role in other markets we serve; for instance, our relationships with companies building real-time digital experiences support the adoption of Dolby OptiView solutions. If we fail to maintain and strengthen our industry relationships, industry participants may be less likely to purchase and use our technologies, products, and services, create content incorporating our technologies, or develop standards that incorporate our technologies.
Our M&A activity is subject to certain risks, including risks associated with integrating acquired businesses. We evaluate a wide array of possible strategic transactions, including acquisitions. We consider these types of transactions as part of our efforts to strengthen our existing lines of business and to expand into new markets and lines of business. Although we cannot predict whether or not we will complete any such acquisitions or other transactions in the future, any of these transactions could be significant in relation to the size and scale of our business. Future acquisitions could result in potentially dilutive issuances of our equity securities, the incurrence of debt, contingent liabilities, amortization expenses, and write-offs of goodwill. Future acquisitions may also require us to obtain additional equity or debt financing, which may not be available on favorable terms or at all, particularly during times of market volatility, elevated interest rates, and general economic instability. Also, the anticipated benefits of our acquisitions may not materialize. Foreign acquisitions involve unique risks in addition to those mentioned above, including those related to integration of operations across different geographies, cultures, and languages; currency risks; and risks associated with the economic, political, and regulatory environment in specific countries.
The process of integrating an acquired company, business, or technology into our organization may create challenges to our business, including: 
•Diversion of management time and focus from operating our business to acquisition integration challenges;
•Cultural and logistical challenges associated with integrating employees from acquired businesses into our organization and integrating acquired businesses' accounting, human resources, and other administrative systems with existing systems;
•Retaining employees, suppliers and customers from businesses we acquire;
•The need to implement or improve internal controls, procedures, and policies appropriate for a public company at businesses that prior to the acquisition may have lacked effective controls, procedures, and policies;
•Possible write-offs or impairment charges resulting from acquisitions; and
•Unanticipated or unknown liabilities relating to acquired businesses.
LEGAL AND REGULATORY COMPLIANCE
Conducting business internationally presents a number of risks to our business, including trade restrictions and changing, unpredictable, and/or inconsistent laws in the jurisdictions in which we operate. We are dependent on international sales for a substantial amount of our total revenue. Approximately 56%, 63% and 65% of our revenue was derived outside of the U.S. in fiscal year 2026, 2025, and 2024, respectively. We are subject to a number of risks related to conducting business internationally, including: 
•U.S. and foreign government trade barriers, or sanctions, including those which may impose restrictions on the importation or exportation of products, equipment, materials, software, technologies, services, on technology transfers, or on the receipt or collection of payments and distribution of royalties, and any political or economic responses or counter-responses to such restrictions or sanctions, including any such restrictions, sanctions, responses, or counter-responses related to global military conflicts, a trade war or changes in US export controls related to China and other countries;
•Other changes in global trade or trade relationships, including changes in trade agreements and fragmentation of technology standards;
•Compliance with applicable international laws and regulations, including antitrust and other competition laws and laws and regulations that relate to environmental, social, and governance matters, that may
23

Table of Contents

change unexpectedly, differ, or conflict with laws in other countries where we conduct business, which may restrict access to certain markets for our products or for products in which our technology is incorporated (including at the U.S. state level), or are otherwise not harmonized with one another;
•Foreign government taxes, regulations, and permit requirements, including foreign taxes that we may not be able to offset against taxes imposed upon us in the U.S., and other laws limiting our ability to repatriate funds to the U.S.;
•Potential adverse changes in the political, social, and/or economic stability of or conflicts within the regions in which we operate or in diplomatic relations between governments, including policy changes, turmoil or disruptions resulting from elections or other leadership changes;
•Difficulty in establishing, staffing, and managing foreign operations, including but not limited to restrictions on the ability to obtain or retain licenses required for operation, relationships with local labor unions and works councils, investment restrictions and/or requirements, and restrictions on foreign ownership of subsidiaries;
•Adverse fluctuations in foreign currency exchange rates and interest rates, including risks related to any interest rate swap or other hedging activities we undertake;
•Poor recognition and enforcement of IP rights;
•Difficulties in enforcing contractual rights;
•Compliance with multi-jurisdictional data protection, privacy, and AI laws particularly where the various compliance regimes may diverge and impose different or conflicting obligations, including, for example, the European Union's General Data Protection Regulation restrictions on transferring personal data outside of a jurisdiction and its Artificial Intelligence Act which could potentially impact our development of products incorporating AI/ML or the use of AI/ML tools in our business; and
•The global macroeconomic environment and potential slowing of key markets we serve.
Any or all of these factors, and the uncertainties associated with them, may impact our ability to operate in foreign countries and our ability to develop, the demand for, and profitability of, our technologies and products, as well as our customers' products that incorporate our technologies.
Certain foreign governments and industry participants have advanced arguments under competition laws that exert downward pressure on royalties for IP. The regulatory enforcement activities in such jurisdictions can be unpredictable, in some cases because these jurisdictions have only recently implemented competition laws. From time to time, we are the subject of requests for information, market conduct examinations, inquiries or investigations by industry groups and/or regulatory agencies in these jurisdictions. In the event that we are involved in significant disputes or are the subject of a formal action by a regulatory agency, our results could be negatively impacted and we could be exposed to costly and time-consuming legal proceedings.
In many foreign countries, particularly in those with developing economies, it is common to engage in business practices that are prohibited by U.S. regulations applicable to us such as the Foreign Corrupt Practices Act ("FCPA") and U.S. export controls. Although we implement policies and procedures designed to ensure compliance with the FCPA and U.S. export controls, such measures can not guarantee that all of our employees, distributors, dealers, and agents will not take actions in violation of our policies or these regulations, which could subject us to criminal or civil penalties as well as potential stockholder litigation.
We are subject to complex and changing tax laws which may impact our financial results. We are a U.S. multi-national company that is subject to tax in multiple U.S. and foreign jurisdictions. We must use judgment to determine our worldwide tax provision. We earn a significant amount of our income outside the U.S. and receive tax benefits from a portion of these foreign sales. Realizability of these benefits are contingent upon existing current tax laws and regulations in the U.S. and countries where we operate. The following could materially affect our effective tax rate: 
•Changes in geographic mix of earnings, where earnings are lower than anticipated in countries with lower tax rates and higher than anticipated in countries with higher tax rates;
•Changes in the valuation of our deferred tax assets and liabilities;
•Changes in transfer pricing arrangements;
•Outcomes of tax audits;
24

Table of Contents

•Changes in accounting principles; or
•Our ability to effectively implement changes to our corporate structure in response to changes in applicable tax laws and regulations in the countries in which we operate.
Changes in tax laws and regulations in the countries in which we operate, including an increase in tax rates or an adverse change in the treatment of an item of income or expense, may affect our results of operations. For example, in July 2025 budget reconciliation bill H.R. 1, referred to as the One Big Beautiful Bill Act (the “OBBBA”), was signed into law. The OBBBA contains several changes to corporate taxation rules which may affect our business.
In addition, the Organization of Economic Cooperation and Development (“OECD”), an international association of many countries including the U.S., has made changes to many long-standing transfer pricing and cross-border taxation rules that affect our operations. The OECD introduced a framework to implement a 15% global minimum corporate tax, referred to as Pillar 2 or the minimum tax directive which has been adopted by the EU and other foreign jurisdictions. Further, the OECD, European Commission, EU Member States and other individual countries are contemplating additional changes to long-standing tax principles. To the extent these developments impact actions by tax jurisdictions in which we operate, it is possible that these and future law changes and efforts may increase uncertainty and have an adverse impact on our effective tax rates or operations.
We are subject to the periodic examination of our income tax returns by tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes and to consider potential responsive actions, but an adverse decision by tax authorities exceeding our reserves could significantly impact our financial results.
STOCK-RELATED ISSUES
The Dolby family has control over stockholder decisions as a result of the control of a majority of the voting power of our outstanding common stock by them and their affiliates. As of September 25, 2026, the Dolby family and their affiliates owned 249,435 shares of our Class A common stock and 33,897,733 shares of our Class B common stock. As of September 25, 2026, the Dolby family and their affiliates had voting power of 99.8% of our outstanding Class B common stock, which combined with their shares of our Class A common stock, represented 85.2% of the combined voting power of our outstanding Class A and Class B common stock. Under our certificate of incorporation, holders of Class B common stock are entitled to ten votes per share while holders of Class A common stock are entitled to one vote per share. Generally, shares of Class B common stock automatically convert into shares of Class A common stock upon transfer of such Class B common stock, other than transfers to certain specified persons and entities, including the spouse and descendants of Ray Dolby and the spouses and domestic partners of such descendants.
As a result of this dual class structure, the Dolby family and their affiliates will, for the foreseeable future, have significant influence over our management and affairs, and will be able to control virtually all matters requiring stockholder approval, including the election of directors and significant corporate transactions such as mergers or other sales of our company or assets, even if they come to own considerably less than 50% of the total number of outstanding shares of our Class A and Class B common stock. Absent a transfer of Class B common stock that would trigger an automatic conversion as described above, there is no threshold or time deadline at which the shares of Class B common stock will automatically convert into shares of Class A common stock.
Moreover, the Dolby family and their affiliates may take actions in their own interests that our other stockholders do not view as beneficial.
Sales of substantial amounts of our Class A common stock in the public markets could reduce the price of our Class A common stock. If our large shareholders, officers, directors or employees sell, or indicate an intention to sell, substantial amounts of our Class A common stock in the public market, including shares of Class A common stock issuable upon conversion of shares of Class B common stock, the trading price of our Class A common stock could decline.
There are risks associated with our stock repurchase program. Our stock repurchase program may reduce the public float of shares available for trading on a daily basis. Such purchases may be limited, suspended, or terminated at any time without prior notice. There can be no assurance that we will buy additional shares of our Class A common stock under our stock repurchase program or that any future repurchases will have a positive impact on our stock price or Earnings Per Share ("EPS"). Important factors that could cause us to discontinue or decrease our share repurchases include, among others, unfavorable market conditions, the market price of our Class A common stock,
25

Table of Contents

the nature of other investment or strategic opportunities presented to us, the rate of dilution of our equity compensation programs, our ability to make appropriate, timely, and beneficial decisions as to when, how, and whether to purchase shares under the stock repurchase program, the tax consequences of any repurchases (including the potential impact of the 1% excise tax on certain stock repurchases), and the availability of funds necessary to continue purchasing stock. If we curtail our repurchase program, our stock price may be negatively affected.
There are risks associated with our dividend program. In October 2014, we announced a quarterly cash dividend program for our stockholders that was initiated by our Board of Directors. Although we anticipate paying regular quarterly dividends for the foreseeable future, we are not obligated to, and cannot provide assurance that we will, continue to pay dividends. Dividend declarations are subject to the Board of Directors’ continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time. If we do not pay dividends, the market price of our Class A common stock must appreciate for investors to realize a gain on their investment. This appreciation may not occur and our Class A common stock may in fact depreciate in value.
GENERAL RISK FACTORS
Macroeconomic conditions, including inflation, elevated interest rates, and supply chain constraints have impacted and may continue to impact the markets we serve and our business and results of operations. Our revenue and operations and the markets we serve have been, and may continue to be, impacted by macroeconomic conditions, including but not limited to, inflation, elevated interest rates, supply chain constraints including shortages of memory and semiconductor materials and components, increased fuel and transportation costs, tariffs and changes in international trade relations, international conflicts and geopolitical instability, reduced discretionary consumer spending, and reduced new product investment by our customers caused by elevated interest rates and lower demand. The current macroeconomic environment has negatively impacted, and may continue to negatively impact, many of our licensees and that directly impacts, and may continue to impact, our financial results. The impacts of the current macroeconomic environment on our partners have resulted in, and may continue to cause, the disruption of consumer products' supply chains, and delays in shipments, product development, and product launches. The macroeconomic conditions also impart substantial uncertainty into our operating environment, which presents additional challenges for our business. These factors and the related uncertainty may cause delays or a decrease in the adoption or implementation of our technologies into new products by partners and licensees. These conditions may impact consumer demand for devices and services and our partners’ ability to manufacture devices. Further, we may be negatively impacted by delays in transaction cycles and our recoveries efforts due to the noted macroeconomic conditions and related uncertainty. The future implications of these macroeconomic conditions on our business, the markets we serve, results of operations and overall financial position remain uncertain.
Adverse changes to tariffs, trade agreements, and trade policies may have a negative effect on our business and results of operations. The U.S. and other countries in our supply chain or in which we have sales have imposed and may impose additional tariffs and other trade regulations, or may adversely adjust prevailing tariff levels and other trade restrictions. We rely on contract manufacturers and component suppliers, some of which are located outside of the U.S., and we export our products to and license our technology in foreign countries. As such, tariffs or other trade barriers could, directly or indirectly, increase the cost or time required to produce or deliver our products and may increase the costs associated with licensing our technology. Our results may also be impacted indirectly by the imposition of tariffs and other trade barriers on our customers and licensees. If the cost to manufacture products that incorporate our technology, such as consumer electronics or cars, is increased as a result of tariffs, it may exert general pricing pressure which could lead manufacturers to discontinue including our technology in their products or to seek price reductions. If the costs or lead times associated with exporting licensees’ products or the components thereof result in higher prices or longer lead times for end consumers, sales of those products may decrease and thus royalty payments to us based on unit shipments may decrease. More generally, the imposition of tariffs and the outbreak of a trade war may lead to general negative economic effects, such as decreased consumer demand, recession or the elevated risk of recession, or higher inflationary pressures, which could adversely impact our business and results of operations.
Our results may be impacted by fluctuations in foreign currency exchange rates. We earn revenue, pay expenses, own assets and incur liabilities in foreign countries using several currencies other than the U.S. dollar. As a result, we face exposure to adverse movements in currency exchange rates as the financial results of our international operations are translated from local currency into U.S. dollars upon consolidation. The majority of our revenue generated from international markets is denominated in U.S. dollars, while the operating expenses of our
26

Table of Contents

foreign subsidiaries are predominantly denominated in local currencies. Therefore, our operating expenses will increase when the U.S. dollar weakens against the local currency and decrease when the U.S. dollar strengthens against the local currency. Additionally, foreign exchange rate fluctuations on transactions denominated in currencies other than the functional currency result in gains or losses that are reflected in our consolidated statements of operations. Further, our hedging programs may not be effective to offset any, or more than a portion, of the adverse impact of currency exchange rate movements. Additional risks related to fluctuations in foreign currency exchange rates are described in the Foreign Currency Exchange Risk section of Part II, Item 7A "Quantitative and Qualitative Disclosures About Market Risk."
Maintaining a credit facility and future debt obligations could adversely affect our business and financial condition. We maintain a revolving credit facility (the “Credit Facility”) with Bank of America, N.A. which is currently undrawn. The Credit Facility provides us with an additional source of capital and liquidity, but maintaining a debt facility inevitably presents certain risks. We are subject to certain covenants and other obligations under the Credit Facility, such as maintaining a required gross leverage ratio, avoiding certain liens and paying commitment fees. Our failure to comply with these covenants could result in the declaration of an event of default and cause us to be unable to borrow under the Credit Facility or result in the acceleration of the maturity of any indebtedness thereunder. In the event we draw on the Credit Facility, our debt obligations could adversely impact us by, for example, requiring us to use a large portion of our cash flow to service the debt, which would reduce the amount of cash flow available to fund working capital, capital expenditures, and other business activities. Borrowing under the Credit Facility would also increase our exposure to interest rate risk from variable rate indebtedness.
Business interruptions by natural disasters and other events beyond our control could adversely impact our business. Although we maintain crisis management plans, our business operations are subject to interruption by natural disasters and catastrophic events beyond our control, including, but not limited to, earthquakes, hurricanes, floods, tsunamis, fires, public health issues and pandemics, severe changes in climate, war, terrorism, and geopolitical unrest and uncertainties. Further, outbreaks of pandemic diseases, or the fear of such events, could provoke (and, in the case of COVID-19, did provoke) responses, including government-imposed travel restrictions and limits on access to entertainment venues. These responses could negatively affect consumer demand and our business, particularly in international markets. War, including the military conflicts between Russia and Ukraine and in the Middle East, as well as any related political or economic responses and counter-responses or otherwise by various global actors or the general effect on the global economy and supply chain, could also affect our business.
Additionally, several of our offices, including our corporate headquarters in San Francisco, are located in seismically active regions. Because we do not carry earthquake insurance for earthquake–related losses and significant recovery time could be required to resume operations, our financial condition and operating results could be materially adversely affected in the event of a major earthquake or catastrophic event.
We face intense competition for employees. In order to be successful, we must attract, develop, and retain employees, including employees to work on our growth initiatives where our current employees may lack experience with the business models and markets we are pursuing. Competition for experienced employees in our markets can be intense. In order to attract and retain employees, we must provide competitive compensation packages, including cash and equity compensation. Our equity awards include stock options, Restricted Stock Units ("RSUs") and Performance-Based Restricted Stock Units ("PSUs"). The future value of these awards is uncertain and depends on our stock price performance over time. In order for our compensation packages to be viewed as competitive, prospective employees must perceive our equity awards to be a valuable benefit.
27

Table of Contents

ITEM 1B. UNRESOLVED STAFF COMMENTS
None.
ITEM 1C. CYBERSECURITY
Risk Management and Strategy
Our approach to cybersecurity risk is based on processes that monitor threats, adapt our capabilities and services, and align our practices with business goals in order to provide security controls that reduce information security risk to the organization and customers.
We implement and maintain controls and capabilities for identifying, assessing, and managing risk from cybersecurity threats to the confidentiality, integrity, or availability of our information systems or any information residing therein. We also carry out broad-scope initiatives and project-specific initiatives aimed at continuously improving our cybersecurity posture. Our risk assessments and initiatives include identification of reasonably foreseeable internal and external risks, assessing the likelihood and potential impact that could result from such risks, and planning and implementing risk management controls as applicable. As a result, we adapt safeguards and processes in order to reduce identified risks in our security posture. Our cybersecurity processes form a part of our overall risk management practices and inform our annual enterprise risk assessment conducted by our internal audit team.
We devote resources and designate high-level personnel, including our Chief Information Security Officer ("CISO") who reports to our Chief Information Officer ("CIO") who in turn reports to our Chief Executive Officer, to manage cybersecurity risk. Our CISO and information security team also develop and implement policies and best practices related to product security. We maintain ISO 27001 certification for our cybersecurity function as well as for streaming media through Dolby OptiView and, in fiscal 2026, we attained ISO 27001 certification for our PC and gaming business. We are subject to annual ISO 27001 standard compliance monitoring audits in connection with those certifications. We maintain TISAX certification, a global information security standard for the automotive industry, for Dolby Atmos for cars. We also take part in periodic security audits by our clients and partners.
As part of our overall risk management processes, our employees at all levels are trained on foundational cybersecurity practices annually, and periodically participate in various activities aimed at increasing their awareness of cybersecurity threats and reinforcing their understanding of our security policies.
Periodically, we engage consultants and other third party service providers in connection with our cybersecurity practices. These service providers assist us in event monitoring, conduct testing and provide feedback on our readiness and compliance, conduct tabletop exercises, and are “on-call” in the event of a significant event. We have implemented a third-party risk management process that we use to evaluate the capabilities and security posture of third-party service providers. As part of that process, we review third-party service providers to ensure that they have implemented appropriate security measures in connection with their work with us.
We have not encountered any cybersecurity incident that had a material impact on our operations or financial standing. We continue to invest in cybersecurity awareness, threat management, and response preparedness as we anticipate ongoing risks from cybersecurity threats, including those driven by advancements in artificial intelligence. Despite our efforts, we can not guarantee that our risk management program will be completely effective in preventing cybersecurity incidents that could adversely affect our business strategy, results of operations or financial condition. For more information regarding risks from cybersecurity threats, please refer to Part I, Item 1A “Risk Factors” in this annual report on Form 10-K, under the heading “Operations.”
Governance
One of the key functions of our Board of Directors is informed oversight of our risk management process, including risks from cybersecurity threats. Our Board of Directors is responsible for monitoring and assessing strategic risk exposure, and our officers are responsible for the day-to-day management of the material risks we face. Our Board of Directors administers its cybersecurity risk oversight function directly as a whole, as well as through the Audit Committee, which has responsibility for overseeing the adequacy and effectiveness of our cybersecurity and information security programs and policies according to its charter.
Our CISO is primarily responsible for assessing and managing our risks from cybersecurity threats. Our CISO manages a team of cybersecurity professionals with broad experience and expertise, including in cybersecurity strategy and operations, incident response, cybersecurity education and awareness, threat management, insider
28

Table of Contents

threats and regulatory compliance. Our CISO has over 25 years of experience in technology, with more than 15 years in information security, holding multiple roles including five years as a CISO for a health insurance company. Our CISO reports on cybersecurity risk management and other matters to our CIO, who in turn reports to our Chief Executive Officer.
Along with our CISO our Security, Privacy, Audit, Risk and Compliance Council (“SPARC Council”), which is a collection of stakeholders from various functions including cybersecurity, legal, IT, engineering, finance, procurement and audit, oversees our cybersecurity policies and processes, including those described in “Risk Management and Strategy” above. Our CISO and our SPARC Council review the results of assessments, including security simulations and tabletop exercises, and discuss and recommend improvements to our policies and processes. In addition to the general reporting structure applicable to our CISO, the other members of the SPARC Council report on those activities through the reporting lines applicable to them, as needed.
Our CISO along with our CIO typically provide quarterly updates to the Audit Committee regarding our company’s cybersecurity risks and activities, including recent cybersecurity incidents and strategy development. The findings from our annual enterprise risk assessment are also presented to the Audit Committee by our internal audit team. Our Audit Committee provides regular reports to the Board of Directors on such updates. In addition, our CISO along with our CIO typically provide annual briefings directly to the Board of Directors on cybersecurity risks and activities.

ITEM 2. PROPERTIES
Headquarters
Our principal corporate office and worldwide headquarters, which we own, is at 1275 Market Street, San Francisco, California.
Other Properties
We also own a commercial office building located in Sunnyvale, California, and lease additional R&D, sales, product testing, and administrative facilities from U.S.-based third parties in California, Colorado, Georgia, Indiana, Maryland, Missouri, New York, and Pennsylvania, and internationally, including in Asia, Europe, Australia, the Middle East, and South America. We believe that our current facilities are adequate to meet our needs for the near future, and that suitable additional or alternative space will be available on commercially reasonable terms to accommodate our foreseeable future operations.
Dolby Wootton Bassett, LLC, of which Dagmar Dolby as Trustee of the Dagmar Dolby Trust under the Dolby Family Trust Instrument dated May 7, 1999 (the "Dagmar Dolby Trust") is the sole member, and the Dagmar Dolby Trust, own a majority financial interest in real estate entities that own and from whom we may lease certain facilities. The Dagmar Dolby Trust has a majority interest in Dolby Properties Burbank, LLC, and Dolby Wootton Bassett, LLC has a majority interest in Dolby Properties, LP. We own the remaining financial interests in these real estate entities. Specifically, we hold a 49.0% minority ownership interest in Dolby Properties Burbank, LLC, which owns a 22,000 square feet facility in Burbank, California that we are leasing until 2030. We also hold a 10.0% minority ownership interest in Dolby Properties, LP, which owns an approximately 34,000 square foot facility in Wootton Bassett, England. We are no longer leasing the Wootton Bassett facility.

ITEM 3. LEGAL PROCEEDINGS
We are involved in various legal proceedings that occasionally arise in the normal course of business activities, including claims of alleged infringement of IP rights, commercial, employment, and other matters. In our opinion, resolution of these proceedings is not expected to have a material adverse impact on our operating results or financial condition. Given the unpredictable nature of legal proceedings, it is possible that an unfavorable resolution of one or more such proceedings could materially affect our future operating results or financial condition in a particular period; however, based on the information known by us as of the date of this filing and the rules and regulations applicable to the preparation of our consolidated financial statements, other than the litigation matter discussed in Note 17 "Legal Matters" to our consolidated financial statements, any such amounts are either immaterial, or it is not probable that a potential loss has been incurred or the amount of loss cannot be reasonably estimated.
29

Table of Contents


ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
30

Table of Contents

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our Class A common stock is traded on the New York Stock Exchange ("NYSE") under the symbol "DLB." Our Class B common stock is neither listed nor publicly traded. As of October 23, 2026, there were 112 holders of record of our Class A common stock and 32 holders of record of our Class B common stock. The number of Class A beneficial stockholders is substantially greater than the number of holders of record since a large portion of our common stock is held through brokerage firms.
Dividend Policy
In October 2014, we announced a quarterly cash dividend program for our stockholders that was initiated by our Board of Directors. Since the program was initiated, a quarterly dividend has been declared and paid to all eligible stockholders of Class A and Class B common stock. Most recently, on November 17, 2026, we announced a dividend in the amount of $0.39 per share, payable on December 9, 2026, to stockholders of record as of the close of business on December 1, 2026.
Dividend declarations and the establishment of future record and payment dates are subject to the Board of Directors' continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time. For additional information related to our quarterly dividend, see Note 9 "Stockholders' Equity and Stock-Based Compensation" to our consolidated financial statements and Shareholder Return in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations."
Sales of Unregistered Securities
None.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
In November 2009, we announced a stock repurchase program ("program"), providing for the repurchase of our Class A common stock. Stock repurchases under the program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended, or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be returned to the status of authorized but unissued shares of Class A common stock.
The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of September 25, 2026 (in thousands):
31

Table of Contents

Date of AuthorizationAuthorization Amount
Fiscal 2010: November 2009$250,000 
Fiscal 2010: July 2010300,000 
Fiscal 2011: July 2011250,000 
Fiscal 2012: February 2012100,000 
Fiscal 2015: October 2014200,000 
Fiscal 2017: January 2017200,000 
Fiscal 2018: July 2018350,000 
Fiscal 2019: July 2019350,000 
Fiscal 2021: July 2021350,000 
Fiscal 2022: February 2022250,000 
Fiscal 2022: August 2022350,000 
Fiscal 2024: August 2024350,000 
Fiscal 2026: July 2026350,000 
Total$3,650,000 
The following table provides information regarding our share repurchases made under this program during the fourth quarter of fiscal 2026:
Repurchase ActivityTotal Shares Purchased
Average Price
Paid Per Share (1)
Total Shares Purchased As Part Of Publicly Announced Programs
Remaining Authorized Share Repurchases (2)
June 27, 2026 - July 24, 2026— — — $76.6 million
July 25, 2026 - August 21, 2026453,220 $61.70 453,220 398.6 million
August 22, 2026 - September 25, 2026601,162 $61.61 601,162 361.6 million
Total1,054,382 1,054,382 
(1)Average price paid per share excludes commission costs.
(2)Amounts represent the approximate dollar value of the maximum remaining number of shares that may yet be purchased under the stock repurchase program as of the end of the applicable period and excludes commission costs.
32

Table of Contents

Stock Price Performance Graph
The following graph compares the total cumulative return of our Class A common stock with the total cumulative return for the New York Stock Exchange Composite Index ("NYSE Composite") and the S&P MidCap 400 Index ("S&P 400") for the five fiscal years ended September 25, 2026. The figures represented below assume an investment of $100 in our Class A common stock at the closing price of $92.47 on September 24, 2021, and in the NYSE Composite and S&P 400 on the same date and the reinvestment of dividends into shares of common stock. The comparisons in the table are required by the SEC and are not intended to forecast or be indicative of possible future performance of our Class A common stock. This graph shall not be deemed "filed" for purposes of Section 18 of Securities Exchange Act of 1934, as amended ("Exchange Act") or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act or the Exchange Act.
4045

ITEM 6. [RESERVED]
33

Table of Contents

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion contains forward-looking statements that are subject to risks and uncertainties. Actual results may differ materially from those referred to herein due to a number of factors, including but not limited to key challenges listed below and risks described in Part I, Item 1A "Risk Factors" and elsewhere in this Annual Report on Form 10-K. We disclaim any duty to update any of the forward-looking statements after the date of this Annual Report on Form 10-K to conform our prior statements to actual results.
Investors and others should note that we disseminate information to the public about our company, our products, services, and other matters through various channels, including our website (www.dolby.com), our investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls, and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public. We encourage investors and others to review the information we make public through these channels, as such information could be deemed to be material information.
MACROECONOMIC CONDITIONS
Our revenue can be negatively impacted by macroeconomic conditions, including but not limited to, the financial health of our licensees, inflation, heightened interest rates, foreign exchange rates, shortages or rising costs of material, increased shipping costs, tariffs and trade barriers, war and other international conflicts, labor disputes, reduced discretionary consumer spending, and reduced new product investment by our customers. Increases in trade barriers may, directly or indirectly, increase the cost of producing or delivering our products, increase the costs to our licensees of licensing our technology, preclude licensee products from certain markets, and may decrease demand for our products and services. Our business may also be impacted by global material shortages that affect the sectors in which we operate, such as shortages and potential shortages that impact the pricing and availability of memory components and ICs for the consumer electronics market. If the foregoing or similar factors increase the costs or lead times required for our licensees to manufacture and export their products, such as consumer electronics products and cars, and that results in higher prices or longer lead times for end consumers, sales of those products may decrease and thus royalty payments payable to Dolby that are based on unit shipments may decrease.
Macroeconomic conditions also impart substantial uncertainty into our operating environment and may lead to follow-on negative economic effects like recession or heightened inflation, each of which presents additional challenges for our business. For example, recent conflicts in the Middle East have increased uncertainty around shipping costs and delays, the availability of materials, and other supply chain issues that may impact our licensees in the short and long term. Uncertainty and its related impacts, or an adverse economic climate generally, may impact consumer demand for our licensees’ products that incorporate our technology and for our own products and services. Such conditions may also cause delays or a decrease in the adoption of our technologies into new products by partners and licensees, or lead manufacturers to discontinue including our technology in their products or to seek price reductions. Further, the noted macroeconomic conditions and related uncertainty may negatively impact transaction cycles and our recovery of revenue associated with past unauthorized or unreported usage.
The future implications of these macroeconomic conditions on our business, results of operations and overall financial position remain uncertain. We continue to monitor the evolving macroeconomic environment, including international conflicts and the imposition of tariffs and other trade barriers, and the potential impacts on our business. Further discussion of the potential impacts of these macroeconomic effects on our business can be found in Part I, Item 1A "Risk Factors."
LICENSING
The majority of our revenue is derived from two licensing models: Branded Technology Licensing and Patent Licensing, each of which individually comprises a substantial portion of our revenue. While each has had successes, they share certain challenges. In particular, factors such as global supply constraints or device lifecycles may impact licensing revenue. Further, in certain countries, we and other IP owners face difficulties enforcing contractual and IP rights, including instances in which our licensees fail to accurately report the shipment of products using our technologies. Finally, we face geopolitical challenges including changes in diplomatic and trade relationships, trade protection measures including the imposition of tariffs, and import or export licensing requirements. Further discussion of the potential impacts of the key challenges on our business can be found in Part I, Item 1A "Risk Factors."
Branded Technology Licensing
34

Table of Contents

Dolby’s branded technology licensing offers complete technology solutions to our licensees, primarily device manufacturers. Licenses include rights to software, patent rights, know-how, and the relevant Dolby brand. Our branded technologies are primarily comprised of Branded Audio Codecs (DD+ and AC-4) and Dolby Atmos and Dolby Vision (Dolby Atmos for audio, and Dolby Vision for imaging). Licensing revenue is primarily driven by the adoption of our technologies on devices and the number of devices shipped by licensees. Our branded audio codecs have broad penetration across a diverse set of devices and end markets. Revenue from these technologies is primarily driven by device shipments from licensees, and as such, is impacted by consumer spending. The remaining portion of our branded licensing revenue is derived from Dolby Vision and Dolby Atmos. Dolby Vision and Dolby Atmos have not been in the market as long as our branded audio codecs, thus revenue growth is driven by device shipments, increased adoption, and the addition of new licensees.
We are focused on expanding our leadership in audio and imaging solutions for premium entertainment content by increasing the number of Dolby experiences that people can enjoy, which will drive revenue growth across the markets we serve. We work across our ecosystem of partners including creators, distributors, and device manufacturers to increase the number of Dolby experiences that people can enjoy by enhancing content, including movies and TV, music and live sports, using Dolby branded technologies. Increased content in these areas increases our value proposition across our end markets. In movies and TV, thousands of movie titles and tens of thousands of TV episodes have been created and released in Dolby Atmos and/or Dolby Vision. Major streaming services such as Netflix, Disney+, Apple TV, Amazon, HBO Max, Paramount+, Peacock, and other streaming services internationally, continue to enhance content in Dolby Vision and/or Dolby Atmos. In fiscal 2026, various sport events were broadcast in Dolby Atmos and/or Dolby Vision, such as the 2026 FIFA World Cup, the Super Bowl, the 2026 Olympic Winter Games, and the ICC Men's T20 Cricket World Cup. Apple is currently streaming the 2026 Formula One season in Dolby Vision and Dolby Atmos for the first time. Additionally, Amazon Prime Video recently announced that it has added support for Dolby Vision to its ad-supported tier.
Patent Licensing
Our patents are incorporated into the AAC, HE-AAC, and Extended HE-AAC standards for audio, and the AVC and HEVC standards for imaging. The licensing of these patents forms the core of our patent licensing. Revenue generated through our patent licensing model is driven primarily by our royalty share within patent pools, licensee penetration, device shipments, and the introduction of new standardized technologies and patent programs. Historically, our patent licensing model has focused primarily on devices incorporating these technologies. As the value created by the use of standardized audio and video technologies has evolved, our patent pool partners’ licensing activities have begun expanding to include services that utilize these technologies, such as video distribution platforms and cloud-based media processing.
In fiscal 2026, we saw continued progress in the development of Access Advance’s VDP Pool, which grew to include 47 licensors, including the addition of Sharp and M&K. The pool now includes some of the largest global social media platforms among its licensees, including the addition of Meta and the expansion of Alibaba’s license to cover its full video ecosystem. In the fourth quarter, Via formally launched the Dynamic Random-Access Memory ("DRAM") program, the first patent pool aimed at facilitating collaborative licensing for the datacenter market. The DRAM program encompasses patented technology that modern data processing relies on for high-performance computing and artificial intelligence applications.
In video programs, Access Advance renewed licenses in its HEVC program through 2030 for all of its approximately 400 licensees, including Samsung, Google, LG, Panasonic, and Sony. Access Advance also added 75 new licensees to the program including Meta, Xiaomi, Hisense, Transsion and Roku. We generate revenue from Access Advance’s video programs by licensing our imaging patents through them and, by virtue of our minority interest in Access Advance, generate income from administration fees.
Via completed the sale of its HEVC/VVC program to Access Advance in fiscal 2026, reducing market fragmentation and helping ensure that essential video technologies remain easily accessible through clear, predictable, and efficient mechanisms. Also in fiscal 2026, we expanded our VVC portfolio through the acquisition of 680 patent assets, including 250 granted patents.
In Audio, Via added 36 new licensees to its AAC program in fiscal 2026, including Meta and Honor.
Other notable developments outside of our core audio and video programs this fiscal year include 12 new licensees joining Via’s Qi wireless program, including Sony and Belkin, with Oppo joining in early fiscal 2027, and 5
35

Table of Contents

new licensees joining the Opus interactive voice and audio transmission program administered by Vectis. Dolby is a licensor in both programs.
Revenue from our patent licensing is driven, in part, by the adoption and use of the standardized technologies in which we participate by implementers. As in any technology licensing business, it is possible that changing partner preferences, consumer preferences, or other market dynamics could lead to increased or decreased adoption, or the use of alternative technologies.
Revenue derived from our patent licensing programs is also driven by the success of the patent pools in which we participate, which is driven by licensee, licensor, and program renewals. The revenue we derive from patent pools also depends significantly on the patent pool administrators’ success in negotiating licenses with companies already using the relevant standard (i.e. licensee penetration). Additionally, our licensing revenue from patent pools is driven, in part, by the royalty share among pool licensors, which is determined based on the value of the patents each licensor contributes to the pool, as governed by allocation rules negotiated among the pool licensors.
The standardized technologies at the core of our patent licensing are intended for broad use across all device categories that play back audio and visual content. Implementers, including device manufacturers and video distribution platforms, typically negotiate and acquire the patent rights for these technologies for implementation across all their devices and services in their applicable markets.
For a discussion of certain risks related to our patent licensing model, please refer to Part I, Item 1A "Risk Factors" in this annual report on Form 10-K, in particular the sections under the headings "Technology Standards" and "Intellectual Property."
Licensing End Markets
The following are highlights and key challenges related to Dolby’s licensing businesses, by market.
Broadcast
Highlights
We have an established global presence and broad adoption of our branded audio and patent licensing technologies in broadcast services and devices, which primarily include TVs and STBs. We work with many TV OEMs and strategic partners to enable and promote Dolby Vision and Dolby Atmos experiences within their TV lineups. We have strong attach rates for Dolby Atmos and Dolby Vision with high end TVs and continue to grow adoption on mid-range TVs. Many partners continue to expand their support of the combined Dolby Vision and Dolby Atmos experience. Dolby Vision 2 is now in market with some Hisense TVs, and by the end of calendar year 2026, TCL and Philips are expected to begin shipping TVs with Dolby Vision 2.
Key Challenges
Our pursuit of new licensees and further adoption of our technologies by existing licensees may be impacted by a number of factors. We must continue to present compelling reasons for consumers to demand our audio and video technologies, including ensuring that there is a breadth of available content in our formats and such content is being widely distributed. To the extent that OEMs do not incorporate our technologies in current and future products or our technology is not included in future broadcast industry standards, our revenue could be negatively impacted. Changing trends in the way that video content is distributed and consumed may impact our business and future growth in the broadcast market, such as the trend away from subscription-based cable and satellite television providers toward streaming services.
Mobile
Highlights
We continue to promote adoption of our technologies across major mobile ecosystems, including Apple and Android. Dolby Atmos and Dolby Vision are included throughout the Apple device line-up and in Apple TV, and Dolby Atmos is supported by Apple Music. Dolby Vision, Dolby Vision Capture, and Dolby Atmos have been supported on all iPhones since the iPhone 12, including the recently introduced iPhone Duo. An increasing number of Android device manufacturers have adopted Dolby Vision and Dolby Vision Capture on high end devices and we are focused on the opportunity to significantly increase our adoption. We have strong adoption of Dolby Atmos and our branded audio codecs across high-end Android mobile devices and are focused on growing our presence on low and mid-tier
36

Table of Contents

phones. The breadth of mobile devices supporting Dolby technologies continues to increase globally. In fiscal 2026, Xiaomi announced its flagship Redmi Note 15 Pro series that supports Dolby Vision, Dolby Vision Capture, and Dolby Atmos. Motorola Vietnam launched its latest razr mobile phones supporting Dolby Vision and Dolby Atmos. OPPO launched the Find X10 series which supports Dolby Vision Capture. Our patent licensing technologies are adopted broadly throughout the mobile device ecosystem.
We increasingly see adoption of our technologies in other personal, battery powered electronics, including devices providing augmented reality and virtual reality experiences. Meta recently announced that Meta AI glasses are the first global consumer device capable of capturing audio in Dolby Atmos. RayNeo, a leading provider of augmented reality glasses, launched the RayNeo GT Max, the first AR smart glasses supporting Dolby Vision. Insta360, a leader in the action and panoramic cameras segments, launched the Luna Ultra, which supports Dolby Vision capture. Meta began supporting Dolby Vision on Facebook, after recently announcing support for Dolby Vision on Instagram. Douyin, known in many parts of the world as TikTok, has made Dolby Vision available to it users in China and has offered their users the ability to capture, share, and edit content in Dolby Vision.
Key Challenges
Growth in this market is dependent on several factors. Due to short product life cycles, mobile device OEMs can readily add or remove certain of our technologies from their devices. Our success depends on our ability to address the rapid pace of change in mobile devices, and we must continuously collaborate with mobile device OEMs to incorporate our technologies. We rely on a small number of partnerships with key participants in this market. If we are unable to maintain these key relationships, we may experience a decline in mobile devices incorporating our technologies. To the extent that OEMs do not incorporate our technologies in current and future products or our technology is not included in future mobile industry standards, our revenue could be impacted. We must also continue to support the development and distribution of Dolby-enabled content via various ecosystems.
Consumer Electronics
Highlights
We have an established presence in the home entertainment market across devices such as wireless and smart speakers, soundbars, DMAs (devices that connect a home media system to the internet), and AVRs, through the inclusion of our branded audio codecs, and increasingly through the inclusion of Dolby Atmos and Dolby Vision. Our patent licensing technologies also have broad adoption in the home entertainment market. We continue to focus on expanding the availability of Dolby technologies to new devices.
Key Challenges
We must continue to present compelling reasons for consumers to demand our technologies wherever they enjoy entertainment content, while promoting creation and broad availability of content in our formats. With relatively short product life cycles for many consumer electronics, OEMs can add or remove certain of our technologies from their products which could impact our revenue. In addition, to the extent that our technology is not included in future industry standards, our revenue could be impacted.
Personal Computers
Highlights
DD+ enhances audio playback in Mac computers through the operating system with native support in the Safari browser, and Windows-based PCs through PC OEM implementations and native support in the Microsoft Edge browser. Dolby's presence in these browsers enables us to reach more users through various types of content, including streaming video entertainment. A number of PCs from partners such as Apple, Lenovo, Dell, Samsung, Microsoft, and ASUS also support Dolby Vision and/or Dolby Atmos, with continued expansion of applications through music, streaming, and gaming. In fiscal 2026, Google announced that select Googlebook models, the first laptops designed for Gemini Intelligence and a unified operating system, support Dolby Atmos.
Key Challenges
Demand for PCs has fluctuated significantly in recent years. We must continuously collaborate and maintain our key partnerships with PC manufacturers to incorporate our technologies, and we must continue to support the
37

Table of Contents

development and distribution of Dolby-enabled content via various ecosystems. To the extent that PC manufacturers do not incorporate our technologies in current and future products, our revenue could be impacted.
Other Markets
Highlights
We generate revenue from the automotive industry primarily through the adoption of Dolby Atmos in cars. As of the end of fiscal 2026, we have announced partnerships with over 40 car makers that are shipping or have announced models that support our technologies, up from over 20 car makers at the end of fiscal 2025. BMW, Mahindra, Hyundai, BYD, Lexus, NIO, Volkswagen, and Buick announced new models that support Dolby Atmos in fiscal 2026. Google announced support for Dolby Atmos through Android Auto with partners including BMW, Genesis, Kia, Mahindra, Mercedes, Renault, and Skoda. We also announced that we have partnered with Qualcomm to integrate Dolby’s latest technology into Qualcomm’s Gen 5 Snapdragon Automotive platform.
Gaming consoles such as the Sony PlayStation and the Microsoft Xbox use DD+ to support gaming content and streaming for movie and television content. The PlayStation 5 supports compatible Dolby Atmos-enabled living room devices. The Xbox Series X and Series S gaming consoles support Dolby Vision and Dolby Atmos for streaming and gaming content. Additionally, our technologies continue to be incorporated into the latest headphones by various OEMs.
Key Challenges
Our automotive-related revenue growth will be impacted if OEMs do not incorporate our technologies in their latest products. The long development cycle of the automotive industry reduces the frequency of our opportunities to be incorporated into additional products. Additionally, the automotive industry is cyclical, so our revenue from the auto market is affected by the broader cycles of the industry. Consumer demand for gaming devices is impacted by anticipation of console refresh cycles, which could result in fluctuations in our revenue. In addition, the gaming console market has competition from mobile devices and gaming PCs, which have faster refresh cycles and appeal to a broader consumer base.
Included within Other Markets is also licensing revenue from audio and video technologies used to create Dolby experiences through Dolby Cinema.
Dolby Cinema
Highlights: We continue to expand our global presence for Dolby Cinema, with sites located in the U.S. and internationally. Additionally, in fiscal 2026, we increased the number of Dolby Atmos and Dolby Vision theaters or exhibitors in South Korea, China, Thailand, Vietnam, Taiwan, Austria, Germany, and in the U.S.
Key Challenges: Although the PLF market for the cinema industry has been growing, Dolby Cinema competes with other existing offerings. Our success depends on our partners and their success, and our ability to differentiate our offering and deploy new sites. In addition, the success of our Dolby Cinema offering is tied to global movie production and box office performance generally.
PRODUCTS AND SERVICES
A majority of our Products and Services revenue is derived from the sale of audio and imaging products for the cinema industry. Revenue from Dolby OptiView is also included in products and services.
Cinema Products and Services
Highlights
To help enable the playback of content in Dolby formats, we offer a range of servers, which include the IMS3000 (an integrated imaging and audio server with Dolby Atmos), and audio processors, such as the CP950, to cinema exhibitors globally. Dolby Atmos has been adopted broadly across studios, content creators, post-production facilities, and exhibitors. As of the end of fiscal 2026, there are over 8,700 Dolby Atmos screens installed or committed and over 5,900 Dolby Atmos theatrical titles have been announced or released.
38

Table of Contents

We also offer a variety of other cinema products, such as the Dolby Multichannel Amplifier and our high-power flexible line of speakers. These products allow us to offer exhibitors a more complete Dolby Atmos solution that is often more cost effective than other commercially available options.
Key Challenges
Demand for our cinema products is dependent upon our partners and their success in the market, industry and economic cycles, box office performance, and our ability to develop and introduce new technologies, further our relationships with content creators, and promote new cinematic audio and video experiences. A significant portion of our growth opportunity lies in international markets, which are subject to geopolitical risks. We may also be faced with pricing pressures or competing technologies, which would affect our revenue. In addition, supply chain constraints may impact our ability to provide cinema products and services to our customers. Long lead times and increased cost of materials due to the macroeconomic conditions, including higher interest rates have also negatively impacted the financial health of our cinema customers and partners, leading to reduced new product investment and lower demand.
Dolby OptiView
Highlights
Our strategy for Dolby OptiView is to expand our addressable market by offering solutions that increase audience engagement to companies offering real-time digital experiences.
We are initially focusing on live sports as a key vertical. We are delivering solutions to improve the streaming experience and drive fan engagement, which is a top priority for the sports industry. These solutions include ultra-low latency streaming of audiovisual content, which enables more interactivity around live content for fantasy sports, betting, communal viewing, and many other benefits; and optimized advertising delivery which increases revenue by delivering ads that are personalized to viewers and more integrated with the content they are watching.
In fiscal 2026, horse racing streaming providers Roberts Communications Network and William Hill began deploying Dolby OptiView for ultra-low latency video streaming. Google announced that Dolby OptiView Ads has been certified through their Ad Manager Technology Partner program. The certification recognizes the performance and monetization improvements that Dolby OptiView Ads delivers when integrated with Google Ad Manager, and creates an opportunity to partner with Google to reach their Google Ad Manager customers more efficiently and with the benefit of Google’s endorsement. We also announced that Genius Sports adopted Dolby OptiView. Genius Sports is a leading data, technology, and broadcast partner that serves the global sports, betting, and media ecosystem. We announced that the Seattle Seahawks are the first team to integrate Dolby OptiView into their live streaming coverage.
Key Challenges
Dolby OptiView is an early-stage business, and it is uncertain when or if it will be a material revenue driver. Our success in this market will depend on adoption by companies building real-time digital experiences that increase audience engagement, the volume of usage of the services and our ability to monetize our services. In addition, the development and maintenance needed to provide a reliable and scalable platform may require us to incur additional costs to develop new skills within our existing employee base or hire external specialized talent. Although the market for real-time experiences has been growing, Dolby OptiView competes with other offerings from third parties.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our consolidated financial statements and accompanying notes are prepared in accordance with U.S. GAAP, pursuant to SEC rules and regulations. The preparation of these financial statements requires us to establish accounting policies and make certain estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses. The SEC considers an accounting policy and estimate to be critical if it is both important to a company’s financial condition or results of operations and requires significant judgment by management in its application. On a regular basis, we evaluate our assumptions, judgments, and estimates, and historically, actual results have not differed significantly from them. If actual results or events differ materially from our judgments and estimates, our reported financial condition and results of operation for future periods could be materially affected. We have reviewed the selection and development of the critical accounting policies and estimates discussed below with the Audit Committee of our Board of Directors.
39

Table of Contents

Revenue Recognition
We derive our revenue primarily from the licensing of our technologies and patents. In determining how revenue should be recognized, a five-step process is used, which requires judgment and estimates within the revenue recognition process. Generally, revenue is recognized upon transfer of control of promised products, services or IP rights to customers in an amount that reflects the consideration that we expect to receive in exchange for those products, services or licensing of the IP rights. The primary judgments include estimating sales-based revenue in advance of receiving statements from our licensees, estimating variable consideration, identifying the performance obligations in the contract, and determining whether the performance obligations are distinct, and allocating consideration accordingly.
Most of our licensing arrangements are structured as sales-based whereby we are paid a unit-based royalty. The unit-based sales data that triggers the royalty obligation is generally reported to us in the quarter after triggering the royalty obligation. We apply the royalty exception to these arrangements, which requires that we recognize sales-based royalties when the sales occur based on our estimates. Our estimates of royalty-based revenue take into consideration the macroeconomic effect of global events, such as inflation, elevated interest rates, economic impacts related to industry challenges, or other economic conditions, which may impact supply chain activities as well as demand for shipments. These estimates also involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Generally, our estimates represent the current period’s shipments for which we expect our licensees to submit royalty statements in the following quarter. Upon receipt of royalty statements from the licensees with the actual reporting of sales-based royalties that we previously estimated, we record a favorable or unfavorable adjustment based on the difference, if any, between estimated and actual sales.
We also enter into fixed and guaranteed licensing fee arrangements, that require the licensee to pay a fixed, non-refundable fee. In these cases, control is transferred and the transaction price - the amount we expect to be entitled to in exchange for the license right - is recognized upon the later of contract execution or the effective date. Transaction price is determined at contract execution and, to the extent variable consideration applies, is updated each subsequent reporting period until the completion of the contract. We evaluate whether other distinct performance obligations exist, such as PCS, and determine the stand-alone selling price. We do so by considering actual stand-alone sales in addition to market conditions such as competitor pricing strategies, customer specific information and industry technology lifecycles, internal conditions such as cost and pricing practices, or applying the residual approach method when the selling price of the good, most commonly a license, is highly variable or uncertain. In addition, we evaluate whether a significant financing component exists when we recognize revenue in advance of customer payments that occur over time and extend beyond one year. In general, if the payment arrangements extend beyond the first year of the contract, we treat a portion of the payments as a financing component. The discount rate used for each arrangement reflects the rate that would be used in a separate financing transaction between us and the licensee at contract inception and takes into account the credit characteristics of the licensee and market interest rates as of the date of the agreement. If we assess the financing component to be significant to the contract, the amount of fixed fee revenue recognized at the beginning of the license term will be reduced by the calculated financing component. The portion related to the financing component is recorded as interest income, and is not material to our consolidated financial statements.
For additional information, see Note 3 "Revenue Recognition" to our consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K.

IMPACT OF NEW ACCOUNTING STANDARDS NOT YET ADOPTED
For information on recent accounting standards that have not been adopted yet and the impact of these standards on our consolidated financial statements, refer to Note 2 "Summary of Significant Accounting Policies" to our consolidated financial statements in this Annual Report on Form 10-K.
RESULTS OF OPERATIONS
For each line item included on our consolidated statements of operations described and analyzed below, the significant factors identified as the leading drivers contributing to the overall fluctuation are presented in descending order of their impact on the overall change (from an absolute value perspective). This discussion and analysis highlights comparisons of material changes in the consolidated financial statements for the years ended September 25, 2026 and September 26, 2025. For the discussion and analysis highlighting comparisons of material changes in the consolidated financial statements for the years ended September 26, 2025 and September 27, 2024,
40

Table of Contents

refer to Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in our Annual Report on Form 10-K for the year ended September 26, 2025, which is incorporated herein by reference. Note that adjustments related to sales-based royalties that were misreported by licensees as well as unlicensed settlement activity, are collectively referred to as "recoveries." Amounts displayed, except percentages, are in thousands.
Revenue and Gross Margin
Licensing
Licensing revenue consists of fees earned from licensing our technologies to customers who incorporate them into their products or use them in their services to enable and enhance audio and imaging capabilities. The technologies that we license are either internally developed, acquired, or licensed from third parties. We also generate administrative fees for managing patent pools on behalf of third party patent owners through our subsidiary, Via. A significant portion of our licensing revenue pertains to customer-shipment royalties that we recognize based on estimates of our licensees’ shipments. To the extent that shipment data reported by licensees differs from estimates we made and recorded, we recognize an adjustment to revenue for such difference in the period we receive the reported shipment data.
Our cost of licensing consists mainly of amortization of certain purchased intangible assets and intangible assets acquired in business combinations, depreciation, third party royalty obligations, and patent pool fees.
Fiscal Year EndedChange
LicensingSeptember 25,
2026
September 26,
2025
$%
Revenue$1,321,201 $1,248,017 $73,184 6 %
Percentage of total revenue93 %93 %
Cost of licensing103,235 83,619 19,616 23 %
Gross profit1,217,966 1,164,398 53,568 5 %
Gross margin92 %93 %
Fiscal Year Ended
Licensing Revenue By MarketSeptember 25, 2026September 26, 2025
Broadcast$446,957 34 %$428,471 34 %
Mobile281,722 21 %268,568 22 %
CE150,046 11 %150,704 12 %
PC145,906 11 %151,894 12 %
Other296,570 23 %248,380 20 %
Total licensing revenue$1,321,201 100 %$1,248,017 100 %
FactorLicensing RevenueGross Margin
OtheráHigher revenue from imaging patents, most notably from the Video Distribution Program, Dolby Cinema and Dolby Atmos adoption in cars, partially offset by lower gaming console unit shipmentsâLower gross margin primarily due to accelerated depreciation on projectors and higher admin fee costs
BroadcastáHigher revenue primarily from recoveries, partially offset by lower true-up and timing of minimum volume commitments
MobileáHigher revenue from Dolby Atmos and Dolby Vision adoption and higher recoveries, partially offset by timing of minimum volume commitments in our patent programs
PCâLower revenue primarily from lower unit shipments and lower recoveries, partially offset by higher revenue in our imaging patent programs
CEâLower revenue from lower unit shipments, partially offset by higher recoveries, higher revenue from our patent programs and adoption of Dolby Atmos
Products and Services
Products revenue is generated from the sale of audio, imaging, accessibility, and other hardware and software solutions primarily for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. Also included in Products revenue are amounts relating to certain Dolby Cinema arrangements that are considered sales-type leases that involve fixed or minimum fees. Cost of products includes materials, labor, manufacturing overhead, amortization of certain intangible assets, and certain third party royalty obligations.
41

Table of Contents

Services revenue consists of fees charged to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training and maintenance, mixing room alignment, equalization, as well as audio, color, and light image calibration. Services revenue also includes PCS for products sold and equipment installed at Dolby Cinema theaters operated by exhibitor partners and support for the implementation of our technologies into products manufactured by our licensees. Also included in Services revenue are amounts generated through Dolby OptiView. Cost of services consists of personnel and personnel-related costs for providing our professional services, software maintenance and support, external contractors, and other direct expenses incurred on behalf of customers.
Fiscal Year EndedChange
Products and ServicesSeptember 25,
2026
September 26,
2025
$%
Revenue$99,666 $101,113 $(1,447)(1)%
Percentage of total revenue7 %7 %
Cost of products and services83,264 76,513 6,751 9 %
Gross profit16,402 24,600 (8,198)(33)%
Gross margin16 %24 %
FactorProducts and Services RevenueGross Margin
ProductsßàNo significant fluctuationsßàNo significant fluctuations
ServicesßàNo significant fluctuationsâLower gross margin due to higher Dolby Cloud Solutions customer support costs and Dolby Cinema equipment maintenance costs
Operating Expenses
Research and Development
Research and Development ("R&D") expenses consist primarily of employee compensation and benefits expenses, stock-based compensation, external contractor costs, depreciation and amortization, facilities costs, costs for outside materials, and information technology expenses.
Fiscal Year EndedChange
September 25,
2026
September 26,
2025
$%
Research and development$262,780$261,792$988—%
Percentage of total revenue18%19%
CategoryKey Drivers
Research and DevelopmentßàNo significant fluctuations
Sales and Marketing
Sales and Marketing ("S&M") expenses consist primarily of employee compensation and benefits expenses, stock-based compensation, marketing and promotional expenses for events such as trade shows and conferences, marketing campaigns, travel-related expenses, contractor fees, facilities costs, depreciation and amortization, information technology expenses, and legal costs associated with unreported and underreported use of our IP.
Fiscal Year EndedChange
September 25,
2026
September 26,
2025
$%
Sales and marketing$350,011$360,711$(10,700)(3)%
Percentage of total revenue25%27%
CategoryKey Drivers
MarketingâLower costs of $4.5 million primarily due to non-repeating marketing activities in the prior year
Taxes and InsuranceâLower costs of $4.2 million due to favorable tax adjustments and refunds
42

Table of Contents

General and Administrative
General and Administrative ("G&A") expenses consist primarily of employee compensation and benefits expenses, stock-based compensation, depreciation and amortization, facilities and information technology costs, as well as professional fees and other costs associated with external contractors.
Fiscal Year EndedChange
September 25,
2026
September 26,
2025
$%
General and administrative$301,589$286,529$15,0605%
Percentage of total revenue21%21%
CategoryKey Drivers
Legal, Professional, and ContractorsáHigher costs of $9.9 million primarily due to litigation expenses and patent pool program-related costs
Stock-based CompensationáHigher costs of $4.4 million primarily due to one-time equity award modifications related to the CEO transition
Restructuring Charges
Restructuring charges recorded as operating expenses in our consolidated statements of operations represent costs associated with separate individual restructuring plans implemented in various fiscal periods. The extent of our costs arising as a result of these actions, including fluctuations in related balances between fiscal periods, is based on the nature of activities under the various plans.
Fiscal Year EndedChange
September 25,
2026
September 26,
2025
$%
Restructuring charges$15,997$15,007$9907%
Percentage of total revenue1%1%
Fiscal 2026 Restructuring Event
In June 2026, we initiated restructuring actions with the purpose of reorganizing and consolidating certain activities and positions within our global business infrastructure. In connection with this plan, we recorded expense in fiscal 2026 of $3.3 million in severance and other related benefits. These activities resulted in estimated gross pre-tax operating income savings of approximately $2 million in fiscal 2026 and are expected to result in pre-tax savings of $10 million in fiscal 2027, due to estimated savings in compensation and benefits of impacted employees. The impact of these estimated savings on our operating expenses will be mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses. Cash payment of the severance and other termination benefits are expected to be substantially completed by the end of the first quarter of fiscal 2027. We estimate that we will incur additional employee-related restructuring costs during fiscal 2027; however, we cannot estimate the total amount expected to be incurred as cost reduction actions continue to be evaluated.
Fiscal 2025 Restructuring Events
In September 2025, we initiated restructuring actions in order to centralize teams into fewer locations, relocate certain roles to provide better access to talent pools, encourage multi-disciplinary collaboration, and simplify operations. In connection with this plan, we recorded expense of $12.7 million in fiscal 2026 and $6.1 million in fiscal 2025 in severance and other related benefits. The majority of the components of this plan were substantially completed during fiscal 2026. Cash payment of the severance and other termination benefits were substantially completed by the end of fiscal 2026. These activities resulted in gross pre-tax operating income savings of approximately $20 million in fiscal 2026, due to savings in compensation and benefits of impacted employees, which was consistent with our expectations. The impact of these savings on our operating expenses was mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
43

Table of Contents

In November 2024, we initiated restructuring actions with the purpose of aligning our R&D resources, and to a lesser extent our S&M resources, with our highest strategic priorities. In connection with this plan, we recorded expense in fiscal 2025 of $9.2 million in severance and other related benefits. Cash payment of the severance and other termination benefits were substantially completed by the end of fiscal 2025. These activities resulted in gross pre-tax operating income savings of approximately $20 million in fiscal 2025, due to savings in compensation and benefits of impacted employees, which was consistent with our expectations. The impact of these savings on our operating expenses was mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
Fiscal 2024 Restructuring Event
In April 2024, we initiated restructuring actions with the purpose of focusing our resources on our highest strategic priorities. These activities resulted in gross pre-tax operating income savings of approximately $11 million within fiscal 2025, which was consistent with our expectations. The impact of these savings on our operating expenses was mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
For additional information on our Restructuring programs, see Note 13 "Restructuring" to our consolidated financial statements.
Other Income/Expense
Other income/expense primarily consists of interest income earned on cash and investments and the net gains or losses from foreign currency transactions, derivative instruments, our proportionate share of net income or losses from our equity method investments, and gains and losses on the sales of marketable securities from our investment portfolio.
Fiscal Year EndedChange
Other income/(expense)September 25,
2026
September 26,
2025
$%
Interest income/(expense), net$16,670$15,376$1,2948%
Other income, net16,71923,150(6,431)(28)%
Total$33,389$38,526$(5,137)(13)%
CategoryKey Drivers
Other IncomeâLower income from our equity method investments in the current year
Income Taxes
Our effective tax rate is based on our fiscal year results and is affected each period end by several factors. These include differences from projected fiscal year results, changes to tax rates, the relative mix of income earned in our domestic and foreign jurisdictions, as well as discrete items such as changes to our uncertain tax benefits that may occur but are not necessarily consistent between periods. For additional information related to effective tax rates, see Note 12 "Income Taxes" to our consolidated financial statements.
Fiscal Year Ended
September 25,
2026
September 26,
2025
Provision for income taxes (in thousands)$(77,855)$(46,993)
Effective tax rate23%15%
FactorImpact On Effective Tax Rate
Tax ContingenciesáLower benefit from release of certain tax contingencies due to the expiration of the statute of limitations.
Research and DevelopmentáLower benefit from R&D tax credits.
Stock-based CompensationáLower benefit related to the settlement of stock-based awards.
Foreign OperationsâHigher benefit from foreign earned income.

44

Table of Contents

LIQUIDITY, CAPITAL RESOURCES, AND FINANCIAL CONDITION
Our principal sources of liquidity are cash, cash equivalents, and investments, as well as cash flows from operations. We also have additional access to liquidity under a revolving credit facility, as noted in our Current Report on Form 8-K filed with the SEC on November 19, 2024. We believe that these sources will be sufficient to satisfy our currently anticipated cash requirements through at least the next twelve months.
As of September 25, 2026, we had cash and cash equivalents of $622.9 million, which consisted of cash and highly liquid money market funds. In addition, we had short and long-term investments of $89.9 million, which primarily consisted of equity method investments and equity securities without a readily determinable fair value.
The following table presents selected financial information as of September 25, 2026 and September 26, 2025 (in thousands):
September 25,
2026
September 26,
2025
Cash and cash equivalents$622,876 $701,893 
Short-term investments500 703 
Accounts receivable, net301,081 331,096 
Accounts payable and accrued liabilities379,274 387,096 
Working capital911,386 950,471 
Capital Expenditures and Uses of Capital
Historically, our capital expenditures consisted of purchases of land, building, building fixtures, laboratory equipment, office equipment, computer hardware and software, leasehold improvements, and production and test equipment. Currently, our capital expenditures primarily include expenditure amounts associated with our Dolby Cinema locations. We continue to invest in S&M and R&D to promote the overall growth of our business and technological innovation.
We continue to retain sufficient cash holdings to support our operations and we also have historically purchased investment-grade securities diversified among security types, industries, and issuers. We have used cash generated from our operations to fund a variety of activities related to our business in addition to our ongoing operations, including business expansion and growth, acquisitions, and repurchases of our Class A common stock. We have historically generated significant cash from operations. However, these cash flows and the value of and return on our investments could be affected by various risks and uncertainties, as described in Part I, Item 1A "Risk Factors."
Shareholder Return
We have returned cash to stockholders through both repurchases of Class A common stock under our repurchase program initiated in fiscal 2010 and our quarterly dividend program initiated in fiscal 2015. Refer to Note 9 "Stockholders' Equity and Stock-Based Compensation" to our consolidated financial statements for a summary of dividend payments made under the program during fiscal 2026 and additional information regarding our stock repurchase program.
Stock Repurchase Program. Our stock repurchase program was approved in fiscal 2010, and since then we have completed approximately $3.3 billion of stock repurchases under the program.
Quarterly Dividend Program. During fiscal 2015, we initiated a recurring quarterly cash dividend program for our stockholders. For fiscal 2026, quarterly dividends of $0.36 per share were paid on our Class A and Class B common stock to eligible stockholders of record. On November 17, 2026, we announced a cash dividend of $0.39 per share of Class A and Class B common stock, payable on December 9, 2026, to stockholders of record as of the close of business on December 1, 2026.
Cash Flows Analysis
For the following comparative analysis performed for each of the sections of the consolidated statements of cash flows, the significant factors identified as the leading drivers contributing to the fluctuation are presented in descending order of their impact relative to the overall change (in thousands).
45

Table of Contents

Operating Activities
Fiscal Year Ended
September 25,
2026
September 26,
2025
Net cash provided by operating activities$399,545 $472,198 
Net cash provided by operating activities decreased $72.7 million in fiscal 2026 compared to fiscal 2025, primarily due to the following:
FactorImpact On Cash Flows
Operating assets and liabilitiesâLower inflows due to higher contract assets and higher prepaids and other assets, offset by higher income taxes payable
Investing Activities
Fiscal Year Ended
September 25,
2026
September 26,
2025
Net cash used in investing activities$(84,183)$(10,586)
Net cash used in investing activities was $73.6 million higher in fiscal 2026 compared to fiscal 2025, primarily due to the following:
FactorImpact On Cash Flows
Purchase of Intangible AssetsâHigher outflows from the purchase of intangible assets
Proceeds from Sale of Assets Held for SaleâLower inflows from sale of held for sale assets
Proceeds from Sale of Intangible AssetsáHigher inflows from sale of intangible assets related to the HEVC/VVC program
Financing Activities
Fiscal Year Ended
September 25,
2026
September 26,
2025
Net cash used in financing activities$(410,892)$(247,238)
Net cash used in financing activities was $163.7 million higher in fiscal 2026 compared to fiscal 2025, primarily due to the following:
FactorImpact On Cash Flows
Share RepurchasesâHigher outflows due to higher common stock repurchases
Common Stock IssuanceâLower inflows from employee stock option exercises
Contractual Obligations and Commitments
Naming Rights
We are party to agreements for naming rights of certain facilities, most significantly for naming rights and related benefits with respect to the Dolby Theatre in Hollywood, California, the location of the Academy Awards®. The term of this agreement is 20 years, over which we will make payments on a semi-annual basis until fiscal 2032. We also hold the naming rights to Dolby Live at the Park MGM in Las Vegas, Nevada. Dolby Live is a fully integrated performance venue offering live concerts in Dolby Atmos. As of September 25, 2026, we had $55.4 million remaining to be paid under these agreements, with $11.1 million due during fiscal 2027. For additional details regarding our naming rights commitments, see Note 14 "Commitments and Contingencies" to our consolidated financial statements.
Operating Leases
We have commitments for future minimum rent made under non-cancelable leases for office space, including those payable to our principal stockholder and portions attributable to the noncontrolling interests in majority-owned subsidiaries. For additional details regarding our leases, see Note 7 "Leases" and Note 18 "Related Parties" to our consolidated financial statements.
Purchase Obligations
46

Table of Contents

Purchase obligations primarily consist of our non-cancelable commitments made under agreements to purchase goods and services related to Dolby Cinema and for purposes that include information technology and telecommunications, marketing and professional services, and manufacturing and other R&D activities. As of September 25, 2026, we had $107.9 million remaining on these commitments, with $47.5 million due during fiscal 2027. For additional details regarding our purchase obligations, see Note 14 "Commitments and Contingencies" to our consolidated financial statements.
Donation Commitments
Our donation commitments relate to non-cancelable obligations that consist of maintenance services and installation of audio and imaging products. As of September 25, 2026, we had $1.0 million remaining under these commitments, with $0.2 million due during fiscal 2027. For additional details regarding our donation commitments, see Note 14 "Commitments and Contingencies" to our consolidated financial statements.
Unrecognized Tax Benefits
As of September 25, 2026, we had an accrued liability for unrecognized tax benefits without interest, penalties, and related deferred tax assets, totaling $92.3 million. We are unable to estimate when any cash settlement with a taxing authority might occur.
Indemnification Clauses
In limited cases, our contractual agreements contain a clause under which we agree to provide indemnification to the counterparty, most commonly to licensees in connection with licensing arrangements that include our IP. In such cases, the indemnification arrangements usually provide for limitations on the scope or amount of potential obligations. We have also, in certain limited instances, elected to defend our licensees from third party IP infringement claims even when not contractually required to do so when it is in our interests. We have also entered into indemnification agreements with our officers, directors, and certain employees, and our bylaws contain similar indemnification obligations. For additional details regarding indemnification clauses within our contractual agreements, see Note 14 "Commitments and Contingencies" to our consolidated financial statements.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Sensitivity
As of September 25, 2026, we had cash and cash equivalents of $622.9 million, which consisted of cash and highly-liquid money market funds. In addition, we had short-term and long-term investments of $89.9 million, which primarily consisted of equity method investments and equity securities without a readily determinable fair value. Our investment policy is focused on the preservation of capital and support for our liquidity requirements. Under the policy, we invest in highly rated securities with a minimum credit rating of A- while limiting the amount of credit exposure to any one issuer other than the U.S. government. We do not invest in financial instruments for trading or speculative purposes, nor do we use leveraged financial instruments. We utilize external investment managers who adhere to the guidelines of our investment policy.
Foreign Currency Exchange Risk
We maintain business operations in foreign countries, most significantly in Australia, China, Germany, Ireland, Poland, and the U.K. Additionally, a portion of our business is conducted outside of the U.S. through subsidiaries with functional currencies other than the U.S. dollar, most notably:
•Australian Dollar
•British Pound
•Chinese Yuan
•Euro
•Polish Zloty
As a result, we face exposure to adverse movements in currency exchange rates as the financial results of our international operations are translated from local currency into U.S. dollars upon consolidation. The majority of our revenue generated from international markets is denominated in U.S. dollars, while the operating expenses of our
47

Table of Contents

foreign subsidiaries are predominantly denominated in local currencies. Therefore, our operating expenses will increase when the U.S. dollar weakens against the local currency and decrease when the U.S. dollar strengthens against the local currency. Additionally, foreign exchange rate fluctuations on transactions denominated in currencies other than the functional currency result in gains or losses that are reflected in our consolidated statements of operations. Our foreign operations are subject to the same risks present when conducting business internationally, including, but not limited to, changes in economic conditions and geopolitical climate, differing tax structures, foreign exchange rate volatility, and other regulations and restrictions.
We also enter into forward currency contracts exclusively designated as cash flow hedges, which have a maturity of thirteen months or less, to reduce the impact of currency volatility on U.S. dollar operating expenses. The gains and losses from the effective portions of cash flow hedges are recorded at fair value as a component of Accumulated Other Comprehensive Income/(Loss) ("AOCI"), until the hedged transaction affects earnings. In the period when the hedged transaction affects earnings, the corresponding gains or losses of the cash flow hedge are recognized in the same line item in our consolidated statements of operations.
The pre-tax loss attributed to the effective portion of cash flow hedges recognized in AOCI was $2.7 million in fiscal 2026. The pre-tax gain attributed to the effective portion of cash flow hedges recognized in AOCI was $1.0 million in fiscal 2025.
The pre-tax effective portion of the gain reclassified to the consolidated statements of operations in fiscal 2026 was $1.6 million, and the pre-tax effective portion of the gain reclassified to the consolidated statements of operations was not material in fiscal 2025.
We also enter into foreign currency forward contracts to hedge against assets and liabilities for which we have foreign currency exchange rate exposure and selected anticipated expenses. The contracts hedging receivables and payables are carried at fair value with changes in the fair value recorded to other income/(expense), net, in our consolidated statements of operations.
As of September 25, 2026 and September 26, 2025, the total notional amounts of outstanding contracts were $142.7 million and $195.9 million, respectively.
For additional information related to our foreign currency forward contracts, see Note 2 "Summary of Significant Accounting Policies" to our consolidated financial statements.
A sensitivity analysis was performed on all of our foreign currency forward contracts as of September 25, 2026. This sensitivity analysis was based on a modeling technique that measures the hypothetical market value resulting from a 10% shift in the value of exchange rates relative to the U.S. dollar. For these forward contracts, duration modeling was used where hypothetical changes were made to the spot rates of the currency. A 10% increase in the value of the U.S. dollar would lead to a decrease in the fair value of our financial instruments by $3.6 million. Conversely, a 10% decrease in the value of the U.S. dollar would result in an increase in the fair value of these financial instruments by $3.6 million.
48

Table of Contents

ITEM 8. CONSOLIDATED FINANCIAL STATEMENTS
DOLBY LABORATORIES, INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 

49

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors
Dolby Laboratories, Inc.:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting

We have audited the accompanying consolidated balance sheets of Dolby Laboratories, Inc. and subsidiaries (the Company) as of September 25, 2026 and September 26, 2025, the related consolidated statements of operations, comprehensive income, stockholders’ equity, and cash flows for each of the fiscal years in the three-year period ended September 25, 2026, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of September 25, 2026, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 25, 2026 and September 26, 2025, and the results of its operations and its cash flows for each of the fiscal years in the three-year period ended September 25, 2026, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 25, 2026 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Basis for Opinions

The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable
50

Table of Contents

assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

Assessment of revenue estimate related to sales-based licensing arrangements

As discussed in Note 3 to the consolidated financial statements, revenue is derived principally from the licensing of technologies and patents to various types of licensees. The Company recognized total licensing revenue of $1.3 billion for the fiscal year ended September 25, 2026. The Company estimates and records sales-based licensing revenue from its licensees’ shipments in the same period in which those shipments occur. After receiving the royalty statements from the licensees, which is generally in the quarter after those shipments have occurred, the Company will record an adjustment based on the difference between the estimated and actual sales-based licensing revenue.

We identified the assessment of the revenue estimates related to the Company’s sales-based licensing arrangements as a critical audit matter. Auditor judgment was required to evaluate the Company’s estimation of sales-based licensing revenue, which included the use of historical data, industry estimates of expected shipments, market penetration, and average sales prices.

The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s sales-based licensing revenue estimation process. This included controls related to the review of (1) historical data, (2) third-party industry expectations for shipments of units, (3) the estimated percentage of market penetration, and (4) estimated average sales prices. We tested the Company’s process to develop the sales-based licensing revenue estimate. Specifically, we evaluated the sources of the historical data and assumptions that the Company used by considering their relevance and reliability. We performed sensitivity analyses over certain assumptions to assess the impact on the sales-based licensing revenue estimate of reasonably possible changes to the assumptions. In addition, we compared the Company’s historical sales-based licensing revenue estimates to actual sales-based licensing royalties received from licensees during the year, to assess the Company’s ability to accurately estimate.

/s/ KPMG LLP

We have served as the Company’s auditor since 2002.

San Francisco, California
November 17, 2026
51

Table of Contents

DOLBY LABORATORIES, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
 
September 25,
2026
September 26,
2025
ASSETS
Current assets:
Cash and cash equivalents$622,876 $701,893 
Restricted cash75,007 91,468 
Short-term investments500 703 
Accounts receivable, net of allowance for credit losses of $10,444 and $7,221
301,081 331,096 
Contract assets, net of allowance for credit losses of $79 and $101
230,791 180,804 
Inventories, net28,454 30,424 
Prepaid expenses and other current assets70,488 51,873 
Total current assets1,329,197 1,388,261 
Long-term investments89,435 80,205 
Property, plant, and equipment, net457,346 470,608 
Operating lease right-of-use assets40,783 33,204 
Intangible assets, net389,414 397,057 
Goodwill529,057 529,900 
Deferred taxes214,937 214,361 
Other non-current assets118,338 114,164 
Total assets$3,168,507 $3,227,760 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$19,780 $17,840 
Accrued liabilities359,494 369,256 
Income taxes payable— 8,928 
Contract liabilities28,362 31,382 
Operating lease liabilities10,175 10,384 
Total current liabilities417,811 437,790 
Non-current contract liabilities22,263 29,687 
Non-current operating lease liabilities35,620 28,494 
Other non-current liabilities80,312 99,843 
Total liabilities556,006 595,814 
Commitments and Contingencies (See Note 14)
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 58,746,229 shares issued and outstanding as of September 25, 2026 and 60,802,616 as of September 26, 2025
52 54 
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 33,951,901 shares issued and outstanding as of September 25, 2026 and 34,660,045 as of September 26, 2025
39 40 
Retained earnings2,616,138 2,634,980 
Accumulated other comprehensive loss(12,635)(12,517)
Total stockholders’ equity – Dolby Laboratories, Inc.2,603,594 2,622,557 
Noncontrolling interest8,907 9,389 
Total stockholders’ equity2,612,501 2,631,946 
Total liabilities and stockholders’ equity$3,168,507 $3,227,760 
See accompanying notes to consolidated financial statements
52

Table of Contents

DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Revenue:
Licensing$1,321,201 $1,248,017 $1,181,794 
Products and services99,666 101,113 91,927 
Total revenue1,420,867 1,349,130 1,273,721 
Cost of revenue:
Cost of licensing103,235 83,619 67,204 
Cost of products and services83,264 76,513 73,292 
Total cost of revenue186,499 160,132 140,496 
Gross profit1,234,368 1,188,998 1,133,225 
Operating expenses:
Research and development262,780 261,792 263,663 
Sales and marketing350,011 360,711 334,460 
General and administrative301,589 286,529 270,392 
Restructuring charges15,997 15,007 6,384 
Total operating expenses930,377 924,039 874,899 
Operating income303,991 264,959 258,326 
Other income/(expense):
Interest income/(expense), net16,670 15,376 34,077 
Other income, net16,719 23,150 20,076 
Total other income33,389 38,526 54,153 
Income before income taxes337,380 303,485 312,479 
Provision for income taxes(77,855)(46,993)(48,163)
Net income including noncontrolling interest259,525 256,492 264,316 
Less: net income attributable to noncontrolling interest(1,788)(1,474)(2,491)
Net income attributable to Dolby Laboratories, Inc.$257,737 $255,018 $261,825 
Net income per share:
Basic$2.73 $2.66 $2.74 
Diluted$2.70 $2.62 $2.69 
Weighted-average shares outstanding:
Basic94,568 95,868 95,544 
Diluted95,587 97,479 97,325 
Related party rent expense:
Included in net income attributable to noncontrolling interest$315 $283 $283 
Cash dividend declared per common share$1.44 $1.32 $1.23 
Cash dividend paid per common share$1.44 $1.32 $1.20 
See accompanying notes to consolidated financial statements

53

Table of Contents

DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Net income including noncontrolling interest$259,525 $256,492 $264,316 
Other comprehensive income/(loss):
Currency translation adjustments gains, net of tax benefit/(expense) of $127, ($200), and $65
1,080 5,367 15,098 
Unrealized gains on investments, net of tax benefit/(expense) of $0, $0, and ($21)
— 83 2,775 
Unrealized gains/(losses) on cash flow hedges, net of tax expense of ($180), ($106), and ($344)
(1,251)1,251 197 
Total other comprehensive income/(loss), net of tax(171)6,701 18,070 
Total comprehensive income259,354 263,193 282,386 
Less: comprehensive income attributable to noncontrolling interest(1,735)(1,505)(2,764)
Comprehensive income attributable to Dolby Laboratories, Inc.$257,619 $261,688 $279,622 
See accompanying notes to consolidated financial statements

54

Table of Contents

DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)
Dolby Laboratories, Inc.
Class AClass BAPICRetained
Earnings
AOCITotal Stockholders’ EquityNoncontrolling
Interest
Total
SharesAmountSharesAmount
Balance as of September 29, 202359,674 $53 36,086 $41 $— $2,391,990 $(36,984)$2,355,100 $17,084 $2,372,184 
Net income— — — — — 261,825 — 261,825 2,491 264,316 
Other comprehensive income, net of tax— — — — — — 17,797 17,797 273 18,070 
Distributions to noncontrolling interest— — — — — — — — (5,164)(5,164)
Stock-based compensation expense— — — — 119,825 — — 119,825 — 119,825 
Capitalized stock-based compensation expense— — — — 573 — — 573 — 573 
Repurchase of common stock(1,936)(2)— — (116,341)(43,658)— (160,001)— (160,001)
Excise tax on common stock repurchases— — — — (261)— — (261)— (261)
Cash dividends declared and paid on common stock— — — — — (114,579)— (114,579)— (114,579)
Common stock issued under employee stock plans2,019 2 — — 40,201 — — 40,203 — 40,203 
Tax withholdings on vesting of restricted stock(450)— — — (39,075)— — (39,075)— (39,075)
Common stock transfers - Class B to Class A415 — (415)— — — — — — — 
Purchase of non-controlling interest in business combinations— — — — (5,282)— — (5,282)(4,638)(9,920)
Deconsolidation of subsidiary— — — — — 677 — 677 (677)— 
Equity issued in connection with business combination— — — — 360 — — 360 362 722 
Balance as of September 27, 202459,722 53 35,671 41 — 2,496,255 (19,187)2,477,162 9,731 2,486,893 
Net income— — — — — 255,018 — 255,018 1,474 256,492 
Other comprehensive income, net of tax— — — — — — 6,670 6,670 31 6,701 
Distributions to noncontrolling interest— — — — — — — — (1,847)(1,847)
Stock-based compensation expense— — — — 128,514 — — 128,514 — 128,514 
Capitalized stock-based compensation expense— — — — 323 — — 323 — 323 
Repurchase of common stock(1,620)(2)— — (135,296)10,306 — (124,992)— (124,992)
Cash dividends declared and paid on common stock— — — — — (126,599)— (126,599)— (126,599)
Common stock issued under employee stock plans2,163 2 — — 43,695 — — 43,697 — 43,697 
Tax withholdings on vesting of restricted stock(473)— — — (37,236)— — (37,236)— (37,236)
Common stock transfers - Class B to Class A1,011 1 (1,011)(1)— — — — — — 
Balance as of September 26, 202560,803 54 34,660 40 — 2,634,980 (12,517)2,622,557 9,389 2,631,946 
Net income— — — — — 257,737 — 257,737 1,788 259,525 
Other comprehensive loss, net of tax— — — — — — (118)(118)(53)(171)
Distributions to noncontrolling interest— — — — — — — — (2,217)(2,217)
Stock-based compensation expense— — — — 133,288 — — 133,288 — 133,288 
Capitalized stock-based compensation expense— — — — 480 — — 480 — 480 
Repurchase of common stock(4,286)(4)— — (124,744)(140,256)— (265,004)— (265,004)
Excise tax on common stock repurchases— — — — (1,675)— — (1,675)— (1,675)
Cash dividends declared and paid on common stock— — — — — (136,323)— (136,323)— (136,323)
Common stock issued under employee stock plans2,043 2 — — 27,268 — — 27,270 — 27,270 
Tax withholdings on vesting of restricted stock(522)(1)— — (34,617)— — (34,618)— (34,618)
Common stock transfers - Class B to Class A708 1 (708)(1)— — — — — 
Balance as of September 25, 202658,746 $52 33,952 $39 $— $2,616,138 $(12,635)$2,603,594 $8,907 $2,612,501 
See accompanying notes to consolidated financial statements
55

Table of Contents

DOLBY LABORATORIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Operating activities:
Net income including noncontrolling interest$259,525 $256,492 $264,316 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization95,005 87,827 75,559 
Stock-based compensation133,288 128,514 119,825 
Amortization of operating lease right-of-use assets10,264 10,770 11,768 
Amortization of premium on investments— — (2,919)
Provision for/(benefit from) credit losses5,018 2,434 (2,256)
Deferred income taxes1,180 4,988 (21,612)
Share of net income of equity method investees, net of cash distributions(11,040)(707)(2,023)
Other non-cash items affecting net income781 (1,108)3,305 
Changes in operating assets and liabilities:
Accounts receivable, net(15,281)(18,463)(28,967)
Contract assets, net(52,336)16,680 (8,707)
Inventories10,196 8,019 (2,654)
Operating lease right-of-use assets(18,016)(4,505)(8,420)
Prepaid expenses and other assets(37,656)15,223 (2,013)
Accounts payable and accrued liabilities40,290 22,851 (34,554)
Income taxes, net(4,756)(42,829)(4,501)
Contract liabilities(4,828)(5,079)(9,738)
Operating lease liabilities7,079 (8,503)(5,263)
Other non-current liabilities(19,168)(406)(13,894)
Net cash provided by operating activities399,545 472,198 327,252 
Investing activities:
Purchases of marketable securities— — (160,198)
Proceeds from sales of marketable securities— 15,911 234,061 
Proceeds from maturities of marketable securities— — 157,729 
Proceeds from sale of assets held for sale— 16,881 — 
Purchases of property, plant, and equipment(39,631)(36,348)(30,007)
Business combinations, net of cash and restricted cash acquired, and other related payments— (1,362)(487,877)
Purchases of intangible assets(61,175)(5,593)— 
Proceeds from sale of intangible assets16,623 — — 
Purchases of other investments— (75)— 
Net cash used in investing activities(84,183)(10,586)(286,292)
Financing activities:
Proceeds from issuance of common stock27,270 43,697 40,203 
Repurchase of common stock(265,004)(124,992)(160,001)
Payment of cash dividend(136,323)(126,599)(114,579)
Distributions to noncontrolling interest(2,217)(1,847)(5,164)
Payment of excise tax on repurchase of common stock — (261)— 
Purchase of noncontrolling interest in business combinations— — (9,920)
Equity issued in connection with business combination— — 722 
Shares repurchased for tax withholdings on vesting of restricted stock(34,618)(37,236)(39,075)
Net cash used in financing activities(410,892)(247,238)(287,814)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash52 1,235 6,640 
Net increase/(decrease) in cash, cash equivalents, and restricted cash(95,478)215,609 (240,214)
Cash, cash equivalents, and restricted cash at beginning of period793,361 577,752 817,966 
Cash, cash equivalents, and restricted cash at end of period$697,883 $793,361 $577,752 
Supplemental disclosure:
Cash paid for income taxes, net of refunds received$69,980 $73,737 $63,217 
Non-cash investing and financing activities:
Change in property, plant, and equipment purchased, unpaid at period-end$(398)$(2,830)$8,711 
Accrual of unpaid stock repurchase excise tax1,675 — 261 
See accompanying notes to consolidated financial statements
56

Table of Contents

DOLBY LABORATORIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. Basis of Presentation
Principles of Consolidation
The consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly-owned and majority-owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder or other entities have a noncontrolling interest. We report these noncontrolling interests as a separate line in our consolidated statements of operations as net income attributable to noncontrolling interest and in our consolidated balance sheets as a noncontrolling interest. We eliminate all intercompany accounts and transactions upon consolidation.
Use of Estimates
The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our consolidated financial statements and accompanying notes.
Significant items subject to such estimates and assumptions include estimated shipments by our licensees for which we are owed a sales-based royalty. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Our estimates of royalty-based revenue also take into consideration the macroeconomic effect of global events that may impact our licensees' supply chain activities as well as demand for shipments.
Additional significant items subject to such estimates and assumptions include Estimated Selling Prices ("ESPs") for performance obligations within revenue arrangements; allowance for credit losses for accounts receivable; carrying values of inventories and certain Property, Plant, and Equipment ("PP&E"), goodwill, and intangible assets; fair values of investments; accrued liabilities including unrecognized tax benefits, deferred income tax assets and liabilities, and contingent liabilities; and stock-based compensation. Actual results could differ from our estimates.
Fiscal Year
Our fiscal year is a 52 or 53 week period ending on the last Friday in September. The fiscal years presented herein include the 52 week period ended September 25, 2026 (fiscal 2026), September 26, 2025 (fiscal 2025), and September 27, 2024 (fiscal 2024). Our fiscal year ending September 24, 2027 (fiscal 2027) will consist of 52 weeks.

2. Summary of Significant Accounting Policies
Concentration of Credit Risk
Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, restricted cash, investments, accounts receivable, and contract assets. We maintain cash, cash equivalents, and investments with multiple financial institutions that have high credit standing, and that we believe are financially sound and have minimal credit risk exposure, although at times our balances may exceed the applicable insurance coverage limits. We monitor and manage the overall counterparty credit risk exposure of our cash balances to individual financial institutions on an ongoing basis. Our investment portfolio may consist of investment-grade securities diversified amongst security types, industries, and issuers. All of our securities are held in custody by large national financial institutions. Our investment policy limits the amount of credit exposure to a maximum of 5% of our total portfolio to any one issuer, except for the U.S. Treasury, and we believe no significant concentration risk exists with respect to these investments. We also mitigate counterparty risk through entering into derivative contracts with high-credit-quality financial institutions. Actual or potential defaults of one or more financial institutions could impact our results of operations or financial position, and make it challenging to find alternative qualified counterparties.
The majority of our licensing revenue is generated from customers outside of the U.S. We manage the credit risk posed by non-U.S. customers by performing regular evaluations of the creditworthiness of our licensing customers and recognize revenue in accordance with U.S. GAAP.
57

Table of Contents

For fiscal 2026, 2025, and 2024, we did not have any individual customers that accounted for 10% or more of our total revenue.
Cash and Cash Equivalents
We consider all short-term highly liquid investments with original maturities of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents primarily consist of funds held in general checking accounts and money market accounts.
Restricted Cash
Restricted cash on our consolidated balance sheets consists of royalties payable to third-party licensors through certain Via-administered patent pools. Restricted cash also consists of cash contributed by Dolby and third-party licensors to Via, our subsidiary, that may only be used for licensor enforcement actions or licensee compliance activities related to certain Via-administered patent pools. Restricted cash may also consist of other amounts for which contractual conditions restrict the use of the cash for general operations.
Investments
Our investments primarily consist of our U.S. government money market funds, equity securities, and our mutual fund investments held in our Supplemental Executive Retirement Plan ("SERP"), which are classified as trading securities. Investments that have an original maturity of 91 days or more at the date of purchase and a current maturity of less than one year are classified as short-term investments, while investments with a current maturity of more than one year are classified as long-term investments. Available-For-Sale ("AFS") securities, if any, and trading securities held in our SERP are recorded at fair value in our consolidated balance sheets. Unrealized gains and losses on AFS securities are reported as a component of AOCI, while realized gains and losses and credit losses are reported as a component of net income. Upon sale, gains and losses are reclassified from AOCI into earnings, and are determined based on specific identification of securities sold.
We evaluate our investment portfolio for impairment by comparing the fair value with the cost basis for each of our investment securities. If the fair value of the AFS securities, if any, is less than amortized cost, such securities are considered impaired. If we have the intent to sell the debt security, or if it is more likely than not that we will be required to sell the debt security before recovery of its amortized cost, the difference between the amortized cost (net of allowance, if any) and the fair value of the securities is reported as an impairment loss in net income. Impaired debt securities that we intend to hold are evaluated to determine whether we need to recognize an allowance for credit losses, limited to the difference between the fair value and amortized cost of the security.
Equity Securities
Equity securities for which we possess the ability to exercise significant influence, but not control, over operating and financing decisions are accounted for under the equity method. In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount of the investment by our proportionate share of the investee's net earnings or losses. We record dividends or other equity distributions as reductions in the carrying value of the investment. Our share of the equity method investee's net income or loss is included in other income/(expense), net in the consolidated statements of operations. Our equity method investments are included within long-term investments in our consolidated balance sheets.
We also hold several investments in equity securities of privately-held companies without a readily determinable fair value, and equity securities of publicly traded companies with a readily determinable fair value. The equity securities without a readily determinable fair value are accounted for using the measurement alternative, which is cost, less any impairment, adjusted for changes in fair value resulting from observable transactions for identical or similar investments of the same issuer. We perform a qualitative assessment at each reporting date to determine whether there are triggering events for impairment. The equity securities with a readily determinable fair value are measured at fair value, with any gains or losses recognized in other income, net on the consolidated statements of operations. These equity securities are included within short-term and long-term investments in our consolidated balance sheets.
Allowance for Credit Losses
We maintain a provision for estimated credit losses on receivables resulting from our customers' inability to make required payments. In determining the provision, we pool receivables with similar risk characteristics to evaluate
58

Table of Contents

the collectability of our receivables. Risk characteristics considered in creating these risk pools include assessing historical or expected loss patterns, credit ratings, current macroeconomic conditions that could impact collectability of cash flows, and structure of customer agreements. In cases where circumstances have changed such that specific customers no longer share similar risk characteristics, customers are excluded from their current pool and their risk profiles are evaluated separately. We recognize allowances for credit losses based on our actual historical loss information, the current business environment, and reasonable and supportable forecasts. Actual future losses from uncollectible accounts may differ from our estimates.
Inventories
Inventories are accounted for using the first-in, first-out method, and are valued at the lower of cost and net realizable value. We evaluate our ending inventories for estimated excess quantities and obsolescence. Our evaluation includes the analysis of future sales demand by product within specific time horizons. Inventories in excess of projected future demand are written down to their net realizable value. In addition, we assess the impact of changing technology on our inventory balances and write-off inventories that are considered obsolete. Write-downs and write-offs of inventory are recorded as cost of products in our consolidated statements of operations. We classify inventory that we do not expect to sell within twelve months as other non-current assets in our consolidated balance sheets.
Property, Plant, and Equipment
PP&E is stated at cost less accumulated depreciation. Depreciation expense is recognized on a straight-line basis according to estimated useful lives assigned to each of our different categories of PP&E as summarized within the following table:    
PP&E CategoryUseful Life
Computer equipment and software
3 to 5 years
Machinery and equipment
3 to 8 years
Furniture and fixtures
5 to 8 years
Leasehold improvementsLesser of useful life or related lease term
Equipment provided under operating leases
15 years
Buildings and building improvements
20 to 40 years
We may encounter scenarios where assets we acquire may deviate from the established standard useful life provided above. Such occurrences are evaluated on a case by case basis, and are assigned a useful life commensurate with the facts and circumstances associated with the specific PP&E being acquired. We capitalize certain costs incurred during the construction phase of a project or asset into construction-in-progress until the construction process is complete. Once the related asset is placed into service, we transfer its carrying value into the appropriate fixed asset category and begin depreciating the value over its useful life.
Equipment Provided Under Operating Leases.  In arrangements that we assess as operating leases, we recognize our equipment installed at third-party sites as PP&E and depreciate the asset on a straight-line basis.
Internal-use Software.  We capitalize qualifying internal-use software development costs, consisting primarily of external and internal labor, including stock based compensation, incurred during the application development stage. Costs incurred during the preliminary project and post-implementation stages are charged to expense. Capitalized costs are included in PP&E, net of accumulated amortization in our consolidated balance sheets. Our capitalized internal-use software costs are amortized on a straight-line basis over estimated useful lives of three years, unless another systematic and rational basis is more representative of the software’s useful life.
Business Combinations
For business combinations, we recognize the identifiable assets acquired, the liabilities assumed and any non-controlling interests in an acquiree, which are measured based on the acquisition date fair value. Goodwill is measured as the excess of consideration transferred over the net amounts of the identifiable tangible and intangible assets acquired and the liabilities assumed at the acquisition date.

We use significant estimates and assumptions to determine the fair value of assets acquired and liabilities assumed, any contractual obligations assumed, pre-acquisition contingencies, and contingent consideration, and the related useful lives of the acquired assets, when applicable, as of the acquisition date. These estimates and assumptions are inherently uncertain and may be subject to change as additional information is received and certain tax returns are finalized.
59

Table of Contents


As a result, during the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. After the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations.

Acquisition costs are recorded in G&A and S&M expenses on the consolidated statements of operations, and are recognized as incurred.
Goodwill, Intangible Assets, and Long-Lived Assets
We perform an assessment of goodwill for potential impairment annually during our third fiscal quarter or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. For our annual goodwill test as of the fiscal quarter ended June 26, 2026, a qualitative assessment was performed and we concluded that it was more likely than not that its fair value was in excess of its carrying amount. Accordingly, no quantitative assessment was performed and no impairment was recorded. We did not incur any goodwill impairment losses in any of the periods presented.
Intangible assets are stated at their original cost less accumulated amortization, and those with definite lives are amortized over their estimated useful lives. Our intangible assets principally consist of acquired technology, patents, customer relationships and contracts, the majority of which are amortized on a straight-line basis over their useful lives using a range from three to eighteen years.
We review long-lived assets, including intangible assets, for impairment whenever events or a change in circumstances indicate an asset or asset group’s carrying value may not be recoverable. Recoverability of an asset or asset group is measured by comparing its carrying amount to the total future undiscounted cash flows that it is expected to generate. If it is determined that an asset or asset group is not recoverable, an impairment loss is recorded in the amount by which the carrying amount exceeds its estimated fair value.
Revenue Recognition
We enter into revenue arrangements with our customers to license technologies, trademarks and patents for sound and imaging solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product, or service to a customer.
For additional financial information and a summary of our accounting policy, refer to Note 3 "Revenue Recognition" to our consolidated financial statements.
Cost of Revenue
Cost of licensing.  Cost of licensing primarily consists of amortization expenses associated with purchased intangible assets and intangible assets acquired in business combinations. Cost of licensing also includes IP royalty obligations to third parties, depreciation of our Dolby Cinema equipment provided under operating leases in collaborative arrangements, and direct fees incurred.
Cost of products and services.  Cost of products primarily consists of the cost of materials related to products sold, applied labor, manufacturing overhead, warranty costs, excess and obsolescence charges, and other inventory-related expenses. Cost of products also includes third-party royalty obligations associated with intellectual property incorporated into our products. Cost of services primarily consists of the personnel and personnel-related costs of employees performing our professional services, and those of outside consultants, and reimbursable expenses incurred on behalf of customers.
Stock-Based Compensation
We measure expenses associated with all employee stock-based compensation awards using a fair-value method and record such expense in our consolidated financial statements on a straight-line basis over the requisite service period.
Advertising and Promotional Costs
60

Table of Contents

Advertising and promotional costs are charged primarily to S&M expense as incurred. Our advertising and promotional costs were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Advertising and promotional costs$50,341 $51,021 $57,338 
Foreign Currency Activities
Foreign Currency Translation.  We maintain business operations in foreign countries. We translate the assets and liabilities of our international subsidiaries, the majority of which are denominated in non-U.S. dollar functional currencies, into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses of these subsidiaries are translated using the average rates for the period. Gains and losses from these translations are included in AOCI within stockholders’ equity.
Foreign Currency Transactions.  Our domestic and foreign subsidiaries transact in currencies other than their functional currency. Therefore, we re-measure non-functional currency assets and liabilities of these subsidiaries using exchange rates at the end of each period. As a result, we recognize foreign currency transaction and re-measurement gains and losses, which are recorded within Other income, net in our consolidated statements of operations. These gains and losses were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Foreign currency transaction gains$1,214 $1,252 $1,800 
Non-designated Hedges.  In an effort to reduce the risk that our earnings will be adversely affected by foreign currency exchange rate fluctuations, we enter into foreign currency forward contracts exclusively to hedge against assets and liabilities for which we have foreign currency exchange rate exposure. These derivative instruments are carried at fair value with changes in the fair value recorded to other income/(expense), net, in our consolidated statements of operations. While not designated as hedging instruments, these foreign currency forward contracts are used to reduce the exchange rate risk associated primarily with intercompany receivables and payables. These contracts do not subject us to material balance sheet risk due to exchange rate movements as gains and losses on these derivatives are intended to offset gains and losses on the related receivables and payables for which we have foreign currency exchange rate exposure. As of September 25, 2026 and September 26, 2025, the total notional amounts of outstanding contracts were $134.2 million and $110.1 million, respectively. As of September 25, 2026, the outstanding derivative instruments had maturities of equal to or less than 28 days. The fair values of these contracts are included within accrued liabilities in our consolidated balance sheets.
Cash Flow Hedges. We also enter into forward currency contracts exclusively designated as cash flow hedges, which have a maturity of thirteen months or less, to reduce the impact of currency volatility on U.S. dollar operating expenses. As of September 25, 2026 and September 26, 2025, the total notional amounts of outstanding contracts were $8.5 million and $85.8 million, respectively. As of September 25, 2026, the outstanding derivative instruments had maturities of equal to or less than one month. The gains and losses from the effective portions of cash flow hedges are recorded at fair value as a component of AOCI, until the hedged item is subsequently reclassified into earnings in the same period in which the hedged transaction affects earnings, with the corresponding hedged item. Amounts reclassified are recorded to the same line item in the consolidated statements of operations as the impact of the hedge transaction, concurrently with the hedged costs.
The pre-tax loss attributed to the effective portion of cash flow hedges recognized in AOCI was $2.7 million in fiscal 2026. The pre-tax gain attributed to the effective portion of cash flow hedges recognized in AOCI was $1.0 million in fiscal 2025. The pre-tax effective portion of the gains reclassified to the consolidated statements of operations in fiscal 2026 was $1.6 million. The pre-tax effective portion of the gains reclassified to the consolidated statements of operations in fiscal 2025 was not material.
Income Taxes
We use the asset and liability method, under which deferred income tax assets and liabilities are determined based upon the difference between the financial statement carrying amounts and the tax bases of assets and liabilities, and Net Operating Loss ("NOL") carryforwards are measured using the enacted tax rate expected to apply
61

Table of Contents

to taxable income in the years in which the differences are expected to be reversed. In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The realization of deferred tax assets is additionally dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities and projected future taxable income in making this assessment, and we record a valuation allowance to reduce our deferred tax assets when it is more-likely-than-not that some portion or all of the deferred tax assets will not be realized.
We record an unrecognized tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities. We include interest and penalties related to gross unrecognized tax benefits within our provision for income taxes. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued are reversed in the period that such determination is made and are reflected as a reduction of the overall income tax provision.
Recently Issued Accounting Standards
We continually assess any Accounting Standards Updates ("ASUs") or other new accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") to determine their applicability and impact on us. Where it is determined that a new accounting pronouncement will result in a change to our financial reporting, we take the appropriate steps to ensure that such changes are properly reflected in our consolidated financial statements or notes thereto.
Adopted Standards
Income Taxes. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires further enhancement of income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. We adopted ASU 2023-09 prospectively beginning with our annual period beginning September 27, 2025. Refer to Note 12 "Income Taxes" for enhanced income tax disclosures. The standard’s adoption did not have a material impact on the consolidated financial statements.
Standards Not Yet Effective
Income Statement. In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in notes to financial statements, including purchases of inventory, employee compensation, depreciation, amortization of intangible assets, and selling expenses. In January 2025, the FASB issued ASU 2025-01, Income Statement — Reporting Comprehensive Income — Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. This standard will be effective for Dolby's annual period beginning September 25, 2027 and interim periods beginning September 30, 2028, with early adoption permitted. We are currently in the process of evaluating the impact of the standard's adoption on our consolidated financial statements and related disclosures.
Intangibles. In September 2025, the FASB issued ASU 2025-06, Intangibles — Goodwill and Other — Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which eliminates references to the previous stage-based model, and requires capitalization of software costs when management has committed to the software project and it is probable the software will be completed and perform its intended use. This standard is effective for Dolby beginning September 30, 2028, and may be applied prospectively, retrospectively, or using a modified transition approach, with early adoption permitted. We are currently in the process of evaluating the impact of the standard's adoption on our consolidated financial statements and related disclosures.
Environmental Credits and Environmental Credit Obligations. In May 2026, the FASB issued ASU 2026-02, Environmental Credits and Environmental Credit Obligations (Topic 818), which establishes guidance for the recognition, measurement, presentation, and disclosure of environmental credits and environmental credit obligations. This standard will be effective for Dolby's annual period beginning September 30, 2028, including interim periods within that annual period, and required to be adopted retrospectively through a cumulative-effect adjustment to the opening balance of retained earnings as of the beginning of the annual reporting period of adoption, with early adoption permitted. We do not expect the adoption of this standard to have a material impact on our consolidated financial statements.
62

Table of Contents


3. Revenue Recognition
We enter into revenue arrangements with our customers to license technologies, trademarks, and patents for sound and imaging solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product, or service to a customer.
A. Identification of the Contract or Contracts with Customers
We generally determine that a contract with a customer exists upon the execution of an agreement and after consideration of collectability, which could include an evaluation of the customer's payment history, the existence of a standby letter of credit between the customer’s financial institution and our financial institution, public financial information, and other factors. At contract inception, we also evaluate whether two or more non-standard agreements with a customer should be combined and accounted for as a single contract.
B. Identification of Performance Obligations in a Contract
We generate revenue principally from the following sources, which represent performance obligations in our contracts with customers:
•Licensing.   We license our technologies, including patents, to a range of customers who incorporate them into their products for audio and imaging functionality across broadcast, mobile, CE, PC, gaming, and other markets.
•Product Sales. We design and provide audio and imaging products for the cinema, television, broadcast, and entertainment industries.
•Services.   We provide various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training, mixing room alignment, equalization, as well as audio, color and light image calibration. We also offer solutions through our platform Dolby OptiView to companies building real-time digital experiences that increase audience engagement. Our solution provides the capability to stream high-quality audiovisual content in ultra-low latency to reduce the delay between the action and the viewer.
•PCS. We provide PCS for products sold and for equipment leased, and we support the implementation of our licensing technologies in our licensees’ products.
•Equipment Leases. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences by leasing equipment and licensing our IP.
•Licensing Administration Fees. We generate administrative fees for managing patent pools on behalf of third party patent owners through our subsidiary, Via.
Some of our revenue arrangements include multiple performance obligations, such as hardware, software, support and maintenance, and extended warranty services. We evaluate whether promised products and services are distinct performance obligations.
The majority of our arrangements with multiple performance obligations pertain to our digital cinema server and processor sales that include the following distinct performance obligations to which we allocate portions of the transaction price based on their stand-alone selling price:
•Digital cinema server hardware and embedded software that is dependent on and interrelated with the hardware. Accordingly, the hardware and embedded software represent a single performance obligation.
•The right to support and maintenance, that is included with the purchase of the digital cinema server hardware, is a distinct performance obligation.
•The right to receive commissioning services is a distinct performance obligation within the sale of the Dolby Atmos Cinema Processor. These services consist of the review of venue designs specifying proposed speaker placement as well as calibration services performed for installed speakers to ensure optimal playback.
63

Table of Contents

C. Determination of Transaction Price for Performance Obligations in a Contract
After identifying the distinct performance obligations, we determine the transaction price in accordance with the terms of the underlying executed contract which may include variable consideration such as discounts, rebates, refunds, rights of returns, and incentives. We assess and update, if necessary, the amount of variable consideration to which we are entitled for each reporting period. At the end of each reporting period, we estimate and accrue a liability for returns and adjustments as a reduction to revenue based on several factors, including past return history.
With the exception of our sales-based royalties, we evaluate whether a significant financing component exists when we recognize revenue in advance of customer payments that occur over time. For example, some of our licensing arrangements include payment terms greater than one year from when we transfer control of our IP to a licensee and the receipt of the final payment for that IP. If a significant financing component exists, we classify a portion of the transaction price as interest income, instead of recognizing all of the transaction price as revenue. We do not adjust the transaction price for the effects of financing if, at contract inception, the period between the transfer of control to a customer and final payment is expected to be one year or less.
D. Allocation of Transaction Price to Distinct Performance Obligations in a Contract
For our sales-based royalties where the license is the predominant item to which the royalties relate, we present all revenue as licensing.
For revenue arrangements that include multiple performance obligations, we determine the stand-alone selling price for each distinct performance obligation based on the actual selling prices made to customers. If the performance obligation is not sold separately, we estimate the stand-alone selling price. We do so by considering market conditions such as competitor pricing strategies, customer specific information and industry technology lifecycles, internal conditions such as cost and pricing practices, or applying the residual approach method when the selling price of the good, most commonly a license, is highly variable or uncertain.
Once the transaction price, including any variable consideration, has been determined, we allocate the transaction price to the performance obligations identified in the contract and recognize revenue as or when control is transferred for each distinct performance obligation.
E. Revenue Recognition as Control is Transferred to a Customer
We generate our licensing revenue by licensing our technologies and patents to various types of licensees, such as chip manufacturers ("implementation licensees"), consumer product manufacturers, software vendors, and communications service providers. Our revenue recognition policies for each of these arrangements are summarized below.
Initial fees from implementation licensees. Implementation licensees incorporate our technologies into their chipsets that, once approved by Dolby, are available for purchase by OEMs for use in end-user products. Implementation licensees only pay us a nominal initial fee on contract execution as consideration for the ongoing services that we provide to assist in their implementation process. Revenue from these initial fees is recognized ratably over the contractual term as a component of licensing revenue.
Sales-based licensing fees. In our royalty bearing licensing agreements with OEMs, control is transferred upon the later of contract execution or the contract’s effective date. We apply the royalty exception, which requires that we recognize sales-based royalties when the sales occur based on our estimates. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Generally, our estimates represent the current period’s shipments for which we expect our licensees to submit royalty statements in the following quarter. Upon receipt of royalty statements from the licensees with the actual reporting of sales-based royalties that we estimated previously, we record a favorable or unfavorable adjustment based on the difference, if any, between estimated and actual sales. In the first, second, and third quarters of fiscal 2026, we recorded favorable adjustments of approximately $7 million, $2 million, and $1 million, respectively. In the fourth quarter of fiscal 2026, we recorded an unfavorable adjustment of approximately $6 million. Each of these adjustments is primarily related to shipments that occurred in the prior two quarters, and is largely based on actual royalty statements received from licensees that differed from our estimates.
Fixed and guaranteed licensing fees.   In certain cases, our arrangements require the licensee to pay fixed, non-refundable fees. In these cases, control is transferred and fees are recognized upon the later of contract
64

Table of Contents

execution or the effective date. Additionally and separate from initial fees from implementation licensees, our sales- and usage-based licensing agreements include a nominal fee, which is also recognized at a point in time in which control of the IP has been transferred. Revenue from these arrangements is included as a component of licensing revenue.
Recoveries.   Through compliance efforts, we identify misreported licensed activity related to non-current periods. We may record a favorable or unfavorable revenue adjustment in connection with the findings from these compliance efforts generally upon resolution with the licensee through agreement of the findings, or upon receipt of the licensee’s correction statement. Revenue from these arrangements is included as a component of licensing revenue.
We undertake activities aimed at identifying potential unauthorized uses of our technologies, which, when successful, result in the recognition of revenue. Recoveries stem from third parties who agree to remit payments to us based on past use of our technology. In these scenarios, a legally binding contract did not exist at the time of use of our technology, and therefore, we recognize revenue recoveries upon execution of the agreement as that is the point in time at which a contract exists and control is transferred. This revenue is classified as licensing revenue.
In general, we classify legal costs associated with activities aimed at identifying potential unauthorized uses of our technologies, auditing existing licensees, and on occasion, pursuing litigation as S&M in our consolidated statements of operations.
We recognize licensing revenue gross of withholding taxes, which our licensees remit directly to their local tax authorities, and for which we receive a partial foreign tax credit in our income tax provision.
In addition to our licensing arrangements, we also enter into arrangements to deliver products and services.
Product Sales.   Revenue from the sale of products is recognized when the customer obtains control of the promised good or service, which is generally upon shipment. Payments are generally made within 90 days of sale.
Services.   We provide various services, such as engineering services related to movie soundtrack print mastering, equipment training and maintenance, mixing room alignment, equalization, and image calibration, which we bill on a fixed fee and time and materials basis. Most of these services are of a short duration and are recognized as control of the performance obligations are transferred which is when the related services are performed.
Cloud Services. We offer solutions through our Dolby OptiView platform as well as cloud encoding services, generally, on either a consumption or subscription basis. Revenue related to cloud services provided on a consumption basis is recognized when the customer utilizes the services, based on the quantity of services consumed. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract term as the customer receives and consumes the benefits of the cloud services.
Collaborative Arrangements.   We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences. Under such collaborations, Dolby and the exhibitor are both active participants, and share the risks and rewards associated with the business. Accordingly, these collaborations are governed by revenue sharing arrangements under which Dolby receives revenue based on box office receipts, in exchange for our proprietary designs and trademarks as well as for the use of our equipment at the exhibitor's venue. The use of our product solution meets the definition of a lease, and for the related portion of Dolby's share of revenue, we apply Accounting Standards Codification ("ASC") 842, Leases, and recognize revenue based on monthly, or quarterly, box office reports from exhibitors. Our revenue share is recognized as licensing revenue in our consolidated statements of operations.
In addition, we also enter into hybrid agreements where a portion of our revenue share involves guaranteed payments, which in some cases result in classifying the arrangement as a sales-type lease. In such arrangements, we consider control to transfer at the point in time to which we have installed and tested the equipment, at which point we record such guaranteed payments as product revenue.
Licensing Administration Fee. We generate administrative fees for managing patent pools on behalf of third party patent owners through our subsidiary, Via. As an agent to licensors in the patent pool, Via receives a share of the sales-based royalty that the patent pool licensors earn from licensees. As such, we apply the sales-based royalty exception as the service provided is directly related to the patent pool licensors’ provision of IP, which results in recognition based on estimates of the licensee’s quarter shipments that use the pool’s patents. In addition to sales-based royalties, Via also has contracts where the fees are fixed. The revenue share Via receives from licensors on
65

Table of Contents

fixed fee contracts is recognized over the term in which we are providing services associated with the fixed fee contract. We recognize our administrative fees net of the consideration paid to the patent licensors in the pool as licensing revenue.
Deferred revenue, which is a component of contract liabilities, represents amounts that are ultimately expected to be recognized as revenue, but for which we have yet to satisfy the performance obligation. As of September 25, 2026, we had $50.6 million of remaining performance obligations, 56% of which we expect to recognize as revenue in fiscal 2027, 16% in fiscal 2028, and the balance of 28% in fiscal years beyond 2028.
F. Disaggregation of Revenue
The following table presents a summary of the composition of our revenue for all periods presented (in thousands, except percentage amounts):
Fiscal Year Ended
RevenueSeptember 25, 2026September 26, 2025September 27, 2024
Licensing$1,321,201 93 %$1,248,017 93 %$1,181,794 93 %
Products and services99,666 7 %101,113 7 %91,927 7 %
Total revenue$1,420,867 100 %$1,349,130 100 %$1,273,721 100 %
The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts):
Fiscal Year Ended
MarketSeptember 25, 2026September 26, 2025September 27, 2024
Broadcast$446,957 34 %$428,471 34 %$409,105 35 %
Mobile281,722 21 %268,568 22 %235,774 20 %
CE150,046 11 %150,704 12 %165,817 14 %
PC145,906 11 %151,894 12 %141,300 12 %
Other296,570 23 %248,380 20 %229,798 19 %
Total licensing revenue$1,321,201 100 %$1,248,017 100 %$1,181,794 100 %
We license our technologies in approximately 60 countries, and our licensees distribute products that incorporate our technologies throughout the world. We generate the majority of our revenue from outside the U.S. Geographic data for our Licensing revenue is based on the location of our licensees’ headquarters, Products revenue is based on the destination to which we ship our products, and Services revenue is based on the location where services are performed. The following table presents the composition of our revenue by geographic location for all periods presented (in thousands, except percentage amounts):
Fiscal Year Ended
Geographic LocationSeptember 25, 2026September 26, 2025September 27, 2024
United States$630,675 44 %$496,990 37 %$450,265 35 %
International790,192 56 %852,140 63 %823,456 65 %
Total revenue$1,420,867 100 %$1,349,130 100 %$1,273,721 100 %
G. Contract Balances
Our contract assets represent rights to consideration from licensees for the use of our IP that we have estimated in a given period in the absence of receiving actual royalty statements from licensees. These estimates reflect our best judgment at that time, and are developed using a number of inputs, including historical data, industry estimates of expected shipments, anticipated sales price and performance, and third party data supporting the percentage of markets using our technologies. In the event that our estimates differ from actual amounts reported, we record an adjustment in the quarter in which the royalty statement is received, which is typically the quarter following our estimate. Actual amounts reported are typically paid within 60 days following the end of the quarter of shipment. The main drivers for change in the contract assets account are variances in quarterly estimates, and to a lesser degree, timing of receipt of actual royalty statements.
Our contract liabilities consist of payments and billings in advance of performance, with the majority satisfied within one year. The non-current portion of contract liabilities is separately disclosed in our consolidated balance sheets. We present the net contract asset or liability when we have both contract assets and contract liabilities for a single contract. In fiscal 2026, we recognized $31.1 million from prior period deferred revenue.
66

Table of Contents

The following table presents a summary of the balances to which contract assets and liabilities related to revenue are recorded for all periods presented (in thousands, except percentage amounts):
September 25, 2026September 26, 2025Change ($)Change (%)
Accounts receivable, net$301,081 $331,096 $(30,015)(9)%
Contract assets, net230,791 180,804 49,987 28 %
Contract liabilities - current28,362 31,382 (3,020)(10)%
Contract liabilities - non-current22,263 29,687 (7,424)(25)%

4. Composition of Certain Financial Statement Captions
The following tables present detailed information from our consolidated balance sheets as of September 25, 2026 and September 26, 2025 (in thousands).
Accounts Receivable and Contract Assets
September 25,
2026
September 26,
2025
Trade accounts receivable$187,424 $186,221 
Accounts receivable from patent administration program licensees124,101 152,096 
Contract assets230,870 180,905 
Accounts receivable and contract assets, gross542,395 519,222 
Less: allowance for credit losses on accounts receivable and contract assets(10,523)(7,322)
Total accounts receivable and contract assets, net$531,872 $511,900 
Accounts receivable as of September 25, 2026 and September 26, 2025, respectively, includes unbilled accounts receivable balances of $146.6 million and $173.5 million, related to amounts that are contractually owed. The unbilled balance represents our unconditional right to consideration related to fixed fee contracts which we are entitled to as a result of satisfying, or partially satisfying, performance obligations, as well as Via's unconditional right to consideration related to its patent administration programs.
Allowance for Credit LossesBeginning BalanceCharges/(Credits)  
to S&M and G&A
DeductionsEnding Balance
For fiscal year ended:
September 27, 2024$10,969 $(2,256)$(1,877)$6,836 
September 26, 20256,836 2,434 (988)8,282 
September 25, 20268,282 5,018 (1,960)11,340 
Allowance for credit losses includes the provision for estimated credit losses on our sales-type leases, which was not material as of September 25, 2026 and September 26, 2025.
Inventories
September 25,
2026
September 26,
2025
Raw materials$7,178 $4,254 
Work in process2,572 4,187 
Finished goods18,704 21,983 
Total inventories$28,454 $30,424 
Inventories are stated at the lower of cost and net realizable value. Inventory with a consumption period expected to exceed twelve months is recorded within other non-current assets in our consolidated balance sheets. We have included $2.9 million and $7.5 million of inventory within non-current assets as of September 25, 2026 and September 26, 2025, respectively. Based on anticipated inventory consumption rates, and aside from existing write-downs due to excess inventory, we do not believe that material risk of obsolescence exists prior to ultimate sale.
Prepaid Expenses and Other Current Assets
67

Table of Contents

September 25,
2026
September 26,
2025
Prepaid expenses$28,126 $28,006 
Other current assets42,362 23,867 
Total prepaid expenses and other current assets$70,488 $51,873 
Accrued Liabilities
September 25,
2026
September 26,
2025
Amounts payable to patent administration program partners$104,492 $166,315 
Accrued compensation and benefits105,767 106,579 
Accrued professional fees21,060 21,165 
Unpaid property, plant, and equipment additions2,674 3,439 
Accrued customer refunds8,950 4,218 
Accrued market development funds1,950 2,578 
Other accrued liabilities (1)
114,601 64,962 
Total accrued liabilities$359,494 $369,256 
(1)    Includes a $37.2 million litigation accrual. Refer to Note 17 "Legal Matters" for additional information.
Other Non-Current Liabilities
September 25,
2026
September 26,
2025
Supplemental retirement plan obligations$5,587 $5,315 
Non-current tax liabilities (1)
51,931 46,159 
Other liabilities22,794 48,369 
Total other non-current liabilities$80,312 $99,843 
(1)     Refer to Note 12 "Income Taxes" for additional information related to our tax liabilities.


5. Investments and Fair Value Measurements
Our cash equivalents consist of highly-liquid money market funds. Our short-term and long-term investments primarily consist of equity method investments and equity securities without a readily determinable fair value. Our mutual fund investments held in our SERP are classified as trading securities. Derivative contracts are used to hedge currency risk, and these are carried at fair value and classified as other current assets, other non-current assets, and accrued liabilities in the consolidated balance sheets.
Our cash and investment portfolio consisted of the following (in thousands):
68

Table of Contents

September 25, 2026
CostUnrealizedEstimated Fair Value
GainsLossesTotalLevel 1Level 2Level 3
Cash and cash equivalents:
Cash$550,536 $— $— $550,536 $550,536 $— $— 
Cash equivalents:
Money market funds72,340 — — 72,340 72,340 — — 
Cash and cash equivalents622,876 — — 622,876 622,876 — — 
Short-term investments:
Marketable equity securities500 — — 500 500 — — 
Short-term investments500 — — 500 500 — — 
Long-term investments:
Other investments89,435 — — 89,435 — — — 
Long-term investments89,435 — — 89,435 — — — 
Total cash, cash equivalents, and investments$712,811 $— $— $712,811 $623,376 $— $— 
Investments held in supplemental retirement plan:
Assets$5,685 $— $— $5,685 $5,685 $— $— 
Included in prepaid expenses and other current assets and other non-current assets
Liabilities$5,685 $— $— $5,685 $5,685 $— $— 
Included in accrued liabilities and other non-current liabilities
Currency derivatives as hedge instruments:
Assets: Included in other current assets$— $276 $— $276 $— $276 $— 
Liabilities: Included in other accrued liabilities— — (67)(67)— (67)— 

69

Table of Contents

September 26, 2025
CostUnrealizedEstimated Fair Value
GainsLossesTotalLevel 1Level 2Level 3
Cash and cash equivalents:
Cash$529,422 $— $— $529,422 $529,422 $— $— 
Cash equivalents:
Money market funds172,471 — — 172,471 172,471 — — 
Cash and cash equivalents701,893 — — 701,893 701,893 — — 
Short-term investments:
Marketable equity securities703 — — 703 703 — — 
Short-term investments703 — — 703 703 — — 
Long-term investments:
Other investments80,205 — — 80,205 — — — 
Long-term investments80,205 — — 80,205 — — — 
Total cash, cash equivalents, and investments$782,801 $— $— $782,801 $702,596 $— $— 
Investments held in supplemental retirement plan:
Assets$5,413 $— $— $5,413 $5,413 $— $— 
Included in prepaid expenses and other current assets and other non-current assets
Liabilities$5,413 $— $— $5,413 $5,413 $— $— 
Included in accrued liabilities and other non-current liabilities
Currency derivatives as hedge instruments:
Assets: Included in other current assets$— $1,442 $— $1,442 $— $1,442 $— 
Assets: included in other non-current assets— 111 — 111 — 111 — 
Liabilities: Included in other accrued liabilities— — (48)(48)— (48)— 
Equity Securities
Our equity securities primarily consist of our equity method investments, including our equity method investment in Access Advance, of $77.7 million and $68.5 million as of September 25, 2026 and September 26, 2025, respectively, and equity securities without a readily determinable fair value, valued at $11.8 million and $11.8 million as of September 25, 2026 and September 26, 2025, respectively. The equity method investments and equity securities without a readily determinable fair value are recorded within long-term investments in our consolidated balance sheets.
The equity method investments are regularly assessed for impairment, and in the case of an impairment, we adjust the carrying value of our investment. Our share of our equity method investees' net income or loss is included in Other income/(expense) on the consolidated statements of operations. Our share of our equity method investees' net income was $17.5 million, $24.1 million and $14.2 million in fiscal 2026, fiscal 2025, and fiscal 2024, respectively.
Fair Value Hierarchy
Fair value is the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. We minimize the use of unobservable inputs and use observable market data, if available, when determining fair value. We classify our inputs to measure fair value using the following three-level hierarchy:
Level 1: Quoted prices in active markets at the measurement date for identical assets and liabilities. We base the fair value of our Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.
Level 2: Prices may be based upon quoted prices in active markets or inputs not quoted on active markets but are corroborated by market data. We obtain the fair value of our Level 2 financial instruments from a professional pricing service, which may use quoted market prices for identical or comparable instruments, or model driven
70

Table of Contents

valuations using observable market data or inputs corroborated by observable market data. To validate the fair value determination provided by our primary pricing service, we perform quality controls over values received which include comparing our pricing service provider’s assessment of the fair values of our investment securities against the fair values of our investment securities obtained from another independent source, reviewing the pricing movement in the context of overall market trends, and reviewing trading information from our investment managers. In addition, we assess the inputs and methods used in determining the fair value in order to determine the classification of securities in the fair value hierarchy. The fair value of the currency derivatives are calculated from market spot rates, forward rates, interest rates, and credit ratings at the end of the period.
Level 3: Unobservable inputs are used when little or no market data is available and reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
The following table describes the valuation techniques and inputs applicable to each class of security held within our investment portfolio:
Asset TypePrimary SourceUpdate FrequencyFair Value MethodologySecondary Source
Level 1
Money Market FundsNot ApplicableDaily$1 per shareNot Applicable
Cash Equivalents Maturities
The following table summarizes the amortized cost and estimated fair value of our cash equivalents as of September 25, 2026 and September 26, 2025, which are recorded within cash and cash equivalents in our consolidated balance sheets (in thousands):
September 25, 2026September 26, 2025
Range of maturityAmortized CostFair ValueAmortized CostFair Value
Due within 1 year$72,340 $72,340 $172,471 $172,471 
Due in 1 to 2 years— — — — 
Due in 2 to 5 years— — — — 
Total$72,340 $72,340 $172,471 $172,471 

6. Property, Plant, and Equipment    
PP&E are recorded at cost, with depreciation expense included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our consolidated statements of operations. Depreciation expense was $48.2 million, $42.5 million, and $42.4 million in fiscal 2026, 2025, and 2024, respectively.
As of September 25, 2026 and September 26, 2025, PP&E consisted of the following (in thousands):
Property, Plant, and EquipmentSeptember 25,
2026
September 26,
2025
Land$42,008 $42,021 
Buildings and building improvements292,101 290,920 
Leasehold improvements46,084 84,605 
Machinery and equipment158,193 163,382 
Computer equipment and software200,239 195,521 
Furniture and fixtures27,690 31,476 
Equipment provided under operating leases258,719 234,426 
Construction-in-progress35,752 36,181 
Property, plant, and equipment, gross1,060,786 1,078,532 
Less: accumulated depreciation(603,440)(607,924)
Property, plant, and equipment, net$457,346 $470,608 

7. Leases
71

Table of Contents

As Lessee
As a lessee, we enter into contracts to access and utilize office space, including portions attributable to the noncontrolling interests in our consolidated subsidiaries. We determine if a contract contains a lease based on whether we have the right to obtain substantially all of the economic benefits from the use of an identified asset and whether we have the right to direct the use of an identified asset in exchange for consideration, which relates to an asset which we do not own. Right-Of-Use ("ROU") assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets are recognized as the lease liability, adjusted for lease incentives received, initial direct costs, and prepaid lease payments. Lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is our Incremental Borrowing Rate ("IBR"), because the interest rate implicit in our leases is not readily determinable. The IBR is a hypothetical rate based on our understanding of what our credit rating would be and resulting interest we would pay to borrow an amount equal to the lease payments in a similar economic environment over the lease term on a collateralized basis. Lease payments may be fixed or variable, however, only fixed payments are included in our lease liability calculation. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments is incurred.
The lease term of operating leases vary from less than one year to 14 years. We have leases that include one or more options to extend the lease term for up to 5 years as well as options to terminate the lease within one year. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise such options.
The components of lease expense were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Lease cost
Operating lease cost$12,837 $13,075 $14,275 
Variable lease cost1,129 2,015 1,947 
Total lease cost$13,966 $15,090 $16,222 
Supplemental cash flow information related to leases was as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Other information
Cash paid for amounts included in the measurement of operating lease liabilities$13,330 $14,862 $15,602 
Right-of-use assets obtained in exchange for operating lease obligations18,213 4,731 21,087 
Supplemental balance sheet information related to leases was as follows:
September 25,
2026
September 26,
2025
Operating Leases
Weighted-average remaining lease term6.5 years4.8 years
Weighted-average discount rate5.5 %6.0 %
The following table presents the maturity analysis of lease liabilities (in thousands):
72

Table of Contents

September 25, 2026
Operating Leases
Fiscal 2027$12,387 
Fiscal 202811,012 
Fiscal 20297,937 
Fiscal 20304,439 
Fiscal 20313,563 
Thereafter15,946 
Total undiscounted lease payments55,284 
Less: imputed interest(9,489)
Total lease liabilities$45,795 
As Lessor
As a lessor, we lease our Dolby Cinema product solution to exhibitors. The terms of these leases are typically 10 to 15 years. Lease components consist of fixed payments and/or variable lease payments based on contracted percentages of revenue. Generally, leases do not grant any right to the lessee to purchase the underlying asset at the end of the lease term. Dolby Cinema lease arrangements have options to extend the lease term at expiration by increments ranging from 1 to 5 years.
Assets provided under an operating lease are carried at cost within property, plant, and equipment, net on the consolidated balance sheets, and depreciated over the useful life of the asset using the straight-line method. Fixed operating lease payments are recognized on a straight-line basis over the lease term to revenue. Variable lease payments received under our Dolby Cinema operating leases are computed as shares of lessees' box office revenue and recognized to revenue in the period that box office sales occur. Lease incentive payments we make to lessees are amortized as a reduction in revenue over the lease term. The components of lease income were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Operating Lease Income
Variable operating lease income$47,765 $36,828 $31,794 
Fixed operating lease income4,042 4,294 3,570 
If a lease is classified as a sales-type lease, the carrying amount of the asset is derecognized from property, plant, and equipment, net, and a net investment in the lease is recorded. The net investment in the lease is measured at commencement date as the sum of the lease receivable and the estimated residual value of the equipment. The unguaranteed residual value of the equipment is determined as the estimated carrying value of the asset at the end of the lease term had the asset been depreciated on a straight-line basis. The unguaranteed residual value of sales-type leases was $0.5 million and $0.5 million as of September 25, 2026 and September 26, 2025, respectively. Selling profit or loss arising from a sales-type lease is recorded at lease commencement and presented on a gross basis. Over the term of the lease, we recognize interest income on the net investment in the lease, and variable lease payments, which are not included in the net investment in the lease. The variable lease payments are not material.
The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands):
September 25, 2026
Operating LeasesSales-Type Leases
Fiscal 2027$— $220 
Fiscal 2028— 220 
Fiscal 2029 and thereafter— — 
Total undiscounted cash flows$— 440 
Less: Carrying value of lease receivables— 
Difference$440 
73

Table of Contents


8. Goodwill and Intangible Assets
Goodwill
The following table outlines changes to the carrying amount of goodwill (in thousands):
Goodwill
Balance as of September 27, 2024$533,208 
Translation adjustments1,757 
Measurement period adjustments(5,065)
Balance as of September 26, 2025$529,900 
Translation adjustments(843)
Balance as of September 25, 2026$529,057 
Intangible Assets
Intangible assets are stated at their original cost less accumulated amortization, and principally consist of acquired patents, technology, and customer relationships and contracts. Intangible assets subject to amortization consisted of the following (in thousands):
September 25, 2026September 26, 2025
Intangible Assets, NetCostAccumulated
Amortization
NetCostAccumulated
Amortization
Net
Acquired patents and technology$648,230 $(356,055)$292,175 $587,743 $(324,507)$263,236 
Customer relationships187,841 (90,698)97,143 221,007 (87,401)133,606 
Other intangible assets23,147 (23,051)96 23,171 (22,956)215 
Total$859,218 $(469,804)$389,414 $831,921 $(434,864)$397,057 
During fiscal 2026, we purchased various patents for cash consideration of $60.3 million, and upon acquisition, these patents had a weighted-average useful life of 12.9 years. These patents have been categorized as "acquired patents and technology" intangible assets class.
During fiscal 2026, Via sold its HEVC/VVC program intangible assets for a total consideration of $25.0 million. Refer to Note 18 "Related Parties" for more information.
During fiscal 2025, we purchased various patents for purchase consideration of $5.6 million, and upon acquisition, these intangible assets had a weighted-average useful life of 14 years.
Amortization expense for our intangible assets is included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our consolidated statements of operations. Amortization expense was $45.5 million, $45.3 million, and $33.2 million in fiscal 2026, fiscal 2025, and fiscal 2024, respectively. As of September 25, 2026, expected amortization expense of our intangible assets in future fiscal periods was as follows (in thousands):
Fiscal Year Amortization Expense
2027$47,612 
202843,893 
202942,927 
203041,604 
203140,291 
Thereafter173,087 
Total$389,414 

9. Stockholders' Equity and Stock-Based Compensation
We provide stock-based awards as a form of compensation for employees, officers, and directors. We issue stock-based awards in the form of stock options and RSUs under our equity incentive plans, as well as shares under our ESPP.
74

Table of Contents

Common Stock - Class A and Class B
Our Board of Directors has authorized two classes of common stock, Class A and Class B. As of September 25, 2026, we had authorized 500,000,000 Class A shares and 500,000,000 Class B shares. As of September 25, 2026, we had 58,746,229 shares of Class A common stock and 33,951,901 shares of Class B common stock issued and outstanding. Holders of our Class A and Class B common stock have identical rights, except that holders of our Class A common stock are entitled to one vote per share and holders of our Class B common stock are entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in our amended and restated certificate of incorporation.
Stock Incentive Plans
Our 2020 Stock Plan originally was adopted by our Board of Directors and shareholders in 2005 (when the 2020 Stock Plan was called the 2005 Stock Plan). Our stockholders last approved amendments to the 2020 Stock Plan at our 2023 annual meeting of stockholders. Our 2020 Stock Plan, as amended and restated, provides for the ability to grant incentive stock options, non-qualified stock options, restricted stock, RSUs, stock appreciation rights, deferred stock units, performance units, performance bonus awards, and performance shares. A total of 64.0 million shares of our Class A common stock have been authorized for issuance under the 2020 Stock Plan in total since inception of the plan. Any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as 1.6 shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as 1.6 shares for every one share returned.
Also, in fiscal 2026, our Board of Directors adopted the 2026 Inducement Stock Plan, which reserved 2.5 million shares of Class A common stock to be used exclusively for grants of equity-based awards to persons who satisfy the standards for an employment inducement award under Section 303A.08 of the NYSE Listed Company Manual, as an inducement material to entering employment with Dolby. The Inducement Plan was adopted by our Board of Directors without stockholder approval pursuant to New York Stock Exchange rules. Equity awards granted to our Chief Executive Officer in connection with the commencement of his employment were issued under this plan.
Stock Options.    Stock options are granted at fair market value on the date of grant. Options generally vest over four years, with 25% of the options becoming exercisable on the one-year anniversary of the date of grant and the balance of the shares vesting in equal monthly installments over the following 36 months. These options expire on the earlier of ten years after the date of grant or three months after termination of service. All options granted vest over the requisite service period and upon the exercise of stock options, we issue new shares of Class A common stock under the 2020 Stock Plan. Our 2020 Stock Plan also allows us to grant stock awards which vest based on the satisfaction of specific performance criteria.
Performance-Based Stock Options.    From fiscal 2016 through fiscal 2019, we granted Performance-Based Stock Options ("PSOs") to certain officers with shares of our Class A common stock underlying such options. The contractual term for the PSOs was seven years, with vesting contingent upon market-based performance conditions, representing the achievement of specified Dolby annualized Total Stockholder Return ("TSR") targets at the end of a three-year measurement period following the date of grant. Anywhere from 0% to 125% of the shares subject to a PSO vested based on achievement of the performance conditions at the end of the three-year performance period.
In valuing the PSOs, which were recognized as compensation cost, we used a Monte Carlo valuation model. Aside from the use of an expected term for the PSOs commensurate with their shorter contractual term, the nature of the valuation inputs used in the Monte Carlo valuation model were consistent with those used to value our non-performance based options granted under the 2020 Stock Plan. Compensation cost was amortized on a straight-line basis over the requisite service period.
75

Table of Contents

The following table summarizes information about stock options, including PSOs, issued under our 2020 Stock Plan:
SharesWeighted-Average Exercise PriceWeighted-Average Remaining Contractual Life
Aggregate Intrinsic
Value (1)
(in thousands)(in years)(in thousands)
Options outstanding as of September 26, 20253,259 $72.71 
Grants504 66.62 
Exercises(223)50.96 
Forfeitures and cancellations(25)68.40 
Options outstanding as of September 25, 20263,515 73.26 5.12$245 
Options vested and expected to vest as of September 25, 20263,386 73.33 5.06245 
Options exercisable as of September 25, 20262,630 73.72 4.03245 
(1)Aggregate intrinsic value is based on the closing stock price of our Class A common stock on September 25, 2026 of $58.56 and excludes the impact of options that were not in-the-money.
Restricted Stock Units.    In fiscal 2008, we began granting RSUs to certain directors, officers, and employees. RSU awards granted to employees and officers generally vest over four years, with annual cliff-vesting. Awards granted to ongoing non-employee directors generally vest over approximately one year. Awards granted to new non-employee directors from fiscal 2014 onward vest on the earlier of the first anniversary of the award’s date of grant, or the day immediately preceding the date of the next annual meeting of stockholders that occurs after the award’s date of grant. At each vesting date, the holder of the award is issued shares of our Class A common stock. Compensation expense from these awards is equal to the adjusted fair market value of our Class A common stock on the date of grant, discounted to account for dividend payments forgone during the vesting period, and is recognized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors. Our 2020 Stock Plan also allows us to grant RSUs that vest based on the satisfaction of specific performance criteria.
Performance-Based Restricted Stock Units.    In fiscal 2020, we began granting PSUs to certain officers with shares of our Class A common stock underlying such awards. These awards generally vest based on Dolby's achievement of annualized TSR targets measured against a comparator index over a three-year performance period following the date of grant, or specified stock-price performance targets over a five-year performance period. Depending on the award terms, anywhere from 0% to 200% of eligible restricted stock units may vest based on achievement of the performance conditions at the end of the performance period. The value of the PSUs, which is recognized as compensation cost, is calculated using a Monte Carlo valuation model. Compensation cost is being amortized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors.
The following table summarizes information on PSUs granted to our officers that have not vested as of September 25, 2026:
Aggregate Shares GrantedPotential Shares at Vest Date (at 200% of Target)
December 15, 202377,283 154,566 
December 16, 202492,971 185,942 
December 15, 2025114,403 228,806 

On December 15, 2020, we granted PSUs to our executive officers for an aggregate of 66,138 shares, which vested in December 2023 at 80% of the target award amount. On December 15, 2021, we granted PSUs to our executive officers for an aggregate of 60,301 shares, which vested in December 2024 at 70% of the target award amount. On December 15, 2022, we granted PSUs to our executive officers for an aggregate of 90,613 shares, which vested in December 2025 at 65% of the target award amount. As of September 25, 2026, PSUs that would vest for an aggregate of 284,657 shares at the target award amount (569,314 shares at 200% of the target award amount) were outstanding.
In addition, during fiscal 2026, 600,000 PSUs, that may vest upon achievement of specified stock price targets, were granted and outstanding.
76

Table of Contents

The following table summarizes information about RSUs, including PSUs, issued under our stock incentive plans:
SharesWeighted-Average
Grant Date Fair Value 
(in thousands)
Non-vested as of September 26, 20254,130 $77.07 
Granted3,075 53.46 
Vested(1,502)77.84 
Forfeitures(364)72.67 
Non-vested as of September 25, 20265,339 $63.55 
The fair value of vested RSUs (measured as of the vesting date) was as follows (in thousands):
Fiscal Year Ended
September 25, 2026
September 26, 2025
September 27, 2024
Restricted stock units - vest date fair value$99,564 $108,069 $113,909 
Employee Stock Purchase Plan.    Our ESPP originally was adopted by our Board of Directors and shareholders in 2005. Our stockholders last approved amendments to the ESPP at our 2023 annual meeting of stockholders. The ESPP allows eligible employees to have up to 10 percent of their eligible compensation withheld and used to purchase Class A common stock, subject to a maximum of $25,000 worth of stock purchased in a calendar year or no more than 1,000 shares in an offering period, whichever is less. An offering period consists of successive six-month purchase periods, with a look back feature to our stock price at the commencement of a one-year offering period. The plan provides for a discount equal to 15 percent of the lower of the closing price of our Class A common stock on the NYSE on the first day of the offering period and the last day of the purchase period. The plan also includes an automatic reset feature that provides for an offering period to be reset and recommenced to a new lower-priced offering if the offering price of a new offering period is less than that of the immediately preceding offering period. A total of 5.5 million shares of our Class A common stock have been authorized for issuance under the ESPP since inception of the plan.
Stock Option Valuation Assumptions
We use the Black-Scholes option pricing model to determine the estimated fair value of employee stock options at the date of the grant. The Black-Scholes model includes inputs that require us to make certain estimates and assumptions regarding the expected term of the award, as well as the future risk-free interest rate, and the volatility of our stock price over the expected term of the award.
Expected Term.    The expected term of an award represents the estimated period of time that options granted will remain outstanding, and is measured from the grant date to the date at which the option is either exercised or canceled. Our determination of the expected term involves an evaluation of historical terms and other factors such as the exercise and termination patterns of our employees who hold options to acquire our Class A common stock, and is based on certain assumptions made regarding the future exercise and termination behavior.
Risk-Free Interest Rate.    The risk-free interest rate is based on the yield curve of U.S. Treasury instruments in effect on the date of grant. In determining an estimate for the risk-free interest rate, we use average interest rates based on these instruments’ constant maturities with a term that approximates and corresponds with the expected term of our awards.
Expected Stock Price Volatility.    The expected volatility represents the estimated volatility in the price of our Class A common stock over a time period that approximates the expected term of the awards. The expected volatility has historically been determined using a blended combination of historical and implied volatility, but is currently being determined using historical volatility only. Historical volatility is representative of the historical trends in our stock price for periods preceding the measurement date for a period that is commensurate with the expected term. Implied volatility is based upon externally traded option contracts of our Class A common stock.
Dividend Yield.    The dividend yield is based on our anticipated dividend payout over the expected term of our option awards. Dividend declarations and the establishment of future record and payment dates are subject to the Board of Directors’ continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time.
77

Table of Contents

The weighted-average assumptions used in the determination of the fair value of our stock options were as follows:
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Expected term (in years)4.964.894.86
Risk-free interest rate3.7 %4.3 %3.9 %
Expected stock price volatility24.6 %29.5 %29.3 %
Dividend yield2.1 %1.7 %1.4 %
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Stock options granted - weighted-average grant date fair value$14.84 $21.61 $24.12 
Stock options exercised - intrinsic value2,775 13,129 14,224 
Stock-Based Compensation Expense
Stock-based compensation expense for equity awards granted to employees is determined by estimating their fair value on the date of grant, and recognizing that value as an expense on a straight-line basis over the requisite service period in which our employees earn the awards. Compensation expense related to these equity awards is recognized net of estimated forfeitures, which reduce the expense recorded in the consolidated statements of operations. The selection of applicable estimated forfeiture rates is based on an evaluation of trends in our historical forfeiture data with consideration for other potential driving factors. If in subsequent periods actual forfeitures significantly differ from our initial estimates, we will revise such estimates accordingly. The estimated annual forfeiture rates used for awards granted were 8.38%, 8.62%, and 8.53% in fiscal 2026, 2025, and 2024, respectively.
The following two tables separately present stock-based compensation expense both by award type and classification in our consolidated statements of operations (in thousands):
Expense - By Award Type
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Compensation expense
Stock options (3)
$10,776 $6,841 $6,726 
Restricted stock units (1) (2) (3)
117,770 117,803 109,031 
Employee stock purchase plan4,742 3,870 4,068 
Total stock-based compensation133,288 128,514 119,825 
Estimated benefit from income taxes(18,980)(19,847)(17,290)
Total stock-based compensation, net of tax$114,308 $108,667 $102,535 
(1)Stock-based compensation expense incurred by restricted stock units includes expense from PSUs.
(2)Excludes $0.5 million, $0.3 million and $0.6 million of capitalized stock-based compensation related to internal-use software in fiscal 2026, fiscal 2025, and fiscal 2024, respectively.
(3)Includes $6.3 million of stock-based compensation expense related to the modification of equity awards held by our former CEO in connection with a post-retirement consulting arrangement.
Expense - By Income Statement Line Item Classification
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Compensation expense
Cost of products and services$1,835 $1,747 $1,501 
Research and development40,603 38,500 38,214 
Sales and marketing42,636 44,480 40,128 
General and administrative48,214 43,787 39,982 
Total stock-based compensation133,288 128,514 119,825 
Estimated benefit from income taxes(18,980)(19,847)(17,290)
Total stock-based compensation, net of tax$114,308 $108,667 $102,535 
78

Table of Contents

The tax benefit that we recognize from shares issued under our ESPP is excluded from the tables above. The tax benefit recognized was not material in fiscal 2026, fiscal 2025, and fiscal 2024.
Unrecognized Compensation Expense.    As of September 25, 2026, total unrecognized compensation expense associated with employee stock options expected to vest was approximately $8.4 million, which is expected to be recognized over a weighted-average period of 2.7 years. As of September 25, 2026, total unrecognized compensation expense associated with RSUs expected to vest was approximately $216.4 million, which is expected to be recognized over a weighted-average period of 2.4 years.
Common Stock Repurchase Program
In November 2009, we announced a stock repurchase program, providing for the repurchase of our Class A common stock. The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of September 25, 2026 (in thousands):
Date of AuthorizationAuthorization Amount
Fiscal 2010: November 2009$250,000 
Fiscal 2010: July 2010300,000 
Fiscal 2011: July 2011250,000 
Fiscal 2012: February 2012100,000 
Fiscal 2015: October 2014200,000 
Fiscal 2017: January 2017200,000 
Fiscal 2018: July 2018350,000 
Fiscal 2019: July 2019350,000 
Fiscal 2021: July 2021350,000 
Fiscal 2022: February 2022250,000 
Fiscal 2022: August 2022350,000 
Fiscal 2024: August 2024350,000 
Fiscal 2026: July 2026350,000
Total$3,650,000 
Stock repurchases under the program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended, or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be retired and returned to the status of authorized but unissued shares of Class A common stock. As of September 25, 2026, the remaining authorization to purchase additional shares was $361.6 million.
The following table provides information regarding share repurchase activity under the program during fiscal 2026:
Quarterly Repurchase ActivityShares
Repurchased
Cost (1)
Average Price Paid Per Share (2)
(in thousands)
Q1 - Quarter ended December 26, 20251,044,838 $70,005 $67.00 
Q2 - Quarter ended March 27, 20261,010,900 64,999 64.30 
Q3 - Quarter ended June 26, 20261,176,036 64,997 55.27 
Q4 - Quarter ended September 25, 20261,054,382 65,003 61.65 
Total4,286,156 $265,004 
(1)Cost of share repurchases includes the price paid per share, and excludes commission costs.
(2)Average price paid per share excludes commission costs.
Dividend Program
79

Table of Contents

The following table summarizes dividends declared under the program during fiscal 2026:
Fiscal PeriodAnnouncement DateRecord DatePayment DateCash Dividend Per Common ShareDividend Payment
Q1 - Quarter ended December 26, 2025November 18, 2025December 2, 2025December 10, 2025$0.36 $34.3 million
Q2 - Quarter ended March 27, 2026January 29, 2026February 10, 2026February 18, 2026$0.36 $34.3 million
Q3 - Quarter ended June 26, 2026April 30, 2026May 12, 2026May 20, 2026$0.36 $34.0 million
Q4 - Quarter ended September 25, 2026July 30, 2026August 11, 2026August 19, 2026$0.36 $33.7 million
On November 17, 2026, Dolby announced a cash dividend of $0.39 per share of Class A and Class B common stock, payable on December 9, 2026, to stockholders of record as of the close of business on December 1, 2026. The estimated dividend payment of $36.2 million related to this cash dividend is based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

10. Accumulated Other Comprehensive Loss
Other comprehensive income/loss consists of three components: unrealized gains or losses on our AFS marketable investment securities, gains and losses on derivatives in cash flow hedge relationships not yet recognized in earnings, and the gains and losses from the translation of assets and liabilities denominated in non-U.S. dollar functional currencies. Until realized and reported as a component of net income, these comprehensive income items accumulate and are included within accumulated other comprehensive loss, a subsection within stockholders’ equity in our consolidated balance sheets. Unrealized gains and losses on our investment securities are reclassified from AOCI into earnings when realized upon sale, and are determined based on specific identification of securities sold. Unrealized gains and losses on our cash flow hedges are reclassified from AOCI into earnings when the hedged operating expenses are recognized, which is also when the gains and losses are realized.
The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our consolidated statements of operations (in thousands):
Fiscal Year EndedFiscal Year Ended
September 25, 2026September 26, 2025
Investment SecuritiesCash Flow HedgesCurrency Translation AdjustmentsTotalInvestment SecuritiesCash Flow HedgesCurrency Translation AdjustmentsTotal
Beginning Balance$— $1,251 $(13,768)$(12,517)$(83)$— $(19,104)$(19,187)
Other comprehensive income/(loss) before reclassifications:
Unrealized gains/(losses)(433)(2,662)— (3,095)(55)952 — 897 
Foreign currency translation gains(1)
— — 1,006 1,006 — — 5,536 5,536 
Income tax effect - benefit/(expense)— — 127 127 — — (200)(200)
Net of tax(433)(2,662)1,133 (1,962)(55)952 5,336 6,233 
Amounts reclassified from AOCI into earnings:
Realized gains(2)
433 1,591 — 2,024 138 405 — 543 
Income tax effect - expense(3)
— (180)— (180)— (106)— (106)
Net of tax433 1,411 — 1,844 138 299 — 437 
Net current-period other comprehensive income/(loss)— (1,251)1,133 (118)83 1,251 5,336 6,670 
Ending Balance$— $— $(12,635)$(12,635)$— $1,251 $(13,768)$(12,517)
(1)The foreign currency translation gains during fiscal 2025 were primarily due to the strengthening of other foreign currencies as compared to the U.S. dollar.
(2)Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our consolidated statements of operations. Realized gains or losses on foreign currency contracts designated as cash flow hedges are included in operating expenses in the consolidated statements of operations.
(3)The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.

11. Earnings Per Share
Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average
80

Table of Contents

shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period.
Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS.
Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and unvested) and vesting of outstanding RSUs. The calculation of dilutive shares outstanding excludes securities that would have an antidilutive effect on EPS.
The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Numerator:
Net income attributable to Dolby Laboratories, Inc.$257,737 255,018 $261,825 
Denominator:
Weighted-average shares outstanding—basic94,568 95,868 95,544 
Potential common shares from options to purchase common stock23 358 586 
Potential common shares from restricted stock units961 1,213 1,158 
Potential common shares from employee stock purchase plan35 40 37 
Weighted-average shares outstanding—diluted95,587 97,479 97,325 
Net income per share attributable to Dolby Laboratories, Inc.:
Basic$2.73 $2.66 $2.74 
Diluted$2.70 $2.62 $2.69 
Antidilutive awards excluded from calculation:
Stock options3,334 1,448 1,152 
Restricted stock units5 1 10 
Employee stock purchase plan7 1 3 

12. Income Taxes
Our income tax expense, deferred tax assets and liabilities, and unrecognized tax benefits reflect management's best assessment of estimated current and future liabilities. We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax expense.
81

Table of Contents

Income Tax Provision
The following two tables present the components of our income before provision for income taxes by geographic region and the portion of our provision for income taxes classified as current and deferred (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
United States$115,427 $102,907 $89,505 
Foreign221,953 200,578 222,974 
Total income before income taxes$337,380 $303,485 $312,479 
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Current:
Federal$(3,928)$(35,095)$702 
State566 581 1,124 
Foreign80,036 76,520 68,013 
Total current76,674 42,006 69,839 
Deferred:
Federal6,493 4,369 (21,357)
State2 (25)43 
Foreign(5,314)643 (362)
Total deferred1,181 4,987 (21,676)
Provision for income taxes$77,855 $46,993 $48,163 
Repatriation of Undistributed Foreign Earnings

As a result of the Tax Cuts and Jobs Act ("Tax Act"), foreign accumulated earnings that were subject to the mandatory Transition Tax as of December 31, 2017, can be repatriated to the U.S. without incurring further U.S. federal tax. The Tax Act changed to a modified territorial tax system through the provision of a 100% dividend received deduction for the foreign-source portions of dividends received from controlled foreign subsidiaries. As a result, we have reevaluated our historical assertion and determined that we no longer consider a vast majority of these earnings to be indefinitely reinvested. During fiscal 2026, we repatriated $75 million of foreign subsidiary earnings which were exempt from foreign withholding tax. As of September 25, 2026, the total undistributed earnings of our foreign subsidiaries were approximately $538 million. As of September 25, 2026, the Company has not recorded a deferred tax liability on the portion of undistributed earnings of certain foreign subsidiaries that it intends to indefinitely reinvest. These amounts would become subject to tax upon repatriation to the U.S. parent or upon sale or liquidation of the subsidiaries. Determination of the amount of the unrecognized deferred tax liability is not practicable.
Deferred Income Taxes
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, using enacted tax rates in effect for the year in which the differences are expected to reverse. A summary of the tax effects of the temporary differences were as follows (in thousands):
82

Table of Contents

Fiscal Year Ended
September 25,
2026
September 26,
2025
Deferred income tax assets:
Investments$2,621 $5,435 
Inventories1,492 3,195 
Net operating loss1,344 1,426 
Accrued expenses14,397 14,427 
Stock-based compensation17,425 17,483 
Revenue recognition2,961 3,000 
Depreciation and amortization141,186 142,408 
Lease liability9,824 7,675 
Research and development credits46,449 42,488 
Foreign tax credits22,054 20,565 
Deemed repatriated earnings tax benefit20,289 14,587 
Other4,948 3,648 
Total gross deferred income tax assets284,990 276,337 
Less: valuation allowance(57,627)(51,015)
Total deferred income tax assets227,363 225,322 
Deferred income tax liabilities:
Right of use asset(6,713)(4,981)
Intangible assets(7,266)(5,980)
Deferred income tax assets, net$213,384 $214,361 
Net Operating Losses and Tax Credit Carryforwards
As of September 25, 2026, the NOL carryforwards for U.S. federal and California were $0.7 million and $1.1 million, respectively, and will start to expire in fiscal 2034 and 2036, respectively. Additionally, we had foreign NOL carryforwards of $4.9 million as of September 25, 2026, which will carry forward indefinitely. As of September 25, 2026, we had foreign tax credit and federal R&D tax credit carryforwards of $26.0 million and $29.3 million, respectively, which will start to expire in fiscal 2029 and fiscal 2035, respectively. We had California R&D tax credits of $52.4 million and foreign R&D tax credits of $9.5 million, which will carry forward indefinitely.
Valuation Allowance. As of September 25, 2026, a $38.5 million valuation allowance was recorded against California deferred tax assets, a $5.6 million valuation allowance was recorded against federal tax credit deferred tax assets, and a $13.5 million valuation allowance was recorded against foreign deferred tax assets for which ultimate realization of its future benefits is uncertain.
Effective Tax Rate
Each period, the combination of multiple different factors can impact our effective tax rate. These factors include both recurring items such as tax rates and the relative amount of income earned in foreign jurisdictions, as well as discrete items that may occur in, but are not necessarily consistent between periods. Upon adoption of ASU 2023-09, the reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes for the fiscal year ended September 25, 2026 was as follows (in thousands):
83

Table of Contents

September 25,
2026
Federal statutory rate$70,850 21.0 %
State income taxes, net of federal effect (1)
477 0.1 
Foreign tax effects
Ireland
Statutory tax rate difference between Ireland and United States (15,055)(4.5)
Foreign tax credits(3,842)(1.1)
Other(592)(0.2)
China
Withholding tax27,850 8.3 
Other622 0.2 
Taiwan
Withholding tax5,155 1.5 
Japan
Withholding tax3,762 1.1 
Australia
Research and development tax credits(3,654)(1.1)
Foreign Valuation Allowance2,467 0.7 
Other1,137 0.3 
All Other Jurisdictions
Withholding tax12,501 3.7 
Other(848)(0.3)
Effects of cross-border tax laws
Foreign derived intangible income deduction(6,322)(1.9)
Global intangible low-taxed income2,209 0.6 
Other768 0.2 
Tax credits
Research and development tax credits(5,680)(1.7)
Foreign tax credits(28,029)(8.1)
Changes in Valuation Allowance1,612 0.5 
Nontaxable or nondeductible items
Stock-based compensation8,620 2.6 
Other(738)(0.2)
Changes in unrecognized tax benefit 4,585 1.4 
Effective tax rate$77,855 23.1 %
(1) The states and local jurisdictions that contribute to the majority (greater than 50%) of the tax effect in this category include New York and Massachusetts.
A reconciliation of the federal statutory tax rate to our effective tax rate on income from continuing operations for the fiscal years ended September 26, 2025 and September 27, 2024 in accordance with the guidance prior to the adoption of ASU 2023-09 was as follows:
Fiscal Year Ended
September 26,
2025
September 27,
2024
Federal statutory rate21.0 %21.0 %
State income taxes, net of federal effect0.2 0.2 
Stock-based compensation3.5 1.1 
Research and development tax credits(5.1)(2.7)
Foreign-derived intangible income deduction(1.4)(1.3)
U.S. tax on foreign entities1.3 1.3 
Foreign rate differential(1.2)(2.1)
Increase (decrease) unrecognized tax benefit(2.7)0.6 
Tax Act of 2017— (3.2)
Other(0.1)0.5 
Effective tax rate15.5 %15.4 %
84

Table of Contents

Our effective tax rate was 23.1% in fiscal 2026, compared with our federal statutory rate of 21.0%, and with our effective tax rate in fiscal 2025 of 15.5%. The increase in our effective tax rate was primarily due to lower recognition of tax benefits from previously unrecognized tax benefits due to the expiration of the statute of limitations, lower tax benefits related to settlement of stock-based awards, and lower tax credits.
Our effective tax rate was 15.5% in fiscal 2025, compared with our effective tax rate in fiscal 2024 of 15.4%. The increase in our effective tax rate was primarily due to lower tax benefits related to settlement of stock-based awards and a non-recurring benefit related to the Transition Tax liability under the Tax Act recognized in fiscal 2024, partially offset by the recognition of tax benefits from previously unrecognized tax benefits due to the expiration of the statute of limitations and higher tax credits.
Income Tax Payments

Upon adoption of ASU 2023-09, cash paid for income taxes, net of refunds, during the year ended September 25, 2026 was as follows (in thousands):

September 25,
2026
Federal$11,144 
State738 
Foreign
China22,551 
Ireland16,495 
Taiwan3,696 
Other15,356 
Cash paid for income taxes, net of refunds received $69,980 
Uncertain Tax Positions
As of September 25, 2026, the total amount of gross unrecognized tax benefits was $92.3 million, of which $28.0 million, if recognized, would reduce our effective tax rate. Our liability increased from fiscal 2025 primarily due to releases from the expiration of the statute of limitations, partially offset by additional accruals in fiscal 2026. Our liability for unrecognized tax benefits is classified within other non-current liabilities in our consolidated balance sheet. Aggregate changes in the balance of gross unrecognized tax benefits, excluding interest and penalties, were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Beginning Balance$83,666 $81,615 $76,304 
Gross increases - tax positions taken during prior years2,159 15,687 2,346 
Gross decreases - tax positions taken during prior years(838)(1,946)— 
Gross increases - tax positions taken during current year11,435 7,514 10,626 
Gross decreases - settlements with tax authorities during current year(116)(343)
Lapse of statute of limitations(4,151)(19,088)(7,318)
Ending Balance$92,271 $83,666 $81,615 
85

Table of Contents

Classification of Interest and Penalties
We include interest and penalties related to gross unrecognized tax benefits within our provision for income taxes. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued are reduced in the period that such determination is made and are reflected as a reduction of the overall income tax provision. In fiscal 2026, our current tax provision was decreased by the release of accrued interest expense of $0.1 million, while in fiscal year 2025, our current tax provision was decreased by the release of accrued interest expense of $12.2 million. Accrued interest and penalties are included within the related tax liability line item in our consolidated balance sheets. Our accrued interest and penalties on unrecognized tax benefits as of September 25, 2026 and September 26, 2025 were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
Accrued interest$1,352 $1,428 
Accrued penalties98 98 
Total$1,450 $1,526 
We continue to monitor the progress of ongoing income tax controversies and the impact, if any, of the expected tolling of the statute of limitations in various taxing jurisdictions. We file income tax returns in the U.S. federal, states, and foreign jurisdictions. Our major tax jurisdictions are the U.S. federal, California, and Ireland.
Our operations in certain jurisdictions remain subject to examination for fiscal 2015 to 2025, some of which are currently under audit or review. We are currently under audit by the IRS for our fiscal 2018 U.S. federal tax year. The resolution of these audits could have a material impact to our consolidated financial statements. We believe that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If resolution of any tax issues addressed in our current audits are inconsistent with management’s expectations, we may be required to adjust our tax provision for income taxes in the period such resolution occurs.

The final U.S. foreign tax credit regulations, issued on January 4, 2022, introduced significant changes to foreign tax credit utilization. However, temporary relief was granted and extended indefinitely until further notice. These provisions may have a material adverse effect on our future tax provisions unless modified or withdrawn.
The OECD published its model rules which established a global minimum corporate tax rate of 15% for certain multinational enterprises ("Pillar Two"). In January 2026, the OECD issued guidance providing for a "Side-by-Side Safe Harbor" election, which allows U.S. domestic operations to be excluded from the application of the 15% global minimum corporate tax. However, it does not exempt foreign subsidiaries from local minimum tax requirements. Many countries have implemented or are in the process of implementing the Pillar Two legislation, which became applicable to us beginning in fiscal 2025. We recorded an immaterial amount of Pillar Two tax in our fiscal 2026 consolidated financial statements. We will continue to monitor the impact as countries implement legislation and the OECD provides additional guidance.
In July 2025, the OBBBA was signed into law in the U.S. the OBBBA contains several changes to corporate income tax provisions, including the extension of many expiring provisions from the Tax Cuts and Jobs Act of 2017, and modifications to capitalization of research and experimental expenditures, accelerated fixed asset depreciation, and other tax provisions. The international provisions are generally effective for our fiscal 2027. We recognized the tax impacts of the OBBBA provisions currently in effect in our financial statements for fiscal 2026. We will continue to evaluate the effects of these provisions for future periods.


13. Restructuring
Restructuring charges recorded as operating expenses in our consolidated statements of operations represent costs associated with separate individual restructuring plans implemented in various fiscal periods. The extent of our costs arising as a result of these actions, including fluctuations in related balances between fiscal periods, is based on the nature of activities under the various plans.
Fiscal 2026 Restructuring Event
86

Table of Contents

In June 2026, we initiated restructuring actions with the purpose of reorganizing and consolidating certain activities and positions within our global business infrastructure. In connection with this plan, we recorded expense in fiscal 2026 of $3.3 million in severance and other related benefits. These activities resulted in estimated gross pre-tax operating income savings of approximately $2 million in fiscal 2026 and are expected to result in pre-tax savings of $10 million in fiscal 2027, due to estimated savings in compensation and benefits of impacted employees. The impact of these estimated savings on our operating expenses will be mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses. Cash payment of the severance and other termination benefits are expected to be substantially completed by the end of the first quarter of fiscal 2027. We estimate that we will incur additional employee-related restructuring costs during fiscal 2027; however, we cannot estimate the total amount expected to be incurred as cost reduction actions continue to be evaluated.
Fiscal 2025 Restructuring Events
In September 2025, we initiated restructuring actions in order to centralize teams into fewer locations, relocate certain roles to provide better access to talent pools, encourage multi-disciplinary collaboration, and simplify operations. In connection with this plan, we recorded expense of $12.7 million in fiscal 2026 and $6.1 million in fiscal 2025 in severance and other related benefits. The majority of the components of this plan were substantially completed during fiscal 2026. Cash payment of the severance and other termination benefits were substantially completed by the end of fiscal 2026. These activities resulted in gross pre-tax operating income savings of approximately $20 million in fiscal 2026, due to savings in compensation and benefits of impacted employees, which was consistent with our expectations. The impact of these savings on our operating expenses was mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
In November 2024, we initiated restructuring actions with the purpose of aligning our R&D resources, and to a lesser extent our S&M resources, with our highest strategic priorities. In connection with this plan, we recorded expense in fiscal 2025 of $9.2 million in severance and other related benefits. Cash payment of the severance and other termination benefits were substantially completed by the end of fiscal 2025. These activities resulted in gross pre-tax operating income savings of approximately $20 million in fiscal 2025, due to savings in compensation and benefits of impacted employees, which was consistent with our expectations. The impact of these savings on our operating expenses was mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
Fiscal 2024 Restructuring Events
In April 2024, we initiated restructuring actions with the purpose of focusing our resources on our highest strategic priorities. In connection with this plan, we recorded an expense in fiscal 2024 of $4.6 million in severance and other related benefits. Cash payment of the severance and other termination benefits were substantially completed by the end of fiscal 2024. These activities resulted in gross pre-tax operating income savings of approximately $3 million in fiscal 2024 and resulted in savings of approximately $11 million within fiscal 2025, which was consistent with our expectations. The impact of these savings on our operating expenses was mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
Fiscal 2023 Restructuring Events
In September 2023, we initiated a restructuring plan with the purpose of focusing our resources on our highest strategic priorities. In continuation with this plan, we recorded an expense in fiscal 2024 of $7.4 million in severance and other related benefits. Cash payment of the severance and other termination benefits were substantially completed by the end of fiscal 2024. These activities resulted in gross pre-tax operating income savings of approximately $40 million within fiscal 2024, which was consistent with our expectations. The impact of these savings on our operating expenses was offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
In June 2023, we implemented a focused restructuring plan, primarily consisting of workforce reductions and facility consolidations to improve execution in alignment with our strategy and to reduce our cost structure through improved utilization of our global infrastructure. Actions and expenses related to this plan were substantially completed by the end of fiscal 2024. These activities resulted in gross pre-tax operating income savings of approximately $20 million in fiscal 2024, which was consistent with our expectations. The impact of these savings on our operating expenses was mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses.
87

Table of Contents

The table presented below summarizes the changes in our restructuring accruals (in thousands):
SeveranceLeased facility exit costs and other costsTotal
Balance at September 27, 2024$2,765 $— $2,765 
Restructuring charges11,624 3,383 15,007 
Cash payments and adjustments(9,724)(3,383)(13,107)
Balance at September 26, 20254,665 — 4,665 
Restructuring charges12,478 3,519 15,997 
Cash payments and adjustments(12,699)(3,519)(16,218)
Balance at September 25, 2026$4,444 $— $4,444 
Accruals for restructuring charges/(credits) incurred for the restructuring plans described above are included within accrued liabilities in our consolidated balance sheets, while restructuring charges are included within restructuring charges in our consolidated statements of operations.

14. Commitments and Contingencies
In the ordinary course of business, we enter into contractual agreements with third parties that include non-cancelable payment obligations, for which we are liable in future periods. These arrangements can include terms binding us to minimum payments and/or penalties if we terminate the agreement for any reason other than an event of default as described by the agreement. The following table presents a summary of our contractual obligations and commitments as of September 25, 2026 (in thousands):
Payments Due By Fiscal Period
Fiscal
2027
Fiscal
2028
Fiscal
2029
Fiscal
2030
Fiscal
2031
ThereafterTotal
Naming rights$11,056 $8,642 $8,751 $8,862 $8,974 $9,087 $55,372 
Purchase obligations47,462 21,875 19,347 19,208 — — 107,892 
Donation commitments153 153 153 153 153 279 1,044 
Total$58,671 $30,670 $28,251 $28,223 $9,127 $9,366 $164,308 
Naming Rights
We are party to agreements for naming rights of certain facilities, most significantly for naming rights and related benefits with respect to the Dolby Theatre in Hollywood, California, the location of the Academy Awards®. The term of this agreement is 20 years, over which we will make payments on a semi-annual basis until fiscal 2032. Our ongoing annual payment obligations are conditioned in part on the Academy Awards being held and broadcast from the Dolby Theatre. Our payment obligations may be suspended or reduced in certain circumstances, including the protracted closure of the Dolby Theatre. We also hold the naming rights to Dolby Live at the Park MGM in Las Vegas, Nevada. Dolby Live is a fully integrated performance venue offering live concerts in Dolby Atmos.
Purchase Obligations
Purchase obligations primarily consist of our commitments made under agreements to purchase goods and services related to Dolby Cinema and for purposes that include information technology and telecommunications, marketing and professional services, and manufacturing and other R&D activities. Also included in purchase obligations are non-cancelable commitments to contract manufacturers, including potentially variable obligations related to inventory based on demand forecasts we provide to the contract manufacturers.
Donation Commitments
Our donation commitments relate to non-cancelable obligations that consist of maintenance services and installation of audio and imaging products in exchange for various marketing, branding, and publicity benefits. These donation agreements either transfer title of our audio and imaging products to the donees or offer use of the products free of charge for a specified period of time via a leasing arrangement. The recipients of these donations participate in or promote the cinema and entertainment industry and our commitments vary in length, lasting up to 15 years.
Indemnification Clauses
88

Table of Contents

In limited cases, our contractual agreements contain a clause under which we agree to provide indemnification to the counterparty, most commonly to licensees in connection with licensing arrangements that include our IP. In such cases, the indemnification arrangements usually provide for limitations on the scope or amount of potential obligations. We have also, in certain limited instances, elected to defend our licensees from third party IP infringement claims even when not contractually required to do so when it is in our interests. We are unable to reasonably estimate the potential exposure that could arise due to indemnifying our licensees.
We have also entered into indemnification agreements with our officers, directors, and certain employees, and our bylaws contain similar indemnification obligations. We are unable to reasonably estimate the potential exposure that could arise due to such indemnification obligations.

15. Business Combinations
Fiscal 2026 and Fiscal 2025
There were no business combinations entered into during fiscal 2026 and fiscal 2025.
Fiscal 2024
GE Licensing
On August 19, 2024, we acquired 100% of the issued and outstanding equity interests of GE Intellectual Property Licensing, LLC and GE Technology Development, Inc., which, collectively with each of their subsidiaries, comprised General Electric’s IP licensing business that primarily targeted the consumer digital media and electronics sectors ("GE Licensing" or the "acquiree"). The acquisition is an extension of our existing licensing businesses and is expected to strengthen and expand the scale of our IP portfolio. The total consideration for the acquisition is comprised as the following (in thousands):
Amount
Total amount paid for consideration$444,882 
Less: Noncontrolling interest in Via(9,921)
Settlement of pre-existing relationship(750)
Total consideration transferred for acquisition of GE Licensing434,211 
Less: Cash acquired(2,232)
Total consideration, net of cash acquired$431,979 
Prior to the acquisition, GE Licensing held a noncontrolling interest in the Company’s majority owned subsidiary Via. The indirect acquisition of this noncontrolling interest was accounted for as a separate transaction under ASC 810. The difference between the fair value of the consideration paid of $9.9 million and the carrying amount of the noncontrolling interest acquired of $4.6 million was recognized as a $5.3 million adjustment to equity on the Company’s consolidated financial statements.
We have accounted for the taxable transaction under the acquisition method of accounting for business combinations, and the results of operations of GE Licensing have been included in our consolidated statements of operations from the date of acquisition. Additionally, we have estimated the fair values of the net tangible and intangible assets acquired, and liabilities assumed as of the acquisition date, with any amounts paid in excess of the net assets recorded as goodwill. The fair values assigned to assets acquired and liabilities assumed were based on management’s estimates and assumptions.
It is impracticable to provide historical supplemental pro forma financial information along with earnings during the period subsequent to the acquisition due to the lack of access to historical information.
The following table summarizes the acquisition date fair values of the assets acquired and liabilities assumed (in thousands):
89

Table of Contents

Recognized Identifiable Assets Acquired and Liabilities AssumedPurchase Price Allocation
Cash and cash equivalents$2,232 
Accounts receivable20,171 
Other current assets9,636 
Assets held for sale, current24,494 
Long-term investments76,000 
Intangible assets274,197 
Goodwill75,387 
Other non-current assets3,503 
Other current liabilities(15,370)
Contingent liabilities(14,199)
Other non-current liabilities(21,840)
Purchase Consideration$434,211 
We initially acquired certain assets valued at $18.2 million and increased the estimated fair value of the assets held for sale by $6.3 million in fiscal 2025 for a total value of $24.5 million. These assets were classified as held for sale within prepaid expenses and other current assets on the consolidated balance sheets and are measured at fair value less cost to sell. During fiscal 2025, we sold $15.8 million of the assets classified as held for sale, and the remaining assets no longer met the criteria for held for sale, and as such, we reclassified $8.7 million in assets held for sale to short-term and long-term investments.
Acquired contingencies relate to contingent payments due under an assumed agreement. The payments are contingent on the Company achieving certain revenue targets in the future and are based on a percentage of revenue that exceeds such targets. The Company determined that it is probable at the acquisition date that a liability has been incurred and the amount of the liability can be reasonably estimated in accordance with ASC 450. The Company recognized a contingent liability of $14.2 million on the acquisition date based on a discounted cash flow valuation technique.
Goodwill is representative of our expectation of the benefits and synergies from the integration of GE Licensing operations and the associated assembled workforce, which does not qualify for separate recognition as an intangible asset. All of the goodwill recognized is expected to be deductible for income tax purposes.
The following table summarizes the fair values allocated to the various intangible assets acquired and the weighted-average useful lives over which they will be amortized using the straight-line method:

Purchase Price AllocationWeighted-Average Useful Life
Intangible Assets Acquired(in thousands)(in years)
Patents and technology – HEVC Codecs$261,697 11
Patents and technology – non-HEVC Codecs12,500 11
Total$274,197 11
The value of acquired intangibles was determined based on the present value of estimated future cash flows using the multi-period excess earnings method with inputs such as projected revenue attributable to licensors in the patent pools, revenue retention rate, maintenance S&M expenses, income tax rate, post-tax returns for contributory assets, and discount rate.
Acquisition-related costs of $6.4 million were incurred during fiscal 2024. These acquisition-related costs were included in G&A expenses for $4.3 million and in S&M expenses for $2.1 million in the consolidated statements of operations.
THEO Technologies
On July 24, 2024, we completed the acquisition of all outstanding equity interests of THEO, a privately held company. THEO's products enable high-quality online video experiences for customers across sports and entertainment. This acquisition expands on our suite of cloud solutions to provide seamless, synchronized viewer experiences in sports and entertainment. We have included the financial results of THEO in our consolidated financial statements from the date of acquisition, and these results were not material. Additionally, the transaction costs associated with the acquisition were not material.
90

Table of Contents

The total purchase consideration of the acquisition was $58.7 million. We allocated $24.6 million in purchase consideration to identifiable intangible assets, which primarily consisted of customer relationships and developed technology, with estimated useful lives of 3 years to 13 years. We also recorded $39.9 million of goodwill, which is representative of our expectation of benefits and synergies from the integration of THEO technology with our existing technology and the assembled workforce of THEO.

16. Operating Segments and Geographic Information
Operating Segments
We operate as a single reportable segment. We derive the majority of our revenue from licensing audio and video technology to electronics manufacturers, and a lesser portion of our revenue by offering premium audio and video technologies to cinema exhibitors. Our Chief Operating Decision Maker ("CODM") is our Chief Executive Officer, who reviews financial information presented on a consolidated basis to assess performance and allocate resources. Our CODM uses consolidated net income, as reported on the consolidated statements of operations, as the primary measure of segment profit or loss by comparing actual results to the prior year comparative results and any internally or externally set expectations. Our CODM does not assess segment performance or make operating decisions using asset or liability information.
The following table presents selected financial information and significant segment expenses for the periods presented (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Total revenue $1,420,867 $1,349,130 $1,273,721 
Less:
Cost of licensing (1)
76,877 56,907 64,314 
Cost of products and services (1) (2)
78,359 71,681 69,441 
Research and development expense (1) (2)
222,177 223,292 225,449 
Sales and marketing expense (1) (2)
305,966 314,466 291,508 
General and administrative expense (1) (2)
246,997 235,254 222,922 
Restructuring charges15,997 15,007 6,384 
Stock-based compensation133,288 128,514 119,825 
Amortization of acquisition-related intangibles38,979 40,856 15,552 
Interest (income)/expense, net(16,670)(15,376)(34,077)
Equity method investees’ net income(17,503)(24,065)(14,212)
Other income, net (1) (3)
(980)(891)(5,864)
Income tax expense77,855 46,993 48,163 
Net income including noncontrolling interest259,525 256,492 264,316 
Less: net income attributable to noncontrolling interest(1,788)(1,474)(2,491)
Net income attributable to Dolby Laboratories, Inc.$257,737 $255,018 $261,825 
(1)Excludes amortization of acquisition-related intangibles presented separately.
(2)Excludes stock-based compensation expense presented separately.
(3)Excludes our proportional share of net income in our equity method investees presented separately.
Geographic Information
The methods to determine revenue by geographic region for each of the three categories included within total revenue in our consolidated statements of operations are described within the table presented below.
Revenue CategoryBasis For Determining Geographic Location
   LicensingRegion in which our licensees’ headquarters are located
   ProductsDestination to which our products are shipped
   ServicesLocation in which the relevant services are performed
91

Table of Contents

The following tables present selected information regarding total revenue by geographic location (amounts presented in thousands).
Revenue Composition—U.S. and International
Fiscal Year Ended
LocationSeptember 25,
2026
September 26,
2025
September 27,
2024
United States$630,675 $496,990 $450,265 
International790,192 852,140 823,456 
Total revenue$1,420,867 $1,349,130 $1,273,721 
Revenue Concentration—Significant Individual Geographic Regions
Fiscal Year Ended
LocationSeptember 25,
2026
September 26,
2025
September 27,
2024
United States44 %37 %35 %
South Korea11 %12 %13 %
China22 %26 %22 %
Japan6 %7 %8 %
Europe11 %9 %12 %
Other6 %9 %10 %
Total100 %100 %100 %
Long-lived tangible assets, net of accumulated depreciation, by geographic region were as follows (in thousands):
LocationSeptember 25,
2026
September 26,
2025
United States$364,460 $374,683 
International92,886 95,925 
Total long-lived tangible assets, net of accumulated depreciation$457,346 $470,608 

17. Legal Matters
From time to time, we are involved in various legal proceedings that occasionally arise in the normal course of business. These can include claims of alleged infringement of IP rights, commercial, employment, and other matters. In our opinion, resolution of these proceedings is not expected to have a material adverse impact on our operating results or financial condition. On a quarterly basis, we evaluate based on the known facts and circumstances whether a potential loss or range of losses is considered probable and reasonably estimable in accordance with U.S. GAAP. We record a provision for a liability relating to these legal proceedings when a loss is both probable and the amount of the loss can be reasonably estimated. Legal costs associated with these legal proceedings are expensed as incurred.
Given the unpredictable nature of legal proceedings, it is possible that an unfavorable resolution of one or more such proceedings could materially affect our future operating results or financial condition in a particular period, including as a result of required changes to our licensing terms, monetary penalties, and other potential consequences. However, based on the information known by us as of the date of this filing and the rules and regulations applicable to the preparation of our consolidated financial statements, other than the litigation matter discussed below, any such amounts are either immaterial, or it is not probable that a potential loss has been incurred or the amount of loss cannot be reasonably estimated.
Litigation
During fiscal 2026, we recognized a $37.2 million accrued liability related to an unfavorable judgment on litigation that we assumed as part of our acquisition of MPEG LA, L.L.C. in fiscal 2023. In connection with this business combination, the sellers provided indemnification for an unfavorable outcome of that litigation. Accordingly, we have recognized an indemnification asset of $37.2 million during fiscal 2026, which we expect to be settled within two years. The liability has been included within accrued liabilities and the indemnification asset has been included within other non-current assets in the consolidated financial statements.
92

Table of Contents


18. Related Parties
Jointly-Owned Real Estate Entities
We maintain contractual agreements relating to certain entities affiliated with the Dolby family, who is considered a related party as our principal stockholder. These jointly-owned entities were established for the purpose of acquiring and leasing commercial property in the U.S. and U.K. primarily for our operational use. Although the entities affiliated with the Dolby family hold a majority economic interest in such jointly-owned entities, they have a noncontrolling interest since they are the limited member or Limited Partner ("LP") in each of these entities. Therefore, we have consolidated the entities’ assets and liabilities and results of operations in our consolidated financial statements. The share of earnings and net assets of the entities attributable to the limited member or LP, as the case may be, is reflected as noncontrolling interest in our consolidated financial statements.
As of September 25, 2026, we hold a 49.0% minority ownership interest in Dolby Properties Burbank, LLC, which owns a facility in Burbank that the Company is leasing until 2030. We also own 10.0% minority ownership interest in Dolby Properties, LP, which owns a facility in Wootton Bassett, England. The Company is no longer leasing the Wootton Bassett facility.
The Company also leased from our principal stockholder a commercial office building located at 100 Potrero Avenue in San Francisco, California under a term that expired on October 31, 2024.
Distributions
Distributions made by the jointly-owned real estate entities to our principal stockholder were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Distributions to principal stockholder$(269)$(250)$(262)
Sale of Intangible Assets to Equity Method Investment
During fiscal 2026, our subsidiary, Via, sold its HEVC/VVC program intangible assets to Access Advance for a total consideration of $25.0 million. We hold an equity method investment in Access Advance.

19. Retirement Plans
We maintain a tax-qualified Section 401(k) retirement plan for employees in the U.S. and similar plans in foreign jurisdictions. Under the plan, employees are eligible to receive matching contributions and profit-sharing contributions. We also maintain a SERP, a non-qualified, employer-funded defined contribution retirement plan which was terminated in fiscal 2005.
Retirement plan expenses, which are included in cost of products and services, R&D, S&M, and G&A expense in our consolidated statements of operations, were as follows (in thousands):
Fiscal Year Ended
September 25,
2026
September 26,
2025
September 27,
2024
Retirement plan expenses$25,091 $24,739 $24,558 
93

Table of Contents

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES
None.

ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain "disclosure controls and procedures," as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended ("Exchange Act"), that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognizes that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Subject to the limitations noted above, our management, with the participation of our CEO and CFO, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the fiscal year covered by this Annual Report on Form 10-K. Based on that evaluation, the CEO and CFO have concluded that, as of such date, our disclosure controls and procedures were effective to meet the objective for which they were designed and operate at the reasonable assurance level.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company as defined in Rule 13a-15(f) or 15d-15(f) of the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP, and includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Our management assessed the effectiveness of the Company’s internal control over financial reporting as of September 25, 2026 using the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). Based on this assessment and those criteria, management concluded that our internal control over financial reporting was effective as of September 25, 2026. Our internal control over financial reporting has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report, which appears in Part II, Item 8 of this Annual Report on Form 10-K.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting during the fiscal quarter ended September 25, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

94

Table of Contents

ITEM 9B. OTHER INFORMATION
Securities Trading Plans of Directors and Executive Officers
During the fiscal year ending September 25, 2026, the following stockholder adopted a "Rule 10b5-1 trading arrangement" as defined in Regulation S-K Item 408, as follows:
On August 28, 2026, Dagmar Dolby as Trustee of the Dagmar Dolby Trust under the Dolby Family Trust Instrument dated May 7, 1999 adopted a Rule 10b5-1 trading arrangement providing for the charitable gifting from time to time of an aggregate of up to 1,000,000 shares of our Class A common stock and, in order to facilitate the gifting of shares under the arrangement, the sale from time to time of an aggregate of up to 40 shares of our Class A common stock, in each case following conversion of such shares from Class B common stock. Each time a share of Class A common stock is sold under the trading arrangement, a corresponding charitable gift of shares will be made. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until August 31, 2027, or earlier if all transactions under the trading arrangement are completed.
No directors or officers as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Regulation S-K Item 408, during the fiscal quarter ending September 25, 2026.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable.
95

Table of Contents

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by this item is incorporated by reference from the information set forth in the sections under the headings "Election of Directors," "Corporate Governance Matters," "Executive Officers," "Compensation Discussion and Analysis—Insider Trading Policies and Procedures," and "Delinquent Section 16(a) Reports" in our Definitive Proxy Statement to be filed with the SEC subsequent to the date hereof in connection with the Annual Meeting of Stockholders to be held in 2027 ("2027 Proxy Statement").

ITEM 11. EXECUTIVE COMPENSATION
The information required by this item is incorporated by reference from the information in the 2027 Proxy Statement under the headings "Compensation Discussion and Analysis," "Report of the Compensation Committee of the Board of Directors," "Executive Compensation Tables and Related Matters," "Compensation of Directors," and "Corporate Governance Matters—Compensation Committee Interlocks and Insider Participation."

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required by this item concerning securities authorized for issuance under equity compensation plans and security ownership of certain beneficial owners and management is incorporated by reference from the information in the 2027 Proxy Statement under the headings "Executive Compensation Tables and Related Matters—Equity Compensation Plan Information" and "Security Ownership of Certain Beneficial Owners and Management."

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
The information required by this item concerning transactions with related persons and director independence is incorporated by reference from the information in the 2027 Proxy Statement under the headings "Certain Relationships and Related Transactions" and "Corporate Governance Matters."

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
The information required by this item is incorporated by reference from the information in the 2027 Proxy Statement under the heading "Ratification of Independent Registered Public Accounting Firm."
96

Table of Contents

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
 
1.Financial Statements: See "Index to Consolidated Financial Statements" in Part II, Item 8 of this Annual Report on Form 10-K.
2.Financial Statement Schedules: Financial statement schedules have been omitted as the information required is inapplicable or the information is presented in the consolidated financial statements and related notes.
3.Exhibits: The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Annual Report on Form 10-K.
97

Table of Contents

INDEX TO EXHIBITS
Exhibit
Number
DescriptionIncorporated by Reference Herein
FormDate
2.1*Registration Statement on Form S-1
(No. 333-120614), Amendment No. 1
December 30, 2004
3.1Registration Statement on Form S-1 (No. 333-120614), Amendment No. 2January 19, 2005
3.2Current Report on Form 8-KFebruary 7, 2025
3.3Current Report on Form 8-KFebruary 9, 2024
4.1Registration Statement on Form S-1
(No. 333-120614), Amendment No. 1
December 30, 2004
4.2Registration Statement on Form 8-AJanuary 25, 2006
4.3Annual Report on Form 10-KNovember 25, 2019
10.1*Current Report on Form 8-KFebruary 10, 2023
10.2*Annual Report on Form 10-KNovember 18, 2025
10.3*Annual Report on Form 10-KNovember 18, 2025
10.4*Annual Report on Form 10-KNovember 18, 2025
10.5*Annual Report on Form 10-KNovember 18, 2025
10.6*Current Report on Form 8-KDecember 11, 2015
10.7*Annual Report on Form 10-KNovember 18, 2025
10.8*Quarterly Report on Form 10-QJuly 29, 2021
10.9*Annual Report on Form 10-KNovember 18, 2025
10.10*Current Report on Form 8-KFebruary 10, 2023
10.11*Annual Report on Form 10-KNovember 18, 2025
10.12*Current Report on Form 8-KNovember 14, 2025
10.13*+
10.14* Quarterly Report on Form 10-QJuly 30, 2026
10.15*Quarterly Report on Form 10-Q    April 30, 2009
10.16*Quarterly Report on Form 10-QFebruary 6, 2013
10.17*+
10.18*+
10.19*+
10.20*Quarterly Report on Form 10-QFebruary 4, 2022
10.21*Quarterly Report on Form 10-QMay 10, 2011
10.22*Quarterly Report on Form 10-QAugust 9, 2022
10.23*Quarterly Report on Form 10-QAugust 1, 2018
10.24Current Report on Form 8-KNovember 19, 2024
10.25*Registration Statement on Form S-8
(No. 333-120614)
September 11, 2026
10.26*+
10.27*+
10.28*+
10.29*+
14.1Annual Report on Form 10-KNovember 18, 2025
19.1Annual Report on Form 10-KNovember 18, 2025
19.2Annual Report on Form 10-KNovember 19, 2024
21.1+
23.1+
24.1
31.1+
31.2+
32.1‡
97.1Annual Report on Form 10-KNovember 19, 2024
101.INS‡ XBRL Instance Document
101.SCH‡ XBRL Taxonomy Extension Schema Document
98

Table of Contents

101.CAL‡ XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF‡ XBRL Extension Definition
101.LAB‡ XBRL Taxonomy Extension Label Linkbase Document
101.PRE‡ XBRL Taxonomy Extension Presentation Linkbase Document
+    Filed herewith.
*    Denotes a management contract or compensatory plan or arrangement.
‡    Furnished herewith.
99

Table of Contents

ITEM 16. FORM 10-K SUMMARY
None.

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 17, 2026
 
DOLBY LABORATORIES, INC.
By:/S/   ROBERT PARK
Robert Park
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Marc Whitten and Robert Park, and each of them, his or her attorney-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitutes, may do or cause to be done by virtue of hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
SIGNATURETITLEDATE
/S/    PETER GOTCHERChairman of the Board of DirectorsNovember 17, 2026
Peter Gotcher
/S/    MARC WHITTEN
President, Chief Executive Officer and Director
(Principal Executive Officer)
November 17, 2026
Marc Whitten
/S/   ROBERT PARKSenior Vice President and Chief Financial Officer
(Principal Financial Officer)
November 17, 2026
Robert Park
/S/    RYAN NICHOLSONVice President, Chief Accounting Officer
(Principal Accounting Officer)
November 17, 2026
Ryan Nicholson
/S/    DAVID DOLBYDirectorNovember 17, 2026
David Dolby
/S/    TONY PROPHETDirectorNovember 17, 2026
Tony Prophet
/S/    EMILY ROLLINSDirectorNovember 17, 2026
Emily Rollins
/S/    SIMON SEGARSDirectorNovember 17, 2026
Simon Segars
/S/    ANJALI SUDDirectorNovember 17, 2026
Anjali Sud
/S/    AVADIS TEVANIAN, JR.DirectorNovember 17, 2026
Avadis Tevanian, Jr.
100

2027 DOLBY EXECUTIVE BONUS PLAN
Eligibility:    Eligible employees are the executive officers and other officers of the Company and its subsidiaries who are selected by the Compensation Committee (“Executives”).
Bonus Amounts:    The amount each Executive may be eligible to receive under the 2027 Executive Bonus Plan (the “Executive Plan”) will be determined as summarized below and pursuant to the level of achievement by the Company of goals for non-GAAP operating income, revenue and/or other metrics, as determined by the Compensation Committee. For purposes of this Executive Plan, “non-GAAP operating income” shall be defined as the Company’s GAAP operating income excluding amounts related to stock based compensation, restructuring charges, and the amortization of intangibles from business combinations. In addition, at the discretion of the Committee, the financial impact of M&A transactions will be excluded (either by adjusting the revenue or operating income results or adjusting the predetermined goals as determined by the Committee).
Target Bonus:    Target bonuses for Executives will be established and approved by the Compensation Committee. Each Executive’s target bonus will be a percentage of the Executive’s base salary at the applicable fiscal year-end or performance period-end, as determined by the Compensation Committee.
Actual Bonus:    The Chief Executive Officer’s actual bonus will be determined by multiplying his base salary by his target bonus percentage and then adjusting such target bonus to reflect the extent to which the Company meets the non-GAAP operating income, revenue or other goals. The actual bonus amount may be less than, or exceed, the Chief Executive Officer’s target bonus, depending on the extent to which the Company meets the applicable goals. The Compensation Committee, in its sole discretion, may adjust the amount otherwise payable to the Chief Executive Officer as determined in accordance with the foregoing formula.
The actual bonuses for all other eligible Executives will be determined by multiplying base salary by the applicable target bonus percentage and then adjusting such number to reflect the (i) the extent to which the Company meets the non-GAAP operating income, revenue and/or other goals and (ii) based upon such other criteria as the Compensation Committee, in its sole and absolute discretion, determines is appropriate to calculate and determine such final bonus amount for any such eligible Executive. The Chief Executive Officer may recommend increases or decreases of up to 25% of each such executive officer’s calculated award payout amount, for the Compensation Committee to consider in determining the final bonus amount payable.
Bonus Payment Approval:    Specific measurable Company revenue, non-GAAP operating income and/or other targets (as applicable) are established by the Compensation Committee, typically near the commencement of the 2027 fiscal year or performance period (as applicable). All Executive bonuses must be approved by the Compensation Committee prior to payment.
Payment of the actual bonuses under the Executive Plan will be made no later than the later of: (i) the 15th day of the third month following the end of the Company’s fiscal year in which the bonus was earned, or (ii) March 15th of the year following the calendar year in which the bonus was earned. To the extent



permitted by applicable law, employees must be employed by the Company at the time of payment of actual bonuses under the Executive Plan in order to be eligible for their actual bonus.
Subject to Plan:    The bonus goal, and the terms of this Executive Plan, are subject to the
applicable terms and conditions of the 2020 Stock Plan.
Maximum Bonus Amount:    Notwithstanding anything to the contrary in this Executive Plan, no “Service Provider,” as that term is defined in the 2020 Stock Plan, may receive a bonus, in any fiscal year, greater than the individual Service Provider’s fiscal year limitation authorized by the terms of the 2020 Stock Plan.

Subject to Reduction, Cancellation, Forfeiture or Recoupment:
Payments and awards made or granted under the Executive Plan shall be subject to reduction, cancellation, forfeiture or recoupment pursuant to the Company’s Policy on Recoupment of Incentive Compensation, as amended and restated effective August 1, 2023, as may be amended from time to time.


DOLBY LABORATORIES, INC. EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is entered into by and between Dolby Laboratories, Inc., a Delaware corporation (“Dolby”), Dolby Laboratories, Inc., a California corporation (the “Company”) and Marc Whitten (the “Executive”). 1. Duties and Scope of Employment. (a) Positions and Duties. Beginning on August 25, 2026, or such other mutually agreeable date as set forth in writing between the parties (the actual date Executive’s employment begins, the “Start Date”), Executive will serve as Dolby’s President and Chief Executive Officer (“CEO”) and commence employment with the Company. Executive will report to Dolby’s Board of Directors (the “Board”). Executive will have all of the duties, responsibilities and authority commensurate with the position of CEO. As of the Start Date, Executive will render such business and professional services in the performance of Executive’s duties, consistent with Executive’s position with Dolby, as will reasonably be assigned to Executive by the Board. The period Executive is employed by the Company under this Agreement is referred to herein as the “Employment Term”. (b) Board Membership. Executive will be appointed to serve as a member of the Board as of the Start Date. Thereafter, and for so long as Executive serves as the CEO, subject to the requirements of applicable law (including, without limitation, any rules or regulations of any exchange on which Dolby’s common stock is listed), the Board and/or the Nominating and Governance Committee of the Board will nominate Executive for reelection to the Board at each annual meeting of Dolby’s stockholders at which Executive is subject to reelection. Executive’s service as a member of the Board will be subject to any required stockholder approval. Upon the termination of Executive’s employment as CEO for any reason, unless otherwise requested by the Board, Executive will be deemed to have resigned from the Board and any committee thereof (and all other positions held at Dolby, the Company and their affiliates), without any further required action by Executive, as of the end of Executive’s employment as CEO and Executive will cooperate with Dolby and the Company to complete any steps the Board determines to be necessary or appropriate to confirm such resignation. (c) Obligations. During the Employment Term, Executive will devote Executive’s full business efforts and time to Dolby and the Company and will use good faith efforts to discharge Executive’s obligations under this Agreement to the best of Executive’s ability and in accordance with each of Dolby’s Code of Business Conduct and Ethics, Insider Trading Policy, and any other Dolby or Company policy applicable to the CEO (collectively, the “Company Policies”). For the duration of the Employment Term, Executive agrees not to actively engage in any other employment, occupation, or consulting activity for any direct or indirect remuneration without the prior approval of the Board (which approval will not be unreasonably withheld); provided, however, that Executive may, without the approval of the Board (but in accordance with any Company Policies then in effect), serve in any capacity with any civic, educational, or charitable organization, provided such services do not create an actual or potential business or


 
fiduciary conflict of interest, or individually or in the aggregate, interfere with Executive’s obligations to Dolby and the Company. (d) Location. Executive understands and agrees that this role is based in San Francisco, California. Executive will be required to travel from time to time for business reasons. (e) Other Entities. Executive may be appointed and agrees to serve, without additional compensation, as an officer and director for each of Dolby’s and the Company’s subsidiaries, partnerships, joint ventures, limited liability companies and other affiliates, including entities in which Dolby or the Company have a significant investment as determined by Dolby. As used in this Agreement, the term “affiliates” will include any entity controlled by, controlling, or under common control of Dolby or the Company, as applicable. 2. At-Will Employment. Executive and the Company agree that Executive’s employment with the Company constitutes “at-will” employment. Executive and the Company acknowledge that this employment relationship may be terminated at any time, upon written notice to the other party, with or without good cause or for any or no cause, at the option either of the Company or Executive. However, as described in this Agreement, Executive may be entitled to severance benefits depending upon the circumstances of Executive’s termination of employment. 3. Compensation. (a) Base Salary. The Company will pay Executive an annual salary of $1,000,000 as compensation for Executive’s services (such annual salary, as is then effective, to be referred to herein as “Base Salary”). The Base Salary will be paid periodically in accordance with the Company’s normal payroll practices and be subject to the usual, required withholdings. Beginning with the Company’s second regular review cycle of executive compensation that occurs after the Start Date, Executive’s Base Salary will be periodically reviewed as a part of the Company’s regular review of compensation, and will be determined by the Compensation Committee of the Board (the “Committee”). (b) Annual Incentive. Beginning in fiscal year 2027, Executive will be eligible for an annual target bonus (the “Target Annual Incentive”) equal to 100% of Executive’s then- current Base Salary, subject to the terms and conditions of the Company’s Executive Bonus Plan in effect for each applicable fiscal year. The actual bonus amounts awarded to Executive (the “Actual Bonus”), if any, will depend upon achievement of performance objectives to be established by the Board or the Committee for such performance periods. To earn any Actual Bonus for any period, Executive must be employed by the Company through the last day of the period to which such bonus relates and the date on which bonuses are to be paid. No Actual Bonus will be paid unless earned, except as set forth below in Section 7. Executive’s Actual Bonus for fiscal year 2027 will equal 100% of the Target Annual Incentive (with no adjustment based on actual performance against the performance objectives). (c) Sign-On Bonus. The Company is also offering Executive the ability to earn a cash sign-on bonus subject to the terms set forth in the Sign-On Bonus Agreement attached hereto as Exhibit A.


 
(d) Relocation Benefits. The Company will reimburse Executive for Executive’s reasonable and customary incurred relocation costs for temporary housing and movement of personal goods to the San Francisco Bay Area, including lease termination costs and fees associated with Executive’s housing in the Seattle Area through March 2027, temporary housing in the San Francisco Bay Area, and movement of cars and personal belongings to the San Francisco Bay Area, with the aggregate reimbursement costs not to exceed $200,000 (together, the “Eligible Relocation Expenses”). In order to be reimbursed, Eligible Relocation Expenses must be incurred by February 16, 2027 and substantiated in writing (by valid receipts or any other reasonable method of invoicing, showing proof of payment for an Eligible Relocation Expense) within thirty (30) days following the date any such Eligible Relocation Expense is incurred (and no later than February 16, 2027). Any reimbursements due to Executive under this Section 3(d) will be paid to Executive via check or electronic funds transfer within thirty (30) days following the date of receipt by the Company of Executive’s written substantiation, but in all cases not later than March 15, 2027. (e) New Hire Equity Awards. As a material inducement to Executive joining as CEO, Dolby will grant Executive the following equity awards (collectively, the “New Hire Equity Awards”): (i) An award of time-based restricted stock units (the “New Hire RSU Grant”) with a value equivalent to approximately $10,000,000 on the date of grant. The New Hire RSU Grant will vest as to 25% of the New Hire RSU Grant on the date that is six (6) months following the date of grant and 25% of the New Hire RSU Grant every six (6) months thereafter. The conversion of the value set forth above into the actual number of shares of Class A common stock underlying the New Hire RSU Grant will be determined in accordance with Dolby’s standard equity grant practices. (ii) An award of 600,000 performance-based restricted stock units (the “New Hire PSU Grant”). The New Hire PSU Grant will be eligible to vest based on the achievement of Dolby’s stock price performance over a five (5)-year performance period beginning on the date of grant. The New Hire PSU Grant will be divided into five tranches that are eligible to become earned (each earned tranche, the “Earned Shares”) based on the achievement of a Dolby stock price goal as set forth in the table below (each, a “Stock Price Target”), measured based on the average of the closing prices of Dolby’s Class A Common Stock over a consecutive sixty (60) trading-day period during the performance period, and, except as set forth in Section 7(a)(v)(B), subject to the Executive remaining as CEO upon the applicable achievement date. The Earned Shares will vest 100% on the certification of achievement of the Stock Price Target, with such certification to occur within five (5) business days following the achievement of the Stock Price Target. Stock Price Target* Number of Earned Shares $75.00 150,000 $100.00 150,000 $125.00 100,000 $150.00 100,000


 
$175.00 100,000 * Stock Price Targets subject to adjustment pursuant to Section 17(a) of the Plan (as defined below). (iii) The New Hire Equity Awards will be granted under and subject to the terms, definitions and provisions of an equity inducement plan with substantially identical terms as Dolby’s 2020 Stock Plan (such equity inducement plan, the “Plan”) and the applicable award agreement under the Plan with substantially identical terms to the applicable forms of award agreement under the Dolby 2020 Stock Plan, which, except as set forth in this Agreement, requires continued service with Dolby, the Company, or its affiliates through the applicable vesting date. The New Hire Equity Awards will have a grant date of the 15th day (or the next business day if the 15th day is not on a business day) of the calendar month on or following the Start Date, and are subject to the Executive remaining in continuous service as CEO through the grant date. Consistent with the Dolby 2020 Stock Plan, in the event that the successor corporation in a Change in Control does not assume, substitute or replace the New Hire RSUs, Executive shall, immediately prior to the merger or Change in Control, fully vest in the New Hire RSUs. (f) FY27 Annual Equity Awards. In addition, and as a material inducement to Executive joining as CEO, Executive will be eligible to receive the following additional equity award grants as part of the Company’s fiscal 2027 annual equity award cycle (collectively, the “FY27 Annual Equity Awards”): (i) A nonstatutory stock option to purchase shares of Dolby’s Class A common stock at a per share exercise price equal to the closing price per share on the New York Stock Exchange on the date of grant (the “FY27 Option Grant”) with a value equivalent to approximately $2,750,000 on the date of grant. The FY27 Option Grant will be scheduled to vest as to 25% of the FY27 Option Grant on the first anniversary of the date of grant, and 1/48th of the FY27 Option Grant each month thereafter. (ii) An award of time-based restricted stock units (the “FY27 RSU Grant”) with a value equivalent to approximately $5,500,000 on the date of grant. The FY27 RSU Grant will be scheduled to vest as to 25% of the FY27 RSU Grant on each of the first four anniversaries of the grant date. (iii) An award of performance-based restricted stock units (the “FY27 PRSU Grant”) with a value equivalent to approximately $2,750,000 (at target achievement) on the date of grant. The FY27 PRSU Grant will be scheduled to be earned from 0%-to-200% of target based on a three (3)-year relative total shareholder return (TSR) of Dolby as compared to the S&P Mid Cap 400 index, with any portion of the FY27 PRSU Grant that becomes earned vesting on the third anniversary of the grant date. (iv) The FY27 Annual Equity Awards will be granted under and subject to Dolby’s standard terms and conditions under the Plan and applicable award agreement under the Plan, which, except as set forth in this Agreement, requires continued service with Dolby, the Company, or its affiliates through the applicable vesting date. The FY27 Annual Equity Awards will be subject to the approval of the Board or Committee, granted at the same time as fiscal year


 
2027 annual equity awards are granted to other senior executives of Dolby, and subject to Executive remaining as CEO through the applicable grant date(s). The conversion of the applicable values set forth above into the actual number of shares underlying the FY27 Annual Equity Awards will be determined in accordance with Dolby’s standard equity grant practices. Consistent with the Dolby 2020 Stock Plan, in the event that the successor corporation in a Change in Control does not assume, substitute or replace the FY27 Option Grant or the FY27 RSU Grant, Executive shall, immediately prior to the merger or Change in Control, fully vest in such awards. (g) Future Grants. Beginning with the Company’s annual equity award cycle in Dolby’s fiscal year 2028, Executive will be eligible for additional equity awards commensurate with Executive’s position, as the Board or the Committee determines in its discretion and in accordance with the Company’s practices from time to time. 4. Employee Benefits. (a) Generally. During the Employment Term, Executive will be eligible to participate in accordance with the terms of all Company employee benefit plans, policies and arrangements that are applicable to other executive officers of the Company, as such plans, policies and arrangements may exist from time to time, on the same terms and conditions as other similarly- situated employees to the extent that Executive’s position, tenure, salary, age, health and other qualifications make Executive eligible to participate in such plans or programs, subject to the rules and regulations applicable thereto, except as set forth in Section 3(d) above. (b) Vacation. During the Employment Term, Executive will be entitled to receive paid annual vacation in accordance with Company policy for other executive officers; provided, however, that as of the Start Date, Executive will be credited with twenty (20) days accrued vacation. 5. Expenses. Except as set forth in Section 3(d) above, the Company will pay or reimburse Executive for reasonable travel, entertainment and other expenses incurred by Executive in the furtherance of the performance of Executive’s duties hereunder, in accordance with the Company’s expense reimbursement policy as in effect from time to time. The Company will pay or reimburse Executive for business-class airfare for all required business-related travel. In addition, the Company in 2026 will directly pay, upon presentation of invoices no later than November 30, 2026, Executive’s reasonable and documented attorney fees incurred in the negotiation and execution of this Agreement in an amount not to exceed $20,000. Subject to the preceding, and except as set forth in Section 3(d) above, the payment for all fees under this Section 5 will be paid pursuant to the Company’s policies and practices, following Executive’s submission of reasonable documentation for such fees. 6. Termination of Employment. In the event Executive’s employment with the Company terminates for any reason, Executive will be entitled to any (a) unpaid Base Salary accrued up to the effective date of termination; (b) pay for accrued but unused vacation; (c) benefits or compensation as provided under the terms of any employee benefit and compensation agreements or plans applicable to Executive; (d) unreimbursed business expenses required to be reimbursed to Executive pursuant to Section 5 of the Agreement; and (e) rights to


 
indemnification Executive may have under applicable law, the Company’s Articles of Incorporation, Bylaws, the Agreement, or separate indemnification agreement, as applicable. In addition, if the termination is by the Company without Cause or Executive resigns for Good Reason, Executive will be entitled to the amounts and benefits specified in Section 7. 7. Severance. (a) Termination Without Cause or Resignation for Good Reason other than in Connection with a Change in Control. If Executive’s employment is terminated by the Company without Cause (and not by reason of Executive’s death or Disability), or if Executive resigns for Good Reason, and in either event, such termination is not in Connection with a Change in Control (such termination, a “Pre-CIC Qualifying Termination”), then, subject to Section 8, Executive will receive: (i) a single lump sum cash severance payment equal to 150% of Executive’s Base Salary for the year in which the termination occurs (less applicable tax withholdings), ignoring any decrease in Base Salary that forms the basis for Good Reason; (ii) a single lump sum cash severance payment equal to 150% of the Target Annual Incentive for the year in which the termination occurs (less applicable tax withholdings), ignoring any decrease in the Target Annual Incentive that forms the basis for Good Reason; (iii) a cash severance payment in an amount equal to the Actual Bonus Executive would have received for the year of termination had Executive’s employment not terminated (which, for years after fiscal year 2027, will be based on actual Company performance for the year of termination), multiplied by a fraction with a numerator equal to the number of days between the later of the Start Date and the start of the then-current fiscal year, and the date of termination and a denominator equal to 365, to be paid at the same time as bonuses are paid for that period to other eligible executives; (iv) 50% of Executive’s then outstanding and unvested stock options (including specifically the FY27 Option Grant), restricted stock units (including specifically the New Hire RSU Grant and the FY27 RSU Grant) and any other equity award denominated in shares of Dolby Class A common stock (collectively the “Equity Awards”) that are subject to time-based vesting (including time-based vesting applicable after the satisfaction of any performance conditions applicable to the Equity Awards) shall become vested and, to the extent applicable, exercisable; (v) with respect to any Equity Awards subject to performance conditions for which the performance period has not completed as of the termination date: (A) for Equity Awards other than the New Hire PSU Grant, Executive will remain eligible to vest in such Equity Awards based on actual achievement of the applicable performance conditions, but with the number of target units or shares subject to such Equity Award equal to the product (rounded to the nearest whole unit or share) of: (i) the original target number of units or shares subject to such Equity Award, multiplied by (ii) the quotient derived from (x) the number of full months Executive remained in continuous service from the beginning of the performance period through the termination date, plus twelve (12), over (y) the total months from the beginning of the performance period through the end of the applicable performance period for such portion (with such quotient not to exceed 1), and (B) for the New Hire PSU Grant, any tranches that have not been earned as of the termination date will remain outstanding for a period of twelve (12) months following the termination date (or, if earlier, until the last day of the five (5)-year performance period) and such tranches will be eligible to become earned based on the achievement of the applicable Stock Price Target, measured based on the average of the closing prices of Dolby’s Class A Common Stock over a consecutive sixty (60) trading-day period during such period; and (vi) direct payment of, or reimbursement for (at the Company’s election), premiums


 
paid for continued health benefits for Executive (and any eligible dependents) under the Company’s health plans until the earlier of (A) eighteen (18) months, payable when such premiums are due (provided Executive validly elects to continue coverage under the Consolidated Omnibus Budget Reconciliation Act or comparable state law (“COBRA”), remains eligible for COBRA coverage and, with respect to reimbursements, pays for COBRA coverage), or (B) the date upon which Executive and Executive’s eligible dependents become covered under similar plans; provided, however, if the Company determines in its sole discretion that it is advisable for legal reasons, the Company may pay Executive a taxable cash payment equal to the amount that the Company would have otherwise paid for COBRA premiums (based on the premium for the first month of coverage), which payment will be made regardless of whether Executive or Executive’s eligible dependents elect COBRA continuation coverage and will be paid in a lump sum payment. (b) Termination Without Cause or Resignation for Good Reason in Connection with a Change in Control. If Executive’s employment is terminated by the Company without Cause (and not by reason of Executive’s death or Disability), or if Executive resigns for Good Reason, and in either event, such termination is in Connection with a Change in Control (a “CIC Qualifying Termination”), then, subject to Section 8, Executive will receive: (i) a single lump sum cash severance payment equal to 200% of Executive’s Base Salary for the year in which the termination occurs (less applicable tax withholdings), ignoring any decrease in Base Salary that forms the basis for Good Reason; (ii) a single lump sum cash severance payment equal to 200% of the Target Annual Incentive for the year in which the termination occurs (less applicable tax withholdings), ignoring any decrease in the Target Annual Incentive that forms the basis for Good Reason; (iii) a single lump sum cash severance payment in an amount determined by multiplying the Target Annual Incentive for the year in which the termination occurs (less applicable tax withholdings), ignoring any decrease in the Target Annual Incentive that forms the basis for Good Reason, by a fraction with a numerator equal to the number of days between the later of the Start Date and the start of the then-current fiscal year, and the date of termination and a denominator equal to 365 (for the avoidance of doubt, Executive shall be paid this severance payment in an amount determined pursuant to this Section 7(b)(iii) in lieu of the actual annual incentive for the year of termination which will be forfeited (regardless of the level of performance obtained thereunder as of such termination date)); (iv) 100% of Executive’s then outstanding and unvested Equity Awards that are subject to time-based vesting (including time-based vesting applicable after the satisfaction of any performance conditions applicable to the Equity Awards) shall become vested and, to the extent applicable, exercisable; provided, however, that any Equity Award that, at the time of such termination, was subject to performance-based vesting, will instead be treated as provided in the award agreement related to such Equity Award (which, in the case of the New Hire PSU Grant and the FY27 PRSU Grant, will provide for the measurement of the Company’s stock price as the price per share in the Change in Control); and (v) direct payment of, or reimbursement for (at the Company’s election), premiums paid for continued health benefits for Executive (and any eligible dependents) under the Company’s health plans until the earlier of (A) twenty-four (24) months, payable when such premiums are due (provided Executive validly elects to continue coverage under COBRA, remains eligible for COBRA coverage and, with respect to reimbursements, pays for COBRA coverage), or (B) the date upon which Executive and Executive’s eligible dependents become covered under similar plans; provided, however, if the Company determines in its sole discretion that it is advisable for legal reasons, the Company may pay Executive a taxable cash


 
payment equal to the amount that the Company would have otherwise paid for COBRA premiums (based on the premium for the first month of coverage), which payment will be made regardless of whether Executive or Executive’s eligible dependents elect COBRA continuation coverage and will be paid in a lump sum payment. For the avoidance of doubt, in the event of Executive’s Pre-CIC Qualifying Termination, any then outstanding and unvested Equity Awards will remain outstanding until the earlier of (x) sixty (60) days following such termination, or (y) the occurrence of a Change in Control, solely so that any benefits due on a CIC Qualifying Termination can be provided if a Change in Control occurs within sixty (60) days following such termination (provided that in no event will Executive’s stock options or similar Equity Awards remain outstanding beyond the Equity Award’s maximum term to expiration). If no Change in Control occurs within sixty (60) days following such Pre-CIC Qualifying Termination, any unvested portion of Executive’s Equity Awards (after accounting for any accelerated vesting rights) automatically and permanently will be forfeited on the date sixty (60) days following the date of such Pre-CIC Qualifying Termination without having vested. Further, for purposes of clarity, in the event of Executive’s Pre-CIC Qualifying Termination, upon a subsequent Change in Control within sixty (60) days following such termination, any severance payments and benefits to be provided to the Executive under Section 7(b) will be reduced by any amounts that already were provided to the Executive under Section 7(a). (c) Voluntary Termination Without Good Reason; Termination for Cause; Termination Due to Death/Disability. If Executive’s employment is terminated voluntarily, including due to death or Disability, without Good Reason or is terminated for Cause by the Company, then, except as provided in Section 6, (i) all further vesting of Executive’s outstanding Equity Awards will terminate immediately (unless the terms and conditions of the Plan and the applicable Equity Awards provide otherwise); (ii) all payments of compensation by the Company to Executive hereunder will terminate immediately, and (iii) Executive will be eligible for severance benefits only in accordance with the Company’s then established, if any, severance plans and arrangements. 8. Conditions to Receipt of Severance; No Duty to Mitigate. (a) Separation Agreement and Release of Claims. The payment of any severance or other benefits pursuant to Section 7 will be subject to Executive signing and not revoking a separation and release of claims with Dolby and the Company, substantially in the form attached as Exhibit B (the “Release”), with such Release subject to good faith modification by Dolby or the Company to comply with and be fully enforceable under applicable law, or to reflect applicable legal changes, Executive’s relocation to another jurisdiction, Executive’s separation in connection with a group termination event, Executive’s agreements and compensatory arrangements then in existence, or other circumstances as may reasonably be considered by Dolby or the Company, upon or following Executive’s separation from service and such Release becoming effective no later than sixty (60) days following Executive’s separation from service (such deadline, the “Release Deadline”). If the Release does not become effective by the Release Deadline, Executive will forfeit any rights to severance or other benefits under this Agreement. In no event will severance payments or benefits be paid or provided until the Release actually


 
becomes effective and irrevocable. Any severance payments and benefits under this Agreement will be paid on, or, in the case of installments, will not commence until, the sixtieth (60th) day following Executive’s separation from service, or, if later, such time as required by Section 13(b); provided, however, that any acceleration of vesting of options and restricted stock will be provided on the Release effectiveness date. Except as required by Section 13(b), any payments and benefits that would have been made to Executive during the sixty (60)-day period immediately following Executive’s separation from service but for the preceding sentence will be paid to Executive on the sixtieth (60th) day following Executive’s separation from service and the remaining payments will be made as provided in this Agreement. In no event will Executive have discretion to determine the taxable year of payment of any severance payments or benefits. (b) Other Requirements. Executive’s receipt of any payments or benefits under Section 7 will be subject to Executive continuing to comply with the terms of the Confidentiality Agreement (as defined below), the Release and the provisions of this Agreement. In the event Executive breaches the provisions of this Section 8(b), all continuing payments and benefits to which Executive may otherwise be entitled pursuant to Section 7 will immediately cease. (c) No Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any earnings that Executive may receive from any other source reduce any such payment. 9. Excise Tax. In the event that the severance or other payments or benefits provided in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), and (ii) but for this Section 9, would be subject to the excise tax imposed by Section 4999 of the Code, then, such payments or benefits will be either: (a) delivered in full, or (b) delivered as to such lesser extent which would result in no portion of such benefits being subject to the excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of severance or other payments or benefits, notwithstanding that all or some portion of such payments or benefits may be taxable under Section 4999 of the Code. If a reduction in severance and/or other payments or benefits constituting “parachute payments” is necessary so that payments or benefits are delivered to a lesser extent, reduction will occur in the following order: (i) reduction of cash payments, which will occur in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced; (ii) cancellation of Equity Awards that were granted “contingent on a change in ownership or control” within the meaning of Section 280G of the Code in the reverse order of date of grant of the Equity Awards (i.e., the most recently granted Equity Awards will be cancelled first); (iii) reduction of vesting acceleration of Equity Awards, which will occur in the reverse order of the date of grant for such stock awards (i.e., the vesting of the most recently granted Equity


 
Awards will be reduced first); and (iv) reduction of other benefits paid or provided to Executive, which will occur in reverse chronological order such that the benefit owed on the latest date following the occurrence of the event triggering such excise tax will be the first benefit to be reduced. If more than one Equity Award was made to Executive on the same date of grant, all such awards will have their acceleration of vesting reduced pro rata. In no event will Executive have any discretion with respect to the ordering of payment reductions. Unless Executive and Dolby agree otherwise in writing, any determination required under this Section 9 will be made in writing by a nationally recognized firm of independent public accountants selected by Dolby (the “Accountants”), whose determination will be conclusive and binding upon Executive and Dolby for all purposes. For purposes of making the calculations required by this Section 9, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. Dolby, the Company and Executive will furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 9. Dolby will bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 9. 10. Definitions. (a) Cause. For purposes of this Agreement, “Cause” will mean: (i) Executive’s willful, material and continued failure to perform the duties and responsibilities of Executive’s position (other than as a result of Executive’s illness or injury) after there has been delivered to Executive a written demand for performance from the Board which describes the basis for the Board’s belief that Executive has not substantially performed Executive’s duties and provides Executive with thirty (30) days to take corrective action, and within such period the applicable corrective actions have not been taken; (ii) Any willful and material act of personal dishonesty taken by Executive in connection with Executive’s responsibilities as an employee of the Company with the intention that such action may result in the substantial personal enrichment of Executive; (iii) Executive’s conviction of, or plea of guilty or nolo contendere to, a felony that the Board in good faith believes has or will have a material detrimental effect on Dolby’s or the Company’s financial condition or reputation; (iv) A willful breach of any fiduciary duty owed to Dolby or the Company by Executive that has a material detrimental effect on Dolby’s financial condition or reputation, or of the Confidentiality Agreement or any other improper disclosure of confidential or proprietary information of Dolby or the Company; (v) Executive being found liable in any Securities and Exchange Commission or other civil or criminal securities law action (regardless of whether or not Executive


 
admits or denies liability), which the Board in good faith determines will have a material detrimental effect on Dolby’s financial condition or reputation; (vi) Executive entering into any cease and desist order with respect to any action which would bar Executive from service as an executive officer or member of a board of directors of any publicly-traded company (regardless of whether or not Executive admits or denies liability); (vii) Executive (A) obstructing or impeding; (B) endeavoring to obstruct or impede, or (C) failing to materially cooperate with, any investigation authorized by the Board or any governmental or self-regulatory entity (an “Investigation”). However, Executive’s failure to waive attorney-client privilege relating to communications with Executive’s own attorney in connection with an Investigation will not constitute “Cause”; (viii) A material breach by Executive of the Code of Business Conduct and Ethics or any other written Company Policies that have been made available to Executive prior to such breach; (ix) Executive’s failure (other than as a result of Executive’s illness or injury) to follow a written directive of the Board after there has been delivered to Executive a written demand for performance from the Board which describes the basis for the Board’s belief that Executive has not followed such written directive and provides Executive with thirty (30) days to take corrective action, and within such period the applicable corrective actions have not been taken; or (x) Executive’s disqualification or bar by any governmental or self- regulatory authority from serving in the capacity contemplated by this Agreement, if (A) the disqualification or bar continues for more than thirty (30) days, and (B) during that period, the Company uses its commercially reasonable efforts to cause the disqualification or bar to be lifted. While any disqualification or bar continues during Executive’s employment, Executive will serve in the capacity contemplated by this Agreement to whatever extent legally permissible and, if Executive’s employment is not permissible, Executive will be placed on administrative leave (which will be paid to the extent legally permissible). Executive shall receive notice and an opportunity to be heard before the Board with Executive’s own attorney before any termination for Cause is deemed effective. Notwithstanding anything to the contrary, the Board may immediately place Executive on administrative leave (with full pay and benefits to the extent legally permissible) and suspend all access to information of Dolby or the Company, employees and business should Executive wish to avail themself of Executive’s opportunity to be heard before the Board prior to a termination for Cause. If Executive avails themself of Executive’s opportunity to be heard before the Board, and then fails to make themself available to the Board within five (5) business days of such request to be heard, the Board may thereafter cancel the administrative leave and terminate Executive for Cause. (b) Change in Control. For purposes of this Agreement, “Change in Control” means the occurrence of any of the following events:


 
(i) Any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) other than a Permitted Transferee (as defined in Dolby’s Amended and Restated Certificate of Incorporation) becomes the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of Dolby representing more than fifty percent (50%) of the total voting power represented by Dolby’s then outstanding voting securities; or (ii) The consummation of the sale or disposition by Dolby of all or substantially all of Dolby’s assets; or (iii) A change in the composition of the Board occurring within a one (1)-year period, as a result of which fewer than a majority of the directors are Incumbent Directors. “Incumbent Directors” means directors who either (A) are directors as of the Start Date, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the directors at the time of such election or nomination (but will not include an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to Dolby); or (iv) The consummation of a merger or consolidation of Dolby with any other corporation, other than a merger or consolidation which would result in the voting securities of Dolby outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of Dolby or such surviving entity or its parent outstanding immediately after such merger or consolidation. Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Section 409A of the Code. Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (x) its primary purpose is to change the jurisdiction of Dolby’s incorporation, or (y) its primary purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held Dolby’s securities immediately before such transaction. (c) Deferred Payments. For purposes of this Agreement, “Deferred Payments” means any severance pay or benefits to be paid or provided to Executive (or Executive’s estate or beneficiaries) pursuant to this Agreement and any other severance payments or separation benefits to be paid or provided to Executive (or Executive’s estate or beneficiaries), that in each case, when considered together, are considered deferred compensation under Section 409A. (d) Disability. For purposes of this Agreement, “Disability” will have the same meaning as “Disability” is defined in the Plan. (e) Good Reason. For purposes of this Agreement, “Good Reason” means Executive’s resignation of employment following the expiration of any Company cure period


 
(discussed below) following the occurrence of any of the following, without Executive’s express written consent: (i) The assignment to or removal from Executive of duties or responsibilities, that results in a material reduction of Executive’s duties, authority, title, or scope of responsibilities, whether occurring before or after a Change in Control; (ii) A material reduction in Executive’s Base Salary or Target Annual Incentive as in effect immediately prior to such reduction (other than pursuant to a reduction that also is applied to substantially all other executive officers of the Company and which reduction reduces the Base Salary and/or Target Annual Incentive by a percentage reduction that is no greater than 10%); (iii) The relocation of Executive’s primary work facility to a location outside of a fifty (50) mile radius from San Francisco; (iv) The material breach by the Company or Dolby of any provision of this Agreement or any equity award agreement; or (v) The failure of the Company or Dolby to obtain the assumption of this Agreement by a successor. The notification and placement of Executive on administrative leave of not more than sixty (60) calendar days pending a potential determination by the Board that Executive may be terminated for Cause shall not constitute Good Reason for purposes of this Agreement. Executive will not resign for Good Reason without first providing the Company with written notice of the acts or omissions constituting the grounds for “Good Reason” within ninety (90) days of the initial existence of the grounds for “Good Reason” and, if such grounds are susceptible to cure, a reasonable cure period of up to thirty (30) days following the date of such notice. Any resignation for Good Reason must occur within one (1) year of the initial existence of the grounds constituting Good Reason. (f) In Connection with a Change in Control. For purposes of this Agreement, a termination of Executive’s employment with the Company is “in Connection with a Change in Control” if Executive’s employment is terminated on or within twelve (12) months following a Change in Control or within sixty (60) days prior to a Change in Control. 11. Indemnification and D&O Insurance. Subject to applicable law, Executive will be provided indemnification to the extent permitted by Dolby’s Articles of Incorporation or Bylaws, including, if applicable, any directors and officers insurance policies, with such indemnification to be on terms determined by the Board or any of its committees, but on terms no less favorable than provided to any other Dolby executive officer or director and subject to the terms of any separate written indemnification agreement. Dolby shall also maintain commercially reasonable D&O insurance covering Executive during the Employment Term in such amount and pursuant to such terms as is typical and customary for companies of similar size and nature as the Company.


 
12. Confidential Information and Other Policies. As a condition to employment, Executive will enter into and be bound by and comply fully with the Company’s standard Confidential Information and Invention Assignment Agreement provided by the Company (the “Confidentiality Agreement”), the Company Policies, as they may be amended from time to time. 13. Code Section 409A. (a) Notwithstanding anything to the contrary in this Agreement, no Deferred Payments, if any, payable to Executive pursuant to this Agreement will be payable until Executive has a “separation from service” within the meaning of Section 409A of the Code and the final regulations and official guidance thereunder (“Section 409A”). Similarly, no severance payable to Executive, if any, pursuant to this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Executive has a “separation from service” within the meaning of Section 409A. (b) Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s separation from service (other than due to death), then the Deferred Payments, if any, that are payable within the first six (6) months following Executive’s separation from service, will become payable on the date six (6) months and one (1) day following the date of Executive’s separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following Executive’s separation from service, but prior to the six (6) month anniversary of the separation from service, then any payments delayed in accordance with this Section 13(b)(ii) will be payable in a lump sum as soon as administratively practicable after the date of Executive’s death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment, installment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. (c) Any severance payment that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Payments for purposes herein. Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A- 1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below) will not constitute Deferred Payments for purposes herein. Any payments or benefits due under Section 7 of this Agreement will be paid as provided under this Agreement, but in no event later than the last day of the second taxable year of Executive following Executive’s taxable year in which Executive’s separation from service from the Company occurs. (d) For purposes of this Agreement, “Section 409A Limit” means two (2) times the lesser of: (x) Executive’s annualized compensation based upon the annual rate of pay paid to Executive during Executive’s taxable year preceding Executive’s taxable year of Executive’s termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto, or (y) the maximum amount that may be taken into account under a qualified


 
plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s employment is terminated. (e) To the extent that any reimbursements provided to Executive constitute Deferred Payments, such amounts shall be paid or reimbursed to Executive promptly, but in no event later than December 31 of the year following the year in which the expense is incurred. The amount of any such payments eligible for reimbursement in one year shall not affect the payments or expenses that are eligible for payment or reimbursement in any other taxable year, and Executive’s right to such payments or reimbursement shall not be subject to liquidation or exchange for any other benefit. (f) The foregoing provisions are intended to comply with or be exempt from the requirements of Section 409A so that none of the severance or other payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to so comply or be exempt. In no event will Dolby or the Company have any liability or obligation to reimburse, indemnify, or hold harmless Executive for any taxes or costs that may be imposed on or incurred by Executive as a result of Section 409A. Executive and the Company agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A. 14. Assignment. This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors and legal representatives of Executive upon Executive’s death, and (b) any successor of Dolby or the Company. Any such successor of Dolby or the Company will be deemed substituted for Dolby or the Company, as applicable, under the terms of this Agreement for all purposes. For this purpose, “successor” means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly acquires all or substantially all of the assets or business of Dolby or the Company. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted assignment, transfer, conveyance, or other disposition of Executive’s right to compensation or other benefits will be null and void. 15. Notices. All notices, requests, demands and other communications called for hereunder will be in writing and will be deemed given (a) on the date of delivery if delivered personally or by email; (b) one (1) day after being sent overnight by a well-established commercial overnight service; or (c) four (4) days after being mailed by registered or certified mail, return receipt requested, prepaid and addressed to the parties or their successors at the following addresses, or at such other addresses as the parties may later designate in writing: If to Dolby or the Company: Attn: Chairman of the Compensation Committee c/o General Counsel Dolby Laboratories, Inc. 1275 Market Street


 
San Francisco, CA 94103 If to Executive: at the last residential address known by the Company. 16. Severability. If any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable, or void, this Agreement will continue in full force and effect without said provision. 17. Arbitration. The parties agree that any and all disputes arising from Executive’s employment, including the termination thereof, or Executive’s compensation or benefits will be subject to arbitration in San Francisco County, before Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Employment Arbitration Rules & Procedures (“JAMS Rules”), unless Executive primarily works in a state outside of California, in which case the arbitration shall take place in the state where Executive primarily works and the arbitration shall be conducted in accordance with the laws of such state. The arbitrator may grant injunctions and other relief in such disputes. If the arbitration is conducted in California, the arbitrator shall administer and conduct the arbitration in accordance with California law, including the California Code of Civil Procedure, and the arbitrator shall apply substantive and procedural California law to any dispute or claim, without reference to any conflict-of-law provisions of any jurisdiction. To the extent that the JAMS Rules conflict with California law, California law shall take precedence. The decision of the arbitrator shall be final, conclusive, and binding on the parties to the arbitration. The parties agree that the prevailing party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. Dolby or the Company will pay for any administrative or hearing fees charged by the arbitrator or JAMS except that Executive shall pay any filing fees associated with any arbitration that Executive initiates, but only so much of the filing fees as Executive would have instead paid had Executive filed a complaint in a court of law. Each party shall separately pay for its respective counsel fees and expenses; provided, however, that the arbitrator shall award attorneys' fees and costs to the prevailing party, except as prohibited by law. The parties hereby agree to waive their right to have any dispute between them resolved in a court of law by a judge or jury. Notwithstanding the foregoing, this Section 17 will not prevent either party from seeking injunctive relief (or any other provisional remedy) from any court having jurisdiction over the parties and the subject matter of their dispute relating to this Agreement and the agreements incorporated herein by reference. Should any part of the arbitration agreement contained in this Section 17 conflict with any other arbitration agreement between the parties, the parties agree that this arbitration agreement shall govern. 18. Integration. This Agreement, together with the Confidentiality Agreement, the Sign-On Bonus Agreement, and the Plan and standard forms of Equity Award agreements that describe Executive’s outstanding Equity Awards, represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in a writing and signed by duly authorized representatives of the parties hereto. In entering into this Agreement, no party has relied on or made any representation, warranty, inducement, promise, or understanding that is not in this


 
Agreement. To the extent that any provisions of this Agreement conflict with those of any other agreement to be signed upon Executive’s hire, the terms in this Agreement will prevail. 19. Acknowledgment. Executive acknowledges that Executive has had the opportunity to discuss this matter with and obtain advice from Executive’s private attorney, has had sufficient time to, and has carefully read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement. 20. Compensation Recoupment. All amounts payable to Executive hereunder, including the Equity Awards, shall be subject to recoupment pursuant to Dolby’s Policy on Recoupment of Incentive Compensation, as it may be hereinafter amended, the Sign-On Bonus Agreement, and any additional compensation clawback or recoupment policy or amendments to the current policy adopted by the Board or as required by law during the term of Executive’s employment with the Company. No recovery of compensation under such a clawback or recoupment policy or agreement will be an event giving rise to a right to resign for “Good Reason” or constitute a termination without “Cause” under this Agreement. 21. Miscellaneous. (a) Governing Law. This Agreement will be governed by the laws of the State of California without regard to its conflict of laws provisions. (b) Waiver of Breach. The waiver of a breach of any term or provision of this Agreement, which must be in writing, will not operate as or be construed to be a waiver of any other previous or subsequent breach of this Agreement. (c) Survival. The Confidentiality Agreement and the provisions of this Agreement shall survive the termination of Executive’s employment for any reason to the extent necessary to enable the parties to enforce their respective rights under this Agreement. (d) Headings. All captions and Section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement. (e) Tax Matters; Withholding. All sums payable to Executive hereunder shall be reduced by all federal, state, local and other withholding and similar taxes and payments required by applicable law. Executive is encouraged to obtain Executive’s own tax advice regarding Executive’s compensation from the Company. Executive agrees that the Company does not have a duty to design its compensation policies in a manner that minimizes Executive’s tax liabilities, and Executive will not make any claim against the Company, Dolby or its Board related to tax liabilities arising from Executive’s compensation. (f) Counterparts. This Agreement may be executed in counterparts, and each counterpart will have the same force and effect as an original and will constitute an effective, binding agreement on the part of each of the undersigned.


 
(g) Employment Eligibility Verification. For purposes of federal immigration law, Executive will be required to provide to the Company documentary evidence of Executive’s identity and eligibility for employment in the United States. Such documentation must be provided to the Company within three (3) business days of Executive’s Start Date, or Executive’s employment relationship with the Company may be terminated. Any termination of Executive’s employment due to Executive’s failure to provide such documentary evidence or due to Executive’s non-eligibility for employment in the United States will not give rise to a right to resign for “Good Reason” or constitute a termination without “Cause” under this Agreement. (h) Absence of Conflicts; Competition with Prior Employer. Executive represents that Executive’s performance of Executive’s duties under this Agreement will not breach any other agreement as to which Executive is a party. Executive agrees that Executive has disclosed to the Company all of Executive’s existing employment and/or business relationships, including, but not limited to, any consulting or advising relationships, outside directorships, investments in privately held companies, and any other relationships that may create a conflict of interest. Executive is not to bring with Executive to the Company, or use or disclose to any person associated with Dolby or the Company, any confidential or proprietary information belonging to any former employer or other person or entity with respect to which Executive owes an obligation of confidentiality under any agreement or otherwise. Dolby and the Company does not need and will not use such information and Dolby and the Company will assist Executive in any way possible to preserve and protect the confidentiality of proprietary information belonging to third parties.


 
IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of Dolby and the Company by a duly authorized individual, as of the day and year written below. EXECUTIVE DOLBY LABORATORIES, INC., A DELAWARE CORPORATION ________________________________ Marc Whitten ________________________________ Peter C. Gotcher Chair of the Board of Directors July 10, 2026 Date July 10, 2026 Date DOLBY LABORATORIES, INC., A CALIFORNIA CORPORATION ________________________________ Linda Rogers Senior Vice President, Chief People Officer July 10, 2026 Date [SIGNATURE PAGE TO WHITTEN EMPLOYMENT AGREEMENT]


 
Exhibit A Sign-On Bonus Agreement


 
Sign-On Bonus Agreement [Date] Marc Whitten via e-mail Dear Marc: This Sign-On Bonus Agreement (the “Agreement”) establishes the terms and conditions of your receipt of a sign-on bonus from Dolby Laboratories, Inc., a California corporation (the “Company”). Capitalized terms used but not defined herein shall have the meaning given such terms in the Employment Agreement between you, the Company, and Dolby Laboratories, Inc., a Delaware corporation (“Dolby”) dated [DATE] (the “Employment Agreement”). 1. Sign-On Bonus. If you choose to accept the Company’s offer of employment, and conditional on you beginning service as Dolby’s President and Chief Executive Officer, the Company agrees to pay you a one-time, discretionary sign-on bonus in cash in the amount of $2,100,000 (the “Bonus”), less applicable withholdings. You acknowledge the Bonus is not tied to specific job performance and is only considered to have been fully earned if you remain continuously employed with the Company for a full twenty-four (24) month retention period beginning on your first day of employment with the Company (the “Retention Period”). The Company will pay the Bonus on the first payroll date following the Start Date, in advance of the Bonus becoming earned. Alternatively, you may choose to receive the Bonus at the end of the Retention Period by checking the box under your signature line below. 2. Repayment Obligations. You agree that if during the Retention Period, your employment with the Company is terminated (i) by you for any reason (other than for Good Reason) including if you tender your resignation (other than for Good Reason) and the Company accelerates your resignation date prior to your chosen date, or (ii) by the Company for Cause (provided that such termination for Cause qualifies as a termination for “misconduct” within the meaning provided by applicable law), and provided that such termination is not by reason of your death or Disability, then you will be required to repay the Company a prorated portion of the Bonus, calculated on an after-tax basis, based on the number of days of the Retention Period that remain unserved as of your termination date (the “Repayment Obligation”). No interest will accrue on the Repayment Obligation. Such repayment must be made to the Company in cash or cash equivalents (such as check or wire transfer) within thirty (30) days of your last day of employment with the Company. 3. Review Period. By your signature below, you acknowledge that you have been notified of your right to consult an attorney regarding this Agreement and have been provided with a reasonable time period of not less than five (5) business days to review the agreement and obtain advice of counsel prior to executing the Agreement. 4. Entire Agreement; At-Will Employment. To indicate your acceptance of this Bonus offer, please sign and date this Agreement in the space provided below. This Agreement constitutes the entire agreement with respect to the subject matter of this Agreement and supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or


 
written and whether expressed or implied) with respect to the subject matter of this Agreement. This Agreement does not alter your status as an at-will employee of the Company, which means that either you or the Company may terminate your employment relationship at any time, with or without cause, and with or without notice, including, but not limited to, before the conclusion of the Retention Period. 5. Deadline. You must execute and return this Agreement to the Company prior to the Start Date or else this Agreement will be null and void and of no further force or effect, and you will not have an opportunity to receive the Bonus. Sincerely, Linda Rogers Senior Vice President, Chief People Officer Acknowledged and accepted: Signature: __________________________________ Date: _______________________________________ By checking this box, I am electing to receive the Bonus only after it is earned at the end of the Retention Period, so long as I remain an employee of the Company through the end of the Retention Period (unless I have been terminated other than for Cause or resigned without Good Reason and other than due to my death or Disability, in which case the Bonus will be paid to me as severance, less applicable withholdings, within sixty (60) days after my termination date, subject to my satisfying Section 8 of the Employment Agreement). I understand that if I select this option, then I will not be paid the Bonus in connection with the Start Date and the Bonus will not be subject to any Repayment Obligation so long as it has been earned.


 
Exhibit B Separation and Release of Claims Agreement


 
CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE This Confidential Separation Agreement and General Release (“Agreement”) is made by and between Dolby Laboratories, Inc., a California corporation (“Employer” or “Company”) and Marc Whitten and his heirs, executors, administrators, successors and assigns (collectively referred to throughout this Agreement as “Employee”) (Employer and Employee collectively referred to as “the Parties” or individually as the “Party”). The Parties agree as follows: 1. Last Day of Employment. Employee’s last day of employment is <<Month DD, 20YY>> (the “Separation Date”). 2. Consideration. In exchange for Employee signing this Agreement and complying with its promises, and conditional upon Employee returning all Company property as provided in Section 11 below, Employer agrees to do the following:1 3. Stock. The Parties agree that for purposes of determining Employee’s equity interests in Dolby Laboratories, Inc., a Delaware corporation (“Dolby”) (be it restricted stock units or stock options), Employee will be considered to have vested only up to the Separation Date (after taking into account any vesting acceleration set forth in Section 2). The exercise of Employee’s vested options and shares shall continue to be governed by the terms and conditions of the applicable stock option plan and stock option agreement(s) (the “Stock Agreements”). 4. Sufficient Consideration. The Parties agree that the monies or benefits in Section 2 constitute good and sufficient consideration for Employee’s promises in this Agreement. Employee further represents that Employee is owed no additional compensation, wages, accrued paid time off, stock, stock options, vesting, reimbursement or other form of remuneration (arising under law or contract) with regard to the services and/or work Employee performed for Employer. 5. No Consideration Absent Execution of this Agreement. Employee understands and agrees that Employer has no obligation to provide Employee the monies or benefits described in Section 2 above unless Employee signs, does not revoke, and complies with the promises and terms of this Agreement. 6. General Release of Claims. Employee knowingly and voluntarily releases and forever discharges Employer, its parent corporation, affiliates, subsidiaries, divisions, successors, and assigns, and their current and former employees, attorneys, officers, directors and agents (collectively, the ”Releasees”), of and from any and all claims or causes of action, known and unknown (“Claims”), Employee has or may have against Releasees as of the date Employee signs this Agreement, including, but not limited to, any alleged violation of or claim arising from: • Title VII of the Civil Rights Act of 1964, as amended; • The Age Discrimination in Employment Act of 1967, as amended (“ADEA”); • The Older Workers Benefit Protection Act; • The Civil Rights Act of 1991; 1 Consideration to be updated at time of termination to reflect terms of Employment Agreement.


 
5 • The Equal Pay Act; • Sections 1981 through 1988 of Title 42 of the United States Code, as amended; • The Employee Retirement Income Security Act of 1974, as amended (“ERISA”); • The Immigration Reform and Control Act, as amended; • The Rehabilitation Act of 1973; • The Americans with Disabilities Act of 1990, as amended; • The Worker Adjustment and Retraining Notification Act, as amended; • The Occupational Safety and Health Act, as amended, and/or the California Occupational Safety and Health Act, as amended; • The Fair Credit Reporting Act, as amended, and/or the California Civil and Labor Code sections governing consumer credit and investigative consumer reports; • The Genetic Information Nondiscrimination Act of 2008, as amended; • The Family and Medical Leave Act, as amended and except as prohibited by law; • The Fair Labor Standards Act, as amended and except as prohibited by law; • The California Family Rights Act; • The California Fair Employment and Housing Act, as amended; • The California Labor Code, as amended and except as prohibited by law; • The California Industrial Welfare Commission Orders; • Any other federal, state or local law, regulation or ordinance which may lawfully be released; • Any public policy, contract, tort, or common law; • Employee’s employment relationship with the Company and the termination of the employment relationship; • Employee’s right to purchase, or actual purchase of shares of Dolby, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law; • Wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of a covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; negligent or intentional misrepresentation; fraud; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; invasion of privacy; false imprisonment; and conversion; • Any claim for any loss, cost, damage, or expense arising out of any dispute over the nonwithholding or other tax treatment of any of the proceeds received by Employee as a result of this Agreement; or • Any claim for costs, fees, or other expenses including attorneys’ fees incurred in these matters. Notwithstanding the foregoing, the parties agree that the scope of this release does not apply to the following: (i) Employee’s right to enforce this Agreement; (ii) Employee’s right, if any, to claim government-provided unemployment or workers’ compensation benefits, or claims for benefits under ERISA vested as of Employee’s separation date, (iii) any rights or claims that may arise after Employee signs this Agreement, (iv) any claim that may not be released as a matter of law, including any Protected Activity (as defined below); or (v) claims for indemnification of


 
6 Employee’s costs or expenses pursuant to California Labor Code Section 2802 or pursuant to the Company’s bylaws or certificate of incorporation or any indemnification agreement between Employee and Dolby or the Company in effect immediately prior to the Separation Date (the “Indemnification Agreement”); or (vi) Dolby’s Policy on Recoupment of Incentive Compensation, as it may be hereinafter amended (the “Clawback Policy”). 7. Waiver of California Civil Code section 1542. To effect a full and complete general release as described above, Employee expressly waives and relinquishes all rights and benefits of section 1542 of the Civil Code of the State of California, and Employee does so understanding and acknowledging the significance and consequence of specifically waiving section 1542. Section 1542 of the Civil Code of the State of California states as follows: A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY. Thus, notwithstanding the provisions of section 1542, and to implement a full and complete release and discharge of the Releasees, Employee expressly acknowledges this Agreement is intended to include in its effect, without limitation, all Claims Employee does not know or suspect to exist in Employee’s favor at the time of signing this Agreement, and that this Agreement contemplates the extinguishment of any such Claim or Claims. Employee has read this Agreement, including this waiver of California Civil Code section 1542, and Employee has consulted counsel or has had the opportunity to consult counsel about this Agreement and specifically about the waiver of section 1542, and Employee understands this Agreement and the section 1542 waiver, and so Employee freely and knowingly enters into this Agreement. Employee acknowledges Employee may later discover facts different from or in addition to those Employee now knows or believes to be true regarding the matters released or described in this Agreement, and even so Employee agrees the releases and agreements contained in this Agreement shall remain effective in all respects notwithstanding any later discovery of any different or additional facts. Employee assumes any and all risk of any mistake in connection with the true facts involved in the matters described in this Agreement or with regard to any facts now unknown to Employee relating to those matters. 8. Affirmations. Employee affirms Employee has not filed, has not caused to be filed, and presently is not a party to any claim, complaint, or action against any of the Releasees in any forum or form. Employee also affirms that Employee has complied in good faith with Dolby or Company policies made known to Employee. Employee further affirms Employee has been paid or has received all leave (paid or unpaid), compensation, wages, bonuses, commissions, or benefits to which Employee may be entitled and that no other leave (paid or unpaid), compensation, wages, bonuses, commissions or benefits are due to Employee, except as provided in this Agreement. And as to any consideration provided under this Agreement related to allegations of unpaid wages, Employee agrees that there is a bona fide and good-faith dispute as to whether such wages are due. Employee further acknowledges and agrees that Employee has been paid for all hours worked and has received all meal and rest break periods to which Employee


 
7 is entitled by law. In light of Employer’s payment of all wages due, the Parties acknowledge and agree that California Labor Code § 206.5 is not applicable to the Parties or this Agreement. That section provides in pertinent part as follows: “No employer shall require the execution of any release of any claim or right on account of wages due, or to become due, or made as an event on wages to be earned, unless payment of such wages has been made.” Employee also affirms Employee has no known workplace injuries or occupational diseases, and that Employee has been provided or has not been denied any leave requested under the Family and Medical Leave Act or under the California Family Rights Act. Employee affirms Employee has not divulged any proprietary or confidential information of Employer and will continue to maintain the confidentiality of such information consistent with Employer’s policies and Employee’s agreement(s) with Employer and/or common law, subject to the paragraph below concerning Protected Activity. 9. Resignation from Positions. Effective as of the Separation Date, Employee agrees that Employee resigned as Dolby’s President and Chief Executive Officer, as a member of the Dolby Board of Directors, and from any officer, director, manager, or similar positions Employee occupied with Dolby or the Company or any subsidiary or affiliate of Dolby or the Company effective as of the Separation Date, and agrees to execute any necessary documents or other forms necessary to effectuate or document Employee’s resignation as a matter of local, state, federal, or international law. 10. Protection of Employer’s Information. During the course of Employee’s employment by Employer, Employee has had access to or has had possession of confidential and proprietary information or materials of Employer or its clients or customers (including, but not necessarily limited to, systems information and processes, sales figures, projections, estimates, client or customer lists, information regarding customer needs and preferences, manufacturing information, pricing information, and promotions). Employee acknowledges that all such information or materials constitute confidential information and/or protected trade secrets of Employer; Employee agrees Employee shall not retain and that Employee must return to Employer all originals or copies of such materials, including electronic or magnetic as well as physical copies. Employee reaffirms and agrees to observe and abide by the terms of Dolby’s Insider Trading Policy and the Confidentiality Agreement (as defined below), specifically including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information, and non-solicitation of Company employees. 11. Company Property. Prior to the Effective Date, Employee agrees to return to Employer all Company property in Employee’s possession, including but not limited to, originals or copies of files, memoranda, documents, hard copy and electronic records, software, credit cards, keys, computer(s), computer equipment, mobile telephones, and any other electronic equipment or office materials. Employee acknowledges and agrees that Employee is not entitled to the consideration set forth in Section 2 above unless all such Company property has been returned. 12. Governing Law and Interpretation. This Agreement shall be governed and conformed in accordance with the laws of the State of California without regard to its conflict of laws provisions. In the event the Employee breaches any provision of this Agreement,


 
8 Employee and Employer affirm that either may institute an action to specifically enforce any term or terms of this Agreement. Should any provision, or part of any provision or application thereof be held invalid, illegal, or unenforceable, this shall not affect any other provisions or applications of the Agreement which shall remain in full force and effect. 13. Non-admission of Wrongdoing. The Parties agree that neither this Agreement nor the furnishing of the consideration for the release in this Agreement shall be deemed or construed at any time for any purpose as an admission by either Party of any liability or unlawful conduct of any kind. 14. Mutual Non-Disparagement and Communications with Company Employees, Customers and Business Partners. Subject to the paragraph below concerning Protected Activity, Employee agrees (a) to refrain from any disparagement, defamation, libel, or slander of the Releasees, (b) to refrain from any tortious interference with any of the Releasees’ contracts and relationships, and (c) to refrain from discussing Dolby or Company confidential business or financial information with third parties, including Dolby’s and the Company’s actual and potential customers or business partners. The Company agrees (x) to refrain from any disparagement, defamation, libel, or slander of Employee and (y) to refrain from any tortious interference with any of Employee’s contracts and relationships. Employee understands that the Company’s obligations under this paragraph extend only to the Company’s current executive officers and members of the Dolby Board of Directors and, in each case, only for so long as such individual remains an officer or director of Dolby or the Company. Employee shall direct any inquiries by potential future employers to the Company’s human resources department, which shall provide only the Employee’s last position and dates of employment, in accordance with the Company’s policy and practice. 15. No Cooperation. Employee further agrees that Employee will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so. Employee agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, in sufficient time for Company to object and no later than within three (3) business days of its receipt, a copy of such subpoena or other court order. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Employee shall state no more than that Employee cannot provide counsel or assistance. 16. Protected Activity Not Prohibited. Employee understands that nothing in this Agreement shall in any way limit or prohibit Employee from engaging in any Protected Activity. For purposes of this Agreement, “Protected Activity” shall mean (a) filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in, any investigation or proceeding that may be conducted by any federal, state or local governmental agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration and the National Labor Relations Board (each, a “Government Agency” and collectively the “Government Agencies”), (b) engaging in protected, concerted activity under Section 7 of the


 
9 National Labor Relations Act (such as discussing wages, benefits, or other terms and conditions of employment or raising complaints about working conditions for Employee’s own and other employees’ mutual aid or protection), or (c) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful. This Agreement does not limit Employee’s right to receive an award from a Government Agency (and not the Company) for information provided to a Government Agency, but Employee otherwise waives the right to any monetary recovery or other individualized relief (including in connection with any collective or class action) should a Government Agency or any other agency or person pursue any claims on Employee’s behalf. Employee understands that, in connection with Protected Activity, Employee is permitted to disclose documents or other information as permitted by law, and without giving notice to, receiving authorization from, the Company. Employee understands that “Protected Activity” does not include the disclosure of any Company attorney-client privileged communications. Any language in the Confidentiality Agreement regarding Employee’s right to engage in Protected Activity that conflicts with, or is contrary to, this Section is superseded by this Agreement. In addition, pursuant to the Defend Trade Secrets Act of 2016, Employee is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. 17. Amendment. This Agreement may not be modified, altered or changed except in a writing signed by both Parties that specifically refers to this Agreement. 18. Arbitration. The Parties agree that any and all disputes arising out of the terms of this Agreement and their interpretation shall be subject to arbitration in San Francisco County, before Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Employment Arbitration Rules & Procedures (“JAMS Rules’”, unless Employee primarily works in a state outside of California, in which case the arbitration shall take place in the state where the Employee primarily works and the arbitration shall be conducted in accordance with the laws of such state. The arbitrator may grant injunctions and other relief in such disputes. If the arbitration is conducted in California, the arbitrator shall administer and conduct the arbitration in accordance with California law, and the arbitrator shall apply substantive and procedural California law to any dispute or claim, without reference to any conflict-of-law provisions of any jurisdiction. To the extent that the JAMS Rules conflict with California law, California law shall take precedence. The decision of the arbitrator shall be final, conclusive, and binding on the Parties to the arbitration. The Parties agree that the prevailing Party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. The Company will pay for any administrative or hearing fees charged by the arbitrator or JAMS except that Employee shall pay any filing fees associated with any arbitration that Employee initiates, but only so much of the filing fees as Employee would have instead paid had Employee filed a complaint in a court of law.


 
10 Each Party shall separately pay for its respective counsel fees and expenses; provided, however, that the arbitrator shall award attorneys' fees and costs to the prevailing Party, except as prohibited by law. The Parties hereby agree to waive their right to have any dispute between them resolved in a court of law by a judge or jury. Notwithstanding the foregoing, this section will not prevent either Party from seeking injunctive relief (or any other provisional remedy) from any court having jurisdiction over the Parties and the subject matter of their dispute relating to this Agreement and the agreements incorporated herein by reference. Should any part of the arbitration agreement contained in this paragraph conflict with any other arbitration agreement between the Parties, the Parties agree that this arbitration agreement shall govern. 19. Tax Consequences. Employer makes no representations or warranties with respect to the tax consequences of the monies and benefits provided under this Agreement. Employee agrees and understands that Employee is responsible for payment of any and all local, state and/or federal taxes on the monies and benefits provided under this Agreement and for any interest, penalties or assessments thereon, if any. Employee agrees to defend, indemnify and hold Employer harmless against any and all loss, cost, damage, or expense, including, without limitation, taxes, interest, penalties, assessments and attorneys' fees, incurred by Employer arising from any failure by Employee to defend against and to timely pay those aforementioned taxes, interest, penalties or assessments. 20. Section 409(A). It is intended that none of the severance payments or benefits under this Agreement will constitute deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), any final regulations and guidance under that statute, and any applicable state law equivalent, as each may be amended or promulgated from time to time (together, “Section 409A”), but rather such payments and benefits will be exempt from Section 409A as payable only within the “short-term deferral period” pursuant to Treasury Regulation Section 1.409A-1(b)(4), or as resulting from an involuntary separation from service pursuant to Treasury Regulation Section 1.409A-1(b)(9)(iii) that does not exceed the applicable amount and time limits set forth in Treasury Regulation Section 1.409A-1(b)(9)(iii), or otherwise be exempt or comply with Section 409A so that none of the payments to be provided under this Agreement will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms will be interpreted in such manner. Each payment, installment and benefit payable under this Agreement or otherwise is intended to constitute a separate payment under Treasury Regulation Section 1.409A-2(b)(2). Notwithstanding the foregoing, if and to the extent necessary to avoid subjecting Employee to an additional tax under Section 409A, any payments or benefits deemed to be separation-related deferred compensation (within the meaning of Section 409A), whether under this Agreement or any other arrangement, payable to Employee will be delayed until the date that is six (6) months and one (1) day following Employee’s separation from service (within the meaning of Section 409A), except that in the event of Employee’s death, any such delayed payments will be paid as soon as practicable after the date of Employee’s death, and in each case all subsequent payments and benefits will be payable in accordance with the payment schedule applicable to such payment or benefit.2 In no event will the Releasees have any liability or obligation to reimburse, indemnify or hold harmless Employee for any taxes or costs that may be imposed on or incurred by Employee as a result of Section 409A. In no event will Employee have discretion to determine the taxable year of payment of any separation-related payments. 2 To be updated at termination based on determination at that time of whether payments need to be delayed.


 
11 21. Entire Agreement. This Agreement sets forth the entire agreement and understanding between Employer and Employee concerning the subject matter of this Agreement and Employee’s employment with and separation from the Company and the events leading thereto and associated therewith, and it and fully supersedes and replaces any and all prior agreements and understanding concerning the subject matter of this Agreement and Employee’s relationship with the Company, with the exception of the Confidential Information and Invention Assignment Agreement signed on or about <<Month DD, 20YY>> between Employee and the Company (the “Confidentiality Agreement”). [TO BE UPDATED AS NECESSARY FOR ANY ADDITIONAL AGREEMENTS OR EQUITY AWARD AGREEMENTS] Employee acknowledges Employee has not relied on any representations, promises, or agreements of any kind made to Employee in connection with Employee’s decision to accept this Agreement, except for those set forth in this Agreement. 22. Attorneys’ Fees. In the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action. 23. Counterparts. Except as provided herein, this Agreement may be executed in counterparts and by facsimile, email or electronic signature, and each counterpart and facsimile, email or electronic signature shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned. 24. Acknowledgment of Waiver of Claims under ADEA. Employee understands and acknowledges that Employee is waiving and releasing any rights Employee may have under the ADEA, and that this waiver and release is knowing and voluntary. Employee understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Employee understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Employee was already entitled. Employee further understands and acknowledges that Employee has been advised by this writing that: (a) Employee should consult with an attorney prior to executing this Agreement; (b) Employee has twenty-one (21) days within which to consider this Agreement; (c) Employee has seven (7) days following Employee’s execution of this Agreement to revoke this Agreement; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Employee signs this Agreement and returns it to the Company in less than the 21-day period identified above, Employee hereby acknowledges that Employee has freely and voluntarily chosen to waive the time period allotted for considering this Agreement. The Parties agree that any changes to the Agreement, whether material or immaterial, do not restart the running of the twenty-one (21) day consideration period. 25. Revocation. Employee may revoke this Agreement for a period of seven (7) calendar days following the day Employee signs this Agreement. Any revocation within this


 
12 period must be submitted to PeopleCare via [OMITTED] and state, “I hereby revoke my acceptance of our Confidential Separation Agreement and General Release.” The revocation must be sent to [OMITTED] no later than seven (7) calendar days of signing this Agreement. This Agreement shall not become effective or enforceable until the revocation period has expired. 26. Effective Date. Employee understands that this Agreement shall be null and void if not executed by Employee within the twenty-one (21) day period set forth under Section 24 above. Each Party has seven (7) days after that Party signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Employee signed this Agreement, so long as Employee has complied with all of its terms and conditions, including those in Section 9 above, it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”). EMPLOYEE IS HEREBY ADVISED THAT EMPLOYEE HAS UP TO TWENTY-ONE (21) CALENDAR DAYS TO REVIEW THIS AGREEMENT. EMPLOYEE IS ADVISED TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS AGREEMENT. THE LAST DAY OF THIS TWENTY-ONE (21) CALENDAR DAY PERIOD IS <<DATE>>. TO OBTAIN THE BENEFITS UNDER THIS AGREEMENT, EMPLOYEE MUST SIGN AND DELIVER THE EXECUTED AGREEMENT TO DOLBY VIA DOCUSIGN OR TO PEOPLECARE VIA [OMITTED] BY THE END OF THE CONSIDERATION PERIOD, <<<<DATE>>. EMPLOYEE HAS SEVEN (7) DAYS AFTER SIGNING THE AGREEMENT TO REVOKE IT. THIS AGREEMENT WILL BECOME EFFECTIVE ON THE EIGHTH (8TH) DAY AFTER EMPLOYEE SIGNED THIS AGREEMENT, SO LONG AS EMPLOYEE HAS COMPLIED WITH ALL OF ITS TERMS AND CONDITIONS, IT HAS BEEN SIGNED BY THE PARTIES, AND HAS NOT BEEN REVOKED BEFORE THAT DATE (THE “EFFECTIVE DATE”). HAVING ELECTED TO EXECUTE THIS AGREEMENT, TO FULFILL ITS PROMISES AND TO RECEIVE THE SUMS AND BENEFITS IN SECTION 2 ABOVE, EMPLOYEE FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS AGREEMENT INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS EMPLOYEE HAS OR MIGHT HAVE AGAINST EMPLOYER. EMPLOYEE CONSENTS TO USE ELECTRONIC SIGNATURE SERVICE FOR PURPOSES OF ACKNOWLEDGING THIS AGREEMENT. [Remainder of Page Intentionally Blank; Signature Page Follows]


 
13 IN WITNESS WHEREOF, the parties hereto knowingly and voluntarily executed this Agreement as of the date set forth below: Marc Whitten, an individual Dated: ________________ Marc Whitten DOLBY LABORATORIES, INC. Dated: ________________ [NAME, TITLE]


 
-1- CONFIDENTIAL TRANSITION AGREEMENT AND GENERAL RELEASE This Confidential Transition Agreement and General Release (“Agreement”) is made by and between Dolby Laboratories, Inc., a California corporation (“Employer” or “Company”), and Kevin Yeaman, his heirs, executors, administrators, successors and assigns (collectively referred to throughout this Agreement as “Executive”) (Employer and Executive collectively referred to as “the Parties” or individually as the “Party”). The Parties agree: 1. Last Day of Employment. Executive’s last day of employment shall be the date on which the appointment of a successor Chief Executive Officer of the Company becomes effective (currently expected to be August 27, 2026) (the date such appointment becomes effective, the “Transition Date”). 2. Consideration. Contingent on the occurrence of the Transition Date, and in exchange for Executive signing this Agreement and complying in all material respects with the promises in this Agreement, Employer agrees: a. Executive shall receive a payment in an amount equivalent to the 2026 annual cash incentive that would have been payable to Executive for the actual achievement of performance goals set by the Compensation Committee (the “Committee”) of the Dolby Laboratories, Inc., a Delaware corporation (“Dolby”) Board of Directors (the “Board”) under the 2026 Dolby Executive Bonus Plan (the “Bonus Plan”), had Executive remained employed with the Company through the payment date. Any such payment and the amount of such payment will depend upon the extent to which the applicable performance goal(s) specified by the Committee are achieved or exceeded under the Bonus Plan and may be adjusted for over- or under- performance on a basis consistent with adjustments applied to other senior executives participating in the Bonus Plan. By signing this Agreement, Executive agrees to receive such amount, if any, pursuant to this section via direct deposit. This amount, if any, will be paid in a lump sum, less applicable withholdings, during the regular payroll period in which the Company makes payments under the Bonus Plan to the Company’s other senior executives participating in the Bonus Plan, but in no case later than March 15, 2027. b. Executive’s health insurance benefits shall cease on the last day of the month in which the Transition Date occurs, provided that if Executive validly elects COBRA continuation coverage, the Company shall reimburse Executive for premiums paid for continued health benefits for Executive (and any eligible dependents) under the Company’s health plans until the earlier of (A) December 31, 2027, payable when such premiums are due, or (B) the date upon which Executive and Executive’s eligible dependents become covered under similar plans. c. Employer will directly pay or reimburse Executive’s reasonable and documented costs incurred for transition coaching services in an amount not to exceed $200,000 (the “Transition Services”). In order to be paid or reimbursed, Transition Services must be incurred by August 31, 2027 and substantiated in writing (by any reasonable method of invoicing, and in the case of reimbursement, showing proof of payment for Transition Services). Any reimbursements due to Executive under this Section 2.c. will be paid to Executive via check or electronic funds transfer within thirty (30) days following the date of receipt by Employer of


 
-2- Executive’s written substantiation, with such substantiation to be provided to Employer no later than September 24, 2027. d. Executive will have the opportunity to provide consulting services to the Company pursuant to the terms set forth in the Consulting Agreement attached hereto as Exhibit 1 (“Consulting Agreement”) and receive the compensation as provided in the Consulting Agreement, including continued vesting in Executive’s outstanding Dolby equity awards (the “Equity Awards”) in accordance with the terms of the Consulting Agreement and the terms of the Equity Awards. Executive’s Equity Awards, including the exercise of Executive’s vested options, shall continue to be governed by the terms and conditions of the applicable equity plan and award agreement(s) (the “Stock Agreements”). e. Employer will reimburse Executive for reasonable attorneys’ fees actually incurred by Executive in connection with the negotiation and documentation of this Agreement and the agreements incorporated herein by reference, in an amount not to exceed $15,000 in the aggregate, less applicable withholdings if required. Such reimbursement will be paid within thirty (30) days following the Company’s receipt of reasonable documentation of such fees, provided that such documentation is submitted no later than sixty (60) days after the Effective Date; provided, however, that in the event the Employer requests that Executive submit invoices associated with such legal representation to substantiate the reimbursement of reasonable attorneys’ fees and costs, Executive shall be permitted to redact such legal invoices to protect and preserve attorney-client privilege. 3. Sufficient Consideration. The Parties agree that the monies or benefits in Section 2 constitute good and sufficient consideration for Executive’s promises in this Agreement. Executive further represents that except as provided in Section 2, and except for any unpaid compensation that accrues prior to the Transition Date, vested benefits under Company benefit plans, rights under the Stock Agreements, and rights under the Indemnification Agreement (as defined below), Executive is owed no additional compensation, wages, accrued paid time off, stock, equity awards, vesting, reimbursement or other form of remuneration (arising under law or contract) with regard to the services and/or work Executive performed for Employer. 4. No Consideration Absent Execution of Agreements. Executive understands and agrees that Employer has no obligation to provide Executive the monies or benefits described in Section 2 above unless the Transition Date occurs and unless Executive signs, does not revoke, and complies in all material respects with the promises and terms of this Agreement and the Consulting Agreement. 5. General Release of Claims. Executive knowingly and voluntarily releases and forever discharges Employer, its parent corporation, affiliates, subsidiaries, divisions, successors, and assigns, and their current and former employees, attorneys, officers, directors and agents (collectively, the “Releasees”), of and from any and all claims or causes of action, known and unknown (“Claims”), Executive has or may have against Releasees as of the date Executive signs this Agreement, including, but not limited to, any alleged violation of or claim arising from: • Title VII of the Civil Rights Act of 1964, as amended;


 
-3- • The Age Discrimination in Employment Act of 1967, as amended (“ADEA”); • The Older Workers Benefit Protection Act; • The Civil Rights Act of 1991; • The Equal Pay Act; • Sections 1981 through 1988 of Title 42 of the United States Code, as amended; • The Executive Retirement Income Security Act of 1974, as amended (“ERISA”); • The Immigration Reform and Control Act, as amended; • The Rehabilitation Act of 1973; • The Americans with Disabilities Act of 1990, as amended; • The Worker Adjustment and Retraining Notification Act, as amended; • The Occupational Safety and Health Act, as amended, and/or the California Occupational Safety and Health Act, as amended; • The Fair Credit Reporting Act, as amended, and/or the California Civil and Labor Code sections governing consumer credit and investigative consumer reports; • The Genetic Information Nondiscrimination Act of 2008, as amended; • The Family and Medical Leave Act, as amended and except as prohibited by law; • The Fair Labor Standards Act, as amended and except as prohibited by law; • The California Family Rights Act; • The California Fair Employment and Housing Act, as amended; • The California Labor Code, as amended and except as prohibited by law; • The California Industrial Welfare Commission Orders; • Any other federal, state or local law, regulation or ordinance which may lawfully be released; • Any public policy, contract, tort, or common law; • Executive’s employment relationship with the Company and the termination of the employment relationship; • Executive’s right to purchase, or actual purchase of shares of Dolby other than any rights Executive may have as a holder of equity or other securities of the Company or any rights under the Equity Awards, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law; • Wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of a covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; negligent or intentional misrepresentation; fraud; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; invasion of privacy; false imprisonment; and conversion; any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement; or any claim for costs, fees, or other expenses including attorneys’ fees incurred in these matters.


 
-4- Notwithstanding the foregoing, the parties agree that the scope of this release does not apply to the following: (i) Executive’s right to receive the consideration set forth in Section 2 above and to enforce this Agreement; (ii) Executive’s right, if any, to claim government-provided unemployment or workers’ compensation benefits, or claims for benefits under ERISA vested as of the Transition Date; (iii) any rights or claims that may arise after Executive signs this Agreement; (iv) any claim that may not be released as a matter of law, including any Protected Activity (as defined below); (v) any claim relating to directors’ and officers’ liability insurance coverage and claims for indemnification of Executive’s costs or expenses pursuant to California Labor Code Section 2802 or pursuant to the Company’s Articles of Incorporation, Bylaws, the Employment Agreement or the indemnification agreement between Executive and the Company in effect immediately prior to the Transition Date (the “Indemnification Agreement”); (vi) Dolby’s Amended and Restated Policy on Recoupment of Incentive Compensation, as it shall hereinafter be amended in accordance with applicable law (the “Clawback Policy”); and (vii) any rights Executive may have as a holder of equity or other securities of the Company, including the Equity Awards. 6. Waiver of California Civil Code section 1542. To effect a full and complete general release as described above, Executive expressly waives and relinquishes all rights and benefits of section 1542 of the Civil Code of the State of California, and Executive does so understanding and acknowledging the significance and consequence of specifically waiving section 1542. Section 1542 of the Civil Code of the State of California states as follows: A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY. Thus, notwithstanding the provisions of section 1542, and to implement a full and complete release and discharge of the Releasees, Executive expressly acknowledges this Agreement is intended to include in its effect, without limitation, all Claims Executive does not know or suspect to exist in Executive’s favor at the time of signing this Agreement, and that this Agreement contemplates the extinguishment of any such Claim or Claims. Executive has read this Agreement, including this waiver of California Civil Code section 1542, and Executive has consulted counsel or has had the opportunity to consult counsel about this Agreement and specifically about the waiver of section 1542, and Executive understands this Agreement and the section 1542 waiver, and so Executive freely and knowingly enters into this Agreement. Executive acknowledges Executive may later discover facts different from or in addition to those Executive now knows or believes to be true regarding the matters released or described in this Agreement, and even so Executive agrees the releases and agreements contained in this Agreement shall remain effective in all respects notwithstanding any later discovery of any different or additional facts. Executive assumes any and all risk of any mistake in connection with the true facts involved in the matters described in this Agreement or with regard to any facts now unknown to Executive relating to those matters.


 
-5- 7. Affirmations. Executive affirms Executive has not filed, has not caused to be filed, and presently is not a party to any claim, complaint, or action against any of the Releasees in any forum or form. Executive also affirms that Executive has complied in good faith with applicable Company policies made known to Executive, including the Company’s insider trading policy. Executive further affirms Executive has been paid or has received all leave (paid or unpaid), compensation, wages, bonuses, commissions, or benefits to which Executive may be entitled and that no other leave (paid or unpaid), compensation, wages, bonuses, commissions or benefits are due to Executive, except as provided in this Agreement. And as to any consideration provided under this Agreement related to allegations of unpaid wages, Executive agrees that there is a bona fide and good-faith dispute as to whether such wages are due. Executive further acknowledges and agrees that Executive has been paid for all hours worked and has received all meal and rest break periods to which Executive is entitled by law. In light of Employer’s payment of all wages due, the Parties acknowledge and agree that California Labor Code § 206.5 is not applicable to the Parties or this Agreement. That section provides in pertinent part as follows: “No employer shall require the execution of any release of any claim or right on account of wages due, or to become due, or made as an event on wages to be earned, unless payment of such wages has been made.” Executive also affirms Executive has no known workplace injuries or occupational diseases, and that Executive has been provided or has not been denied any leave requested under the Family and Medical Leave Act or under the California Family Rights Act. Executive affirms Executive has not divulged any proprietary or confidential information of Employer and will continue to maintain the confidentiality of such information consistent with Employer’s policies and Executive’s agreement(s) with Employer and/or common law, subject to the paragraph below concerning Protected Activity. 8. Resignation from Positions. Effective as of the Transition Date, Executive agrees that Executive resigned as Dolby’s President, Chief Executive Officer, as a member of the Board, and from any officer, director, manager, or similar positions Executive occupied with Dolby or the Company or any subsidiary or affiliate of Dolby or the Company immediately prior to the Transition Date, and agrees to execute any necessary documents or other forms necessary to effectuate or document Executive’s resignation as a matter of local, state, federal, or international law. For purposes of clarification, if Executive revokes this Agreement pursuant to Section 24, such revocation will not impact Executive’s resignation as of the Transition Date pursuant to the terms of this Section 8. 9. Protection of Employer’s Information. During the course of Executive’s employment by Employer, Executive has had access to or has had possession of confidential and proprietary information or materials of Employer or its clients or customers (including, but not necessarily limited to, systems information and processes, sales figures, projections, estimates, client or customer lists, information regarding customer needs and preferences, manufacturing information, pricing information, and promotions). Executive acknowledges that all such information or materials constitute confidential information and/or protected trade secrets of Employer; Executive agrees Executive shall not retain and that Executive must return to Employer all originals or copies of such materials, including electronic or magnetic as well as physical copies. Executive reaffirms and agrees to observe and abide by the terms of Dolby’s Insider Trading Policy and the Confidentiality Agreement (as defined below), specifically including the


 
-6- provisions therein regarding nondisclosure of Dolby’s or the Company’s trade secrets and confidential and proprietary information. 10. Company Property. Upon termination of the Consulting Agreement, Executive agrees to return to Employer all Company property of which Executive is aware (based upon a diligent search) is then in Executive’s possession or control, including but not limited to, originals or copies of files, memoranda, documents, hard copy and electronic records, software, credit cards, keys, computer(s), computer equipment, mobile telephones, and any other electronic equipment or office materials. Executive acknowledges and agrees that Executive is not entitled to the consideration set forth in Section 2 above unless all such Company property has been returned; provided that the Company acknowledges and agrees that immaterial failures to return Company property shall not be deemed a breach hereof or of the Consulting Agreement, so long as Executive promptly returns such property upon becoming aware it is in his possession or control. 11. Governing Law and Interpretation. This Agreement shall be governed and conformed in accordance with the laws of the State of California without regard to its conflict of laws provisions. In the event either Party breaches any provision of this Agreement, Executive and Employer affirm that either may institute an action to specifically enforce any term or terms of this Agreement. Should any provision, or part of any provision or application thereof be held invalid, illegal, or unenforceable, this shall not affect any other provisions or applications of the Agreement which shall remain in full force and effect. 12. Non-admission of Wrongdoing. The Parties agree that neither this Agreement nor the furnishing of the consideration for the release in this Agreement shall be deemed or construed at any time for any purpose as an admission by either Party of any liability or unlawful conduct of any kind. 13. Non-Disparagement and Communications with Company Employees, Customers and Business Partners. Subject to the paragraph below concerning Protected Activity, Executive agrees (a) to refrain from any disparagement, defamation, libel, or slander of the Releasees, (b) to refrain from any tortious interference with any of the Releasees’ contracts and relationships, and (c) to refrain from discussing Company confidential business or financial information with third parties, including the Company’s actual and potential customers or business partners (unless such information is shared pursuant to the terms of the Consulting Agreement). Executive shall direct any inquiries by potential future employers to the Company’s human resources department, which shall provide only the Executive’s last position and dates of employment, in accordance with the Company’s policy and practice. In addition, the Company agrees not to knowingly and materially disparage, criticize, or otherwise make any derogatory statements regarding Executive. 14. No Cooperation. Subject to Section 15 (Protected Activity Not Prohibited), Executive further agrees that Executive will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so, or unless such activity constitutes Protected Activity. Executive agrees both to immediately notify the Company upon receipt of any such subpoena or


 
-7- court order, and to furnish, in sufficient time for Company to object and no later than within five (5) business days of its receipt, a copy of such subpoena or other court order. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive shall state no more than that Executive cannot provide counsel or assistance. 15. Protected Activity Not Prohibited. Executive understands that nothing in this Agreement shall in any way limit or prohibit Executive from engaging in any Protected Activity. For purposes of this Agreement, “Protected Activity” shall mean (a) filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in, any investigation or proceeding that may be conducted by any federal, state or local governmental agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration and the National Labor Relations Board (each, a “Government Agency” and collectively the “Government Agencies”), (b) engaging in protected, concerted activity under Section 7 of the National Labor Relations Act (such as discussing wages, benefits, or other terms and conditions of employment or raising complaints about working conditions for Executive’s own and other employees’ mutual aid or protection), or (c) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Executive has reason to believe is unlawful. This Agreement does not limit Executive’s right to receive an award from a Government Agency (and not the Company) for information provided to a Government Agency, but Executive otherwise waives the right to any monetary recovery or other individualized relief (including in connection with any collective or class action) should a Government Agency or any other agency or person pursue any claims on Executive’s behalf. For clarity, and as provided by law, such waiver does not prevent Executive from accepting a whistleblower award from the Securities and Exchange Commission pursuant to Section 21F of the Securities Exchange Act of 1934, as amended. Executive understands that, in connection with Protected Activity, Executive is permitted to disclose documents or other information as permitted by law, and without giving notice to, receiving authorization from, the Company. Executive understands that “Protected Activity” does not include the disclosure of any Company attorney- client privileged communications. Any language in the Confidentiality Agreement regarding Executive’s right to engage in Protected Activity that conflicts with, or is contrary to, this section is superseded by this Agreement. In addition, pursuant to the Defend Trade Secrets Act of 2016, Executive is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. 16. Amendment. This Agreement may not be modified, altered or changed except in a writing signed by both Parties that specifically refers to this Agreement and approved by the Board or the Committee or their authorized designee.


 
-8- 17. Arbitration. The Parties agree that any and all disputes arising out of the terms of this Agreement and their interpretation shall be subject to arbitration in San Francisco County, before Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Employment Arbitration Rules & Procedures (“JAMS Rules”), unless Executive primarily works in a state outside of California, in which case the arbitration shall take place in the state where the Executive primarily works and the arbitration shall be conducted in accordance with the laws of such state. The arbitrator may grant injunctions and other relief in such disputes. If the arbitration is conducted in California, the arbitrator shall administer and conduct the arbitration in accordance with California law, and the arbitrator shall apply substantive and procedural California law to any dispute or claim, without reference to any conflict-of-law provisions of any jurisdiction. To the extent that the JAMS Rules conflict with California law, California law shall take precedence. The decision of the arbitrator shall be final, conclusive, and binding on the Parties to the arbitration. The Parties agree that the prevailing Party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. The Company will pay for any administrative or hearing fees charged by the arbitrator or JAMS except that Executive shall pay any filing fees associated with any arbitration that Executive initiates, but only so much of the filing fees as Executive would have instead paid had Executive filed a complaint in a court of law. Each Party shall separately pay for its respective counsel fees and expenses; provided, however, that the arbitrator shall award attorneys’ fees and costs to the prevailing Party, except as prohibited by law. The Parties hereby agree to waive their right to have any dispute between them resolved in a court of law by a judge or jury. Notwithstanding the foregoing, this section will not prevent either Party from seeking injunctive relief (or any other provisional remedy) from any court having jurisdiction over the Parties and the subject matter of their dispute relating to this Agreement and the agreements incorporated herein by reference. Should any part of the arbitration agreement contained in this paragraph conflict with any other arbitration agreement between the Parties, the Parties agree that this arbitration agreement shall govern. 18. Tax Consequences. Employer makes no representations or warranties with respect to the tax consequences of the monies and benefits provided under this Agreement. Executive agrees and understands that Executive is responsible for payment of any and all local, state and/or federal taxes on the monies and benefits provided under this Agreement and for any interest, penalties or assessments thereon, if any. 19. Section 409A. It is intended that none of the payments or benefits provided for under this Agreement will constitute deferred compensation for purposes of Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), but rather such payments and benefits will be exempt from Section 409A as payable only within the “short-term deferral period” pursuant to Treasury Regulation Section 1.409A-1(b)(4), or otherwise be exempt or comply with the requirements of Section 409A so that none of the payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted in such manner. Each payment, installment and benefit payable under this Agreement or otherwise is intended to constitute a separate payment under Treasury Regulation Section 1.409A-2(b)(2). To the extent that any reimbursements provided to Executive pursuant to Section 2.c. or Section 2.e. constitute Deferred Payments, such amounts shall be paid or reimbursed to Executive promptly, but in no event later than December 31


 
-9- of the year following the year in which the expense is incurred. The amount of any such payments eligible for reimbursement in one year shall not affect the payments or expenses that are eligible for payment or reimbursement in any other taxable year, and Executive’s right to such payments or reimbursement shall not be subject to liquidation or exchange for any other benefit. For purposes of this Agreement, “Deferred Payments” means any payments or benefits to be paid or provided to Executive (or Executive’s estate or beneficiaries) pursuant to this Agreement and any other payments or benefits to be paid or provided to Executive (or Executive’s estate or beneficiaries), that in each case, when considered together, are considered deferred compensation under Section 409A. To the extent that any provision hereof is modified in order to comply with Section 409A, such modification shall be made in good faith and shall, to the maximum extent reasonably possible, maintain the original intent and economic benefit to Executive and the Company of the applicable provision without violating the provisions of Section 409A. 20. Entire Agreement. This Agreement sets forth the entire agreement and understanding between Employer and Executive concerning the subject matter of this Agreement and Executive’s employment with and separation from the Company and the events leading thereto and associated therewith, and it fully supersedes and replaces any and all prior agreements and understanding concerning the subject matter of this Agreement and Executive’s relationship with the Company, with the exception of the surviving provisions of the Employment Agreement incorporated herein by reference, the Company’s confidential information and intellectual property agreement previously executed by the Executive (the “Confidentiality Agreement”), the Consulting Agreement, the Stock Agreements (except to the extent they are amended by the Consulting Agreement), the Indemnification Agreement and the Clawback Policy. Executive acknowledges Executive has not relied on any representations, promises, or agreements of any kind made to Executive in connection with Executive’s decision to accept this Agreement, except for those set forth in this Agreement. 21. Attorneys’ Fees. In the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action. 22. Counterparts. Except as provided herein, this Agreement may be executed in counterparts and by facsimile, email or electronic signature, and each counterpart and facsimile, email or electronic signature shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned. 23. Acknowledgment of Waiver of Claims under ADEA. Executive understands and acknowledges that Executive is waiving and releasing any rights Executive may have under the ADEA, and that this waiver and release is knowing and voluntary. Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled. Executive further understands and acknowledges that Executive has been advised by this writing that: (a) Executive should consult with an attorney prior to executing this Agreement; (b) Executive has twenty-one (21) days within which to


 
-10- consider this Agreement; (c) Executive has seven (7) days following Executive’s execution of this Agreement to revoke this Agreement other than with respect to Section 8; (d) this Agreement (other than with respect to Section 8) shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Executive signs this Agreement and returns it to the Company in less than the twenty-one (21)-day period identified above, Executive hereby acknowledges that Executive has freely and voluntarily chosen to waive the time period allotted for considering this Agreement. The Parties agree that any changes to the Agreement, whether material or immaterial, do not restart the running of the twenty-one (21) day consideration period. 24. Revocation. Other than with respect to Section 8, Executive may revoke this Agreement for a period of seven (7) calendar days following the day Executive signs this Agreement. Any revocation within this period must be submitted to the General Counsel of the Company via [OMITTED] and state, “I hereby revoke my acceptance of our Confidential Transition Agreement and General Release.” The revocation must be sent to [OMITTED] no later than seven (7) calendar days of signing this Agreement. Except as provided in this paragraph, this Agreement shall not become effective or enforceable until the revocation period has expired. 25. Effective Date. Executive understands that this Agreement shall be null and void if not executed by Executive by the deadline set forth in the next paragraph. Executive has seven (7) days after he signs this Agreement to revoke it. This Agreement will become effective (a) as to Section 8 of this Agreement, on the Transition Date and (b) as to all sections other than Section 8, on the eighth (8th) day after Executive signed this Agreement, so long as Executive has complied in all material respects with all of its terms and conditions, it has been signed by the Parties and has not been revoked by Executive before that date (the “Effective Date”). EXECUTIVE IS HEREBY ADVISED THAT EXECUTIVE HAS AT LEAST TWENTY-ONE (21) CALENDAR DAYS TO REVIEW THIS AGREEMENT. EXECUTIVE IS ADVISED TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS AGREEMENT. TO OBTAIN THE BENEFITS UNDER THIS AGREEMENT, EXECUTIVE MUST SIGN AND DELIVER THE EXECUTED AGREEMENT TO THE COMPANY VIA DOCUSIGN OR TO THE GENERAL COUNSEL OF THE COMPANY NO EARLIER THAN AUGUST 25, 2026, AND NO LATER THAN AUGUST 26, 2026. EXECUTIVE HAS SEVEN (7) DAYS AFTER SIGNING THE AGREEMENT TO REVOKE IT (OTHER THAN THE COVENANTS SET FORTH IN SECTION 8 OF THIS AGREEMENT). OTHER THAN WITH RESPECT TO SECTION 8 OF THIS AGREEMENT, THIS AGREEMENT WILL BECOME EFFECTIVE ON THE EIGHTH (8TH) DAY AFTER EXECUTIVE SIGNED THIS AGREEMENT, SO LONG AS THE TRANSITION DATE OCCURS, EXECUTIVE HAS COMPLIED IN ALL MATERIAL RESPECTS WITH ALL OF ITS TERMS AND CONDITIONS, IT HAS BEEN SIGNED BY THE PARTIES, AND HAS NOT BEEN REVOKED BEFORE THAT DATE (THE “EFFECTIVE DATE”).


 
-11- HAVING ELECTED TO EXECUTE THIS AGREEMENT, TO FULFILL ITS PROMISES AND TO RECEIVE THE SUMS AND BENEFITS IN SECTION 2 ABOVE, EXECUTIVE FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS AGREEMENT INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS EXECUTIVE HAS OR MIGHT HAVE AGAINST EMPLOYER. EXECUTIVE CONSENTS TO USE ELECTRONIC SIGNATURE SERVICE FOR PURPOSES OF ACKNOWLEDGING THIS AGREEMENT. [Remainder of Page Intentionally Blank; Signature Page Follows]


 
-12- IN WITNESS WHEREOF, the parties hereto knowingly and voluntarily executed this Agreement as of the date set forth below: KEVIN YEAMAN, an individual Dated: ________________ Kevin Yeaman DOLBY LABORATORIES, INC. Dated: ________________ Linda Rogers Senior Vice President and Chief People Officer


 
-1- EXHIBIT 1 CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is made and entered into as of August __, 2026, to become effective as of, and contingent upon, the date on which the appointment of a successor Chief Executive Officer of the Company becomes effective (currently expected to be August 27, 2026) (the “Effective Date”) by and between Dolby Laboratories, Inc., a California corporation (the “Company”), and Kevin Yeaman (“Consultant”) (each herein referred to individually as a “Party,” or collectively as the “Parties”). The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant is willing to perform such services, on the terms described below. In consideration of the mutual promises contained herein, the Parties agree as follows: 1. Services and Compensation Consultant shall perform the services described in Exhibit A (the “Services”) for the Company (or its designee), and the Company agrees to pay Consultant the compensation described in Exhibit A for Consultant’s performance of the Services. The Company acknowledges and agrees that Consultant shall be deemed a Service Provider (as defined in the 2020 Stock Plan) at all times during the term of this Agreement. The Company agrees to indemnify Consultant for any and all liabilities, fees and expenses, losses, or damages incurred by Consultant arising from or in connection with Consultant’s participation in any meeting, call, or other engagement with current or potential investors, Dolby stockholders, analysts, or other third parties carried out at the request of the Company or in connection with the Services. 2. Confidentiality a. Definition of Confidential Information. “Company Confidential Information” means any information (including any and all combinations of individual items of information) that the Company has or will develop, acquire, create, compile, discover or own, that has value in or to the Company’s business which is not generally known and which the Company wishes to maintain as confidential. Company Confidential Information includes both (i) information created by others that Consultant learns or that becomes available to Consultant through the Company or its agents; and (ii) information that Consultant creates that the Company owns pursuant to Section 3 of this Agreement. By way of example, and without limitation, Company Confidential Information includes any and all non-public information that relates to the actual or anticipated business and/or products, research or development of the Company, its affiliates or subsidiaries, or to the Company’s or its affiliates’ or subsidiaries’ technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company’s or its affiliates’ or subsidiaries’ products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company on which Consultant called or with which Consultant becomes acquainted during the term of this Agreement), software, developments, inventions, discoveries, ideas, processes, formulas,


 
-2- technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing, orally or by drawings or inspection of premises, parts, equipment, or other Company property. Notwithstanding the foregoing, Company Confidential Information does not include general knowledge, skill, and experience that Consultant has acquired during the course of or in connection with Consultant’s performance of the Services or from a former employer. Company Confidential Information shall not include any such information which Consultant can establish (i) was publicly known or made generally available prior to the time of disclosure by the Company to Consultant; (ii) becomes publicly known or made generally available after disclosure by the Company to Consultant through no wrongful action or omission by Consultant; or (iii) is in Consultant’s rightful possession, without confidentiality obligations, at the time of disclosure by the Company as shown by Consultant’s then- contemporaneous written records; provided that any combination of individual items of information shall not be deemed to be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless the combination as a whole is within such exception. b. Nonuse and Nondisclosure. During and after the term of this Agreement, Consultant will hold in the strictest confidence, and take all reasonable precautions to prevent any unauthorized use or disclosure of, Company Confidential Information. Consultant will not (i) use Company Confidential Information for any purpose whatsoever other than as necessary for the performance of the Services on behalf of the Company, or (ii) subject to Consultant’s right to engage in protected conduct (as described in the Protected Activity Not Prohibited section below), disclose Company Confidential Information to any third party without the prior written consent of an authorized representative of the Company, except that Consultant may disclose Confidential Information to the extent compelled by applicable law; provided however, prior to such disclosure, Consultant shall provide prior written notice to the Company and seek a protective order or such similar confidential protection as may be available under applicable law. Consultant agrees that no ownership of Company Confidential Information is conveyed to Consultant. Without limiting the foregoing, Consultant shall not use or disclose any Company property, intellectual property rights, trade secrets or other proprietary know-how of the Company to invent, author, make, develop, design, or otherwise enable others to invent, author, make, develop, or design identical or substantially similar designs as those developed under this Agreement for any third party. Consultant agrees that Consultant’s obligations under this Section 2.b shall continue after the termination of this Agreement. Nothing in this Agreement prevents workers from engaging in protected conduct, as described in the Protected Activity Not Prohibited section below. c. Other Client Confidential Information. Consultant agrees that Consultant will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former or current employer of Consultant or other person or entity with which Consultant has an obligation to keep such proprietary information or trade secrets in confidence. Consultant further agrees that Consultant will not bring onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document, proprietary information, or trade secrets belonging to any such third party unless disclosure to, and use by, the Company has been consented to, in writing, by such third party and the Company.


 
-3- d. Third Party Confidential Information. Consultant recognizes that the Company has received, and in the future may receive, from third parties (for example, customers, suppliers, licensors, licensees, partners, and collaborators) as well as its subsidiaries and affiliates (“Associated Third Parties”), information which the Company is required to maintain and treat as confidential or proprietary information of such Associated Third Parties (“Associated Third Party Confidential Information”), and Consultant agrees to use such Associated Third Party Confidential Information only as directed by the Company and to not use or disclose such Associated Third Party Confidential Information in a manner that would violate the Company’s obligations to such Associated Third Parties. By way of example, Associated Third Party Confidential Information may include the habits or practices of Associated Third Parties, the technology of Associated Third Parties, requirements of Associated Third Parties, and information related to the business conducted between the Company and such Associated Third Parties. Consultant agrees that at all times during the term of this Agreement and thereafter, Consultant owes the Company and its Associated Third Parties a duty to hold all such Associated Third Party Confidential Information in the strictest confidence, and not to use it or to disclose it to any person, firm, corporation, or other third party except as necessary in carrying out the Services for the Company consistent with the Company’s agreement with such Associated Third Parties. 3. Ownership a. Assignment of Inventions. As between the Company and Consultant, Consultant agrees that all right, title, and interest in and to any and all copyrightable material, notes, records, drawings, designs, logos, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered, authored, invented, developed or reduced to practice by Consultant, solely or in collaboration with others, during the term of this Agreement and arising out of, or in connection with, performing the Services under this Agreement and any copyrights, patents, trade secrets, mask work rights or other intellectual property rights relating to the foregoing (collectively, “Inventions”), are the sole property of the Company and, if Consultant is reclassified by a state or federal agency or court as the Company’s employee, to the fullest extent allowed by California Labor Code Section 2870 (which is attached as Exhibit B). Consultant also agrees to promptly make full written disclosure to the Company of any Inventions and to deliver and assign (or cause to be assigned) and hereby irrevocably assigns fully to the Company all of Consultant’s right, title and interest in and to the Inventions. Consultant agrees that this assignment includes a present conveyance to the Company of ownership of Inventions that are not yet in existence. Consultant understands and agrees that the decision whether or not to commercialize or market any Inventions is within the Company’s sole discretion and for the Company’s sole benefit, and that no royalty or other consideration will be due to Consultant as a result of the Company’s efforts to commercialize or market any such Inventions. b. Pre-Existing Materials. Subject to Section 3.a, Consultant will inform the Company, in writing, before incorporating any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets, and other proprietary information or intellectual property rights owned by Consultant or in which Consultant has an interest, prior to, or separate from, performing the Services under this Agreement (“Prior Inventions”) into any Invention or otherwise utilizing any Prior Invention in the course of performing the Services; and the Company is hereby granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable,


 
-4- worldwide license (with the right to grant and authorize sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such incorporated or utilized Prior Inventions, without restriction, including, without limitation, as part of or in connection with such Invention, and to practice any method related thereto. Consultant will not incorporate any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets, and other proprietary information or intellectual property rights owned by any third party into any Invention without Company’s prior written permission. c. Moral Rights. Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral rights,” “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”). To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby waives and agrees not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under applicable law. d. Maintenance of Records. Consultant agrees to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by Consultant (solely or jointly with others) during the term of this Agreement, and for a period of three (3) years thereafter. The records will be in the form of notes, sketches, drawings, electronic files, reports, or any other format that is customary in the industry and/or otherwise specified by the Company. As between the Company and Consultant, the records are and will be available to and remain the sole property of the Company at all times and upon Company’s request, Consultant shall deliver (or cause to be delivered) the same. e. Further Assurances. Consultant agrees to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments that the Company shall deem proper or necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights, and in order to deliver, assign and convey to the Company, its successors, assigns and nominees the sole and exclusive rights, title, and interest in and to all Inventions, and testifying in a suit or other proceeding relating to such Inventions. Consultant further agrees that Consultant’s obligations under 3.e shall continue after the termination of this Agreement. f. Attorney-in-Fact. Consultant agrees that, if the Company is unable because of Consultant’s unavailability, dissolution, mental or physical incapacity, or for any other reason, to secure Consultant’s signature with respect to any Inventions, including, without limitation, for the purpose of applying for or pursuing any application for any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section 3.a, then Consultant hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Consultant’s agent and attorney-in-fact, to act for and on Consultant’s behalf to execute and file any papers and oaths and to do all other lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright


 
-5- and mask work registrations with the same legal force and effect as if executed by Consultant. This power of attorney shall be deemed coupled with an interest, and shall be irrevocable. 4. Conflicting Obligations Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any other person or entity that conflict with the provisions of this Agreement, Consultant’s obligations to the Company under this Agreement, and/or Consultant’s ability to perform the Services. Consultant will not enter into any such conflicting agreement during the term of this Agreement. Consultant shall require all Consultant’s employees, contractors, or other third-parties performing Services under this Agreement, if any, to execute a confidential information and assignment agreement in a form provided by the Company, and promptly provide a copy of each such executed agreement to the Company. Consultant’s violation of this Section 4 will be considered a material breach under Section 6.b. 5. Return of Company Materials Upon the termination of this Agreement, or upon Company’s earlier request, Consultant will immediately deliver to the Company, and will not keep in Consultant’s possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Company Confidential Information, tangible embodiments of the Inventions, all devices and equipment belonging to the Company, all electronically-stored information and passwords to access such property, those records maintained pursuant to Section 3.d and any reproductions of any of the foregoing items that Consultant may have in Consultant’s possession or control. Consultant agrees that in discharging Consultant’s obligations pursuant to this section, Consultant will conduct a reasonable and good faith search for such information, property and equipment, including searching external storage devices, personal computers and email accounts, as well as cloud accounts; provided that the Company acknowledges and agrees that immaterial failures to return Company property shall not be deemed a breach hereof, so long as Consultant promptly returns such property upon becoming aware it is in his possession or control. 6. Term and Termination a. Term. The term of this Agreement will begin on the Effective Date of this Agreement and will continue until the earlier of (i) December 31, 2027 or (ii) termination as provided in Section 6.b (the “Termination Date”). b. Termination. The Company may terminate this Agreement immediately and without prior notice if Consultant refuses to or fails to perform the Services, is in material breach of any material provision of this Agreement (including failure to comply with the Supplemental Release Execution Condition set forth in Section 9 below), or is in material breach of any provision of the Confidential Transition Agreement and General Release between the Company and Consultant (the “Transition Agreement”), including if Consultant revokes the Transition Agreement; provided, however, that with respect to any material breach, the Company must first provide notice to Consultant within ten (10) days of the date it has actual or constructive


 
-6- knowledge of such breach and, to the extent curable, the Consultant will have up to ten (10) days to cure such breach. The Parties may also terminate this Agreement at any time by mutual agreement. 7. Survival. Upon any termination, all rights and duties of the Company and Consultant toward each other under this Agreement shall cease except: a. The Company will pay, within thirty (30) days after the effective Termination Date, all amounts owing to Consultant for Services completed and accepted by the Company prior to the Termination Date and related reimbursable expenses, if any, submitted in accordance with the Company’s policies and in accordance with the provisions of Section 1 of this Agreement; and b. The sections entitled Confidentiality, Ownership, Conflicting Obligations, Return of Company Materials, Term and Termination, Independent Contractor; Benefits, Limitation of Liability, Arbitration, and Miscellaneous will survive termination or expiration of this Agreement in accordance with their terms. 8. Independent Contractor; Benefits a. Independent Contractor. It is the express intention of the Company and Consultant that Consultant perform the Services as an independent contractor to the Company. Nothing in this Agreement shall in any way be construed to constitute Consultant as an agent, employee or representative of the Company. Without limiting the generality of the foregoing, Consultant is not authorized to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant agrees to furnish (or reimburse the Company for) all tools and materials necessary to accomplish this Agreement and shall incur all expenses associated with performance. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant to this Agreement. Consultant agrees to and acknowledges the obligation to pay all self-employment and other taxes on such income. b. Benefits. The Company and Consultant agree that Consultant will receive no Company-sponsored benefits from the Company where benefits include, but are not limited to, paid vacation, sick leave, medical insurance and 401k participation. If Consultant is reclassified by a state or federal agency or court as the Company’s employee, Consultant will become a reclassified employee and will receive no benefits from the Company, except those mandated by state or federal law, even if by the terms of the Company’s benefit plans or programs of the Company in effect at the time of such reclassification, Consultant would otherwise be eligible for such benefits. 9. Supplemental Releases. On the twenty-fourth (24th) day prior to the Termination Date (which shall be December 7, 2027 if the scheduled Termination Date is December 31, 2027), Consultant agrees to sign a Supplemental Release attached hereto as Exhibit C (“Supplemental Release” and the timely execution of the Supplemental Release, the “Supplemental Release


 
-7- Execution Condition”). Consultant acknowledges and agrees that if Consultant fails to comply with the Supplemental Release Execution Condition, this Agreement immediately shall terminate and Consultant shall not receive any additional consulting compensation that otherwise could be payable under this Agreement thereafter, including any additional vesting of Awards (as defined in Exhibit A attached hereto); provided, however, that any Awards that have already vested prior to the date of such failure shall not be affected. Consultant further acknowledges and agrees that Consultant’s right to receive any consulting compensation, including any vesting of Awards, payable after the date the Supplemental Release Execution Condition is scheduled to be satisfied is expressly conditioned upon Consultant timely signing the Supplemental Release as required by this section. 10. Reserved. 11. Arbitration. The Parties agree that any and all disputes arising out of the terms of this Agreement and their interpretation shall be subject to arbitration in San Francisco County, before Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Employment Arbitration Rules & Procedures (“JAMS Rules”), unless Executive primarily works in a state outside of California, in which case the arbitration shall take place in the state where the Executive primarily works and the arbitration shall be conducted in accordance with the laws of such state. The arbitrator may grant injunctions and other relief in such disputes. If the arbitration is conducted in California, the arbitrator shall administer and conduct the arbitration in accordance with California law, and the arbitrator shall apply substantive and procedural California law to any dispute or claim, without reference to any conflict-of-law provisions of any jurisdiction. To the extent that the JAMS Rules conflict with California law, California law shall take precedence. The decision of the arbitrator shall be final, conclusive, and binding on the Parties to the arbitration. The Parties agree that the prevailing Party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. The Company will pay for any administrative or hearing fees charged by the arbitrator or JAMS except that Executive shall pay any filing fees associated with any arbitration that Executive initiates, but only so much of the filing fees as Executive would have instead paid had Executive filed a complaint in a court of law. Each Party shall separately pay for its respective counsel fees and expenses; provided, however, that the arbitrator shall award attorneys' fees and costs to the prevailing Party, except as prohibited by law. The Parties hereby agree to waive their right to have any dispute between them resolved in a court of law by a judge or jury. Notwithstanding the foregoing, this section will not prevent either Party from seeking injunctive relief (or any other provisional remedy) from any court having jurisdiction over the Parties and the subject matter of their dispute relating to this Agreement and the agreements incorporated herein by reference. Should any part of the arbitration agreement contained in this paragraph conflict with any other arbitration agreement between the Parties, the Parties agree that this arbitration agreement shall govern. 12. Miscellaneous a. Governing Law; Consent to Personal Jurisdiction. This Agreement will be governed by the laws of the State of California, without regard to the conflicts of law provisions of California or any other jurisdiction, except that any dispute regarding the enforceability of the arbitration section of this Agreement shall be governed by the FAA. To the extent that any lawsuit


 
-8- is permitted under this Agreement, the Parties hereby expressly consent to the personal and exclusive jurisdiction and venue of the state and federal courts located in California. b. Assignability. This Agreement will be binding upon Consultant’s heirs, executors, assigns, administrators, and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns. The Associated Third Parties are intended third-party beneficiaries to this Agreement with respect to Consultant’s obligations in Section 2.d. There are no intended third-party beneficiaries to this Agreement, except as expressly stated. Except as may otherwise be provided in this Agreement, Consultant may not sell, assign or delegate any rights or obligations under this Agreement. Notwithstanding anything to the contrary herein, the Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all or substantially all of the Company’s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, or otherwise; provided that the Company shall require such successor to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. For the avoidance of doubt, the Company’s successors and assigns are authorized to enforce the Company’s rights under this Agreement. c. Entire Agreement. This Agreement, together with the Exhibits attached hereto, the Confidentiality Agreement and the applicable provisions of the Transition Agreement incorporated herein by reference sets forth the entire agreement and understanding between the Parties with respect to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between the Parties, with the exception of the Award Documents (as defined on Exhibit A) (except as amended by this Agreement). Consultant represents and warrants that Consultant is not relying on any statement or representation not contained in this Agreement. To the extent any terms set forth in any exhibit or schedule conflict with the terms set forth in this Agreement, the terms of this Agreement shall control unless otherwise expressly agreed by the Parties in such exhibit or schedule. d. Headings. Headings are used in this Agreement for reference only and shall not be considered when interpreting this Agreement. e. Severability. If a court or other body of competent jurisdiction finds, or the Parties mutually believe, any provision of this Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to effect the intent of the Parties, and the remainder of this Agreement will continue in full force and effect. f. Modification, Waiver. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in a writing signed by the Parties and approved by the Board of Directors of Dolby Laboratories, a Delaware corporation (“Dolby”) or the Compensation Committee thereof. Waiver by the Company of a breach of any provision of this Agreement will not operate as a waiver of any other or subsequent breach. g. Notices. Any notice or other communication required or permitted by this Agreement to be given to a Party shall be in writing and shall be deemed given (i) if delivered personally or by commercial messenger or courier service, (ii) when sent by confirmed facsimile,


 
-9- electronic mail, or electronic signature or (iii) if mailed by U.S. registered or certified mail (return receipt requested), to the Party at the Party’s address written below or at such other address as the Party may have previously specified by like notice. If by mail, delivery shall be deemed effective three business days after mailing in accordance with this Section 12.g. If to the Company, to: 1275 Market Street, San Francisco, CA 94103 Attention: General Counsel [OMITTED] If to Consultant, to the address or e-mail address for notice on the signature page to this Agreement or, if no such address or e-mail address is provided, to the last address or e-mail address of Consultant provided by Consultant to the Company. h. Attorneys’ Fees. In any court action at law or equity that is brought by one of the Parties to this Agreement to enforce or interpret the provisions of this Agreement, the prevailing Party will be entitled to reasonable attorneys’ fees, in addition to any other relief to which that Party may be entitled. i. Signatures. This Agreement may be signed in two counterparts, each of which shall be deemed an original, with the same force and effectiveness as though executed in a single document. j. Protected Activity Not Prohibited. Consultant understands that nothing in this Agreement shall in any way limit or prohibit Consultant from filing and/or pursuing a charge or complaint with, or otherwise communicating or cooperating with or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission (“Government Agencies”), including disclosing documents or other information as permitted by law. In addition, Consultant understands that nothing in this Agreement, including its definition of Confidential Information, prevents Consultant from discussing or disclosing information about unlawful acts, such as harassment or discrimination or any other conduct that Consultant have reason to believe is unlawful. Notwithstanding the preceding, Consultant agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any Company trade secrets, proprietary information, or confidential information that does not involve unlawful acts or the activity otherwise protected herein. Consultant further understands that Consultant is not permitted to disclose the Company’s attorney-client privileged communications or attorney work product. Pursuant to the Defend Trade Secrets Act of 2016, Consultant is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose


 
-10- the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. (signature page follows)


 
-11- IN WITNESS WHEREOF, the Parties hereto have executed this Consulting Agreement as of the date written below. CONSULTANT Dated: ________________ Kevin Yeaman Address: E-mail: DOLBY LABORATORIES, INC. Dated: ________________ By: ____________________


 
- 1 - EXHIBIT A SERVICES AND COMPENSATION I. Services. The Services will include, but will not be limited to, the following: transition duties and responsibilities and advising on general business matters, in each case, as reasonably requested by Dolby’s Chief Executive Officer, designated members of the executive management team or Dolby’s Board of Directors. The Company agrees that Consultant’s provision of the Services will be scheduled at times and in a manner reasonably convenient to Consultant, and such requested Services shall not unreasonably interfere with Consultant’s then existing professional and personal obligations. II. Compensation. A. The Company will pay Consultant $40,000 per month for six months beginning with the month following the Effective Date, subject to earlier termination under Section 6 of this Agreement. For the avoidance of doubt, following the expiration of such six-month period, Consultant’s obligation to perform Services shall continue but Consultant’s level of availability shall be substantially reduced; provided that Consultant shall remain a Service Provider under the 2020 Stock Plan throughout the term of this Agreement. The monthly payment shall be paid at the end of each month in arrears and will be prorated for each month of partial service under this Agreement. In order to help prevent any applicable adverse tax consequences to Consultant under Section 409A (as defined below), in no event will any payment under this Section II.A. of this Exhibit be made later than the later of (1) March 15th of the calendar year following the calendar year in which such payment was earned, or (2) the 15th day of the third (3rd) month following the end of the Company’s fiscal year in which such payment was earned. B. Consultant previously was granted certain equity awards that are outstanding as of the date hereof (“Awards”) under Dolby’s equity incentive plan(s) as amended from time to time (each, a “Plan”), and applicable award agreements thereunder including any amendments thereto (such award agreements and any amendments thereto, together with the Plan, the “Award Documents”). Consultant will continue to vest in the Awards during the term of this Agreement in accordance with the applicable Award Documents. The exercise of Consultant’s options that are or become vested shall continue to be governed by the terms and conditions of the applicable Award Documents. C. The Company will reimburse Consultant, in accordance with Company policy, for reasonable expenses incurred by Consultant in performing the Services pursuant to this Agreement, if Consultant submits receipts for such expenses to the Company in accordance with Company policy. D. To the extent applicable, all payments and benefits provided for under this Agreement are intended to be exempt from or otherwise comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (together, “Section 409A”), so that none of the payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. Each payment and


 
- 2 - benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. In no event will Dolby or the Company reimburse Consultant for any taxes that may be imposed on Consultant as a result of Section 409A. [Remainder of page intentionally left blank]


 
- 1 - EXHIBIT B CALIFORNIA LABOR CODE SECTION 2870 INVENTION ON OWN TIME - EXEMPTION FROM AGREEMENT “(a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either: (1) Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or (2) Result from any work performed by the employee for the employer. (b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.”


 
- 1 - EXHIBIT C SUPPLEMENTAL RELEASE In consideration for the mutual promises and consideration provided both herein and in the Confidential Transition Agreement and General Release signed on or about August 25, 2026 (the “Agreement”) and the Consulting Agreement between Kevin Yeaman (“Consultant”) and Dolby Laboratories, Inc., a California corporation, and its indirect and direct subsidiaries and/or parent companies (together, the “Company”) (collectively the “Parties”) (the “Consulting Agreement”), the Parties hereby extend by this Supplemental Release (the “Supplemental Release”) the release and waiver therein to any and all claims that may have arisen between the date of the Consultant’s signature to the Agreement and Consultant’s signature date, below; provided, however, that the carve-outs and exceptions set forth in the penultimate paragraph of Section 5 of the Agreement (including, without limitation, rights to indemnification, D&O insurance, equity rights, Protected Activity, and enforcement of the Agreement and Consulting Agreement) shall apply with equal force to this Supplemental Release. 1. Supplemental Release. The undersigned Parties expressly acknowledge and agree that the terms of the Agreement shall apply equally to this Supplemental Release and are incorporated herein. Consultant agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Consultant by the Company and its current and former officers, directors, consultants, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, divisions, and indirect or direct parent companies and/or subsidiaries, and predecessor and successor corporations and assigns (collectively, the “Releasees”). Consultant, on Consultant’s own behalf and on behalf of Consultant’s respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Consultant may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the date Consultant signs this Supplemental Release, including any claims Consultant may have under the California Fair Employment and Housing Act. Consultant acknowledges and agrees that the consideration provided to Consultant under the Agreement and the Consulting Agreement fully satisfies any obligation that the Company had to pay Consultant wages or any other compensation for any of the services that Consultant rendered to the Company, that the amount paid is in excess of any disputed wage claim, if any, that Consultant may have. To the extent any wage dispute exists, Consultant specifically acknowledges that the consideration paid shall be deemed to be paid first in satisfaction of any disputed wage claim with the remainder sufficient to act as consideration for the release of claims set forth herein, and that Consultant has not earned and is not entitled to receive any additional wages or other form of compensation from the Company. 2. California Civil Code Section 1542. Consultant acknowledges that Consultant has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section 1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows: “GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS


 
- 2 - OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND THAT IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.” Consultant, being aware of this code section, agrees to expressly waive any rights Consultant may have thereunder, as well as under any other statute or common law principles of similar effect. 3. ADEA Waiver. Consultant further expressly understands and acknowledges that Consultant is waiving and releasing any rights Consultant may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Consultant understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the date Consultant executes this Supplemental Release. Consultant understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Consultant was already entitled. Consultant further understands and acknowledges that Consultant has been advised by this writing that: (a) Consultant should consult with an attorney prior to executing this Supplemental Release; (b) Consultant has twenty-one (21) days within which to consider this Supplemental Release, by which time the Company must receive an executed copy; (c) Consultant has seven (7) days following Consultant’s execution of this Supplemental Release to revoke this Supplemental Release, and agrees that any such revocation must be in a writing by email to [OMITTED] or federal express received by Dolby by midnight on the seventh day following Consultant’s execution of this Supplemental Release; (d) this Supplemental Release shall not be effective until after the revocation period has expired; and (e) nothing in this Supplemental Release prevents or precludes Consultant from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Consultant signs this Supplemental Release and returns it to the Company in less than the twenty-one (21)-day period identified above, Consultant hereby acknowledges that Consultant has freely and voluntarily chosen to waive the time period allotted for considering this Supplemental Release. Consultant understands and agrees that Consultant executed this Supplemental Release voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Consultant’s claims against the Releasees. 4. Incorporation of Terms of Release Agreement. In addition to the above, the undersigned Parties further acknowledge that the terms of the Agreement, including, but not limited to, Sufficient Consideration, Affirmations, Protection of Employer’s Information, Company Property, Governing Law and Interpretation, Non-Disparagement and Communications with Company Employees, Customers and Business Partners, No Cooperation, Protected Activity Not Prohibited, Arbitration, Attorneys’ Fees, and Entire Agreement shall apply to this Supplemental Release and are incorporated herein to the extent that they are not inconsistent with the express terms of this Supplemental Release. 5. Voluntary Execution of Supplemental Release. Consultant understands and agrees that Consultant executed this Supplemental Release voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Consultant’s claims against the Company and any of the other Releasees. Consultant acknowledges that: (a) Consultant has read this Supplemental Release; (b) Consultant has been represented in the preparation, negotiation, and execution of this Supplemental Release by legal counsel of Consultant’s own choice or has elected not to retain


 
- 3 - legal counsel; (c) Consultant understands the terms and consequences of this Supplemental Release and of the releases it contains; and (d) Consultant is fully aware of the legal and binding effect of this Supplemental Release. CONSULTANT IS ADVISED TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS SUPPLEMENTAL RELEASE. TO OBTAIN THE BENEFITS SET FORTH IN SECTION 9 OF THE CONSULTING AGREEMENT, CONSULTANT MUST SIGN AND DELIVER THE EXECUTED SUPPLEMENTAL RELEASE TO DOLBY VIA DOCUSIGN OR TO THE GENERAL COUNSEL OF DOLBY ON THE DEADLINE SET FORTH IN SECTION 9 OF THE CONSULTING AGREEMENT. CONSULTANT HAS SEVEN (7) DAYS AFTER SIGNING THIS SUPPLEMENTAL RELEASE TO REVOKE IT. THIS SUPPLEMENTAL RELEASE WILL BECOME EFFECTIVE ON THE EIGHTH (8TH) DAY AFTER CONSULTANT SIGNED THIS SUPPLEMENTAL RELEASE, SO LONG AS CONSULTANT HAS COMPLIED WITH ALL OF ITS TERMS AND CONDITIONS, IT HAS BEEN SIGNED BY THE PARTIES, AND HAS NOT BEEN REVOKED BEFORE THAT DATE. HAVING ELECTED TO EXECUTE THIS SUPPLEMENTAL RELEASE, TO FULFILL ITS PROMISES AND TO RECEIVE THE CONSIDERATION HEREIN, CONSULTANT FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS SUPPLEMENTAL RELEASE INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS CONSULTANT HAS OR MIGHT HAVE AGAINST THE RELEASEES SINCE THE EFFECTIVE DATE. CONSULTANT CONSENTS TO USE ELECTRONIC SIGNATURE SERVICE FOR PURPOSES OF ACKNOWLEDGING THIS SUPPLEMENTAL RELEASE. [Remainder of Page Intentionally Blank; Signature Page Follows]


 
- 4 - IN WITNESS WHEREOF, the Parties have executed this Supplemental Release on the respective dates set forth below. CONSULTANT Dated: ________________ Kevin Yeaman DOLBY LABORATORIES, INC. Dated: ________________ By: ________________


 
-1- CONSULTING AGREEMENT This Consulting Agreement (this “Agreement”) is made and entered into as of August 25, 2026, to become effective as of, and contingent upon, the date on which the appointment of a successor Chief Executive Officer of the Company becomes effective (currently expected to be August 27, 2026) (the “Effective Date”) by and between Dolby Laboratories, Inc., a California corporation (the “Company”), and Kevin Yeaman (“Consultant”) (each herein referred to individually as a “Party,” or collectively as the “Parties”). The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company, and Consultant is willing to perform such services, on the terms described below. In consideration of the mutual promises contained herein, the Parties agree as follows: 1. Services and Compensation Consultant shall perform the services described in Exhibit A (the “Services”) for the Company (or its designee), and the Company agrees to pay Consultant the compensation described in Exhibit A for Consultant’s performance of the Services. The Company acknowledges and agrees that Consultant shall be deemed a Service Provider (as defined in the 2020 Stock Plan) at all times during the term of this Agreement. The Company agrees to indemnify Consultant for any and all liabilities, fees and expenses, losses, or damages incurred by Consultant arising from or in connection with Consultant’s participation in any meeting, call, or other engagement with current or potential investors, Dolby stockholders, analysts, or other third parties carried out at the request of the Company or in connection with the Services. 2. Confidentiality a. Definition of Confidential Information. “Company Confidential Information” means any information (including any and all combinations of individual items of information) that the Company has or will develop, acquire, create, compile, discover or own, that has value in or to the Company’s business which is not generally known and which the Company wishes to maintain as confidential. Company Confidential Information includes both (i) information created by others that Consultant learns or that becomes available to Consultant through the Company or its agents; and (ii) information that Consultant creates that the Company owns pursuant to Section 3 of this Agreement. By way of example, and without limitation, Company Confidential Information includes any and all non-public information that relates to the actual or anticipated business and/or products, research or development of the Company, its affiliates or subsidiaries, or to the Company’s or its affiliates’ or subsidiaries’ technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company’s or its affiliates’ or subsidiaries’ products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company on which Consultant called or with which Consultant becomes acquainted during the term of this Agreement), software, developments, inventions, discoveries, ideas, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries,


 
-2- either directly or indirectly, in writing, orally or by drawings or inspection of premises, parts, equipment, or other Company property. Notwithstanding the foregoing, Company Confidential Information does not include general knowledge, skill, and experience that Consultant has acquired during the course of or in connection with Consultant’s performance of the Services or from a former employer. Company Confidential Information shall not include any such information which Consultant can establish (i) was publicly known or made generally available prior to the time of disclosure by the Company to Consultant; (ii) becomes publicly known or made generally available after disclosure by the Company to Consultant through no wrongful action or omission by Consultant; or (iii) is in Consultant’s rightful possession, without confidentiality obligations, at the time of disclosure by the Company as shown by Consultant’s then- contemporaneous written records; provided that any combination of individual items of information shall not be deemed to be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless the combination as a whole is within such exception. b. Nonuse and Nondisclosure. During and after the term of this Agreement, Consultant will hold in the strictest confidence, and take all reasonable precautions to prevent any unauthorized use or disclosure of, Company Confidential Information. Consultant will not (i) use Company Confidential Information for any purpose whatsoever other than as necessary for the performance of the Services on behalf of the Company, or (ii) subject to Consultant’s right to engage in protected conduct (as described in the Protected Activity Not Prohibited section below), disclose Company Confidential Information to any third party without the prior written consent of an authorized representative of the Company, except that Consultant may disclose Confidential Information to the extent compelled by applicable law; provided however, prior to such disclosure, Consultant shall provide prior written notice to the Company and seek a protective order or such similar confidential protection as may be available under applicable law. Consultant agrees that no ownership of Company Confidential Information is conveyed to Consultant. Without limiting the foregoing, Consultant shall not use or disclose any Company property, intellectual property rights, trade secrets or other proprietary know-how of the Company to invent, author, make, develop, design, or otherwise enable others to invent, author, make, develop, or design identical or substantially similar designs as those developed under this Agreement for any third party. Consultant agrees that Consultant’s obligations under this Section 2.b shall continue after the termination of this Agreement. Nothing in this Agreement prevents workers from engaging in protected conduct, as described in the Protected Activity Not Prohibited section below. c. Other Client Confidential Information. Consultant agrees that Consultant will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former or current employer of Consultant or other person or entity with which Consultant has an obligation to keep such proprietary information or trade secrets in confidence. Consultant further agrees that Consultant will not bring onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document, proprietary information, or trade secrets belonging to any such third party unless disclosure to, and use by, the Company has been consented to, in writing, by such third party and the Company. d. Third Party Confidential Information. Consultant recognizes that the Company has received, and in the future may receive, from third parties (for example, customers,


 
-3- suppliers, licensors, licensees, partners, and collaborators) as well as its subsidiaries and affiliates (“Associated Third Parties”), information which the Company is required to maintain and treat as confidential or proprietary information of such Associated Third Parties (“Associated Third Party Confidential Information”), and Consultant agrees to use such Associated Third Party Confidential Information only as directed by the Company and to not use or disclose such Associated Third Party Confidential Information in a manner that would violate the Company’s obligations to such Associated Third Parties. By way of example, Associated Third Party Confidential Information may include the habits or practices of Associated Third Parties, the technology of Associated Third Parties, requirements of Associated Third Parties, and information related to the business conducted between the Company and such Associated Third Parties. Consultant agrees that at all times during the term of this Agreement and thereafter, Consultant owes the Company and its Associated Third Parties a duty to hold all such Associated Third Party Confidential Information in the strictest confidence, and not to use it or to disclose it to any person, firm, corporation, or other third party except as necessary in carrying out the Services for the Company consistent with the Company’s agreement with such Associated Third Parties. 3. Ownership a. Assignment of Inventions. As between the Company and Consultant, Consultant agrees that all right, title, and interest in and to any and all copyrightable material, notes, records, drawings, designs, logos, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered, authored, invented, developed or reduced to practice by Consultant, solely or in collaboration with others, during the term of this Agreement and arising out of, or in connection with, performing the Services under this Agreement and any copyrights, patents, trade secrets, mask work rights or other intellectual property rights relating to the foregoing (collectively, “Inventions”), are the sole property of the Company and, if Consultant is reclassified by a state or federal agency or court as the Company’s employee, to the fullest extent allowed by California Labor Code Section 2870 (which is attached as Exhibit B). Consultant also agrees to promptly make full written disclosure to the Company of any Inventions and to deliver and assign (or cause to be assigned) and hereby irrevocably assigns fully to the Company all of Consultant’s right, title and interest in and to the Inventions. Consultant agrees that this assignment includes a present conveyance to the Company of ownership of Inventions that are not yet in existence. Consultant understands and agrees that the decision whether or not to commercialize or market any Inventions is within the Company’s sole discretion and for the Company’s sole benefit, and that no royalty or other consideration will be due to Consultant as a result of the Company’s efforts to commercialize or market any such Inventions. b. Pre-Existing Materials. Subject to Section 3.a, Consultant will inform the Company, in writing, before incorporating any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets, and other proprietary information or intellectual property rights owned by Consultant or in which Consultant has an interest, prior to, or separate from, performing the Services under this Agreement (“Prior Inventions”) into any Invention or otherwise utilizing any Prior Invention in the course of performing the Services; and the Company is hereby granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of,


 
-4- display, perform, and otherwise exploit such incorporated or utilized Prior Inventions, without restriction, including, without limitation, as part of or in connection with such Invention, and to practice any method related thereto. Consultant will not incorporate any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets, and other proprietary information or intellectual property rights owned by any third party into any Invention without Company’s prior written permission. c. Moral Rights. Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral rights,” “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”). To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby waives and agrees not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under applicable law. d. Maintenance of Records. Consultant agrees to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by Consultant (solely or jointly with others) during the term of this Agreement, and for a period of three (3) years thereafter. The records will be in the form of notes, sketches, drawings, electronic files, reports, or any other format that is customary in the industry and/or otherwise specified by the Company. As between the Company and Consultant, the records are and will be available to and remain the sole property of the Company at all times and upon Company’s request, Consultant shall deliver (or cause to be delivered) the same. e. Further Assurances. Consultant agrees to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments that the Company shall deem proper or necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights, and in order to deliver, assign and convey to the Company, its successors, assigns and nominees the sole and exclusive rights, title, and interest in and to all Inventions, and testifying in a suit or other proceeding relating to such Inventions. Consultant further agrees that Consultant’s obligations under 3.e shall continue after the termination of this Agreement. f. Attorney-in-Fact. Consultant agrees that, if the Company is unable because of Consultant’s unavailability, dissolution, mental or physical incapacity, or for any other reason, to secure Consultant’s signature with respect to any Inventions, including, without limitation, for the purpose of applying for or pursuing any application for any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section 3.a, then Consultant hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Consultant’s agent and attorney-in-fact, to act for and on Consultant’s behalf to execute and file any papers and oaths and to do all other lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright and mask work registrations with the same legal force and effect as if executed by Consultant. This power of attorney shall be deemed coupled with an interest, and shall be irrevocable.


 
-5- 4. Conflicting Obligations Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any other person or entity that conflict with the provisions of this Agreement, Consultant’s obligations to the Company under this Agreement, and/or Consultant’s ability to perform the Services. Consultant will not enter into any such conflicting agreement during the term of this Agreement. Consultant shall require all Consultant’s employees, contractors, or other third-parties performing Services under this Agreement, if any, to execute a confidential information and assignment agreement in a form provided by the Company, and promptly provide a copy of each such executed agreement to the Company. Consultant’s violation of this Section 4 will be considered a material breach under Section 6.b. 5. Return of Company Materials Upon the termination of this Agreement, or upon Company’s earlier request, Consultant will immediately deliver to the Company, and will not keep in Consultant’s possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Company Confidential Information, tangible embodiments of the Inventions, all devices and equipment belonging to the Company, all electronically-stored information and passwords to access such property, those records maintained pursuant to Section 3.d and any reproductions of any of the foregoing items that Consultant may have in Consultant’s possession or control. Consultant agrees that in discharging Consultant’s obligations pursuant to this section, Consultant will conduct a reasonable and good faith search for such information, property and equipment, including searching external storage devices, personal computers and email accounts, as well as cloud accounts; provided that the Company acknowledges and agrees that immaterial failures to return Company property shall not be deemed a breach hereof, so long as Consultant promptly returns such property upon becoming aware it is in his possession or control. 6. Term and Termination a. Term. The term of this Agreement will begin on the Effective Date of this Agreement and will continue until the earlier of (i) December 31, 2027 or (ii) termination as provided in Section 6.b (the “Termination Date”). b. Termination. The Company may terminate this Agreement immediately and without prior notice if Consultant refuses to or fails to perform the Services, is in material breach of any material provision of this Agreement (including failure to comply with the Supplemental Release Execution Condition set forth in Section 9 below), or is in material breach of any provision of the Confidential Transition Agreement and General Release between the Company and Consultant (the “Transition Agreement”), including if Consultant revokes the Transition Agreement; provided, however, that with respect to any material breach, the Company must first provide notice to Consultant within ten (10) days of the date it has actual or constructive knowledge of such breach and, to the extent curable, the Consultant will have up to ten (10) days to cure such breach. The Parties may also terminate this Agreement at any time by mutual agreement.


 
-6- 7. Survival. Upon any termination, all rights and duties of the Company and Consultant toward each other under this Agreement shall cease except: a. The Company will pay, within thirty (30) days after the effective Termination Date, all amounts owing to Consultant for Services completed and accepted by the Company prior to the Termination Date and related reimbursable expenses, if any, submitted in accordance with the Company’s policies and in accordance with the provisions of Section 1 of this Agreement; and b. The sections entitled Confidentiality, Ownership, Conflicting Obligations, Return of Company Materials, Term and Termination, Independent Contractor; Benefits, Limitation of Liability, Arbitration, and Miscellaneous will survive termination or expiration of this Agreement in accordance with their terms. 8. Independent Contractor; Benefits a. Independent Contractor. It is the express intention of the Company and Consultant that Consultant perform the Services as an independent contractor to the Company. Nothing in this Agreement shall in any way be construed to constitute Consultant as an agent, employee or representative of the Company. Without limiting the generality of the foregoing, Consultant is not authorized to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant agrees to furnish (or reimburse the Company for) all tools and materials necessary to accomplish this Agreement and shall incur all expenses associated with performance. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant to this Agreement. Consultant agrees to and acknowledges the obligation to pay all self-employment and other taxes on such income. b. Benefits. The Company and Consultant agree that Consultant will receive no Company-sponsored benefits from the Company where benefits include, but are not limited to, paid vacation, sick leave, medical insurance and 401k participation. If Consultant is reclassified by a state or federal agency or court as the Company’s employee, Consultant will become a reclassified employee and will receive no benefits from the Company, except those mandated by state or federal law, even if by the terms of the Company’s benefit plans or programs of the Company in effect at the time of such reclassification, Consultant would otherwise be eligible for such benefits. 9. Supplemental Releases. On the twenty-fourth (24th) day prior to the Termination Date (which shall be December 7, 2027 if the scheduled Termination Date is December 31, 2027), Consultant agrees to sign a Supplemental Release attached hereto as Exhibit C (“Supplemental Release” and the timely execution of the Supplemental Release, the “Supplemental Release Execution Condition”). Consultant acknowledges and agrees that if Consultant fails to comply with the Supplemental Release Execution Condition, this Agreement immediately shall terminate and Consultant shall not receive any additional consulting compensation that otherwise could be payable under this Agreement thereafter, including any additional vesting of Awards (as defined


 
-7- in Exhibit A attached hereto); provided, however, that any Awards that have already vested prior to the date of such failure shall not be affected. Consultant further acknowledges and agrees that Consultant’s right to receive any consulting compensation, including any vesting of Awards, payable after the date the Supplemental Release Execution Condition is scheduled to be satisfied is expressly conditioned upon Consultant timely signing the Supplemental Release as required by this section. 10. Reserved. 11. Arbitration. The Parties agree that any and all disputes arising out of the terms of this Agreement and their interpretation shall be subject to arbitration in San Francisco County, before Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Employment Arbitration Rules & Procedures (“JAMS Rules”), unless Executive primarily works in a state outside of California, in which case the arbitration shall take place in the state where the Executive primarily works and the arbitration shall be conducted in accordance with the laws of such state. The arbitrator may grant injunctions and other relief in such disputes. If the arbitration is conducted in California, the arbitrator shall administer and conduct the arbitration in accordance with California law, and the arbitrator shall apply substantive and procedural California law to any dispute or claim, without reference to any conflict-of-law provisions of any jurisdiction. To the extent that the JAMS Rules conflict with California law, California law shall take precedence. The decision of the arbitrator shall be final, conclusive, and binding on the Parties to the arbitration. The Parties agree that the prevailing Party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. The Company will pay for any administrative or hearing fees charged by the arbitrator or JAMS except that Executive shall pay any filing fees associated with any arbitration that Executive initiates, but only so much of the filing fees as Executive would have instead paid had Executive filed a complaint in a court of law. Each Party shall separately pay for its respective counsel fees and expenses; provided, however, that the arbitrator shall award attorneys' fees and costs to the prevailing Party, except as prohibited by law. The Parties hereby agree to waive their right to have any dispute between them resolved in a court of law by a judge or jury. Notwithstanding the foregoing, this section will not prevent either Party from seeking injunctive relief (or any other provisional remedy) from any court having jurisdiction over the Parties and the subject matter of their dispute relating to this Agreement and the agreements incorporated herein by reference. Should any part of the arbitration agreement contained in this paragraph conflict with any other arbitration agreement between the Parties, the Parties agree that this arbitration agreement shall govern. 12. Miscellaneous a. Governing Law; Consent to Personal Jurisdiction. This Agreement will be governed by the laws of the State of California, without regard to the conflicts of law provisions of California or any other jurisdiction, except that any dispute regarding the enforceability of the arbitration section of this Agreement shall be governed by the FAA. To the extent that any lawsuit is permitted under this Agreement, the Parties hereby expressly consent to the personal and exclusive jurisdiction and venue of the state and federal courts located in California.


 
-8- b. Assignability. This Agreement will be binding upon Consultant’s heirs, executors, assigns, administrators, and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns. The Associated Third Parties are intended third-party beneficiaries to this Agreement with respect to Consultant’s obligations in Section 2.d. There are no intended third-party beneficiaries to this Agreement, except as expressly stated. Except as may otherwise be provided in this Agreement, Consultant may not sell, assign or delegate any rights or obligations under this Agreement. Notwithstanding anything to the contrary herein, the Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all or substantially all of the Company’s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, or otherwise; provided that the Company shall require such successor to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. For the avoidance of doubt, the Company’s successors and assigns are authorized to enforce the Company’s rights under this Agreement. c. Entire Agreement. This Agreement, together with the Exhibits attached hereto, the Confidentiality Agreement and the applicable provisions of the Transition Agreement incorporated herein by reference sets forth the entire agreement and understanding between the Parties with respect to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between the Parties, with the exception of the Award Documents (as defined on Exhibit A) (except as amended by this Agreement). Consultant represents and warrants that Consultant is not relying on any statement or representation not contained in this Agreement. To the extent any terms set forth in any exhibit or schedule conflict with the terms set forth in this Agreement, the terms of this Agreement shall control unless otherwise expressly agreed by the Parties in such exhibit or schedule. d. Headings. Headings are used in this Agreement for reference only and shall not be considered when interpreting this Agreement. e. Severability. If a court or other body of competent jurisdiction finds, or the Parties mutually believe, any provision of this Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to effect the intent of the Parties, and the remainder of this Agreement will continue in full force and effect. f. Modification, Waiver. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in a writing signed by the Parties and approved by the Board of Directors of Dolby Laboratories, a Delaware corporation (“Dolby”) or the Compensation Committee thereof. Waiver by the Company of a breach of any provision of this Agreement will not operate as a waiver of any other or subsequent breach. g. Notices. Any notice or other communication required or permitted by this Agreement to be given to a Party shall be in writing and shall be deemed given (i) if delivered personally or by commercial messenger or courier service, (ii) when sent by confirmed facsimile, electronic mail, or electronic signature or (iii) if mailed by U.S. registered or certified mail (return receipt requested), to the Party at the Party’s address written below or at such other address as the


 
-9- Party may have previously specified by like notice. If by mail, delivery shall be deemed effective three business days after mailing in accordance with this Section 12.g. If to the Company, to: 1275 Market Street, San Francisco, CA 94103 Attention: General Counsel [OMITTED] If to Consultant, to the address or e-mail address for notice on the signature page to this Agreement or, if no such address or e-mail address is provided, to the last address or e-mail address of Consultant provided by Consultant to the Company. h. Attorneys’ Fees. In any court action at law or equity that is brought by one of the Parties to this Agreement to enforce or interpret the provisions of this Agreement, the prevailing Party will be entitled to reasonable attorneys’ fees, in addition to any other relief to which that Party may be entitled. i. Signatures. This Agreement may be signed in two counterparts, each of which shall be deemed an original, with the same force and effectiveness as though executed in a single document. j. Protected Activity Not Prohibited. Consultant understands that nothing in this Agreement shall in any way limit or prohibit Consultant from filing and/or pursuing a charge or complaint with, or otherwise communicating or cooperating with or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission (“Government Agencies”), including disclosing documents or other information as permitted by law. In addition, Consultant understands that nothing in this Agreement, including its definition of Confidential Information, prevents Consultant from discussing or disclosing information about unlawful acts, such as harassment or discrimination or any other conduct that Consultant have reason to believe is unlawful. Notwithstanding the preceding, Consultant agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any Company trade secrets, proprietary information, or confidential information that does not involve unlawful acts or the activity otherwise protected herein. Consultant further understands that Consultant is not permitted to disclose the Company’s attorney-client privileged communications or attorney work product. Pursuant to the Defend Trade Secrets Act of 2016, Consultant is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court


 
-10- proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order. (signature page follows)


 
-11- IN WITNESS WHEREOF, the Parties hereto have executed this Consulting Agreement as of the date written below. CONSULTANT Dated: ________________ Kevin Yeaman Address: E-mail: DOLBY LABORATORIES, INC. Dated: ________________ Linda Rogers Senior Vice President and Chief People Officer


 
- 1 - EXHIBIT A SERVICES AND COMPENSATION I. Services. The Services will include, but will not be limited to, the following: transition duties and responsibilities and advising on general business matters, in each case, as reasonably requested by Dolby’s Chief Executive Officer, designated members of the executive management team or Dolby’s Board of Directors. The Company agrees that Consultant’s provision of the Services will be scheduled at times and in a manner reasonably convenient to Consultant, and such requested Services shall not unreasonably interfere with Consultant’s then existing professional and personal obligations. II. Compensation. A. The Company will pay Consultant $40,000 per month for six months beginning with the month following the Effective Date, subject to earlier termination under Section 6 of this Agreement. For the avoidance of doubt, following the expiration of such six-month period, Consultant’s obligation to perform Services shall continue but Consultant’s level of availability shall be substantially reduced; provided that Consultant shall remain a Service Provider under the 2020 Stock Plan throughout the term of this Agreement. The monthly payment shall be paid at the end of each month in arrears and will be prorated for each month of partial service under this Agreement. In order to help prevent any applicable adverse tax consequences to Consultant under Section 409A (as defined below), in no event will any payment under this Section II.A. of this Exhibit be made later than the later of (1) March 15th of the calendar year following the calendar year in which such payment was earned, or (2) the 15th day of the third (3rd) month following the end of the Company’s fiscal year in which such payment was earned. B. Consultant previously was granted certain equity awards that are outstanding as of the date hereof (“Awards”) under Dolby’s equity incentive plan(s) as amended from time to time (each, a “Plan”), and applicable award agreements thereunder including any amendments thereto (such award agreements and any amendments thereto, together with the Plan, the “Award Documents”). Consultant will continue to vest in the Awards during the term of this Agreement in accordance with the applicable Award Documents. The exercise of Consultant’s options that are or become vested shall continue to be governed by the terms and conditions of the applicable Award Documents. C. The Company will reimburse Consultant, in accordance with Company policy, for reasonable expenses incurred by Consultant in performing the Services pursuant to this Agreement, if Consultant submits receipts for such expenses to the Company in accordance with Company policy. D. To the extent applicable, all payments and benefits provided for under this Agreement are intended to be exempt from or otherwise comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (together, “Section 409A”), so that none of the payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. Each payment and


 
- 2 - benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. In no event will Dolby or the Company reimburse Consultant for any taxes that may be imposed on Consultant as a result of Section 409A. [Remainder of page intentionally left blank]


 
- 1 - EXHIBIT B CALIFORNIA LABOR CODE SECTION 2870 INVENTION ON OWN TIME - EXEMPTION FROM AGREEMENT “(a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either: (1) Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or (2) Result from any work performed by the employee for the employer. (b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.”


 
- 1 - EXHIBIT C SUPPLEMENTAL RELEASE In consideration for the mutual promises and consideration provided both herein and in the Confidential Transition Agreement and General Release signed on or about August 25, 2026 (the “Agreement”) and the Consulting Agreement between Kevin Yeaman (“Consultant”) and Dolby Laboratories, Inc., a California corporation, and its indirect and direct subsidiaries and/or parent companies (together, the “Company”) (collectively the “Parties”) (the “Consulting Agreement”), the Parties hereby extend by this Supplemental Release (the “Supplemental Release”) the release and waiver therein to any and all claims that may have arisen between the date of the Consultant’s signature to the Agreement and Consultant’s signature date, below; provided, however, that the carve-outs and exceptions set forth in the penultimate paragraph of Section 5 of the Agreement (including, without limitation, rights to indemnification, D&O insurance, equity rights, Protected Activity, and enforcement of the Agreement and Consulting Agreement) shall apply with equal force to this Supplemental Release. 1. Supplemental Release. The undersigned Parties expressly acknowledge and agree that the terms of the Agreement shall apply equally to this Supplemental Release and are incorporated herein. Consultant agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Consultant by the Company and its current and former officers, directors, consultants, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, divisions, and indirect or direct parent companies and/or subsidiaries, and predecessor and successor corporations and assigns (collectively, the “Releasees”). Consultant, on Consultant’s own behalf and on behalf of Consultant’s respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Consultant may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the date Consultant signs this Supplemental Release, including any claims Consultant may have under the California Fair Employment and Housing Act. Consultant acknowledges and agrees that the consideration provided to Consultant under the Agreement and the Consulting Agreement fully satisfies any obligation that the Company had to pay Consultant wages or any other compensation for any of the services that Consultant rendered to the Company, that the amount paid is in excess of any disputed wage claim, if any, that Consultant may have. To the extent any wage dispute exists, Consultant specifically acknowledges that the consideration paid shall be deemed to be paid first in satisfaction of any disputed wage claim with the remainder sufficient to act as consideration for the release of claims set forth herein, and that Consultant has not earned and is not entitled to receive any additional wages or other form of compensation from the Company. 2. California Civil Code Section 1542. Consultant acknowledges that Consultant has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section 1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows: “GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS


 
- 2 - OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND THAT IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.” Consultant, being aware of this code section, agrees to expressly waive any rights Consultant may have thereunder, as well as under any other statute or common law principles of similar effect. 3. ADEA Waiver. Consultant further expressly understands and acknowledges that Consultant is waiving and releasing any rights Consultant may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Consultant understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the date Consultant executes this Supplemental Release. Consultant understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Consultant was already entitled. Consultant further understands and acknowledges that Consultant has been advised by this writing that: (a) Consultant should consult with an attorney prior to executing this Supplemental Release; (b) Consultant has twenty-one (21) days within which to consider this Supplemental Release, by which time the Company must receive an executed copy; (c) Consultant has seven (7) days following Consultant’s execution of this Supplemental Release to revoke this Supplemental Release, and agrees that any such revocation must be in a writing by email to [OMITTED] or federal express received by Dolby by midnight on the seventh day following Consultant’s execution of this Supplemental Release; (d) this Supplemental Release shall not be effective until after the revocation period has expired; and (e) nothing in this Supplemental Release prevents or precludes Consultant from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Consultant signs this Supplemental Release and returns it to the Company in less than the twenty-one (21)-day period identified above, Consultant hereby acknowledges that Consultant has freely and voluntarily chosen to waive the time period allotted for considering this Supplemental Release. Consultant understands and agrees that Consultant executed this Supplemental Release voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Consultant’s claims against the Releasees. 4. Incorporation of Terms of Release Agreement. In addition to the above, the undersigned Parties further acknowledge that the terms of the Agreement, including, but not limited to, Sufficient Consideration, Affirmations, Protection of Employer’s Information, Company Property, Governing Law and Interpretation, Non-Disparagement and Communications with Company Employees, Customers and Business Partners, No Cooperation, Protected Activity Not Prohibited, Arbitration, Attorneys’ Fees, and Entire Agreement shall apply to this Supplemental Release and are incorporated herein to the extent that they are not inconsistent with the express terms of this Supplemental Release. 5. Voluntary Execution of Supplemental Release. Consultant understands and agrees that Consultant executed this Supplemental Release voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Consultant’s claims against the Company and any of the other Releasees. Consultant acknowledges that: (a) Consultant has read this Supplemental Release; (b) Consultant has been represented in the preparation, negotiation, and execution of this


 
- 3 - Supplemental Release by legal counsel of Consultant’s own choice or has elected not to retain legal counsel; (c) Consultant understands the terms and consequences of this Supplemental Release and of the releases it contains; and (d) Consultant is fully aware of the legal and binding effect of this Supplemental Release. CONSULTANT IS ADVISED TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS SUPPLEMENTAL RELEASE. TO OBTAIN THE BENEFITS SET FORTH IN SECTION 9 OF THE CONSULTING AGREEMENT, CONSULTANT MUST SIGN AND DELIVER THE EXECUTED SUPPLEMENTAL RELEASE TO DOLBY VIA DOCUSIGN OR TO THE GENERAL COUNSEL OF DOLBY ON THE DEADLINE SET FORTH IN SECTION 9 OF THE CONSULTING AGREEMENT. CONSULTANT HAS SEVEN (7) DAYS AFTER SIGNING THIS SUPPLEMENTAL RELEASE TO REVOKE IT. THIS SUPPLEMENTAL RELEASE WILL BECOME EFFECTIVE ON THE EIGHTH (8TH) DAY AFTER CONSULTANT SIGNED THIS SUPPLEMENTAL RELEASE, SO LONG AS CONSULTANT HAS COMPLIED WITH ALL OF ITS TERMS AND CONDITIONS, IT HAS BEEN SIGNED BY THE PARTIES, AND HAS NOT BEEN REVOKED BEFORE THAT DATE. HAVING ELECTED TO EXECUTE THIS SUPPLEMENTAL RELEASE, TO FULFILL ITS PROMISES AND TO RECEIVE THE CONSIDERATION HEREIN, CONSULTANT FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTERS INTO THIS SUPPLEMENTAL RELEASE INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS CONSULTANT HAS OR MIGHT HAVE AGAINST THE RELEASEES SINCE THE EFFECTIVE DATE. CONSULTANT CONSENTS TO USE ELECTRONIC SIGNATURE SERVICE FOR PURPOSES OF ACKNOWLEDGING THIS SUPPLEMENTAL RELEASE. [Remainder of Page Intentionally Blank; Signature Page Follows]


 
- 4 - IN WITNESS WHEREOF, the Parties have executed this Supplemental Release on the respective dates set forth below. CONSULTANT Dated: ________________ Kevin Yeaman DOLBY LABORATORIES, INC. Dated: ________________ By: ________________


 
1 DOLBY LABORATORIES, INC. 2026 INDUCEMENT STOCK PLAN NOTICE OF GRANT OF EXECUTIVE PERFORMANCE-BASED RESTRICTED STOCK UNITS Unless otherwise defined herein, the terms defined in the Dolby Laboratories, Inc. 2026 Inducement Stock Plan, as amended from time to time (the “Plan”) shall have the same defined meanings in this Notice of Grant of Executive Performance-Based Restricted Stock Units (the “Notice of Grant”) and the Global Restricted Stock Unit Agreement attached hereto as Exhibit A (collectively, the “Executive Performance-Based Restricted Stock Unit Agreement” or the “Agreement”), including any terms and conditions for participants outside the U.S. in the Appendix. Participant: %%FIRST_NAME_MIDDLE_NAME_LAST_NAME%-% You have been granted an award of Restricted Stock Units (the “Award”). Each such Restricted Stock Unit is equivalent to one share of the Company’s Class A Common Stock for purposes of determining the number of Shares subject to this Award. None of the Restricted Stock Units will be issued (nor will you have the rights of a stockholder with respect to the underlying Shares) until the vesting conditions described below are satisfied. Additional terms of this grant are as follows: Date of Grant: %%OPTION_DATE,'Month DD, YYYY'%-% Target Number of Restricted Stock Units (“Target”): 300,000 Maximum Number of Restricted Stock Units (“Maximum”): 600,000 Vesting Schedule: The Restricted Stock Units subject to the Award will vest only upon achievement of the Stock Price Target(s) (as defined below) during the Performance Period (as defined below) and the satisfaction of the applicable service-based vesting condition, as described below. The Award will be divided into five (5) tranches and each tranche will have a Stock Price Target associated with such tranche. On each Achievement Date (as defined below) during the Performance Period, and subject to you satisfying the Service Condition (as defined below) through the Achievement Date (except as provided herein), a number of Restricted Stock Units will become eligible to vest equal to the number of Restricted Stock Units listed as the “Number of Earned


 
2 Shares” corresponding to the applicable Stock Price Target in the table below (such Restricted Stock Units eligible to vest, the “Earned Shares”). If Restricted Stock Units are determined to be Earned Shares on a Certification Date (as defined below) (including in the event of a Change in Control (as defined below)), then 100% of the Earned Shares will vest on the Certification Date. For the avoidance of doubt, if you satisfy the Service Condition through the applicable Achievement Date, but cease to be a Service Provider prior to the Certification Date, then the Award will remain outstanding through the Certification Date and the date the Award is settled to the extent it is determined that a number of Earned Shares were earned and vested pursuant to the terms of the Award Agreement. Tranche Stock Price Target* Number of Earned Shares* 1 $75.00 150,000 2 $100.00 150,000 3 $125.00 100,000 4 $150.00 100,000 5 $175.00 100,000 * The Stock Price (as defined below), the Stock Price Targets and the Number of Earned Shares, as applicable and without duplication, will be adjusted to reflect any transaction described in Section 17(a) of the Plan and, notwithstanding the language in Section 17(a) of the Plan, the Stock Price or Stock Price Targets, as applicable and without duplication, will be adjusted to reflect any regular course dividends or distributions. The Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Agreement, will make the determination of any such adjustments required in connection with any such event. Upon your Qualifying Termination (as defined below), any tranches of Restricted Stock Units that have not been earned as of your termination date will not terminate and will instead remain outstanding through the end of the Performance Period. During the Performance Period, such tranches of Restricted Stock Units will remain eligible to vest on the Certification Date associated with such Earned Shares, subject to the satisfaction of the terms and conditions of your Employment Agreement (as defined below). If a Change in Control occurs during the Performance Period, the Stock Price will mean the Per Share Deal Price (as defined below). After determining the Stock Price in accordance with the prior sentence, the same rules under the table above apply in determining whether any additional “Stock Price Targets” are achieved and additional Restricted Stock Units subject to the Award will become Earned Shares. For the avoidance of doubt, if, prior to the Change in Control, Restricted Stock Units subject to the Award already have become Earned Shares based on the achievement of a Stock Price Target, such Restricted Stock Units will not again become Earned Shares with respect to that Stock Price Target achievement. If, after applying the rules set forth in this paragraph, additional Restricted Stock Units subject to the Award satisfy a Stock Price Target, then the Achievement Date, the Certification Date and the vesting date for such Restricted Stock Units will be the date immediately prior to the Closing (as defined below).


 
3 Any Restricted Stock Units subject to the Award that have not become Earned Shares and vested as of the end of the Performance Period will terminate immediately following the end of the Performance Period and you will have no further rights with respect to such Shares. Definitions: “Achievement Date” means the first Trading Day (as defined below) occurring during the Performance Period on which a Stock Price Target is achieved. For the avoidance of doubt, (i) each Stock Price Target may only be achieved once during the Performance Period, and (ii) more than one Stock Price Target may be achieved on a particular date. No partial achievement will occur and no Restricted Stock Units will become Earned Shares for achievement between two Stock Price Targets. “Certification Date” means the date that the Administrator certifies achievement of the Stock Price Target, with such Certification Date to occur within five (5) business days following the Achievement Date, and in all cases, no later than the last day of the Performance Period. “Change in Control” has the meaning of such term as defined in your Employment Agreement. “Closing” means the closing of the first Change in Control that occurs following the Date of Grant. “Employment Agreement” means your Employment Agreement with the Company dated July 10, 2026. “Per Share Deal Price” means the total amount of cash consideration and value of any non- cash consideration received or potentially receivable for a Share by holders of Class A Common Stock in connection with the Change in Control, provided that if the nature of the Change in Control is such that the Per Share Deal Price is not readily calculable, the Per Share Deal Price will be determined in good faith by the Board. The value of any non-cash consideration will be determined in good faith by the Board. “Performance Period” means the period (i) commencing on the Date of Grant and (ii) ending on the first to occur of (A) your failure to satisfy the Service Condition (except in the event of a Qualifying Termination, in which case the Performance Period will end on the twelve (12) month anniversary of the Qualifying Termination unless terminated earlier pursuant to (B) or (C)); (B) a Closing; or (C) the five (5) year anniversary of the Date of Grant. “Qualifying Termination” means your employment as Chief Executive Officer of the Company is terminated by the Company without Cause (as such term is defined in your Employment Agreement) (and not by reason of your death or Disability (as such term is defined in your Employment Agreement), or you resign for Good Reason (as such term is defined in your Employment Agreement). “Service Condition” means your continuous service as Chief Executive Officer of the Company.


 
4 “Stock Price” means the average closing price of a Share for any sixty (60) consecutive Trading Days during the Performance Period. “Stock Price Target” means each Stock Price set forth in the table above. “Trading Day” means a day the stock exchange or national market system on which the Company’s Class A Common Stock is listed is open for trading. You acknowledge and agree that the Agreement and the vesting schedule set forth herein do not constitute an express or implied promise of continued engagement as a Service Provider for the vesting period, for any period, or at all, and shall not interfere with your right or the right of the Company or the Related Entity that is your employer to terminate your relationship as a Service Provider at any time, with or without cause. You hereby agree to accept as binding, conclusive, and final all decisions or interpretations of the Administrator upon any questions relating to the Plan, the Recoupment Policy (as defined in Exhibit A hereto) and this Agreement. By your electronic signature and the electronic signature of the Company’s representative, you and the Company agree that the Award is granted under and governed by the terms and conditions of the Plan, the Recoupment Policy and the Agreement. You have reviewed the Plan, the Recoupment Policy and the Agreement in their entirety, have had an opportunity to obtain the advice of counsel prior to executing the Agreement and fully understand all provisions of the Plan, the Recoupment Policy and the Agreement. You hereby agree to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan, the Recoupment Policy and the Agreement. You must execute and deliver or electronically accept the terms set forth in the Agreement, in the manner specified by the Administrator. The Administrator may, in its sole discretion, cancel the Award if you fail to execute and deliver or electronically accept the Agreement and related documents by the first scheduled vesting date.


 
5 EXHIBIT A DOLBY LABORATORIES, INC. 2026 INDUCEMENT STOCK PLAN GLOBAL RESTRICTED STOCK UNIT AGREEMENT 1. Grant. Dolby Laboratories, Inc. (the “Company”) hereby grants to the individual set forth in the Notice of Grant of Restricted Stock Units (“Participant”) an award of Restricted Stock Units (“RSUs”) pursuant to Section 8 of the Dolby Laboratories, Inc. 2026 Inducement Stock Plan, as set forth in the Notice of Grant of Executive Performance-Based Restricted Stock Units (the “Notice of Grant”) and subject to the terms and conditions in this Global Restricted Stock Unit Agreement, including any special terms and conditions for participants outside the U.S. in the attached Appendix (collectively, the “Agreement”), and the Dolby Laboratories, Inc. 2026 Inducement Stock Plan as may be amended from time to time (the “Plan”). Unless otherwise defined herein, the terms defined in the Plan and the Notice of Grant shall have the same defined meanings in this Agreement. 2. Company’s Obligation. Each RSU represents the right to receive a Share after satisfying the applicable vesting conditions set forth in the Notice of Grant. Unless and until the RSUs vest, Participant will have no right to receive Shares under such RSUs. Prior to actual distribution of any Shares pursuant to the vesting of any RSUs, such RSUs will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company. 3. Vesting Schedule. Subject to paragraph 4, and to relevant Plan provisions, the RSUs awarded by this Agreement will vest in Participant according to the vesting schedule specified in the Notice of Grant. 4. Forfeiture upon Termination of Service. Except as provided in the Notice of Grant, if Participant ceases to be a Service Provider, for any or no reason prior to vesting, the unvested RSUs awarded by this Agreement will thereupon be forfeited at no cost to the Company. 5. Payment after Vesting. Any RSUs that vest in accordance with this Agreement will be paid to Participant (or in the event of Participant’s death, to his or her estate) in whole Shares. Subject to the provisions of paragraph 10, such vested RSUs shall be paid in whole Shares as soon as practicable after vesting, but in each such case within sixty (60) days following the vesting date. In no event will Participant be permitted, directly or indirectly, to specify the taxable year of payment of any RSUs payable under this Agreement. Payment upon vesting will be subject to Participant (or his or her estate) satisfying the applicable Tax-Related Items (defined below) withholding obligations set forth in paragraph 11. 6. Payments after Death. Any distribution or delivery to be made to Participant under this Agreement will, if Participant is then deceased, be made to the administrator or executor of Participant’s estate. Any such administrator or executor must furnish the Company with (a) written


 
6 notice of his or her status as transferee, and (b) evidence satisfactory to the Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer. 7. Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until Shares (in certificated or uncertificated form in the Company’s sole discretion) have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant or Participant’s broker. 8. No Guarantee of Continued Service. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF RSUS PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY PURSUANT TO THE TERMS OF THIS AGREEMENT, INCLUDING BY CONTINUED ENGAGEMENT AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR ANY RELATED ENTITY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE COMPANY (OR ANY RELATED ENTITY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. 9. Address for Notices. Any notice to be given to the Company under the terms of this Agreement will be addressed to the Company at 1275 Market Street, San Francisco, CA 94103, U.S.A., Attn: Stock Administration, or at such other address as the Company may hereafter designate in writing or electronically. 10. Acceleration. (a) Discretionary Acceleration. The Administrator, in its discretion, may accelerate the vesting of the balance, or some lesser portion of the balance, of the unvested RSUs at any time, subject to the terms of the Plan. If so accelerated, such RSUs will be considered as having vested as of the date specified by the Administrator. If Participant is a U.S. taxpayer, the payment of Shares vesting pursuant to this Section 10 shall in all cases be paid at a time or in a manner that is exempt from, or complies with, Section 409A of the Code and the Treasury Regulations and guidance thereunder, and any applicable state law equivalent, as each may be promulgated, amended or modified from time to time (“Section 409A”). The prior sentence may be superseded in a future agreement or amendment to this Agreement only by direct and specific reference to such sentence. (b) Acceleration in Connection with Termination of Service. Notwithstanding anything in the Plan or this Agreement or any other agreement (whether entered into before, on or after the Date of Grant), if the vesting of the balance, or some lesser portion of the balance, of the


 
7 RSUs is accelerated in connection with Participant’s termination as a Service Provider (provided that such termination is a “separation from service” within the meaning of Section 409A, as determined by the Company), other than due to Participant’s death, and if (x) Participant is a U.S. taxpayer and a “specified employee” within the meaning of Section 409A at the time of such termination as a Service Provider and (y) the payment of such accelerated RSUs will result in the imposition of additional tax under Section 409A if paid to Participant on or within the six (6) month period following Participant’s termination as a Service Provider, then the payment of such accelerated RSUs will not be made until the date six (6) months and one (1) day following the date of Participant’s termination as a Service Provider, unless Participant dies following his or her termination as a Service Provider, in which case, the RSUs will be paid in Shares to Participant’s estate as soon as practicable following his or her death. (c) Section 409A. It is the intent of this Agreement that it and all payments and benefits to U.S. taxpayers hereunder be exempt from, or comply with, the requirements of Section 409A so that none of the RSUs provided under this Agreement or Shares issuable thereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to be so exempt or so comply. Each payment payable under this Agreement is intended to constitute a separate payment for purposes of Treasury Regulation Section 1.409A-2(b)(2). However, in no event will the Company reimburse Participant, or be otherwise responsible for, any taxes or costs that may be imposed on Participant as a result of Section 409A or any other tax law or rule. 11. Withholding Taxes. Regardless of any action the Company or the Related Entity that is Participant’s employer (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding items related to Participant’s participation in the Plan and legally applicable to Participant, or deemed by the Company or the Employer to be an appropriate charge to Participant even if technically due by the Company or the Employer (“Tax-Related Items”), Participant hereby acknowledges that the ultimate liability for all Tax-Related Items is and remains Participant’s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the issuance of Shares in settlement of the RSUs, the subsequent sale of Shares acquired at vesting and the receipt of any dividends and/or any dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the Award or any aspect of the RSUs to reduce or eliminate Participant’s liability for Tax-Related Items or achieve a particular tax result. Further, if Participant is subject to tax in more than one jurisdiction, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax- Related Items in more than one jurisdiction. In connection with any relevant taxable or tax withholding event, Participant shall pay or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax- Related Items. In this regard, Participant authorizes and directs the Company and/or the Employer or their respective agents, in their sole discretion and without any notice or authorization by Participant, to satisfy any applicable withholding obligations, if any, with regard to all Tax-Related Items by withholding in Shares to be issued upon settlement of the RSUs. In the event that such


 
8 withholding in Shares is problematic under applicable tax or securities law or has materially adverse accounting consequences, by Participant’s acceptance of the RSUs, Participant authorizes the Company and any brokerage firm to satisfy the obligations with regard to all Tax-Related Items by withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or to sell on Participant’s behalf a whole number of Shares from those Shares issued to Participant as the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the obligation for Tax-Related Items. Depending upon the withholding method, the Company may withhold or account for Tax- Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates in Participant’s jurisdiction(s), including maximum applicable rates. If the Company and/or the Employer withhold more than the amount necessary to satisfy the liability for Tax-Related Items, Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent Shares or, if not refunded, Participant may be able to seek a refund from the applicable tax authorities. If the Company and/or the Employer withhold less than the amount necessary to satisfy the liability for Tax-Related Items, Participant may be required to pay additional Tax-Related Items directly to the applicable tax authorities or to the Company and/or the Employer. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of Participant’s participation in the Plan. No fractional Shares will be withheld or issued pursuant to the grant of RSUs and the issuance of Shares thereunder. Finally, Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described. Participant acknowledges and agrees that the Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if Participant fails to comply with Participant’s obligations in connection with the Tax-Related Items. Participant shall have no further rights with respect to any Shares that are retained by the Company pursuant to this provision, and under no circumstances will the Company be required to issue any fractional Shares. 12. Acknowledgements. In accepting the RSUs, Participant acknowledges, understands and agrees that: (a) Participant acknowledges receipt of a copy of the Plan (including any applicable appendixes or sub-plans thereunder) and represents that he or she is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof. Participant has reviewed the Plan (including any applicable appendixes or sub- plans thereunder), the Recoupment Policy and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Recoupment Policy or this Agreement. Participant further agrees to notify the Company upon any change in the residence address in the Notice of Grant;


 
9 (b) the Company (and not the Employer) is granting the RSU. The Company will administer the Plan from outside Participant’s country of residence; (c) the Plan is established voluntarily by the Company, is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time; (d) the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past; (e) all decisions with respect to future awards of RSUs, if any, will be at the sole discretion of the Company; (f) Participant is voluntarily participating in the Plan; (g) the RSUs and the Shares subject to the RSUs, and the income and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which are outside the scope of Participant’s employment or service contract, if any; (h) unless otherwise agreed with the Company, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not granted as consideration for, or in connection with, the service Participant may provide as a director of a Related Entity; (i) the RSUs and the Shares subject to the RSUs, and the income and value of same, are not intended to replace any pension rights or compensation; (j) although provided by the Company, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not part of Participant’s normal or expected salary or compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, leave-related pay, pension, retirement or welfare benefits or any other similar payments and in no event should be considered as compensation for or relating in any way to past services for the Company, the Employer, or any other Related Entity; (k) the RSU grant and Participant’s participation in the Plan will not be interpreted to form an employment contract or relationship with the Company or any Related Entity and the Company will not incur any liability of any kind to Participant as a result of any change or amendment, or any cancellation, of the Plan at any time; (l) the future value of the underlying Shares is unknown and cannot be predicted with certainty; (m) in the event of termination of Participant’s status as a Service Provider (whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid), Participant’s right to vest in the RSUs under the Plan, if any, will terminate effective as of the date that Participant is no longer actively employed and will not be


 
10 extended by any notice period mandated under local law (e.g., active employment would not include a period of “garden leave” or similar period pursuant to local law); the Administrator shall have the exclusive discretion to determine when Participant is no longer actively employed for purposes of the Award (including whether Participant may still be considered actively employed while on an approved leave of absence); (n) unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits under the Plan, if any, do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; (o) the RSUs and the Shares subject to the RSUs are not part of Participant’s normal or expected compensation or salary for any purpose; (p) neither the Company, the Employer nor any other Related Entity shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement; and (q) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from termination of Participant’s status as a Service Provider by the Company or the Employer (for any reason whatsoever and whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid). 13. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares. Participant acknowledges and agrees that he or she should consult with his or her own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan 14. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Agreement and any other RSU materials by and among, as applicable, the Employer, the Company, and its Related Entities for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan. Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, e-mail address, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency status, job title, any Shares or directorships held in the Company or any Related Entity, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), for the purpose of implementing, administering and managing the Plan.


 
11 Participant understands that Data may be transferred to Morgan Stanley Smith Barney LLC and its affiliated company, E*TRADE Financial Corporate Services, Inc. (collectively, “E*TRADE”), or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company in the implementation, administration and management of the Plan. Participant understands that the recipients may be located in the United States, or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws and protections than Participant’s country. Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting Participant’s local human resources representative. Participant authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing Participant’s participation in the Plan, including any transfer of such Data, as may be required for the administration of the Plan and/or the subsequent holding of Shares on Participant’s behalf, to a broker or third party with whom the Shares acquired on exercise may be deposited. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan. Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case, without cost, by contacting in writing Participant’s local human resources representative, or if there is no local human resources representative, the human resources department of the Company. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, his or her employment status or service with the Employer will not be affected; the only consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant RSUs or other equity awards or administer or maintain such awards. Participant understands, however, that refusal or withdrawal of consent may affect Participant’s ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative, or if there is no local human resources representative, the human resources department of the Company. 15. Grant is Not Transferable. Except to the limited extent provided in paragraph 6, this grant and the rights and privileges conferred hereby will not be transferred, assigned, pledged, or hypothecated in any way (whether by operation of law or otherwise) and will not be subject to sale under execution, attachment, or similar process. Upon any attempt to transfer, assign, pledge, hypothecate, or otherwise dispose of this grant, or any right or privilege conferred hereby, or upon any attempted sale under any execution, attachment, or similar process, this grant and the rights and privileges conferred hereby immediately will become null and void. 16. Binding Agreement. Subject to the limitation on the transferability of this grant contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors, and assigns of the parties hereto.


 
12 17. Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its discretion, that the listing, registration, or qualification of the Shares upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Participant (or his or her estate), such issuance will not occur unless and until such listing, registration, qualification, consent, or approval will have been effected or obtained free of any conditions not acceptable to the Company. The Company will make all reasonable efforts to meet the requirements of any such state or federal law or securities exchange and to obtain any such consent or approval of any such governmental authority. 18. Plan Governs. This Agreement and the Notice of Grant are subject to all terms and provisions of the Plan. In the event of a conflict between one or more provisions of this Agreement or the Notice of Grant and one or more provisions of the Plan, the provisions of the Plan will govern. 19. Governing Law and Venue. The Award will be governed by the internal substantive laws, but not the choice of law rules, of the State of California, U.S.A. without regard to principles of conflict of laws. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by the Award or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of San Francisco County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed. 20. Language. Participant has received the terms and conditions of this Agreement and any other related communications in English. Participant acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of this RSU Agreement, or, alternatively, Participant acknowledges that he or she will seek appropriate assistance. Furthermore, if Participant consents to having received these documents in English. If Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control, unless otherwise required by applicable laws. 21. Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. By Participant’s electronic signature and the electronic signature of the Company’s representative, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan and this Agreement. 22. Administrator Authority. The Administrator will have the power to interpret the Plan, the Recoupment Policy and this Agreement and to adopt such rules for the administration, interpretation, and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any RSUs have vested and whether Participant is actively employed). All actions taken and all interpretations and


 
13 determinations made by the Administrator in good faith will be final and binding upon Participant, the Company, and all other interested persons. No member of the Administrator will be personally liable for any action, determination, or interpretation made in good faith with respect to the Plan, the Recoupment Policy or this Agreement. 23. Severability. The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable. 24. Appendix. Notwithstanding any provisions in this Agreement, the Award shall be subject to any terms and conditions set forth in any Appendix to this Agreement for Participant’s country. Moreover, if Participant relocates to one of the countries included in the Appendix, the terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable under Applicable Laws with regard to the issuance or sale of Shares or facilitate the administration of the Plan. The Appendix constitutes part of this Agreement. 25. Imposition of Other Requirements. The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable under Applicable Laws with regard to the issuance or sale of Shares or to facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. 26. Insider Trading/Market Abuse Restrictions. Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect Participant’s ability to, directly or indirectly, accept, acquire, sell, attempt to sell or otherwise dispose of Shares, rights to Shares (e.g., RSUs), or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as Participant is considered to have “inside information” regarding the Company as defined by the laws or regulations in the applicable jurisdiction or Participant’s country. Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed insider information. Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under the Company’s Insider Trading Policy. Participant is responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter. 27. Exchange Control, Tax and/or Foreign Asset/Account Reporting. Participant acknowledges that there may be exchange control, tax, foreign asset and/or account reporting requirements which may affect Participant’s ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends paid on Shares acquired under the Plan) in a brokerage, bank account or legal entity outside Participant’s country. Participant may be required to report such accounts, assets or transactions to the tax or other authorities in Participant’s country. Participant also may be required to repatriate sale proceeds or other funds received as a result of participation in the Plan to Participant’s country through a


 
14 designated bank or broker within a certain time after receipt. Participant acknowledges that it is his or her responsibility to be compliant with such regulations, and should consult his or her personal legal advisor for any details. 28. Waiver. Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Participant or any other participant. 29. Reduction, Cancellation, Forfeiture or Recoupment. This Award, any Shares issued in payment for vested RSUs pursuant to this Award and any other rights, payments and benefits with respect to this Award shall be subject to reduction, cancellation, forfeiture or recoupment pursuant to (i) the Company’s Policy on Recoupment of Incentive Compensation (the “Recoupment Policy”), (ii) any other recovery, recoupment, “clawback” or similar policy adopted by the Company after the Date of Grant, and (iii) as required for the Participant or the Company to comply with any requirements imposed under applicable laws and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, in each case for clauses (i), (ii) and (iii), as may be amended from time to time (with the provisions contained in such policies and the relevant provisions of such laws, rules and regulations deemed incorporated into this Agreement without the Participant’s additional or separate consent). For purposes of the foregoing, the Participant expressly and explicitly authorizes the Company to issue instructions, on the Participant’s behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to the Award to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company upon the Company’s enforcement of this paragraph 29.


 
15 APPENDIX TO DOLBY LABORATORIES, INC. 2026 INDUCEMENT STOCK PLAN GLOBAL RESTRICTED STOCK UNIT AGREEMENT Terms and Conditions for Participants Outside the U.S. This Appendix includes additional country-specific terms and conditions that apply to Participants resident in countries listed below. This Appendix is part of the Agreement and contains terms and conditions material to participation in the Plan. Unless otherwise provided below, capitalized terms used but not defined herein shall have the same meanings assigned to them in the Plan and the Agreement. The information is based on the securities, exchange control, income tax and other laws in effect in the respective countries as of October 2025. Such laws are often complex and change frequently. As a result, the Company strongly recommends that Participant not rely on the information in this Appendix as the only source of information relating to the consequences of Participant’s participation in the Plan because the information may be out of date when Participant vests in the RSUs or Shares acquired under the Plan are sold. In addition, the information contained herein is general in nature and may not apply to Participant’s particular situation, and the Company is not in a position to assure Participant of a particular result. Accordingly, Participant should seek appropriate professional advice as to how the relevant laws in Participant’s country may apply to his or her situation. Finally, if Participant is a citizen or resident of a country other than the one in which he or she is currently working or Participant transfers employment or residency after the Date of Grant, or if Participant is considered resident of another country for local law purposes, then the provisions contained herein may not be applicable to Participant. The Company shall, in its sole discretion, determine to what extent the terms and conditions included herein will apply under these circumstances. Countries Within the European Economic Area and the United Kingdom Data Privacy: The Dolby Employee Privacy Notice supersedes and replaces paragraph 14 of the Agreement. The Dolby Employee Privacy Notice for each respective country in the European Union and European Economic Area can be found at [OMITTED] Australia Securities Law Notice. The grant of the RSUs is being made pursuant to Division 1A, Part 7.12 of the Corporations Act 2001 (Cth). If Participant acquires Shares under the Plan and offers such Shares for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under


 
16 Australian law. Participant should obtain legal advice on disclosure obligations prior to making any such offer. Tax Notice. The Plan is a plan to which subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act). Exchange Control Notice. Exchange control reporting is required for cash transactions exceeding AUD 10,000 and for international fund transfers. Participant understands that if an Australian bank is assisting with the transaction, the bank will file the report on Participant’s behalf. Participant understands that if there is no Australian bank involved in the transfer, Participant will have to file the exchange control report on his or her own behalf. Belgium Foreign Asset/Account Reporting Information. Belgian residents are required to report any Shares acquired under the Plan or bank account established outside of Belgium on their personal annual tax return. In a separate report, Belgian residents also are required to provide a central contact point of the National Bank of Belgium with the account number of those foreign bank accounts, the name of the bank with which the accounts were opened and the country in which they were opened in a separate report. This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under the Kredietcentrales / Centrales des credits caption. Stock Exchange Tax Information. A stock exchange tax applies to transactions executed by Belgian residents through a non- Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the Plan are sold. Annual Securities Account Tax. An annual securities accounts tax may be payable if the total average value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. Brazil Compliance with Law.


 
17 By accepting the RSUs, Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with Participant’s participation in the Plan, including the vesting of the RSUs, the receipt of any dividends, and the sale of Shares acquired under the Plan. Nature of Award Grants. By accepting the RSUs, Participant agrees that (1) he or she is making an investment decision, (2) the Shares will be issued to Participant only if the vesting conditions are met and any necessary services are rendered by Participant over the vesting period and (3) the value of the underlying Shares is not fixed and may increase or decrease in value over time without compensation to Participant. Exchange Control Notice. Individuals who are resident or domiciled in Brazil are generally required to submit an annual declaration of assets and rights held outside Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is greater than US$1,000,000. If such amount is equal to or greater than US$100,000,000, the referenced declaration must be submitted quarterly, in the month following the end of each quarter. Assets and rights to be included in this annual declaration include Shares acquired under the Plan. Tax on Financial Transaction (IOF). Payments to foreign countries and repatriation of funds into Brazil and the conversion between BRL and US$ associated with such fund transfers may be subject to the Tax on Financial Transactions. It is Participant’s responsibility to comply with any applicable Tax on Financial Transactions arising from Participant’s participation in the Plan. Participant should consult with his or her personal tax advisor for additional details. Canada Form of Settlement. RSUs granted to employees resident in Canada shall be paid in Shares only. Acknowledgments. The following provision replaces Section 12(c) of the Agreement: except as explicitly and minimally required under applicable legislation, no Related Entity (including, but not limited to, the Employer) has any obligation to make any payment of any kind under this Agreement; The following provision replaces Section 12(h) of the Agreement: except as explicitly and minimally required under applicable legislation, the RSUs and the


 
18 Shares subject to the RSUs, and the income and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which are outside the scope of Participant’s employment or service contract, if any; The following provision replaces Section 12(r) of the Agreement: except as explicitly and minimally required under applicable legislation, no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from termination of Participant’s status as a Service Provider by the Company or the Employer (for any reason whatsoever and whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid). Termination of Service Provider Relationship. The following provision replaces paragraph 12(n) of the Agreement: For purposes of the Award, except as explicitly and minimally required under applicable legislation: (i) Participant’s period of service for purposes of the Award and Participant’s status as an eligible Service Provider will cease; and (ii) Participant’s right, if any, to vest in any RSUs under the Plan, seek damages in lieu, or otherwise benefit from or participate in the Plan will be measured by and immediately terminate, as of the date Participant ceases to provide services to the Company or a Related Entity, regardless of the reason for termination and whether or not later to be found invalid or in breach of applicable laws in the jurisdiction where Participant is employed or providing services or the terms of Participant’s employment or service agreement, if any (the “Termination Date”). Except to the extent explicitly and minimally required under applicable legislation, the Termination Date shall exclude any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under statute, contract, common/civil law or otherwise. Participant shall not earn or be entitled to any pro-rated vesting or other participation for that portion of time before the Termination Date, nor shall Participant be entitled to any compensation for lost vesting or other participation. If, notwithstanding the foregoing, applicable employment legislation explicitly requires continued entitlement to vesting or other participation during a statutory notice period, Participant’s right to vest in the RSUs or otherwise participate in or benefit from the Plan, if any, shall terminate effective as of the last date of the minimum statutory notice period. For clarity, Participant shall not earn or be entitled to pro-rated vesting or other participation if the vesting date falls after the end of Participant’s statutory notice period, nor shall Participant be entitled to any compensation for lost vesting. Any reference to termination as a Service Provider or cessation or termination of employment or service in this Agreement or the Plan shall be interpreted to mean the Termination Date as defined above.


 
19 Subject to applicable legislation, the Administrator shall have the exclusive discretion to determine when Participant is no longer actively employed or providing services for purposes of the Award (including whether Participant may still be considered actively providing services while on an approved leave of absence). Sale of Shares. Participant acknowledges that he or she is permitted to sell the Shares acquired under the Plan through E*TRADE or such other broker as may be selected by the Company in the future, provided the sale of the Shares takes place outside of Canada through facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange. French Language Documents for Quebec Service Providers. A French translation of the Agreement and the Plan will be made available to Participant as soon as reasonably practicable. Notwithstanding anything to the contrary in the Agreement, and unless Participant indicates otherwise, the French translation of the Agreement and the Plan will govern Participant’s participation in the Plan. Une traduction française de l’Accord et du Plan sera mise à la disposition du Participant dès que raisonnablement possible. Nonobstant toute disposition contraire de l’Accord, et sauf indication contraire du Participant, la traduction française de l’Accord et du Plan régira la participation du Participant au Plan. Authorization to Release and Transfer Necessary Personal Information for Quebec Service Providers. The following provision supplements paragraph 14 of the Agreement: Participant hereby authorizes the Company and the Company’s representatives, including the broker(s) designated by the Company, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. Participant further authorizes the Company, any Related Entity and the Administrator of the Plan to disclose and discuss the Plan with their advisors. Participant further authorizes the Company and any Related Entity to record such information and to keep such information in Participant’s employee file. Participant acknowledges and agrees that Participant’s personal information, including any sensitive personal information, may be transferred or disclosed outside the province of Quebec, including to the U.S. If applicable, Participant also acknowledges and authorizes the Company, any Related Entity, the Administrator and any third party brokers/administrators that are assisting the Company with the operation and administration of the Plan to use technology for profiling purposes and to make automated decisions that may have an impact on Participant or the administration of the Plan. Foreign Asset/Account Reporting Notice.


 
20 Canadian residents may be required to report foreign specified property on Form T1135 (Foreign Income Verification Statement) if the total cost of the foreign specified property exceeds CAD 100,000 at any time in the year. Foreign specified property includes Shares acquired under the Plan and may include RSUs. The RSUs must be reported - generally at a nil cost - if the CAD 100,000 cost threshold is exceeded because of other foreign specified property Participant holds. The cost of RSUs generally is the adjusted cost base (“ACB”) of the Shares. The ACB ordinarily would equal the fair market value of the Shares at the time of acquisition, but if the Canadian resident owns other Shares of the Company, this ACB may have to be leveraged with the ACB of the other Shares. The Form T1135 generally must be filed by April 30 of the following year. Canadian residents should consult with a personal advisor to ensure compliance with the applicable reporting requirements. China Settlement of RSUs and Sale of Shares. The following provision supplements paragraph 5 of the Agreement: Due to local regulatory requirements, Participant agrees that the Company may force the sale of any Shares to be issued upon settlement of the Award. The sale may occur (i) immediately upon vesting, (ii) following Participant’s termination as a Service Provider, or (iii) or within any other time frame as the Company determines to be necessary or advisable for legal or administrative reasons. Participant agrees that he or she must maintain any Shares acquired under the Plan in an account maintained by E*TRADE or such other stock plan service provider as may be selected by the Company. Participant further agrees that the Company is authorized to instruct E*TRADE or such other stock plan service provider as may be selected by the Company in the future to assist with the mandatory sale of such Shares (on Participant’s behalf pursuant to this authorization) and Participant expressly authorizes E*TRADE or such other stock plan service provider as may be selected by the Company in the future to complete the sale of such Shares. Participant acknowledges that E*TRADE or such other stock plan service provider as may be selected by the Company in the future is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the Company agrees to pay Participant the cash proceeds from the sale of the Shares, less any brokerage fees or commissions and subject to any obligation to satisfy Tax-Related Items. Exchange Control Acknowledgement. Participant understands and agrees that participation in the Plan is subject to the Company or the Employer obtaining any required approval from the China State Administration of Foreign Exchange (“SAFE”), as determined by the Company in its sole and absolute discretion. If the Company or the Employer is unable to obtain such approval, Participant may not be entitled to receive any benefit in connection with the Plan without any liability to the Company, the Employer or any Related Entity.


 
21 Participant understands and agrees that, pursuant to local exchange control requirements, Participant will be required to repatriate the cash proceeds from the sale of Shares issued upon the vesting of the RSUs as well as any cash dividends paid on such Shares to China. Participant further understands that, under local law, such repatriation of the cash proceeds may need to be effectuated through a special exchange control account established by the Company, or one of its Related Entities, and Participant hereby consents and agrees that any proceeds from the sale of any Shares issued upon the vesting of the RSUs as well as any cash dividends paid on such Shares may be transferred to such special account prior to being delivered to Participant. If the proceeds from the sale of Participant’s Shares or cash dividends are converted to local currency, Participant acknowledges that the Company is under no obligation to secure any exchange conversion rate, and the Company may face delays in converting the proceeds to local currency due to exchange control restrictions in China. Participant agrees to bear the risk of any exchange conversion rate fluctuation between the date the RSUs vest and the date of conversion of the proceeds from the sale of the Shares issued upon vesting to local currency. Participant further agrees to comply with any other requirements that may be imposed by the Company in the future in order to facilitate compliance with exchange control requirements in China. Foreign Asset/Account Reporting Notice. Chinese residents are required to report to the SAFE all details of his or her foreign financial assets and liabilities, as well as details of any economic transactions conducted with non- Chinese residents, either directly or through financial institutions. France Consent to Receive Information in English. By accepting the grant of the RSUs, Participant confirms having read and understood the Plan and the Agreement, which were provided in English language. Participant accepts the terms of those documents accordingly. En acceptant cette attribution gratuite d’actions, le Participant confirme avoir lu et compris le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont été transmis en langue anglaise. Le Participant accepte les dispositions de ces documents en connaissance de cause. Foreign Asset/Account Reporting Notice. French residents must report annually any shares and bank accounts held outside France, including the accounts that were opened, used and/or closed during the tax year, to the French tax authorities, on an annual basis on a special Form N° 3916, together with Participant’s personal income tax return. Failure to report triggers a significant penalty. Exchange Control Information.


 
22 The value of any cash or securities imported to or exported from France without the use of a financial institution must be reported to the customs and excise authorities when the value of such cash or securities is equal to or greater than a certain amount (currently €10,000). Germany Exchange Control Notice. Cross-border payments (including proceeds realized upon the sale of Shares or from the receipt of any dividends paid on such Shares) and certain other transactions with a value in excess of €50,000 must be reported to the German Federal Bank (Bundesbank). In addition, Participant may be required to report (i) the acquisition of Shares, and (ii) the withholding or the sale of Shares to cover withholding obligations or rights for Tax-Related Items, in either case if the value of the Shares exceeds €50,000. The report must be filed either electronically using the “General Statistics Reporting Portal” (“Allgemeines Meldeportal Statistik”) available via the Bundesbank’s website (www.bundesbank.de) or via such other method (e.g., by email or telephone) as is permitted or required by the Bundesbank. The report must be submitted monthly or within such timing as is permitted or required by the Bundesbank. Participant should consult with their personal tax advisor for details regarding this requirement. Foreign Asset/Account Reporting Information. German residents holding Shares must notify their local tax office if the acquisition of Shares under the Plan leads to a so-called qualified participation at any point during the calendar year. A qualified participation is attained only in the unlikely event (i) Participant owns at least 1% of the Company and the value of the Shares acquired exceeds €150,000, or (ii) Participant holds Shares exceeding 10% of the total capital of the Company. Hong Kong Form of Settlement. RSUs granted to Participants resident in Hong Kong shall be paid in Shares only. Sale of Shares. Any Shares acquired under the Plan are accepted as a personal investment. In the event that the Award vests and Shares are issued to Participant (or Participant's heirs) within six months of the Date of Grant, Participant (or Participant's heirs) agrees that the Shares will not be offered to the public or otherwise disposed of prior to the six-month anniversary of the date of grant. Securities Law Notice. Warning: None of the documents related to the Plan have been reviewed by any regulatory authority in Hong Kong. If Participant is in any doubt about any of the contents of the Agreement, including this Appendix, the Plan, or any other communication materials, Participant should obtain independent professional advice. The RSUs and Shares issued at vesting do not constitute a public offering of securities under Hong Kong law and are available only to employees of the


 
23 Company and its Related Entities. The Agreement, including this Appendix, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong. The RSUs are intended only for the personal use of each eligible employee of the Employer, the Company or any Related Entity and may not be distributed to any other person. India Exchange Control Notice. Participant understands that the RSUs are subject to compliance with the exchange control requirements of the Reserve Bank of India. Participant understands that he or she must repatriate any proceeds from the sale of Shares and any dividends received acquired under the Plan within such period of time as required under applicable regulations. Participant must obtain a foreign inward remittance certificate (“FIRC”) from the bank where Participant deposits the funds and must maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or the Employer requests proof of repatriation. Participant may be required to provide information regarding funds received from participation in the Plan to the Company and/or the Employer to enable them to comply with their filing requirements under exchange control laws in India. Participant is personally responsible for complying with exchange control laws in India, and neither the Company nor the Employer will be liable for any fines or penalties resulting from Participant’s failure to comply with applicable laws. Foreign Asset/Account Reporting Notice. Indian residents are required to declare the following items in their annual tax return: (i) any foreign assets held by them (including Shares acquired under the Plan), and (ii) any foreign bank accounts for which they have signing authority. Indian residents should consult with their personal tax advisor to ensure that they are properly reporting foreign assets and bank accounts. Ireland Director Notification Requirement. If Participant is a director, shadow director, or secretary of an Irish subsidiary, pursuant to the Companies Act 2014, Participant must notify that subsidiary in writing if Participant receives or disposes of an interest exceeding 1% of the share capital of the Company (e.g., RSUs, Shares), if Participant becomes aware of the event giving rise to the notification requirement, or if Participant becomes a director or secretary if such an interest exceeding 1% of the share capital of the Company exists at the time. This notification requirement also applies with respect to the interests of a spouse, civil partner, or minor children (whose interests will be attributed to the director, shadow director, or secretary). Participant should consult his or her personal legal advisor to ensure compliance with the applicable requirements. Japan


 
24 Exchange Control Notice. Japanese residents acquiring Shares valued at more than ¥100,000,000 in a single transaction, must file a Securities Acquisition Report with the Ministry of Finance through the Bank of Japan within twenty (20) days of the acquisition of the Shares. Foreign Asset/Account Reporting Notice. Japanese residents are required to report details of any assets held outside of Japan as of December 31, including Shares acquired under the Plan, to the extent such assets have a total net fair market value exceeding ¥50,000,000. Such report will be due by March 15 each year. Japanese residents are responsible for complying with this reporting obligation. Korea Sale of Shares. Korean residents are not permitted to sell foreign securities (e.g., Shares) through non-Korean brokers or deposit funds resulting from the sale of Shares in an account with an overseas financial institution. If a Korean resident wishes to sell Shares acquired under the Plan, the Korean resident may be required to transfer the Shares to a domestic investment broker in Korea and to effect the sale through such broker. The Korean resident is solely responsible for engaging the domestic broker. Non-compliance with the requirement to sell Shares through a domestic broker can result in significant penalties. Because regulations may change without notice, Korean residents should consult with a legal advisor to ensure compliance with any regulations applicable to any aspect of participation in the Plan. Foreign Asset/Account Reporting Notice. Korean residents must declare all foreign financial accounts (i.e., non-Korean bank accounts, brokerage accounts, etc.) to the Korean tax authority and file a report with respect to such accounts if the value of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency). Korea residents should consult with their personal tax advisor for additional information about this reporting obligation. Exchange Control Notice. If a Korean resident sells Shares and deposits sale proceeds in excess of a certain threshold (currently, US$5,000 per transaction) into a non-Korean bank account, the Korean resident must file a report with a Korean foreign exchange bank. This reporting is not required if sale proceeds are instead deposited into a non-Korean brokerage account. Participant should consult their personal legal advisor to ensure compliance with the applicable requirements. Netherlands No country-specific provisions. Poland


 
25 Exchange Control Notice. Transfers of funds into and out of Poland in excess of €15,000 (or PLN 15,000 if such transfer of funds is connected with the business activity of an entrepreneur) must be made via a bank account held at a bank in Poland. Additionally, Polish residents are required to store all documents connected with any foreign exchange transactions that Polish residents are engaged in for a period of five years, as measured from the end of the year in which such transaction occurred. Foreign Asset/Account Reporting Notice. If Participant maintains bank or brokerage accounts holding cash and foreign securities (including Shares) outside of Poland, Participant will be required to report information to the National Bank of Poland on transactions and balances in such accounts if the value of such cash and securities exceeds certain thresholds. If required, such reports must be filed on special forms available on the website of the National Bank of Poland. Participant should consult with their personal legal advisor to determine whether Participant will be required to submit reports to the National Bank of Poland. Singapore Sale Restriction. Participant agrees that any Shares acquired pursuant to the RSUs will not be offered for sale in Singapore prior to the six-month anniversary of the Date of Grant unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA. Securities Law Notice. The grant of the RSUs is being made to Participant in reliance on the “Qualifying Person” exemption under section 273(1)(f) of the SFA under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying Shares being subsequently offered for sale to any other party. The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore, and hence, statutory liability under the SFA in relation to the content of prospectuses will not apply. Director Reporting Notice. If Participant is a director, associate director or shadow director of a Singapore Related Entity of the Company, as the terms are used in the Singapore Companies Act (the “SCA”), Participant agrees to comply with notification requirements under the SCA. Among these requirements is an obligation to notify the Singapore Related Entity in writing when Participant receives an interest (e.g., RSUs, Shares) in the Company or any related companies (including when Participant sells Shares acquired under the Plan). In addition, Participant must notify the Singapore Related Entity when Participant sells or receives Shares of the Company or any related company


 
26 (including when Participant sells or receives Shares acquired under the Plan). These notifications must be made within two (2) business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of Participant’s interests in the Company or any related company within two (2) business days of becoming a director, associate director or shadow director. Participant should consult with his or her personal legal advisor regarding his or her notification obligations under the SCA. Spain No Entitlement for Claims or Compensation. The following provisions supplement paragraphs 4 and 12 of the Agreement: By accepting the RSUs, Participant consents to participation in the Plan and acknowledges that Participant has received a copy of the Plan document. Participant understands and agrees that, as a condition of the grant of the RSUs, the termination of Participant’s status as a Service Provider for any reason (including for the reasons listed below) prior to the vesting date will automatically result in the loss of the unvested RSUs that may have been granted to Participant. In particular, Participant understands and agrees that any unvested RSUs shall be forfeited without entitlement to the underlying Shares or to any amount as indemnification in the event of a termination of status as a Service Provider, including, but not limited to: resignation, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a “despido improcedente”), individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause, material modification of the terms of employment under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Employer, and under Article 10.3 of Royal Decree 1382/1985. Participant understands that the Company has unilaterally, gratuitously and in its sole discretion decided to grant RSUs under the Plan to individuals who may be Employees, Directors or Consultants throughout the world. The decision is limited and entered into based upon the express assumption and condition that: (i) any RSU grant will not economically or otherwise bind the Company or any Related Entity, including the Employer, presently or in the future, other than as expressly set forth in the Agreement; (ii) the RSUs and any Shares acquired upon settlement of the RSUs are not part of any employment contract (whether with the Company or a Related Entity) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation), or any other right whatsoever; and (iii) unless otherwise expressly provided for by the Company in the Agreement or in this Appendix, your participation in the Plan will cease as of the date Participant’s employment is terminated.


 
27 Furthermore, Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from the grant of RSUs, which is gratuitous and discretionary, since the future value of the RSUs and the underlying Shares is unknown and unpredictable. Participant also understands that the grant of RSUs would not be made but for the assumptions and conditions set forth hereinabove; thus, Participant understands, acknowledges and freely accepts that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the RSUs and any right to the underlying Shares shall be null and void. Securities Law Notice. No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of RSUs. The Agreement, this Appendix and the Plan have not been registered with the Comisión Nacional del Mercado de Valores (Spanish Securities Exchange Commission) and do not constitute a public offering prospectus. Exchange Control Notice. Participant may be required to declare electronically to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), as well as any foreign instruments (including any Shares acquired under the Plan) held in such accounts if the value of the transactions for all such accounts during the prior year or the balances of such accounts as of December 31 of the prior year exceeds €1,000,000. Different thresholds and deadlines to file the declaration apply. However, if neither such transactions during the immediately preceding year nor the balances or positions as of December 31 exceed €1,000,000, no such declaration must be filed unless expressly required by the Bank of Spain. If any of such thresholds were exceeded during the current year, Participant understands that they may be required to file the relevant declaration corresponding to the prior year; however, a summarized form of declaration may be available. Participant should consult their personal legal advisor to ensure compliance with the applicable requirements. Foreign Asset/Account Reporting Notice. Spanish residents are required to report rights or assets deposited or held outside of Spain (including Shares acquired under the Plan or cash proceeds from the sale of such Shares) as of December 31 of each year, if the value of such rights or assets exceeds EUR 50,000 per type of right or asset. After such rights and/or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than EUR 20,000 per type of right or asset as of December 31 of each year, or if Participant sells Shares or cancel bank accounts that were previously reported. If reporting is required, the report must be filed on Form 720 by March 31 following the end of the relevant year. Sweden Tax Withholding Obligations. The following supplements paragraph 11 of the Agreement:


 
28 Without limiting the Company’s and the Employer’s authority to satisfy their withholding obligations for Tax-Related Items as set forth in paragraph 11 of the Agreement, by accepting the RSUs, Participant authorizes the Company and/or the Employer to withhold Shares or to sell Shares otherwise deliverable to Participant upon exercise to satisfy Tax-Related Items, regardless of whether the Company and/or the Employer have an obligation to withhold such Tax-Related Items. Taiwan Securities Law Notice. The offer of participation in the Plan is available only for Service Providers of the Company and Related Entities. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company. Data Privacy Acknowledgement. Participant hereby acknowledges that he or she has read and understood the terms regarding collection, processing and transfer of Data contained in paragraph 14 of the Agreement and by participating in the Plan, Participant agrees to such terms. In this regard, upon request of the Company or the Employer, Participant agrees to provide an executed data privacy consent form to the Employer or the Company (or any other agreements or consents that may be required by the Employer or the Company) that the Company and/or the Employer may deem necessary to obtain under the data privacy laws in Participant’s country, either now or in the future. Participant understands he or she will not be able to participate in the Plan if Participant fails to execute any such consent or agreement. Exchange Control Notice. Taiwanese residents may acquire and remit foreign currency (including proceeds from the sale of Shares or the receipt of any dividends paid on such Shares) into Taiwan up to US$10,000,000 per year. If the transaction amount is TWD 500,000 or more in a single transaction, residents must submit a Foreign Exchange Transaction Form and also provide supporting documentation to the satisfaction of the remitting bank. If the transaction amount is US$500,000 or more, Taiwanese residents may be required to provide additional supporting documentation to the satisfaction of the remitting bank. Taiwanese residents should consult their personal legal advisor to ensure compliance with applicable exchange control laws in Taiwan. Türkiye Securities Law Notice. Pursuant to Turkish securities law, selling shares acquired under the Plan is not permitted within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol “DLB” and the Shares may be sold through this exchange. Financial Intermediary Requirement Notice.


 
29 The purchase and sale of securities traded in foreign financial markets (e.g., the purchase and sale of Shares) are permitted. However, transactions in foreign securities must be conducted through the local banks and financial intermediary institutions licensed by the Turkish Capital Markets Board in accordance with relevant regulations and Central Bank communiqués. Participant acknowledges that Participant is solely responsible for engaging such Turkish financial intermediary. Participants should contact a personal legal advisor for further information regarding these requirements. United Arab Emirates (“UAE”) Securities Law Notice. The offer of participation in the Plan is available only for select employees of the Company and Related Entities and is in the nature of providing employee incentives in the UAE. The Agreement, this Appendix, the Plan and other incidental communication materials are intended for distribution only to Service Providers for the purposes of an employee compensation or reward scheme, and must not be delivered to, or relied on, by any other person. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the RSUs or the Agreement. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved the Agreement nor taken steps to verify the information set out in it, and have no responsibility for it. The securities to which the Agreement relates may be illiquid and/or subject to restrictions on their resale. Individuals should conduct their own due diligence on the securities. Residents of the UAE who do not understand or have questions regarding the Agreement, this Appendix or the Plan should consult an authorized financial adviser. United Kingdom Form of Settlement. RSUs granted to Service Providers resident in the United Kingdom shall be paid in Shares only. Joint Election. As a condition of the vesting of the RSUs under the Plan, Participant agrees to accept any liability for secondary Class 1 NICs (“Employer NICs”) which may be payable by the Company or the Employer with respect to the vesting of the RSUs or otherwise payable in connection with the RSUs and the issuance of Shares. Without prejudice to the foregoing, Participant agrees to execute a joint election with the Company and/or the Employer (the “Election”), the form of such Election being formally approved by HM Revenue and Customs (“HMRC”), and any other consent or elections required to accomplish the transfer of the Employer NICs to Participant. Participant further agrees to execute such other joint elections as may be required between Participant and any successor to the Company and/or the Employer. Participant agrees to enter into an Election prior


 
30 to the vesting of the RSUs. Participant further agrees that the Company and/or the Employer may collect the Employer NICs by any of the means set forth in paragraph 11 of the Agreement. Tax Withholding Obligations. The following supplements paragraph 11 of the Agreement: Without limitation to paragraph 11 of the Agreement, Participant agrees that he or she is liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by HMRC (or any other tax authority or any other relevant authority). Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on Participant’s behalf (or any other tax authority or any other relevant authority). If Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of the immediately foregoing provision will not apply. In the event that Participant is a director or executive officer and income tax due is not collected from or paid by Participant, the amount of any income tax due but not collected from or paid by Participant may constitute an additional benefit to Participant on which additional income tax and National Insurance Contributions (“NICs”) may be payable. Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company and/or the Employer the amount of any employee NICs due on this additional benefit, which the Company and/or the Employer may recover at any time thereafter by any of the means referred to in this Agreement.


 
1 DOLBY LABORATORIES, INC. 2026 INDUCEMENT STOCK PLAN NOTICE OF GRANT OF RESTRICTED STOCK UNITS Unless otherwise defined herein, the terms defined in the Dolby Laboratories, Inc. 2026 Inducement Stock Plan, as amended from time to time (the “Plan”) shall have the same defined meanings in this Notice of Grant of Restricted Stock Units (the “Notice of Grant”) and the Global Restricted Stock Unit Agreement attached hereto as Exhibit A (collectively, the “Restricted Stock Unit Agreement” or the “Agreement”), including any terms and conditions for participants outside the U.S. in the Appendix. Participant: %%FIRST_NAME_MIDDLE_NAME_LAST_NAME%-% You have been granted an award of Restricted Stock Units (the “Award”). Each such Restricted Stock Unit is equivalent to one share of the Company’s Class A Common Stock for purposes of determining the number of Shares subject to this Award. None of the Restricted Stock Units will be issued (nor will you have the rights of a stockholder with respect to the underlying Shares) until the vesting conditions described below are satisfied. Additional terms of this grant are as follows: Total Award Shares Granted: %%TOTAL_SHARES_GRANTED,'999,999,999'%-% Date of Grant: %%OPTION_DATE,'Month DD, YYYY'%-% Vesting Schedule: Subject to your continuing to be a Service Provider and other limitations set forth in the Plan and the Global Restricted Stock Unit Agreement and country-specific provisions for Non-U.S. participants as set forth in the Appendix to the Global Restricted Stock Unit Agreement, and subject to any acceleration provisions contained in any written agreement between you and the Company governing the terms of the Award (including, for the avoidance of doubt, the terms of the Employment Agreement between you and the Company dated July 10, 2026 (the “Employment Agreement”)), the Award will vest over two (2) years, with 25% of the Restricted Stock Units vesting on the six (6) month anniversary of the Date of Grant and an additional 25% of the Restricted Stock Units vesting on each six (6) month anniversary thereafter. To the extent the amount vesting would result in the vesting of fractional Shares, Shares will be rounded down to the nearest whole Share. You acknowledge and agree that the Agreement and the vesting schedule set forth herein do not constitute an express or implied promise of continued engagement as a Service Provider for the vesting period, for any period, or at all, and shall not interfere with your right or the right of the


 
2 Company or the Related Entity that is your employer to terminate your relationship as a Service Provider at any time, with or without cause. You hereby agree to accept as binding, conclusive, and final all decisions or interpretations of the Administrator upon any questions relating to the Plan, the Recoupment Policy (as defined in Exhibit A hereto) and this Agreement. By your electronic signature and the electronic signature of the Company’s representative, you and the Company agree that the Award is granted under and governed by the terms and conditions of the Plan, the Recoupment Policy and the Agreement. You have reviewed the Plan, the Recoupment Policy and the Agreement in their entirety, have had an opportunity to obtain the advice of counsel prior to executing the Agreement and fully understand all provisions of the Plan, the Recoupment Policy and the Agreement. You hereby agree to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan, the Recoupment Policy and the Agreement. You must execute and deliver or electronically accept the terms set forth in the Agreement, in the manner specified by the Administrator. The Administrator may, in its sole discretion, cancel the Award if you fail to execute and deliver or electronically accept the Agreement and related documents by the first scheduled vesting date.


 
3 EXHIBIT A DOLBY LABORATORIES, INC. 2026 INDUCEMENT STOCK PLAN GLOBAL RESTRICTED STOCK UNIT AGREEMENT 1. Grant. Dolby Laboratories, Inc. (the “Company”) hereby grants to the individual set forth in the Notice of Grant of Restricted Stock Units (“Participant”) an award of Restricted Stock Units (“RSUs”) pursuant to Section 8 of the Dolby Laboratories, Inc. 2026 Inducement Stock Plan, as set forth in the Notice of Grant of Restricted Stock Units (the “Notice of Grant”) and subject to the terms and conditions in this Global Restricted Stock Unit Agreement, including any special terms and conditions for participants outside the U.S. in the attached Appendix (collectively, the “Agreement”), and the Dolby Laboratories, Inc. 2026 Inducement Stock Plan as may be amended from time to time (the “Plan”). Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Agreement. 2. Company’s Obligation. Each RSU represents the right to receive a Share after satisfying the applicable vesting conditions set forth in the Notice of Grant. Unless and until the RSUs vest, Participant will have no right to receive Shares under such RSUs. Prior to actual distribution of any Shares pursuant to the vesting of any RSUs, such RSUs will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company. 3. Vesting Schedule. Subject to paragraph 4, and to relevant Plan provisions, the RSUs awarded by this Agreement will vest in Participant according to the vesting schedule specified in the Notice of Grant. 4. Forfeiture upon Termination of Service. Notwithstanding any contrary provision of this Agreement or the Notice of Grant and subject to any acceleration provisions contained in the Employment Agreement, if Participant ceases to be a Service Provider, for any or no reason prior to vesting, the unvested RSUs awarded by this Agreement will thereupon be forfeited at no cost to the Company. 5. Payment after Vesting. Any RSUs that vest in accordance with this Agreement will be paid to Participant (or in the event of Participant’s death, to his or her estate) in Shares. Payment upon vesting will be subject to Participant (or his or her estate) satisfying the applicable Tax- Related Items (defined below) withholding obligations set forth in paragraph 11. 6. Payments after Death. Any distribution or delivery to be made to Participant under this Agreement will, if Participant is then deceased, be made to the administrator or executor of Participant’s estate. Any such administrator or executor must furnish the Company with (a) written notice of his or her status as transferee, and (b) evidence satisfactory to the Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer.


 
4 7. Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in respect of any Shares deliverable hereunder unless and until Shares (in certificated or uncertificated form in the Company’s sole discretion) have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant or Participant’s broker. 8. No Guarantee of Continued Service. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF RSUS PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUED ENGAGEMENT AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR ANY RELATED ENTITY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE COMPANY (OR ANY RELATED ENTITY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. 9. Address for Notices. Any notice to be given to the Company under the terms of this Agreement will be addressed to the Company at 1275 Market Street, San Francisco, CA 94103, U.S.A., Attn: Stock Administration, or at such other address as the Company may hereafter designate in writing or electronically. 10. Code Section 409A. Notwithstanding anything in this Agreement to the contrary, if any Participant would be considered a “specified employee” within the meaning of Section 409A of the Code and the regulations thereunder at the time of such Participant’s ceases to be a Service Provider, the RSUs (and/or at the election of Participant the cash received from the sale of the Shares underlying the vested RSUs) will not be paid to Participant until the date that is six (6) months and one (1) day following the date of Participant’s ceases to be a Service Provider. 11. Withholding Taxes. Regardless of any action the Company or the Related Entity that is Participant’s employer (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding items related to Participant’s participation in the Plan and legally applicable to Participant, or deemed by the Company or the Employer to be an appropriate charge to Participant even if technically due by the Company or the Employer (“Tax- Related Items”), Participant hereby acknowledges that the ultimate liability for all Tax-Related Items is and remains Participant’s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the issuance of Shares in settlement of the RSUs, the


 
5 subsequent sale of Shares acquired at vesting and the receipt of any dividends and/or any dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the Award or any aspect of the RSUs to reduce or eliminate Participant’s liability for Tax-Related Items or achieve a particular tax result. Further, if Participant is subject to tax in more than one jurisdiction, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. In connection with any relevant taxable or tax withholding event, Participant shall pay or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax- Related Items. In this regard, Participant authorizes and directs the Company and/or the Employer or their respective agents, in their sole discretion and without any notice or authorization by Participant, to satisfy any applicable withholding obligations, if any, with regard to all Tax-Related Items by withholding in Shares to be issued upon settlement of the RSUs. In the event that such withholding in Shares is problematic under applicable tax or securities law or has materially adverse accounting consequences, by Participant’s acceptance of the RSUs, Participant authorizes the Company and any brokerage firm to satisfy the obligations with regard to all Tax-Related Items by withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or to sell on Participant’s behalf a whole number of Shares from those Shares issued to Participant as the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the obligation for Tax-Related Items. Depending upon the withholding method, the Company may withhold or account for Tax- Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates in Participant’s jurisdiction(s), including maximum applicable rates. If the Company and/or the Employer withhold more than the amount necessary to satisfy the liability for Tax-Related Items, Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent Shares or, if not refunded, Participant may be able to seek a refund from the applicable tax authorities. If the Company and/or the Employer withhold less than the amount necessary to satisfy the liability for Tax-Related Items, Participant may be required to pay additional Tax-Related Items directly to the applicable tax authorities or to the Company and/or the Employer. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of Participant’s participation in the Plan. No fractional Shares will be withheld or issued pursuant to the grant of RSUs and the issuance of Shares thereunder. Finally, Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described. Participant acknowledges and agrees that the Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if Participant fails to comply with Participant’s obligations in connection with the Tax-Related Items. Participant shall have no further rights with respect to any Shares that are retained by the Company pursuant to this provision, and under no circumstances will the Company be required to issue any fractional Shares.


 
6 12. Acknowledgements. In accepting the RSUs, Participant acknowledges, understands and agrees that: (a) Participant acknowledges receipt of a copy of the Plan (including any applicable appendixes or sub-plans thereunder) and represents that he or she is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof. Participant has reviewed the Plan (including any applicable appendixes or sub- plans thereunder), the Recoupment Policy and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Recoupment Policy or this Agreement. Participant further agrees to notify the Company upon any change in the residence address in the Notice of Grant; (b) the Company (and not the Employer) is granting the RSU. The Company will administer the Plan from outside Participant’s country of residence; (c) the Plan is established voluntarily by the Company, is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time; (d) the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past; (e) all decisions with respect to future awards of RSUs, if any, will be at the sole discretion of the Company; (f) Participant is voluntarily participating in the Plan; (g) the RSUs and the Shares subject to the RSUs, and the income and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which are outside the scope of Participant’s employment or service contract, if any; (h) unless otherwise agreed with the Company, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not granted as consideration for, or in connection with, the service Participant may provide as a director of a Related Entity; (i) the RSUs and the Shares subject to the RSUs, and the income and value of same, are not intended to replace any pension rights or compensation; (j) although provided by the Company, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not part of Participant’s normal or expected salary or compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, leave-related pay, pension, retirement or welfare benefits or any other similar payments and in no event should be considered as compensation for or relating in any way to past services for the Company, the Employer, or any other Related Entity;


 
7 (k) the RSU grant and Participant’s participation in the Plan will not be interpreted to form an employment contract or relationship with the Company or any Related Entity and the Company will not incur any liability of any kind to Participant as a result of any change or amendment, or any cancellation, of the Plan at any time; (l) the future value of the underlying Shares is unknown and cannot be predicted with certainty; (m) in the event of termination of Participant’s status as a Service Provider (whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid), Participant’s right to vest in the RSUs under the Plan, if any, will terminate effective as of the date that Participant is no longer actively employed and will not be extended by any notice period mandated under local law (e.g., active employment would not include a period of “garden leave” or similar period pursuant to local law); the Administrator shall have the exclusive discretion to determine when Participant is no longer actively employed for purposes of the Award (including whether Participant may still be considered actively employed while on an approved leave of absence); (n) unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits under the Plan, if any, do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; (o) the RSUs and the Shares subject to the RSUs are not part of Participant’s normal or expected compensation or salary for any purpose; (p) neither the Company, the Employer nor any other Related Entity shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement; and (q) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from termination of Participant’s status as a Service Provider by the Company or the Employer (for any reason whatsoever and whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid). 13. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares. Participant acknowledges and agrees that he or she should consult with his or her own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan 14. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as


 
8 described in this Agreement and any other RSU materials by and among, as applicable, the Employer, the Company, and its Related Entities for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan. Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, e-mail address, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency status, job title, any Shares or directorships held in the Company or any Related Entity, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), for the purpose of implementing, administering and managing the Plan. Participant understands that Data may be transferred to Morgan Stanley Smith Barney LLC and its affiliated company, E*TRADE Financial Corporate Services, Inc. (collectively, “E*TRADE”), or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company in the implementation, administration and management of the Plan. Participant understands that the recipients may be located in the United States, or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws and protections than Participant’s country. Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting Participant’s local human resources representative. Participant authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing Participant’s participation in the Plan, including any transfer of such Data, as may be required for the administration of the Plan and/or the subsequent holding of Shares on Participant’s behalf, to a broker or third party with whom the Shares acquired on exercise may be deposited. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan. Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case, without cost, by contacting in writing Participant’s local human resources representative, or if there is no local human resources representative, the human resources department of the Company. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, his or her employment status or service with the Employer will not be affected; the only consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant RSUs or other equity awards or administer or maintain such awards. Participant understands, however, that refusal or withdrawal of consent may affect Participant’s ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative, or if there is no local human resources representative, the human resources department of the Company.


 
9 15. Grant is Not Transferable. Except to the limited extent provided in paragraph 6, this grant and the rights and privileges conferred hereby will not be transferred, assigned, pledged, or hypothecated in any way (whether by operation of law or otherwise) and will not be subject to sale under execution, attachment, or similar process. Upon any attempt to transfer, assign, pledge, hypothecate, or otherwise dispose of this grant, or any right or privilege conferred hereby, or upon any attempted sale under any execution, attachment, or similar process, this grant and the rights and privileges conferred hereby immediately will become null and void. 16. Binding Agreement. Subject to the limitation on the transferability of this grant contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors, and assigns of the parties hereto. 17. Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its discretion, that the listing, registration, or qualification of the Shares upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Participant (or his or her estate), such issuance will not occur unless and until such listing, registration, qualification, consent, or approval will have been effected or obtained free of any conditions not acceptable to the Company. The Company will make all reasonable efforts to meet the requirements of any such state or federal law or securities exchange and to obtain any such consent or approval of any such governmental authority. 18. Plan Governs. This Agreement and the Notice of Grant are subject to all terms and provisions of the Plan. In the event of a conflict between one or more provisions of this Agreement or the Notice of Grant and one or more provisions of the Plan, the provisions of the Plan will govern. 19. Governing Law and Venue. The Award will be governed by the internal substantive laws, but not the choice of law rules, of the State of California, U.S.A. without regard to principles of conflict of laws. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by the Award or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of San Francisco County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed. 20. Language. Participant has received the terms and conditions of this Agreement and any other related communications in English. Participant acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of this RSU Agreement, or, alternatively, Participant acknowledges that he or she will seek appropriate assistance. Furthermore, if Participant consents to having received these documents in English. If Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control, unless otherwise required by applicable laws. 21. Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic


 
10 means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. By Participant’s electronic signature and the electronic signature of the Company’s representative, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan and this Agreement. 22. Administrator Authority. The Administrator will have the power to interpret the Plan, the Recoupment Policy and this Agreement and to adopt such rules for the administration, interpretation, and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any RSUs have vested and whether Participant is actively employed). All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company, and all other interested persons. No member of the Administrator will be personally liable for any action, determination, or interpretation made in good faith with respect to the Plan, the Recoupment Policy or this Agreement. 23. Severability. The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable. 24. Appendix. Notwithstanding any provisions in this Agreement, the Award shall be subject to any terms and conditions set forth in any Appendix to this Agreement for Participant’s country. Moreover, if Participant relocates to one of the countries included in the Appendix, the terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable under Applicable Laws with regard to the issuance or sale of Shares or facilitate the administration of the Plan. The Appendix constitutes part of this Agreement. 25. Imposition of Other Requirements. The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable under Applicable Laws with regard to the issuance or sale of Shares or to facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. 26. Insider Trading/Market Abuse Restrictions. Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect Participant’s ability to, directly or indirectly, accept, acquire, sell, attempt to sell or otherwise dispose of Shares, rights to Shares (e.g., RSUs), or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as Participant is considered to have “inside information” regarding the Company as defined by the laws or regulations in the applicable jurisdiction or Participant’s country. Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed insider information. Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are


 
11 separate from and in addition to any restrictions that may be imposed under the Company’s Insider Trading Policy. Participant is responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter. 27. Exchange Control, Tax and/or Foreign Asset/Account Reporting. Participant acknowledges that there may be exchange control, tax, foreign asset and/or account reporting requirements which may affect Participant’s ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends paid on Shares acquired under the Plan) in a brokerage, bank account or legal entity outside Participant’s country. Participant may be required to report such accounts, assets or transactions to the tax or other authorities in Participant’s country. Participant also may be required to repatriate sale proceeds or other funds received as a result of participation in the Plan to Participant’s country through a designated bank or broker within a certain time after receipt. Participant acknowledges that it is his or her responsibility to be compliant with such regulations, and should consult his or her personal legal advisor for any details. 28. Waiver. Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Participant or any other participant. 29. Reduction, Cancellation, Forfeiture or Recoupment. This Award, any Shares issued in payment for vested RSUs pursuant to this Award and any other rights, payments and benefits with respect to this Award shall be subject to reduction, cancellation, forfeiture or recoupment pursuant to (i) the Company’s Policy on Recoupment of Incentive Compensation (the “Recoupment Policy”), (ii) any other recovery, recoupment, “clawback” or similar policy adopted by the Company after the Date of Grant, and (iii) as required for the Participant or the Company to comply with any requirements imposed under applicable laws and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, in each case for clauses (i), (ii) and (iii), as may be amended from time to time (with the provisions contained in such policies and the relevant provisions of such laws, rules and regulations deemed incorporated into this Agreement without the Participant’s additional or separate consent). For purposes of the foregoing, the Participant expressly and explicitly authorizes the Company to issue instructions, on the Participant’s behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to the Award to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company upon the Company’s enforcement of this paragraph 29.


 
12 APPENDIX TO DOLBY LABORATORIES, INC. 2026 INDUCEMENT STOCK PLAN GLOBAL RESTRICTED STOCK UNIT AGREEMENT Terms and Conditions for Participants Outside the U.S. This Appendix includes additional country-specific terms and conditions that apply to Participants resident in countries listed below. This Appendix is part of the Agreement and contains terms and conditions material to participation in the Plan. Unless otherwise provided below, capitalized terms used but not defined herein shall have the same meanings assigned to them in the Plan and the Agreement. The information is based on the securities, exchange control, income tax and other laws in effect in the respective countries as of October 2025. Such laws are often complex and change frequently. As a result, the Company strongly recommends that Participant not rely on the information in this Appendix as the only source of information relating to the consequences of Participant’s participation in the Plan because the information may be out of date when Participant vests in the RSUs or Shares acquired under the Plan are sold. In addition, the information contained herein is general in nature and may not apply to Participant’s particular situation, and the Company is not in a position to assure Participant of a particular result. Accordingly, Participant should seek appropriate professional advice as to how the relevant laws in Participant’s country may apply to his or her situation. Finally, if Participant is a citizen or resident of a country other than the one in which he or she is currently working or Participant transfers employment or residency after the Date of Grant, or if Participant is considered resident of another country for local law purposes, then the provisions contained herein may not be applicable to Participant. The Company shall, in its sole discretion, determine to what extent the terms and conditions included herein will apply under these circumstances. Countries Within the European Economic Area and the United Kingdom Data Privacy: The Dolby Employee Privacy Notice supersedes and replaces paragraph 14 of the Agreement. The Dolby Employee Privacy Notice for each respective country in the European Union and European Economic Area can be found at [OMITTED] Australia Securities Law Notice. The grant of the RSUs is being made pursuant to Division 1A, Part 7.12 of the Corporations Act 2001 (Cth). If Participant acquires Shares under the Plan and offers such Shares for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under


 
13 Australian law. Participant should obtain legal advice on disclosure obligations prior to making any such offer. Tax Notice. The Plan is a plan to which subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act). Exchange Control Notice. Exchange control reporting is required for cash transactions exceeding AUD 10,000 and for international fund transfers. Participant understands that if an Australian bank is assisting with the transaction, the bank will file the report on Participant’s behalf. Participant understands that if there is no Australian bank involved in the transfer, Participant will have to file the exchange control report on his or her own behalf. Belgium Foreign Asset/Account Reporting Information. Belgian residents are required to report any Shares acquired under the Plan or bank account established outside of Belgium on their personal annual tax return. In a separate report, Belgian residents also are required to provide a central contact point of the National Bank of Belgium with the account number of those foreign bank accounts, the name of the bank with which the accounts were opened and the country in which they were opened in a separate report. This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under the Kredietcentrales / Centrales des credits caption. Stock Exchange Tax Information. A stock exchange tax applies to transactions executed by Belgian residents through a non- Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the Plan are sold. Annual Securities Account Tax. An annual securities accounts tax may be payable if the total average value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. Brazil Compliance with Law.


 
14 By accepting the RSUs, Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with Participant’s participation in the Plan, including the vesting of the RSUs, the receipt of any dividends, and the sale of Shares acquired under the Plan. Nature of Award Grants. By accepting the RSUs, Participant agrees that (1) he or she is making an investment decision, (2) the Shares will be issued to Participant only if the vesting conditions are met and any necessary services are rendered by Participant over the vesting period and (3) the value of the underlying Shares is not fixed and may increase or decrease in value over time without compensation to Participant. Exchange Control Notice. Individuals who are resident or domiciled in Brazil are generally required to submit an annual declaration of assets and rights held outside Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is greater than US$1,000,000. If such amount is equal to or greater than US$100,000,000, the referenced declaration must be submitted quarterly, in the month following the end of each quarter. Assets and rights to be included in this annual declaration include Shares acquired under the Plan. Tax on Financial Transaction (IOF). Payments to foreign countries and repatriation of funds into Brazil and the conversion between BRL and US$ associated with such fund transfers may be subject to the Tax on Financial Transactions. It is Participant’s responsibility to comply with any applicable Tax on Financial Transactions arising from Participant’s participation in the Plan. Participant should consult with his or her personal tax advisor for additional details. Canada Form of Settlement. RSUs granted to employees resident in Canada shall be paid in Shares only. Acknowledgments. The following provision replaces Section 12(c) of the Agreement: except as explicitly and minimally required under applicable legislation, no Related Entity (including, but not limited to, the Employer) has any obligation to make any payment of any kind under this Agreement; The following provision replaces Section 12(h) of the Agreement: except as explicitly and minimally required under applicable legislation, the RSUs and the


 
15 Shares subject to the RSUs, and the income and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which are outside the scope of Participant’s employment or service contract, if any; The following provision replaces Section 12(r) of the Agreement: except as explicitly and minimally required under applicable legislation, no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from termination of Participant’s status as a Service Provider by the Company or the Employer (for any reason whatsoever and whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid). Termination of Service Provider Relationship. The following provision replaces paragraph 12(n) of the Agreement: For purposes of the Award, except as explicitly and minimally required under applicable legislation: (i) Participant’s period of service for purposes of the Award and Participant’s status as an eligible Service Provider will cease; and (ii) Participant’s right, if any, to vest in any RSUs under the Plan, seek damages in lieu, or otherwise benefit from or participate in the Plan will be measured by and immediately terminate, as of the date Participant ceases to provide services to the Company or a Related Entity, regardless of the reason for termination and whether or not later to be found invalid or in breach of applicable laws in the jurisdiction where Participant is employed or providing services or the terms of Participant’s employment or service agreement, if any (the “Termination Date”). Except to the extent explicitly and minimally required under applicable legislation, the Termination Date shall exclude any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under statute, contract, common/civil law or otherwise. Participant shall not earn or be entitled to any pro-rated vesting or other participation for that portion of time before the Termination Date, nor shall Participant be entitled to any compensation for lost vesting or other participation. If, notwithstanding the foregoing, applicable employment legislation explicitly requires continued entitlement to vesting or other participation during a statutory notice period, Participant’s right to vest in the RSUs or otherwise participate in or benefit from the Plan, if any, shall terminate effective as of the last date of the minimum statutory notice period. For clarity, Participant shall not earn or be entitled to pro-rated vesting or other participation if the vesting date falls after the end of Participant’s statutory notice period, nor shall Participant be entitled to any compensation for lost vesting. Any reference to termination as a Service Provider or cessation or termination of employment or service in this Agreement or the Plan shall be interpreted to mean the Termination Date as defined above.


 
16 Subject to applicable legislation, the Administrator shall have the exclusive discretion to determine when Participant is no longer actively employed or providing services for purposes of the Award (including whether Participant may still be considered actively providing services while on an approved leave of absence). Sale of Shares. Participant acknowledges that he or she is permitted to sell the Shares acquired under the Plan through E*TRADE or such other broker as may be selected by the Company in the future, provided the sale of the Shares takes place outside of Canada through facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange. French Language Documents for Quebec Service Providers. A French translation of the Agreement and the Plan will be made available to Participant as soon as reasonably practicable. Notwithstanding anything to the contrary in the Agreement, and unless Participant indicates otherwise, the French translation of the Agreement and the Plan will govern Participant’s participation in the Plan. Une traduction française de l’Accord et du Plan sera mise à la disposition du Participant dès que raisonnablement possible. Nonobstant toute disposition contraire de l’Accord, et sauf indication contraire du Participant, la traduction française de l’Accord et du Plan régira la participation du Participant au Plan. Authorization to Release and Transfer Necessary Personal Information for Quebec Service Providers. The following provision supplements paragraph 14 of the Agreement: Participant hereby authorizes the Company and the Company’s representatives, including the broker(s) designated by the Company, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. Participant further authorizes the Company, any Related Entity and the Administrator of the Plan to disclose and discuss the Plan with their advisors. Participant further authorizes the Company and any Related Entity to record such information and to keep such information in Participant’s employee file. Participant acknowledges and agrees that Participant’s personal information, including any sensitive personal information, may be transferred or disclosed outside the province of Quebec, including to the U.S. If applicable, Participant also acknowledges and authorizes the Company, any Related Entity, the Administrator and any third party brokers/administrators that are assisting the Company with the operation and administration of the Plan to use technology for profiling purposes and to make automated decisions that may have an impact on Participant or the administration of the Plan. Foreign Asset/Account Reporting Notice.


 
17 Canadian residents may be required to report foreign specified property on Form T1135 (Foreign Income Verification Statement) if the total cost of the foreign specified property exceeds CAD 100,000 at any time in the year. Foreign specified property includes Shares acquired under the Plan and may include RSUs. The RSUs must be reported - generally at a nil cost - if the CAD 100,000 cost threshold is exceeded because of other foreign specified property Participant holds. The cost of RSUs generally is the adjusted cost base (“ACB”) of the Shares. The ACB ordinarily would equal the fair market value of the Shares at the time of acquisition, but if the Canadian resident owns other Shares of the Company, this ACB may have to be leveraged with the ACB of the other Shares. The Form T1135 generally must be filed by April 30 of the following year. Canadian residents should consult with a personal advisor to ensure compliance with the applicable reporting requirements. China Settlement of RSUs and Sale of Shares. The following provision supplements paragraph 5 of the Agreement: Due to local regulatory requirements, Participant agrees that the Company may force the sale of any Shares to be issued upon settlement of the Award. The sale may occur (i) immediately upon vesting, (ii) following Participant’s termination as a Service Provider, or (iii) or within any other time frame as the Company determines to be necessary or advisable for legal or administrative reasons. Participant agrees that he or she must maintain any Shares acquired under the Plan in an account maintained by E*TRADE or such other stock plan service provider as may be selected by the Company. Participant further agrees that the Company is authorized to instruct E*TRADE or such other stock plan service provider as may be selected by the Company in the future to assist with the mandatory sale of such Shares (on Participant’s behalf pursuant to this authorization) and Participant expressly authorizes E*TRADE or such other stock plan service provider as may be selected by the Company in the future to complete the sale of such Shares. Participant acknowledges that E*TRADE or such other stock plan service provider as may be selected by the Company in the future is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the Company agrees to pay Participant the cash proceeds from the sale of the Shares, less any brokerage fees or commissions and subject to any obligation to satisfy Tax-Related Items. Exchange Control Acknowledgement. Participant understands and agrees that participation in the Plan is subject to the Company or the Employer obtaining any required approval from the China State Administration of Foreign Exchange (“SAFE”), as determined by the Company in its sole and absolute discretion. If the Company or the Employer is unable to obtain such approval, Participant may not be entitled to receive any benefit in connection with the Plan without any liability to the Company, the Employer or any Related Entity.


 
18 Participant understands and agrees that, pursuant to local exchange control requirements, Participant will be required to repatriate the cash proceeds from the sale of Shares issued upon the vesting of the RSUs as well as any cash dividends paid on such Shares to China. Participant further understands that, under local law, such repatriation of the cash proceeds may need to be effectuated through a special exchange control account established by the Company, or one of its Related Entities, and Participant hereby consents and agrees that any proceeds from the sale of any Shares issued upon the vesting of the RSUs as well as any cash dividends paid on such Shares may be transferred to such special account prior to being delivered to Participant. If the proceeds from the sale of Participant’s Shares or cash dividends are converted to local currency, Participant acknowledges that the Company is under no obligation to secure any exchange conversion rate, and the Company may face delays in converting the proceeds to local currency due to exchange control restrictions in China. Participant agrees to bear the risk of any exchange conversion rate fluctuation between the date the RSUs vest and the date of conversion of the proceeds from the sale of the Shares issued upon vesting to local currency. Participant further agrees to comply with any other requirements that may be imposed by the Company in the future in order to facilitate compliance with exchange control requirements in China. Foreign Asset/Account Reporting Notice. Chinese residents are required to report to the SAFE all details of his or her foreign financial assets and liabilities, as well as details of any economic transactions conducted with non- Chinese residents, either directly or through financial institutions. France Consent to Receive Information in English. By accepting the grant of the RSUs, Participant confirms having read and understood the Plan and the Agreement, which were provided in English language. Participant accepts the terms of those documents accordingly. En acceptant cette attribution gratuite d’actions, le Participant confirme avoir lu et compris le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont été transmis en langue anglaise. Le Participant accepte les dispositions de ces documents en connaissance de cause. Foreign Asset/Account Reporting Notice. French residents must report annually any shares and bank accounts held outside France, including the accounts that were opened, used and/or closed during the tax year, to the French tax authorities, on an annual basis on a special Form N° 3916, together with Participant’s personal income tax return. Failure to report triggers a significant penalty. Exchange Control Information.


 
19 The value of any cash or securities imported to or exported from France without the use of a financial institution must be reported to the customs and excise authorities when the value of such cash or securities is equal to or greater than a certain amount (currently €10,000). Germany Exchange Control Notice. Cross-border payments (including proceeds realized upon the sale of Shares or from the receipt of any dividends paid on such Shares) and certain other transactions with a value in excess of €50,000 must be reported to the German Federal Bank (Bundesbank). In addition, Participant may be required to report (i) the acquisition of Shares, and (ii) the withholding or the sale of Shares to cover withholding obligations or rights for Tax-Related Items, in either case if the value of the Shares exceeds €50,000. The report must be filed either electronically using the “General Statistics Reporting Portal” (“Allgemeines Meldeportal Statistik”) available via the Bundesbank’s website (www.bundesbank.de) or via such other method (e.g., by email or telephone) as is permitted or required by the Bundesbank. The report must be submitted monthly or within such timing as is permitted or required by the Bundesbank. Participant should consult with their personal tax advisor for details regarding this requirement. Foreign Asset/Account Reporting Information. German residents holding Shares must notify their local tax office if the acquisition of Shares under the Plan leads to a so-called qualified participation at any point during the calendar year. A qualified participation is attained only in the unlikely event (i) Participant owns at least 1% of the Company and the value of the Shares acquired exceeds €150,000, or (ii) Participant holds Shares exceeding 10% of the total capital of the Company. Hong Kong Form of Settlement. RSUs granted to Participants resident in Hong Kong shall be paid in Shares only. Sale of Shares. Any Shares acquired under the Plan are accepted as a personal investment. In the event that the Award vests and Shares are issued to Participant (or Participant's heirs) within six months of the Date of Grant, Participant (or Participant's heirs) agrees that the Shares will not be offered to the public or otherwise disposed of prior to the six-month anniversary of the date of grant. Securities Law Notice. Warning: None of the documents related to the Plan have been reviewed by any regulatory authority in Hong Kong. If Participant is in any doubt about any of the contents of the Agreement, including this Appendix, the Plan, or any other communication materials, Participant should obtain independent professional advice. The RSUs and Shares issued at vesting do not constitute a public offering of securities under Hong Kong law and are available only to employees of the


 
20 Company and its Related Entities. The Agreement, including this Appendix, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong. The RSUs are intended only for the personal use of each eligible employee of the Employer, the Company or any Related Entity and may not be distributed to any other person. India Exchange Control Notice. Participant understands that the RSUs are subject to compliance with the exchange control requirements of the Reserve Bank of India. Participant understands that he or she must repatriate any proceeds from the sale of Shares and any dividends received acquired under the Plan within such period of time as required under applicable regulations. Participant must obtain a foreign inward remittance certificate (“FIRC”) from the bank where Participant deposits the funds and must maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or the Employer requests proof of repatriation. Participant may be required to provide information regarding funds received from participation in the Plan to the Company and/or the Employer to enable them to comply with their filing requirements under exchange control laws in India. Participant is personally responsible for complying with exchange control laws in India, and neither the Company nor the Employer will be liable for any fines or penalties resulting from Participant’s failure to comply with applicable laws. Foreign Asset/Account Reporting Notice. Indian residents are required to declare the following items in their annual tax return: (i) any foreign assets held by them (including Shares acquired under the Plan), and (ii) any foreign bank accounts for which they have signing authority. Indian residents should consult with their personal tax advisor to ensure that they are properly reporting foreign assets and bank accounts. Ireland Director Notification Requirement. If Participant is a director, shadow director, or secretary of an Irish subsidiary, pursuant to the Companies Act 2014, Participant must notify that subsidiary in writing if Participant receives or disposes of an interest exceeding 1% of the share capital of the Company (e.g., RSUs, Shares), if Participant becomes aware of the event giving rise to the notification requirement, or if Participant becomes a director or secretary if such an interest exceeding 1% of the share capital of the Company exists at the time. This notification requirement also applies with respect to the interests of a spouse, civil partner, or minor children (whose interests will be attributed to the director, shadow director, or secretary). Participant should consult his or her personal legal advisor to ensure compliance with the applicable requirements. Japan


 
21 Exchange Control Notice. Japanese residents acquiring Shares valued at more than ¥100,000,000 in a single transaction, must file a Securities Acquisition Report with the Ministry of Finance through the Bank of Japan within twenty (20) days of the acquisition of the Shares. Foreign Asset/Account Reporting Notice. Japanese residents are required to report details of any assets held outside of Japan as of December 31, including Shares acquired under the Plan, to the extent such assets have a total net fair market value exceeding ¥50,000,000. Such report will be due by March 15 each year. Japanese residents are responsible for complying with this reporting obligation. Korea Sale of Shares. Korean residents are not permitted to sell foreign securities (e.g., Shares) through non-Korean brokers or deposit funds resulting from the sale of Shares in an account with an overseas financial institution. If a Korean resident wishes to sell Shares acquired under the Plan, the Korean resident may be required to transfer the Shares to a domestic investment broker in Korea and to effect the sale through such broker. The Korean resident is solely responsible for engaging the domestic broker. Non-compliance with the requirement to sell Shares through a domestic broker can result in significant penalties. Because regulations may change without notice, Korean residents should consult with a legal advisor to ensure compliance with any regulations applicable to any aspect of participation in the Plan. Foreign Asset/Account Reporting Notice. Korean residents must declare all foreign financial accounts (i.e., non-Korean bank accounts, brokerage accounts, etc.) to the Korean tax authority and file a report with respect to such accounts if the value of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency). Korea residents should consult with their personal tax advisor for additional information about this reporting obligation. Exchange Control Notice. If a Korean resident sells Shares and deposits sale proceeds in excess of a certain threshold (currently, US$5,000 per transaction) into a non-Korean bank account, the Korean resident must file a report with a Korean foreign exchange bank. This reporting is not required if sale proceeds are instead deposited into a non-Korean brokerage account. Participant should consult their personal legal advisor to ensure compliance with the applicable requirements. Netherlands No country-specific provisions. Poland


 
22 Exchange Control Notice. Transfers of funds into and out of Poland in excess of €15,000 (or PLN 15,000 if such transfer of funds is connected with the business activity of an entrepreneur) must be made via a bank account held at a bank in Poland. Additionally, Polish residents are required to store all documents connected with any foreign exchange transactions that Polish residents are engaged in for a period of five years, as measured from the end of the year in which such transaction occurred. Foreign Asset/Account Reporting Notice. If Participant maintains bank or brokerage accounts holding cash and foreign securities (including Shares) outside of Poland, Participant will be required to report information to the National Bank of Poland on transactions and balances in such accounts if the value of such cash and securities exceeds certain thresholds. If required, such reports must be filed on special forms available on the website of the National Bank of Poland. Participant should consult with their personal legal advisor to determine whether Participant will be required to submit reports to the National Bank of Poland. Singapore Sale Restriction. Participant agrees that any Shares acquired pursuant to the RSUs will not be offered for sale in Singapore prior to the six-month anniversary of the Date of Grant unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA. Securities Law Notice. The grant of the RSUs is being made to Participant in reliance on the “Qualifying Person” exemption under section 273(1)(f) of the SFA under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying Shares being subsequently offered for sale to any other party. The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore, and hence, statutory liability under the SFA in relation to the content of prospectuses will not apply. Director Reporting Notice. If Participant is a director, associate director or shadow director of a Singapore Related Entity of the Company, as the terms are used in the Singapore Companies Act (the “SCA”), Participant agrees to comply with notification requirements under the SCA. Among these requirements is an obligation to notify the Singapore Related Entity in writing when Participant receives an interest (e.g., RSUs, Shares) in the Company or any related companies (including when Participant sells Shares acquired under the Plan). In addition, Participant must notify the Singapore Related Entity when Participant sells or receives Shares of the Company or any related company


 
23 (including when Participant sells or receives Shares acquired under the Plan). These notifications must be made within two (2) business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of Participant’s interests in the Company or any related company within two (2) business days of becoming a director, associate director or shadow director. Participant should consult with his or her personal legal advisor regarding his or her notification obligations under the SCA. Spain No Entitlement for Claims or Compensation. The following provisions supplement paragraphs 4 and 12 of the Agreement: By accepting the RSUs, Participant consents to participation in the Plan and acknowledges that Participant has received a copy of the Plan document. Participant understands and agrees that, as a condition of the grant of the RSUs, the termination of Participant’s status as a Service Provider for any reason (including for the reasons listed below) prior to the vesting date will automatically result in the loss of the unvested RSUs that may have been granted to Participant. In particular, Participant understands and agrees that any unvested RSUs shall be forfeited without entitlement to the underlying Shares or to any amount as indemnification in the event of a termination of status as a Service Provider, including, but not limited to: resignation, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a “despido improcedente”), individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause, material modification of the terms of employment under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Employer, and under Article 10.3 of Royal Decree 1382/1985. Participant understands that the Company has unilaterally, gratuitously and in its sole discretion decided to grant RSUs under the Plan to individuals who may be Employees, Directors or Consultants throughout the world. The decision is limited and entered into based upon the express assumption and condition that: (i) any RSU grant will not economically or otherwise bind the Company or any Related Entity, including the Employer, presently or in the future, other than as expressly set forth in the Agreement; (ii) the RSUs and any Shares acquired upon settlement of the RSUs are not part of any employment contract (whether with the Company or a Related Entity) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation), or any other right whatsoever; and (iii) unless otherwise expressly provided for by the Company in the Agreement or in this Appendix, your participation in the Plan will cease as of the date Participant’s employment is terminated.


 
24 Furthermore, Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from the grant of RSUs, which is gratuitous and discretionary, since the future value of the RSUs and the underlying Shares is unknown and unpredictable. Participant also understands that the grant of RSUs would not be made but for the assumptions and conditions set forth hereinabove; thus, Participant understands, acknowledges and freely accepts that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the RSUs and any right to the underlying Shares shall be null and void. Securities Law Notice. No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of RSUs. The Agreement, this Appendix and the Plan have not been registered with the Comisión Nacional del Mercado de Valores (Spanish Securities Exchange Commission) and do not constitute a public offering prospectus. Exchange Control Notice. Participant may be required to declare electronically to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), as well as any foreign instruments (including any Shares acquired under the Plan) held in such accounts if the value of the transactions for all such accounts during the prior year or the balances of such accounts as of December 31 of the prior year exceeds €1,000,000. Different thresholds and deadlines to file the declaration apply. However, if neither such transactions during the immediately preceding year nor the balances or positions as of December 31 exceed €1,000,000, no such declaration must be filed unless expressly required by the Bank of Spain. If any of such thresholds were exceeded during the current year, Participant understands that they may be required to file the relevant declaration corresponding to the prior year; however, a summarized form of declaration may be available. Participant should consult their personal legal advisor to ensure compliance with the applicable requirements. Foreign Asset/Account Reporting Notice. Spanish residents are required to report rights or assets deposited or held outside of Spain (including Shares acquired under the Plan or cash proceeds from the sale of such Shares) as of December 31 of each year, if the value of such rights or assets exceeds EUR 50,000 per type of right or asset. After such rights and/or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than EUR 20,000 per type of right or asset as of December 31 of each year, or if Participant sells Shares or cancel bank accounts that were previously reported. If reporting is required, the report must be filed on Form 720 by March 31 following the end of the relevant year. Sweden Tax Withholding Obligations. The following supplements paragraph 11 of the Agreement:


 
25 Without limiting the Company’s and the Employer’s authority to satisfy their withholding obligations for Tax-Related Items as set forth in paragraph 11 of the Agreement, by accepting the RSUs, Participant authorizes the Company and/or the Employer to withhold Shares or to sell Shares otherwise deliverable to Participant upon exercise to satisfy Tax-Related Items, regardless of whether the Company and/or the Employer have an obligation to withhold such Tax-Related Items. Taiwan Securities Law Notice. The offer of participation in the Plan is available only for Service Providers of the Company and Related Entities. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company. Data Privacy Acknowledgement. Participant hereby acknowledges that he or she has read and understood the terms regarding collection, processing and transfer of Data contained in paragraph 14 of the Agreement and by participating in the Plan, Participant agrees to such terms. In this regard, upon request of the Company or the Employer, Participant agrees to provide an executed data privacy consent form to the Employer or the Company (or any other agreements or consents that may be required by the Employer or the Company) that the Company and/or the Employer may deem necessary to obtain under the data privacy laws in Participant’s country, either now or in the future. Participant understands he or she will not be able to participate in the Plan if Participant fails to execute any such consent or agreement. Exchange Control Notice. Taiwanese residents may acquire and remit foreign currency (including proceeds from the sale of Shares or the receipt of any dividends paid on such Shares) into Taiwan up to US$10,000,000 per year. If the transaction amount is TWD 500,000 or more in a single transaction, residents must submit a Foreign Exchange Transaction Form and also provide supporting documentation to the satisfaction of the remitting bank. If the transaction amount is US$500,000 or more, Taiwanese residents may be required to provide additional supporting documentation to the satisfaction of the remitting bank. Taiwanese residents should consult their personal legal advisor to ensure compliance with applicable exchange control laws in Taiwan. Türkiye Securities Law Notice. Pursuant to Turkish securities law, selling shares acquired under the Plan is not permitted within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol “DLB” and the Shares may be sold through this exchange. Financial Intermediary Requirement Notice.


 
26 The purchase and sale of securities traded in foreign financial markets (e.g., the purchase and sale of Shares) are permitted. However, transactions in foreign securities must be conducted through the local banks and financial intermediary institutions licensed by the Turkish Capital Markets Board in accordance with relevant regulations and Central Bank communiqués. Participant acknowledges that Participant is solely responsible for engaging such Turkish financial intermediary. Participants should contact a personal legal advisor for further information regarding these requirements. United Arab Emirates (“UAE”) Securities Law Notice. The offer of participation in the Plan is available only for select employees of the Company and Related Entities and is in the nature of providing employee incentives in the UAE. The Agreement, this Appendix, the Plan and other incidental communication materials are intended for distribution only to Service Providers for the purposes of an employee compensation or reward scheme, and must not be delivered to, or relied on, by any other person. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the RSUs or the Agreement. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved the Agreement nor taken steps to verify the information set out in it, and have no responsibility for it. The securities to which the Agreement relates may be illiquid and/or subject to restrictions on their resale. Individuals should conduct their own due diligence on the securities. Residents of the UAE who do not understand or have questions regarding the Agreement, this Appendix or the Plan should consult an authorized financial adviser. United Kingdom Form of Settlement. RSUs granted to Service Providers resident in the United Kingdom shall be paid in Shares only. Joint Election. As a condition of the vesting of the RSUs under the Plan, Participant agrees to accept any liability for secondary Class 1 NICs (“Employer NICs”) which may be payable by the Company or the Employer with respect to the vesting of the RSUs or otherwise payable in connection with the RSUs and the issuance of Shares. Without prejudice to the foregoing, Participant agrees to execute a joint election with the Company and/or the Employer (the “Election”), the form of such Election being formally approved by HM Revenue and Customs (“HMRC”), and any other consent or elections required to accomplish the transfer of the Employer NICs to Participant. Participant further agrees to execute such other joint elections as may be required between Participant and any successor to the Company and/or the Employer. Participant agrees to enter into an Election prior


 
27 to the vesting of the RSUs. Participant further agrees that the Company and/or the Employer may collect the Employer NICs by any of the means set forth in paragraph 11 of the Agreement. Tax Withholding Obligations. The following supplements paragraph 11 of the Agreement: Without limitation to paragraph 11 of the Agreement, Participant agrees that he or she is liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by HMRC (or any other tax authority or any other relevant authority). Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on Participant’s behalf (or any other tax authority or any other relevant authority). If Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of the immediately foregoing provision will not apply. In the event that Participant is a director or executive officer and income tax due is not collected from or paid by Participant, the amount of any income tax due but not collected from or paid by Participant may constitute an additional benefit to Participant on which additional income tax and National Insurance Contributions (“NICs”) may be payable. Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company and/or the Employer the amount of any employee NICs due on this additional benefit, which the Company and/or the Employer may recover at any time thereafter by any of the means referred to in this Agreement.


 
1 DOLBY LABORATORIES, INC. 2020 STOCK PLAN NOTICE OF GRANT OF RESTRICTED STOCK UNITS Unless otherwise defined herein, the terms defined in the Dolby Laboratories, Inc. 2020 Stock Plan, as amended from time to time (the “Plan”) shall have the same defined meanings in this Notice of Grant of Restricted Stock Units (the “Notice of Grant”) and the Global Restricted Stock Unit Agreement attached hereto as Exhibit A (collectively, the “Restricted Stock Unit Agreement” or the “Agreement”), including any terms and conditions for participants outside the U.S. in the Appendix. Participant: %%FIRST_NAME_MIDDLE_NAME_LAST_NAME%-% You have been granted an award of Restricted Stock Units (the “Award”). Each such Restricted Stock Unit is equivalent to one share of the Company’s Class A Common Stock for purposes of determining the number of Shares subject to this Award. None of the Restricted Stock Units will be issued (nor will you have the rights of a stockholder with respect to the underlying Shares) until the vesting conditions described below are satisfied. Additional terms of this grant are as follows: Total Award Shares Granted: %%TOTAL_SHARES_GRANTED,'999,999,999'%-% Date of Grant: September 15, 2026 Vesting Schedule: Subject to your continuing to be a Service Provider and other limitations set forth in the Plan and the Global Restricted Stock Unit Agreement and country-specific provisions for Non-U.S. participants as set forth in the Appendix to the Global Restricted Stock Unit Agreement, and subject to the acceleration provisions contained herein, 100% of the Restricted Stock Units subject to the Award will vest on the two (2) year anniversary of the Date of Grant. Notwithstanding the foregoing, if your employment is terminated either (i) by Dolby Laboratories, Inc., a California corporation (“DLI CA”) other than for Cause (as defined herein), death, or Disability, or (ii) by you for Good Reason (as defined herein) (such termination, a “Qualified Termination”), then subject to you signing and not revoking DLI CA’s then-standard separation agreement and release of claims (the “Release” and such requirement, the “Release Requirement”), which must become effective and irrevocable no later than the sixtieth (60th) day following your Qualified Termination (the “Release Deadline”), 100% of the Restricted Stock Units subject to the Award will fully vest. If the Release does not become effective and irrevocable by the Release Deadline, you will forfeit any right to the vesting acceleration described in this Agreement.


 
2 For purposes of this Agreement, “Cause” means any of the following: (i) your willful, material and continued failure to perform the duties and responsibilities of your position (other than as a result of your illness or injury) after there has been delivered to you a written demand for performance from the Company’s Chief Executive Officer (“CEO”) or the Board which describes the basis for the CEO’s or the Board’s belief that you have not substantially performed your duties and provides you with thirty (30) days to take corrective action, and within such period the applicable corrective actions have not been taken; (ii) any willful and material act of personal dishonesty taken by you in connection with your responsibilities as an employee of DLI CA with the intention that such action may result in your substantial personal enrichment; (iii) your conviction of, or plea of guilty or nolo contendere to, a felony that the Board in good faith believes has or will have a material detrimental effect on the Company’s or DLI CA’s financial condition or reputation; (iv) a willful breach of any fiduciary duty owed to the Company or DLI CA by you that has a material detrimental effect on the Company’s financial condition or reputation or of your Confidential Information and Invention Assignment Agreement or any other improper disclosure of confidential or proprietary information of the Company or DLI CA; (v) you being found liable in any Securities and Exchange Commission or other civil or criminal securities law action (regardless of whether or not you admit or deny liability), which the Board in good faith determines will have a material detrimental effect on the Company’s financial condition or reputation; (vi) you entering into any cease and desist order with respect to any action which would bar you from service as an executive officer or member of a board of directors of any publicly-traded company (regardless of whether or not you admit or deny liability); (vii) you (A) obstructing or impeding; (B) endeavoring to obstruct or impede, or (C) failing to materially cooperate with, any investigation authorized by the Board or any governmental or self-regulatory entity (an “Investigation”), provided that your failure to waive attorney-client privilege relating to communications with your own attorney in connection with an Investigation will not constitute “Cause”; (viii) your material breach of the Company’s Code of Business Conduct and Ethics, Insider Trading Policy, and any other written Company or DLI CA policy applicable to you that has been made available to you prior to such breach; (ix) your failure (other than as a result of your illness or injury) to follow a written directive of the CEO or the Board after there has been delivered to you a written demand for performance from the CEO or the Board which describes the basis for the CEO’s or the Board’s belief that you have not followed such written directive and provides you with thirty (30) days to take corrective action, and within such period the applicable corrective actions have not been taken; or (x) your disqualification or bar by any governmental or self-regulatory authority from serving in the capacity contemplated by your then current role with the Company or DLI CA, if (A) the disqualification or bar continues for more than thirty (30) days, and (B) during that period, the Company or DLI CA uses its commercially reasonable efforts to cause the disqualification or bar to be lifted. While any disqualification or bar continues during your employment, you will serve in the capacity contemplated by your then current role with DLI CA to whatever extent legally permissible and, if your employment is not permissible, you will be placed on administrative leave (which will be paid to the extent legally permissible). You shall receive notice and an opportunity to be heard before the Board with your own attorney before any termination for Cause is deemed effective. Notwithstanding anything to the contrary, the Board may immediately place you on administrative leave (with full pay and benefits to the extent legally permissible) and suspend all access to information of the Company or DLI CA, employees and business should you wish to avail themself of your opportunity to be heard before the Board prior to a termination for Cause. If you avail


 
3 yourself of your opportunity to be heard before the Board, and then fail to make yourself available to the Board within five (5) business days of such request to be heard, the Board may thereafter cancel the administrative leave and terminate you for Cause. For purposes of this Agreement, “Good Reason” means your resignation of employment following the expiration of any Company cure period (discussed below) following the occurrence of any of the following, without your express written consent: (i) the assignment to or removal from your duties or responsibilities that results in a material reduction of your duties, authority, title, or scope of responsibilities; (ii) a material reduction in your base salary or target annual incentive as in effect immediately prior to such reduction (other than pursuant to a reduction that also is applied to substantially all other executive officers of the Company and which reduction reduces the base salary and/or target annual incentive by a percentage reduction that is no greater than 10%); (iii) a material change in the geographic location of your primary work facility or location; provided, that a relocation of fifty (50) miles or less from your then present work location or to your home as your primary work location will not be considered a material change in geographic location; or (iv) the material breach by the Company of this Agreement. The notification and placement of you on administrative leave of not more than sixty (60) calendar days pending a potential determination by the Board that you may be terminated for Cause shall not constitute Good Reason for purposes of this Agreement. You will not resign for Good Reason without first providing the Company with written notice of the acts or omissions constituting the grounds for “Good Reason” within ninety (90) days of the initial existence of the grounds for “Good Reason” and, if such grounds are susceptible to cure, a reasonable cure period of up to thirty (30) days following the date of such notice. Any resignation for Good Reason must occur within one (1) year of the initial existence of the grounds constituting Good Reason. You acknowledge and agree that the Agreement and the vesting schedule set forth herein do not constitute an express or implied promise of continued engagement as a Service Provider for the vesting period, for any period, or at all, and shall not interfere with your right or the right of the Company or the Related Entity that is your employer to terminate your relationship as a Service Provider at any time, with or without cause. You hereby agree to accept as binding, conclusive, and final all decisions or interpretations of the Administrator upon any questions relating to the Plan, the Recoupment Policy (as defined in Exhibit A hereto) and this Agreement. By your electronic signature and the electronic signature of the Company’s representative, you and the Company agree that the Award is granted under and governed by the terms and conditions of the Plan, the Recoupment Policy and the Agreement. You have reviewed the Plan, the Recoupment Policy and the Agreement in their entirety, have had an opportunity to obtain the advice of counsel prior to executing the Agreement and fully understand all provisions of the Plan, the Recoupment Policy and the Agreement. You hereby agree to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and the Recoupment Policy and Agreement. You must execute and deliver or electronically accept the terms set forth in the Agreement, in the manner specified by the Administrator. The Administrator may, in its sole discretion,


 
4 cancel the Award if you fail to execute and deliver or electronically accept the Agreement and related documents by the first scheduled vesting date.


 
5 EXHIBIT A DOLBY LABORATORIES, INC. 2020 STOCK PLAN GLOBAL RESTRICTED STOCK UNIT AGREEMENT 1. Grant. Dolby Laboratories, Inc. (the “Company”) hereby grants to the individual set forth in the Notice of Grant of Restricted Stock Units (“Participant”) an award of Restricted Stock Units (“RSUs”) pursuant to Section 8 of the Dolby Laboratories, Inc. 2020 Stock Plan, as set forth in the Notice of Grant of Restricted Stock Units (the “Notice of Grant”) and subject to the terms and conditions in this Global Restricted Stock Unit Agreement, including any special terms and conditions for participants outside the U.S. in the attached Appendix (collectively, the “Agreement”), and the Dolby Laboratories, Inc. 2020 Stock Plan as may be amended from time to time (the “Plan”). Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Agreement. 2. Company’s Obligation. Each RSU represents the right to receive a Share after satisfying the applicable vesting conditions set forth in the Notice of Grant. Unless and until the RSUs vest, Participant will have no right to receive Shares under such RSUs. Prior to actual distribution of any Shares pursuant to the vesting of any RSUs, such RSUs will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company. 3. Vesting Schedule. Subject to paragraph 4, and to relevant Plan provisions, the RSUs awarded by this Agreement will vest in Participant according to the vesting schedule specified in the Notice of Grant. 4. Forfeiture upon Termination of Service. Except as otherwise set forth in this Agreement or the Notice of Grant, if Participant ceases to be a Service Provider, for any or no reason prior to vesting, the unvested RSUs awarded by this Agreement will thereupon be forfeited at no cost to the Company. 5. Payment after Vesting. Any RSUs that vest in accordance with this Agreement will be paid to Participant (or in the event of Participant’s death, to his or her estate) in Shares. Payment upon vesting will be subject to Participant (or his or her estate) satisfying the applicable Tax- Related Items (defined below) withholding obligations set forth in paragraph 11. 6. Payments after Death. Any distribution or delivery to be made to Participant under this Agreement will, if Participant is then deceased, be made to the administrator or executor of Participant’s estate. Any such administrator or executor must furnish the Company with (a) written notice of his or her status as transferee, and (b) evidence satisfactory to the Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer. 7. Rights as Stockholder. Neither Participant nor any person claiming under or through Participant will have any of the rights or privileges of a stockholder of the Company in


 
6 respect of any Shares deliverable hereunder unless and until Shares (in certificated or uncertificated form in the Company’s sole discretion) have been issued, recorded on the records of the Company or its transfer agents or registrars, and delivered to Participant or Participant’s broker. 8. No Guarantee of Continued Service. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF RSUS PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUED ENGAGEMENT AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR ANY RELATED ENTITY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND WILL NOT INTERFERE IN ANY WAY WITH PARTICIPANT’S RIGHT OR THE RIGHT OF THE COMPANY (OR ANY RELATED ENTITY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. 9. Address for Notices. Any notice to be given to the Company under the terms of this Agreement will be addressed to the Company at 1275 Market Street, San Francisco, CA 94103, U.S.A., Attn: Stock Administration, or at such other address as the Company may hereafter designate in writing or electronically. 10. Code Section 409A. Notwithstanding anything in this Agreement to the contrary, if any Participant would be considered a “specified employee” within the meaning of Section 409A of the Code and the regulations thereunder at the time of such Participant’s ceases to be a Service Provider, the RSUs (and/or at the election of Participant the cash received from the sale of the Shares underlying the vested RSUs) will not be paid to Participant until the date that is six (6) months and one (1) day following the date of Participant’s ceases to be a Service Provider. 11. Withholding Taxes. Regardless of any action the Company or the Related Entity that is Participant’s employer (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding items related to Participant’s participation in the Plan and legally applicable to Participant, or deemed by the Company or the Employer to be an appropriate charge to Participant even if technically due by the Company or the Employer (“Tax- Related Items”), Participant hereby acknowledges that the ultimate liability for all Tax-Related Items is and remains Participant’s responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including, but not limited to, the grant, vesting or settlement of the RSUs, the issuance of Shares in settlement of the RSUs, the subsequent sale of Shares acquired at vesting and the receipt of any dividends and/or any dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the


 
7 Award or any aspect of the RSUs to reduce or eliminate Participant’s liability for Tax-Related Items or achieve a particular tax result. Further, if Participant is subject to tax in more than one jurisdiction, Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction. In connection with any relevant taxable or tax withholding event, Participant shall pay or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy all Tax- Related Items. In this regard, Participant authorizes and directs the Company and/or the Employer or their respective agents, in their sole discretion and without any notice or authorization by Participant, to satisfy any applicable withholding obligations, if any, with regard to all Tax-Related Items by withholding in Shares to be issued upon settlement of the RSUs. In the event that such withholding in Shares is problematic under applicable tax or securities law or has materially adverse accounting consequences, by Participant’s acceptance of the RSUs, Participant authorizes the Company and any brokerage firm to satisfy the obligations with regard to all Tax-Related Items by withholding from Participant’s wages or other cash compensation paid to Participant by the Company and/or the Employer; or to sell on Participant’s behalf a whole number of Shares from those Shares issued to Participant as the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the obligation for Tax-Related Items. Depending upon the withholding method, the Company may withhold or account for Tax- Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates in Participant’s jurisdiction(s), including maximum applicable rates. If the Company and/or the Employer withhold more than the amount necessary to satisfy the liability for Tax-Related Items, Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent Shares or, if not refunded, Participant may be able to seek a refund from the applicable tax authorities. If the Company and/or the Employer withhold less than the amount necessary to satisfy the liability for Tax-Related Items, Participant may be required to pay additional Tax-Related Items directly to the applicable tax authorities or to the Company and/or the Employer. If the obligation for Tax-Related Items is satisfied by withholding in Shares, for tax purposes Participant is deemed to have been issued the full number of Shares subject to the vested RSUs, notwithstanding that a number of the Shares is held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of Participant’s participation in the Plan. No fractional Shares will be withheld or issued pursuant to the grant of RSUs and the issuance of Shares thereunder. Finally, Participant shall pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant’s participation in the Plan that cannot be satisfied by the means previously described. Participant acknowledges and agrees that the Company may refuse to issue or deliver the Shares or the proceeds of the sale of Shares, if Participant fails to comply with Participant’s obligations in connection with the Tax-Related Items. Participant shall have no further rights with respect to any Shares that are retained by the Company pursuant to this provision, and under no circumstances will the Company be required to issue any fractional Shares. 12. Acknowledgements. In accepting the RSUs, Participant acknowledges, understands and agrees that:


 
8 (a) Participant acknowledges receipt of a copy of the Plan (including any applicable appendixes or sub-plans thereunder) and represents that he or she is familiar with the terms and provisions thereof, and hereby accepts this Agreement subject to all of the terms and provisions thereof. Participant has reviewed the Plan (including any applicable appendixes or sub- plans thereunder), the Recoupment Policy and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, the Recoupment Policy or this Agreement. Participant further agrees to notify the Company upon any change in the residence address in the Notice of Grant; (b) the Company (and not the Employer) is granting the RSU. The Company will administer the Plan from outside Participant’s country of residence; (c) the Plan is established voluntarily by the Company, is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time; (d) the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past; (e) all decisions with respect to future awards of RSUs, if any, will be at the sole discretion of the Company; (f) Participant is voluntarily participating in the Plan; (g) the RSUs and the Shares subject to the RSUs, and the income and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which are outside the scope of Participant’s employment or service contract, if any; (h) unless otherwise agreed with the Company, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not granted as consideration for, or in connection with, the service Participant may provide as a director of a Related Entity; (i) the RSUs and the Shares subject to the RSUs, and the income and value of same, are not intended to replace any pension rights or compensation; (j) although provided by the Company, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not part of Participant’s normal or expected salary or compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end of service payments, bonuses, holiday pay, long-service awards, leave-related pay, pension, retirement or welfare benefits or any other similar payments and in no event should be considered as compensation for or relating in any way to past services for the Company, the Employer, or any other Related Entity; (k) the RSU grant and Participant’s participation in the Plan will not be interpreted to form an employment contract or relationship with the Company or any Related


 
9 Entity and the Company will not incur any liability of any kind to Participant as a result of any change or amendment, or any cancellation, of the Plan at any time; (l) the future value of the underlying Shares is unknown and cannot be predicted with certainty; (m) in the event of termination of Participant’s status as a Service Provider (whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid), Participant’s right to vest in the RSUs under the Plan, if any, will terminate effective as of the date that Participant is no longer actively employed and will not be extended by any notice period mandated under local law (e.g., active employment would not include a period of “garden leave” or similar period pursuant to local law); the Administrator shall have the exclusive discretion to determine when Participant is no longer actively employed for purposes of the Award (including whether Participant may still be considered actively employed while on an approved leave of absence); (n) unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits under the Plan, if any, do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; (o) the RSUs and the Shares subject to the RSUs are not part of Participant’s normal or expected compensation or salary for any purpose; (p) neither the Company, the Employer nor any other Related Entity shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the United States Dollar that may affect the value of the RSUs or of any amounts due to Participant pursuant to the settlement of the RSUs or the subsequent sale of any Shares acquired upon settlement; and (q) no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from termination of Participant’s status as a Service Provider by the Company or the Employer (for any reason whatsoever and whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid). 13. No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Participant’s participation in the Plan, or Participant’s acquisition or sale of the underlying Shares. Participant acknowledges and agrees that he or she should consult with his or her own personal tax, legal and financial advisors regarding Participant’s participation in the Plan before taking any action related to the Plan 14. Data Privacy. Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of Participant’s personal data as described in this Agreement and any other RSU materials by and among, as applicable, the


 
10 Employer, the Company, and its Related Entities for the exclusive purpose of implementing, administering and managing Participant’s participation in the Plan. Participant understands that the Company and the Employer may hold certain personal information about Participant, including, but not limited to, Participant’s name, home address and telephone number, e-mail address, date of birth, social insurance number, passport number or other identification number, salary, nationality, residency status, job title, any Shares or directorships held in the Company or any Related Entity, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), for the purpose of implementing, administering and managing the Plan. Participant understands that Data may be transferred to Morgan Stanley Smith Barney LLC and its affiliated company, E*TRADE Financial Corporate Services, Inc. (collectively, “E*TRADE”), or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company in the implementation, administration and management of the Plan. Participant understands that the recipients may be located in the United States, or elsewhere, and that the recipient’s country (e.g., the United States) may have different data privacy laws and protections than Participant’s country. Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting Participant’s local human resources representative. Participant authorizes the Company, E*TRADE and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing Participant’s participation in the Plan, including any transfer of such Data, as may be required for the administration of the Plan and/or the subsequent holding of Shares on Participant’s behalf, to a broker or third party with whom the Shares acquired on exercise may be deposited. Participant understands that Data will be held only as long as is necessary to implement, administer and manage Participant’s participation in the Plan. Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case, without cost, by contacting in writing Participant’s local human resources representative, or if there is no local human resources representative, the human resources department of the Company. Further, Participant understands that he or she is providing the consents herein on a purely voluntary basis. If Participant does not consent, or if Participant later seeks to revoke his or her consent, his or her employment status or service with the Employer will not be affected; the only consequence of refusing or withdrawing Participant’s consent is that the Company would not be able to grant Participant RSUs or other equity awards or administer or maintain such awards. Participant understands, however, that refusal or withdrawal of consent may affect Participant’s ability to participate in the Plan. For more information on the consequences of Participant’s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative, or if there is no local human resources representative, the human resources department of the Company.


 
11 15. Grant is Not Transferable. Except to the limited extent provided in paragraph 6, this grant and the rights and privileges conferred hereby will not be transferred, assigned, pledged, or hypothecated in any way (whether by operation of law or otherwise) and will not be subject to sale under execution, attachment, or similar process. Upon any attempt to transfer, assign, pledge, hypothecate, or otherwise dispose of this grant, or any right or privilege conferred hereby, or upon any attempted sale under any execution, attachment, or similar process, this grant and the rights and privileges conferred hereby immediately will become null and void. 16. Binding Agreement. Subject to the limitation on the transferability of this grant contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors, and assigns of the parties hereto. 17. Additional Conditions to Issuance of Stock. If at any time the Company will determine, in its discretion, that the listing, registration, or qualification of the Shares upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory authority is necessary or desirable as a condition to the issuance of Shares to Participant (or his or her estate), such issuance will not occur unless and until such listing, registration, qualification, consent, or approval will have been effected or obtained free of any conditions not acceptable to the Company. The Company will make all reasonable efforts to meet the requirements of any such state or federal law or securities exchange and to obtain any such consent or approval of any such governmental authority. 18. Plan Governs. This Agreement and the Notice of Grant are subject to all terms and provisions of the Plan. In the event of a conflict between one or more provisions of this Agreement or the Notice of Grant and one or more provisions of the Plan, the provisions of the Plan will govern. 19. Governing Law and Venue. The Award will be governed by the internal substantive laws, but not the choice of law rules, of the State of California, U.S.A. without regard to principles of conflict of laws. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by the Award or this Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of San Francisco County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed. 20. Language. Participant has received the terms and conditions of this Agreement and any other related communications in English. Participant acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of this RSU Agreement, or, alternatively, Participant acknowledges that he or she will seek appropriate assistance. Furthermore, if Participant consents to having received these documents in English. If Participant has received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control, unless otherwise required by applicable laws. 21. Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic


 
12 means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company. By Participant’s electronic signature and the electronic signature of the Company’s representative, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan and this Agreement. 22. Administrator Authority. The Administrator will have the power to interpret the Plan, the Recoupment Policy and this Agreement and to adopt such rules for the administration, interpretation, and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any RSUs have vested and whether Participant is actively employed). All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company, and all other interested persons. No member of the Administrator will be personally liable for any action, determination, or interpretation made in good faith with respect to the Plan, the Recoupment Policy or this Agreement. 23. Severability. The provisions of this Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable. 24. Appendix. Notwithstanding any provisions in this Agreement, the Award shall be subject to any terms and conditions set forth in any Appendix to this Agreement for Participant’s country. Moreover, if Participant relocates to one of the countries included in the Appendix, the terms and conditions for such country will apply to Participant, to the extent the Company determines that the application of such terms and conditions is necessary or advisable under Applicable Laws with regard to the issuance or sale of Shares or facilitate the administration of the Plan. The Appendix constitutes part of this Agreement. 25. Imposition of Other Requirements. The Company reserves the right to impose other requirements on Participant’s participation in the Plan, on the Award and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable under Applicable Laws with regard to the issuance or sale of Shares or to facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. 26. Insider Trading/Market Abuse Restrictions. Participant may be subject to insider trading restrictions and/or market abuse laws, which may affect Participant’s ability to, directly or indirectly, accept, acquire, sell, attempt to sell or otherwise dispose of Shares, rights to Shares (e.g., RSUs), or rights linked to the value of Shares (e.g., phantom awards, futures) during such times as Participant is considered to have “inside information” regarding the Company as defined by the laws or regulations in the applicable jurisdiction or Participant’s country. Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed insider information. Furthermore, Participant could be prohibited from (i) disclosing the inside information to any third party (other than on a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. Third parties include fellow employees. Any restrictions under these laws or regulations are


 
13 separate from and in addition to any restrictions that may be imposed under the Company’s Insider Trading Policy. Participant is responsible for ensuring compliance with any applicable restrictions and should consult his or her personal legal advisor on this matter. 27. Exchange Control, Tax and/or Foreign Asset/Account Reporting. Participant acknowledges that there may be exchange control, tax, foreign asset and/or account reporting requirements which may affect Participant’s ability to acquire or hold Shares acquired under the Plan or cash received from participating in the Plan (including from any dividends paid on Shares acquired under the Plan) in a brokerage, bank account or legal entity outside Participant’s country. Participant may be required to report such accounts, assets or transactions to the tax or other authorities in Participant’s country. Participant also may be required to repatriate sale proceeds or other funds received as a result of participation in the Plan to Participant’s country through a designated bank or broker within a certain time after receipt. Participant acknowledges that it is his or her responsibility to be compliant with such regulations, and should consult his or her personal legal advisor for any details. 28. Waiver. Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Participant or any other participant. 29. Reduction, Cancellation, Forfeiture or Recoupment. This Award, any Shares issued in payment for vested RSUs pursuant to this Award and any other rights, payments and benefits with respect to this Award shall be subject to reduction, cancellation, forfeiture or recoupment pursuant to (i) the Company’s Policy on Recoupment of Incentive Compensation (the “Recoupment Policy”), (ii) any other recovery, recoupment, “clawback” or similar policy adopted by the Company after the Date of Grant, and (iii) as required for the Participant or the Company to comply with any requirements imposed under applicable laws and/or the rules and regulations of the securities exchange or inter-dealer quotation system on which the Shares are listed or quoted, in each case for clauses (i), (ii) and (iii), as may be amended from time to time (with the provisions contained in such policies and the relevant provisions of such laws, rules and regulations deemed incorporated into this Agreement without the Participant’s additional or separate consent). For purposes of the foregoing, the Participant expressly and explicitly authorizes the Company to issue instructions, on the Participant’s behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold any Shares and other amounts acquired pursuant to the Award to re-convey, transfer or otherwise return such Shares and/or other amounts to the Company upon the Company’s enforcement of this paragraph 29.


 
14 APPENDIX TO DOLBY LABORATORIES, INC. 2020 STOCK PLAN GLOBAL RESTRICTED STOCK UNIT AGREEMENT Terms and Conditions for Participants Outside the U.S. This Appendix includes additional country-specific terms and conditions that apply to Participants resident in countries listed below. This Appendix is part of the Agreement and contains terms and conditions material to participation in the Plan. Unless otherwise provided below, capitalized terms used but not defined herein shall have the same meanings assigned to them in the Plan and the Agreement. The information is based on the securities, exchange control, income tax and other laws in effect in the respective countries as of October 2025. Such laws are often complex and change frequently. As a result, the Company strongly recommends that Participant not rely on the information in this Appendix as the only source of information relating to the consequences of Participant’s participation in the Plan because the information may be out of date when Participant vests in the RSUs or Shares acquired under the Plan are sold. In addition, the information contained herein is general in nature and may not apply to Participant’s particular situation, and the Company is not in a position to assure Participant of a particular result. Accordingly, Participant should seek appropriate professional advice as to how the relevant laws in Participant’s country may apply to his or her situation. Finally, if Participant is a citizen or resident of a country other than the one in which he or she is currently working or Participant transfers employment or residency after the Date of Grant, or if Participant is considered resident of another country for local law purposes, then the provisions contained herein may not be applicable to Participant. The Company shall, in its sole discretion, determine to what extent the terms and conditions included herein will apply under these circumstances. Countries Within the European Economic Area and the United Kingdom Data Privacy: The Dolby Employee Privacy Notice supersedes and replaces paragraph 14 of the Agreement. The Dolby Employee Privacy Notice for each respective country in the European Union and European Economic Area can be found at [OMITTED] Australia Securities Law Notice. The grant of the RSUs is being made pursuant to Division 1A, Part 7.12 of the Corporations Act 2001 (Cth). If Participant acquires Shares under the Plan and offers such Shares for sale to a person or entity resident in Australia, the offer may be subject to disclosure requirements under


 
15 Australian law. Participant should obtain legal advice on disclosure obligations prior to making any such offer. Tax Notice. The Plan is a plan to which subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to conditions in the Act). Exchange Control Notice. Exchange control reporting is required for cash transactions exceeding AUD 10,000 and for international fund transfers. Participant understands that if an Australian bank is assisting with the transaction, the bank will file the report on Participant’s behalf. Participant understands that if there is no Australian bank involved in the transfer, Participant will have to file the exchange control report on his or her own behalf. Belgium Foreign Asset/Account Reporting Information. Belgian residents are required to report any Shares acquired under the Plan or bank account established outside of Belgium on their personal annual tax return. In a separate report, Belgian residents also are required to provide a central contact point of the National Bank of Belgium with the account number of those foreign bank accounts, the name of the bank with which the accounts were opened and the country in which they were opened in a separate report. This report, as well as additional information on how to complete it, can be found on the website of the National Bank of Belgium, www.nbb.be, under the Kredietcentrales / Centrales des credits caption. Stock Exchange Tax Information. A stock exchange tax applies to transactions executed by Belgian residents through a non- Belgian financial intermediary, such as a U.S. broker. The stock exchange tax will apply when Shares acquired pursuant to the Plan are sold. Annual Securities Account Tax. An annual securities accounts tax may be payable if the total average value of securities held in a Belgian or foreign securities account (e.g., Shares acquired under the Plan) exceeds a certain threshold on four reference dates within the relevant reporting period (i.e., December 31, March 31, June 30 and September 30). In such case, the tax will be due on the value of the qualifying securities held in such account. Brazil Compliance with Law.


 
16 By accepting the RSUs, Participant acknowledges that he or she agrees to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with Participant’s participation in the Plan, including the vesting of the RSUs, the receipt of any dividends, and the sale of Shares acquired under the Plan. Nature of Award Grants. By accepting the RSUs, Participant agrees that (1) he or she is making an investment decision, (2) the Shares will be issued to Participant only if the vesting conditions are met and any necessary services are rendered by Participant over the vesting period and (3) the value of the underlying Shares is not fixed and may increase or decrease in value over time without compensation to Participant. Exchange Control Notice. Individuals who are resident or domiciled in Brazil are generally required to submit an annual declaration of assets and rights held outside Brazil to the Central Bank of Brazil if the aggregate value of such assets and rights is greater than US$1,000,000. If such amount is equal to or greater than US$100,000,000, the referenced declaration must be submitted quarterly, in the month following the end of each quarter. Assets and rights to be included in this annual declaration include Shares acquired under the Plan. Tax on Financial Transaction (IOF). Payments to foreign countries and repatriation of funds into Brazil and the conversion between BRL and US$ associated with such fund transfers may be subject to the Tax on Financial Transactions. It is Participant’s responsibility to comply with any applicable Tax on Financial Transactions arising from Participant’s participation in the Plan. Participant should consult with his or her personal tax advisor for additional details. Canada Form of Settlement. RSUs granted to employees resident in Canada shall be paid in Shares only. Acknowledgments. The following provision replaces Section 12(c) of the Agreement: except as explicitly and minimally required under applicable legislation, no Related Entity (including, but not limited to, the Employer) has any obligation to make any payment of any kind under this Agreement; The following provision replaces Section 12(h) of the Agreement: except as explicitly and minimally required under applicable legislation, the RSUs and the


 
17 Shares subject to the RSUs, and the income and value of same, are extraordinary items that do not constitute compensation of any kind for services of any kind rendered to the Company or the Employer, and which are outside the scope of Participant’s employment or service contract, if any; The following provision replaces Section 12(r) of the Agreement: except as explicitly and minimally required under applicable legislation, no claim or entitlement to compensation or damages shall arise from forfeiture of the RSUs or recoupment of any Shares acquired under the Plan resulting from termination of Participant’s status as a Service Provider by the Company or the Employer (for any reason whatsoever and whether or not in breach of any employment laws in the country where Participant resides, even if otherwise applicable to Participant’s employment benefits from the Employer, and/or whether later found to be invalid). Termination of Service Provider Relationship. The following provision replaces paragraph 12(n) of the Agreement: For purposes of the Award, except as explicitly and minimally required under applicable legislation: (i) Participant’s period of service for purposes of the Award and Participant’s status as an eligible Service Provider will cease; and (ii) Participant’s right, if any, to vest in any RSUs under the Plan, seek damages in lieu, or otherwise benefit from or participate in the Plan will be measured by and immediately terminate, as of the date Participant ceases to provide services to the Company or a Related Entity, regardless of the reason for termination and whether or not later to be found invalid or in breach of applicable laws in the jurisdiction where Participant is employed or providing services or the terms of Participant’s employment or service agreement, if any (the “Termination Date”). Except to the extent explicitly and minimally required under applicable legislation, the Termination Date shall exclude any period during which notice, pay in lieu of notice or related payments or damages are provided or required to be provided under statute, contract, common/civil law or otherwise. Participant shall not earn or be entitled to any pro-rated vesting or other participation for that portion of time before the Termination Date, nor shall Participant be entitled to any compensation for lost vesting or other participation. If, notwithstanding the foregoing, applicable employment legislation explicitly requires continued entitlement to vesting or other participation during a statutory notice period, Participant’s right to vest in the RSUs or otherwise participate in or benefit from the Plan, if any, shall terminate effective as of the last date of the minimum statutory notice period. For clarity, Participant shall not earn or be entitled to pro-rated vesting or other participation if the vesting date falls after the end of Participant’s statutory notice period, nor shall Participant be entitled to any compensation for lost vesting. Any reference to termination as a Service Provider or cessation or termination of employment or service in this Agreement or the Plan shall be interpreted to mean the Termination Date as defined above.


 
18 Subject to applicable legislation, the Administrator shall have the exclusive discretion to determine when Participant is no longer actively employed or providing services for purposes of the Award (including whether Participant may still be considered actively providing services while on an approved leave of absence). Sale of Shares. Participant acknowledges that he or she is permitted to sell the Shares acquired under the Plan through E*TRADE or such other broker as may be selected by the Company in the future, provided the sale of the Shares takes place outside of Canada through facilities of a stock exchange on which the Shares are listed. The Shares are currently listed on the New York Stock Exchange. French Language Documents for Quebec Service Providers. A French translation of the Agreement and the Plan will be made available to Participant as soon as reasonably practicable. Notwithstanding anything to the contrary in the Agreement, and unless Participant indicates otherwise, the French translation of the Agreement and the Plan will govern Participant’s participation in the Plan. Une traduction française de l’Accord et du Plan sera mise à la disposition du Participant dès que raisonnablement possible. Nonobstant toute disposition contraire de l’Accord, et sauf indication contraire du Participant, la traduction française de l’Accord et du Plan régira la participation du Participant au Plan. Authorization to Release and Transfer Necessary Personal Information for Quebec Service Providers. The following provision supplements paragraph 14 of the Agreement: Participant hereby authorizes the Company and the Company’s representatives, including the broker(s) designated by the Company, to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. Participant further authorizes the Company, any Related Entity and the Administrator of the Plan to disclose and discuss the Plan with their advisors. Participant further authorizes the Company and any Related Entity to record such information and to keep such information in Participant’s employee file. Participant acknowledges and agrees that Participant’s personal information, including any sensitive personal information, may be transferred or disclosed outside the province of Quebec, including to the U.S. If applicable, Participant also acknowledges and authorizes the Company, any Related Entity, the Administrator and any third party brokers/administrators that are assisting the Company with the operation and administration of the Plan to use technology for profiling purposes and to make automated decisions that may have an impact on Participant or the administration of the Plan. Foreign Asset/Account Reporting Notice.


 
19 Canadian residents may be required to report foreign specified property on Form T1135 (Foreign Income Verification Statement) if the total cost of the foreign specified property exceeds CAD 100,000 at any time in the year. Foreign specified property includes Shares acquired under the Plan and may include RSUs. The RSUs must be reported - generally at a nil cost - if the CAD 100,000 cost threshold is exceeded because of other foreign specified property Participant holds. The cost of RSUs generally is the adjusted cost base (“ACB”) of the Shares. The ACB ordinarily would equal the fair market value of the Shares at the time of acquisition, but if the Canadian resident owns other Shares of the Company, this ACB may have to be leveraged with the ACB of the other Shares. The Form T1135 generally must be filed by April 30 of the following year. Canadian residents should consult with a personal advisor to ensure compliance with the applicable reporting requirements. China Settlement of RSUs and Sale of Shares. The following provision supplements paragraph 5 of the Agreement: Due to local regulatory requirements, Participant agrees that the Company may force the sale of any Shares to be issued upon settlement of the Award. The sale may occur (i) immediately upon vesting, (ii) following Participant’s termination as a Service Provider, or (iii) or within any other time frame as the Company determines to be necessary or advisable for legal or administrative reasons. Participant agrees that he or she must maintain any Shares acquired under the Plan in an account maintained by E*TRADE or such other stock plan service provider as may be selected by the Company. Participant further agrees that the Company is authorized to instruct E*TRADE or such other stock plan service provider as may be selected by the Company in the future to assist with the mandatory sale of such Shares (on Participant’s behalf pursuant to this authorization) and Participant expressly authorizes E*TRADE or such other stock plan service provider as may be selected by the Company in the future to complete the sale of such Shares. Participant acknowledges that E*TRADE or such other stock plan service provider as may be selected by the Company in the future is under no obligation to arrange for the sale of the Shares at any particular price. Upon the sale of the Shares, the Company agrees to pay Participant the cash proceeds from the sale of the Shares, less any brokerage fees or commissions and subject to any obligation to satisfy Tax-Related Items. Exchange Control Acknowledgement. Participant understands and agrees that participation in the Plan is subject to the Company or the Employer obtaining any required approval from the China State Administration of Foreign Exchange (“SAFE”), as determined by the Company in its sole and absolute discretion. If the Company or the Employer is unable to obtain such approval, Participant may not be entitled to receive any benefit in connection with the Plan without any liability to the Company, the Employer or any Related Entity.


 
20 Participant understands and agrees that, pursuant to local exchange control requirements, Participant will be required to repatriate the cash proceeds from the sale of Shares issued upon the vesting of the RSUs as well as any cash dividends paid on such Shares to China. Participant further understands that, under local law, such repatriation of the cash proceeds may need to be effectuated through a special exchange control account established by the Company, or one of its Related Entities, and Participant hereby consents and agrees that any proceeds from the sale of any Shares issued upon the vesting of the RSUs as well as any cash dividends paid on such Shares may be transferred to such special account prior to being delivered to Participant. If the proceeds from the sale of Participant’s Shares or cash dividends are converted to local currency, Participant acknowledges that the Company is under no obligation to secure any exchange conversion rate, and the Company may face delays in converting the proceeds to local currency due to exchange control restrictions in China. Participant agrees to bear the risk of any exchange conversion rate fluctuation between the date the RSUs vest and the date of conversion of the proceeds from the sale of the Shares issued upon vesting to local currency. Participant further agrees to comply with any other requirements that may be imposed by the Company in the future in order to facilitate compliance with exchange control requirements in China. Foreign Asset/Account Reporting Notice. Chinese residents are required to report to the SAFE all details of his or her foreign financial assets and liabilities, as well as details of any economic transactions conducted with non- Chinese residents, either directly or through financial institutions. France Consent to Receive Information in English. By accepting the grant of the RSUs, Participant confirms having read and understood the Plan and the Agreement, which were provided in English language. Participant accepts the terms of those documents accordingly. En acceptant cette attribution gratuite d’actions, le Participant confirme avoir lu et compris le Plan et ce Contrat, incluant tous leurs termes et conditions, qui ont été transmis en langue anglaise. Le Participant accepte les dispositions de ces documents en connaissance de cause. Foreign Asset/Account Reporting Notice. French residents must report annually any shares and bank accounts held outside France, including the accounts that were opened, used and/or closed during the tax year, to the French tax authorities, on an annual basis on a special Form N° 3916, together with Participant’s personal income tax return. Failure to report triggers a significant penalty. Exchange Control Information.


 
21 The value of any cash or securities imported to or exported from France without the use of a financial institution must be reported to the customs and excise authorities when the value of such cash or securities is equal to or greater than a certain amount (currently €10,000). Germany Exchange Control Notice. Cross-border payments (including proceeds realized upon the sale of Shares or from the receipt of any dividends paid on such Shares) and certain other transactions with a value in excess of €50,000 must be reported to the German Federal Bank (Bundesbank). In addition, Participant may be required to report (i) the acquisition of Shares, and (ii) the withholding or the sale of Shares to cover withholding obligations or rights for Tax-Related Items, in either case if the value of the Shares exceeds €50,000. The report must be filed either electronically using the “General Statistics Reporting Portal” (“Allgemeines Meldeportal Statistik”) available via the Bundesbank’s website (www.bundesbank.de) or via such other method (e.g., by email or telephone) as is permitted or required by the Bundesbank. The report must be submitted monthly or within such timing as is permitted or required by the Bundesbank. Participant should consult with their personal tax advisor for details regarding this requirement. Foreign Asset/Account Reporting Information. German residents holding Shares must notify their local tax office if the acquisition of Shares under the Plan leads to a so-called qualified participation at any point during the calendar year. A qualified participation is attained only in the unlikely event (i) Participant owns at least 1% of the Company and the value of the Shares acquired exceeds €150,000, or (ii) Participant holds Shares exceeding 10% of the total capital of the Company. Hong Kong Form of Settlement. RSUs granted to Participants resident in Hong Kong shall be paid in Shares only. Sale of Shares. Any Shares acquired under the Plan are accepted as a personal investment. In the event that the Award vests and Shares are issued to Participant (or Participant's heirs) within six months of the Date of Grant, Participant (or Participant's heirs) agrees that the Shares will not be offered to the public or otherwise disposed of prior to the six-month anniversary of the date of grant. Securities Law Notice. Warning: None of the documents related to the Plan have been reviewed by any regulatory authority in Hong Kong. If Participant is in any doubt about any of the contents of the Agreement, including this Appendix, the Plan, or any other communication materials, Participant should obtain independent professional advice. The RSUs and Shares issued at vesting do not constitute a public offering of securities under Hong Kong law and are available only to employees of the


 
22 Company and its Related Entities. The Agreement, including this Appendix, the Plan and other incidental communication materials have not been prepared in accordance with and are not intended to constitute a “prospectus” for a public offering of securities under the applicable securities legislation in Hong Kong. The RSUs are intended only for the personal use of each eligible employee of the Employer, the Company or any Related Entity and may not be distributed to any other person. India Exchange Control Notice. Participant understands that the RSUs are subject to compliance with the exchange control requirements of the Reserve Bank of India. Participant understands that he or she must repatriate any proceeds from the sale of Shares and any dividends received acquired under the Plan within such period of time as required under applicable regulations. Participant must obtain a foreign inward remittance certificate (“FIRC”) from the bank where Participant deposits the funds and must maintain the FIRC as evidence of the repatriation of funds in the event the Reserve Bank of India or the Employer requests proof of repatriation. Participant may be required to provide information regarding funds received from participation in the Plan to the Company and/or the Employer to enable them to comply with their filing requirements under exchange control laws in India. Participant is personally responsible for complying with exchange control laws in India, and neither the Company nor the Employer will be liable for any fines or penalties resulting from Participant’s failure to comply with applicable laws. Foreign Asset/Account Reporting Notice. Indian residents are required to declare the following items in their annual tax return: (i) any foreign assets held by them (including Shares acquired under the Plan), and (ii) any foreign bank accounts for which they have signing authority. Indian residents should consult with their personal tax advisor to ensure that they are properly reporting foreign assets and bank accounts. Ireland Director Notification Requirement. If Participant is a director, shadow director, or secretary of an Irish subsidiary, pursuant to the Companies Act 2014, Participant must notify that subsidiary in writing if Participant receives or disposes of an interest exceeding 1% of the share capital of the Company (e.g., RSUs, Shares), if Participant becomes aware of the event giving rise to the notification requirement, or if Participant becomes a director or secretary if such an interest exceeding 1% of the share capital of the Company exists at the time. This notification requirement also applies with respect to the interests of a spouse, civil partner, or minor children (whose interests will be attributed to the director, shadow director, or secretary). Participant should consult his or her personal legal advisor to ensure compliance with the applicable requirements. Japan


 
23 Exchange Control Notice. Japanese residents acquiring Shares valued at more than ¥100,000,000 in a single transaction, must file a Securities Acquisition Report with the Ministry of Finance through the Bank of Japan within twenty (20) days of the acquisition of the Shares. Foreign Asset/Account Reporting Notice. Japanese residents are required to report details of any assets held outside of Japan as of December 31, including Shares acquired under the Plan, to the extent such assets have a total net fair market value exceeding ¥50,000,000. Such report will be due by March 15 each year. Japanese residents are responsible for complying with this reporting obligation. Korea Sale of Shares. Korean residents are not permitted to sell foreign securities (e.g., Shares) through non-Korean brokers or deposit funds resulting from the sale of Shares in an account with an overseas financial institution. If a Korean resident wishes to sell Shares acquired under the Plan, the Korean resident may be required to transfer the Shares to a domestic investment broker in Korea and to effect the sale through such broker. The Korean resident is solely responsible for engaging the domestic broker. Non-compliance with the requirement to sell Shares through a domestic broker can result in significant penalties. Because regulations may change without notice, Korean residents should consult with a legal advisor to ensure compliance with any regulations applicable to any aspect of participation in the Plan. Foreign Asset/Account Reporting Notice. Korean residents must declare all foreign financial accounts (i.e., non-Korean bank accounts, brokerage accounts, etc.) to the Korean tax authority and file a report with respect to such accounts if the value of such accounts exceeds KRW 500 million (or an equivalent amount in foreign currency). Korea residents should consult with their personal tax advisor for additional information about this reporting obligation. Exchange Control Notice. If a Korean resident sells Shares and deposits sale proceeds in excess of a certain threshold (currently, US$5,000 per transaction) into a non-Korean bank account, the Korean resident must file a report with a Korean foreign exchange bank. This reporting is not required if sale proceeds are instead deposited into a non-Korean brokerage account. Participant should consult their personal legal advisor to ensure compliance with the applicable requirements. Netherlands No country-specific provisions. Poland


 
24 Exchange Control Notice. Transfers of funds into and out of Poland in excess of €15,000 (or PLN 15,000 if such transfer of funds is connected with the business activity of an entrepreneur) must be made via a bank account held at a bank in Poland. Additionally, Polish residents are required to store all documents connected with any foreign exchange transactions that Polish residents are engaged in for a period of five years, as measured from the end of the year in which such transaction occurred. Foreign Asset/Account Reporting Notice. If Participant maintains bank or brokerage accounts holding cash and foreign securities (including Shares) outside of Poland, Participant will be required to report information to the National Bank of Poland on transactions and balances in such accounts if the value of such cash and securities exceeds certain thresholds. If required, such reports must be filed on special forms available on the website of the National Bank of Poland. Participant should consult with their personal legal advisor to determine whether Participant will be required to submit reports to the National Bank of Poland. Singapore Sale Restriction. Participant agrees that any Shares acquired pursuant to the RSUs will not be offered for sale in Singapore prior to the six-month anniversary of the Date of Grant unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA. Securities Law Notice. The grant of the RSUs is being made to Participant in reliance on the “Qualifying Person” exemption under section 273(1)(f) of the SFA under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying Shares being subsequently offered for sale to any other party. The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore, and hence, statutory liability under the SFA in relation to the content of prospectuses will not apply. Director Reporting Notice. If Participant is a director, associate director or shadow director of a Singapore Related Entity of the Company, as the terms are used in the Singapore Companies Act (the “SCA”), Participant agrees to comply with notification requirements under the SCA. Among these requirements is an obligation to notify the Singapore Related Entity in writing when Participant receives an interest (e.g., RSUs, Shares) in the Company or any related companies (including when Participant sells Shares acquired under the Plan). In addition, Participant must notify the Singapore Related Entity when Participant sells or receives Shares of the Company or any related company


 
25 (including when Participant sells or receives Shares acquired under the Plan). These notifications must be made within two (2) business days of acquiring or disposing of any interest in the Company or any related company. In addition, a notification must be made of Participant’s interests in the Company or any related company within two (2) business days of becoming a director, associate director or shadow director. Participant should consult with his or her personal legal advisor regarding his or her notification obligations under the SCA. Spain No Entitlement for Claims or Compensation. The following provisions supplement paragraphs 4 and 12 of the Agreement: By accepting the RSUs, Participant consents to participation in the Plan and acknowledges that Participant has received a copy of the Plan document. Participant understands and agrees that, as a condition of the grant of the RSUs, the termination of Participant’s status as a Service Provider for any reason (including for the reasons listed below) prior to the vesting date will automatically result in the loss of the unvested RSUs that may have been granted to Participant. In particular, Participant understands and agrees that any unvested RSUs shall be forfeited without entitlement to the underlying Shares or to any amount as indemnification in the event of a termination of status as a Service Provider, including, but not limited to: resignation, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without good cause (i.e., subject to a “despido improcedente”), individual or collective layoff on objective grounds, whether adjudged to be with cause or adjudged or recognized to be without cause, material modification of the terms of employment under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Employer, and under Article 10.3 of Royal Decree 1382/1985. Participant understands that the Company has unilaterally, gratuitously and in its sole discretion decided to grant RSUs under the Plan to individuals who may be Employees, Directors or Consultants throughout the world. The decision is limited and entered into based upon the express assumption and condition that: (i) any RSU grant will not economically or otherwise bind the Company or any Related Entity, including the Employer, presently or in the future, other than as expressly set forth in the Agreement; (ii) the RSUs and any Shares acquired upon settlement of the RSUs are not part of any employment contract (whether with the Company or a Related Entity) and shall not be considered a mandatory benefit, salary for any purpose (including severance compensation), or any other right whatsoever; and (iii) unless otherwise expressly provided for by the Company in the Agreement or in this Appendix, your participation in the Plan will cease as of the date Participant’s employment is terminated.


 
26 Furthermore, Participant understands and freely accepts that there is no guarantee that any benefit whatsoever shall arise from the grant of RSUs, which is gratuitous and discretionary, since the future value of the RSUs and the underlying Shares is unknown and unpredictable. Participant also understands that the grant of RSUs would not be made but for the assumptions and conditions set forth hereinabove; thus, Participant understands, acknowledges and freely accepts that, should any or all of the assumptions be mistaken or any of the conditions not be met for any reason, the RSUs and any right to the underlying Shares shall be null and void. Securities Law Notice. No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory in connection with the grant of RSUs. The Agreement, this Appendix and the Plan have not been registered with the Comisión Nacional del Mercado de Valores (Spanish Securities Exchange Commission) and do not constitute a public offering prospectus. Exchange Control Notice. Participant may be required to declare electronically to the Bank of Spain any foreign accounts (including brokerage accounts held abroad), as well as any foreign instruments (including any Shares acquired under the Plan) held in such accounts if the value of the transactions for all such accounts during the prior year or the balances of such accounts as of December 31 of the prior year exceeds €1,000,000. Different thresholds and deadlines to file the declaration apply. However, if neither such transactions during the immediately preceding year nor the balances or positions as of December 31 exceed €1,000,000, no such declaration must be filed unless expressly required by the Bank of Spain. If any of such thresholds were exceeded during the current year, Participant understands that they may be required to file the relevant declaration corresponding to the prior year; however, a summarized form of declaration may be available. Participant should consult their personal legal advisor to ensure compliance with the applicable requirements. Foreign Asset/Account Reporting Notice. Spanish residents are required to report rights or assets deposited or held outside of Spain (including Shares acquired under the Plan or cash proceeds from the sale of such Shares) as of December 31 of each year, if the value of such rights or assets exceeds EUR 50,000 per type of right or asset. After such rights and/or assets are initially reported, the reporting obligation will only apply for subsequent years if the value of any previously-reported rights or assets increases by more than EUR 20,000 per type of right or asset as of December 31 of each year, or if Participant sells Shares or cancel bank accounts that were previously reported. If reporting is required, the report must be filed on Form 720 by March 31 following the end of the relevant year. Sweden Tax Withholding Obligations. The following supplements paragraph 11 of the Agreement:


 
27 Without limiting the Company’s and the Employer’s authority to satisfy their withholding obligations for Tax-Related Items as set forth in paragraph 11 of the Agreement, by accepting the RSUs, Participant authorizes the Company and/or the Employer to withhold Shares or to sell Shares otherwise deliverable to Participant upon exercise to satisfy Tax-Related Items, regardless of whether the Company and/or the Employer have an obligation to withhold such Tax-Related Items. Taiwan Securities Law Notice. The offer of participation in the Plan is available only for Service Providers of the Company and Related Entities. The offer of participation in the Plan is not a public offer of securities by a Taiwanese company. Data Privacy Acknowledgement. Participant hereby acknowledges that he or she has read and understood the terms regarding collection, processing and transfer of Data contained in paragraph 14 of the Agreement and by participating in the Plan, Participant agrees to such terms. In this regard, upon request of the Company or the Employer, Participant agrees to provide an executed data privacy consent form to the Employer or the Company (or any other agreements or consents that may be required by the Employer or the Company) that the Company and/or the Employer may deem necessary to obtain under the data privacy laws in Participant’s country, either now or in the future. Participant understands he or she will not be able to participate in the Plan if Participant fails to execute any such consent or agreement. Exchange Control Notice. Taiwanese residents may acquire and remit foreign currency (including proceeds from the sale of Shares or the receipt of any dividends paid on such Shares) into Taiwan up to US$10,000,000 per year. If the transaction amount is TWD 500,000 or more in a single transaction, residents must submit a Foreign Exchange Transaction Form and also provide supporting documentation to the satisfaction of the remitting bank. If the transaction amount is US$500,000 or more, Taiwanese residents may be required to provide additional supporting documentation to the satisfaction of the remitting bank. Taiwanese residents should consult their personal legal advisor to ensure compliance with applicable exchange control laws in Taiwan. Türkiye Securities Law Notice. Pursuant to Turkish securities law, selling shares acquired under the Plan is not permitted within Turkey. The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol “DLB” and the Shares may be sold through this exchange. Financial Intermediary Requirement Notice.


 
28 The purchase and sale of securities traded in foreign financial markets (e.g., the purchase and sale of Shares) are permitted. However, transactions in foreign securities must be conducted through the local banks and financial intermediary institutions licensed by the Turkish Capital Markets Board in accordance with relevant regulations and Central Bank communiqués. Participant acknowledges that Participant is solely responsible for engaging such Turkish financial intermediary. Participants should contact a personal legal advisor for further information regarding these requirements. United Arab Emirates (“UAE”) Securities Law Notice. The offer of participation in the Plan is available only for select employees of the Company and Related Entities and is in the nature of providing employee incentives in the UAE. The Agreement, this Appendix, the Plan and other incidental communication materials are intended for distribution only to Service Providers for the purposes of an employee compensation or reward scheme, and must not be delivered to, or relied on, by any other person. The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with the RSUs or the Agreement. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved the Agreement nor taken steps to verify the information set out in it, and have no responsibility for it. The securities to which the Agreement relates may be illiquid and/or subject to restrictions on their resale. Individuals should conduct their own due diligence on the securities. Residents of the UAE who do not understand or have questions regarding the Agreement, this Appendix or the Plan should consult an authorized financial adviser. United Kingdom Form of Settlement. RSUs granted to Service Providers resident in the United Kingdom shall be paid in Shares only. Joint Election. As a condition of the vesting of the RSUs under the Plan, Participant agrees to accept any liability for secondary Class 1 NICs (“Employer NICs”) which may be payable by the Company or the Employer with respect to the vesting of the RSUs or otherwise payable in connection with the RSUs and the issuance of Shares. Without prejudice to the foregoing, Participant agrees to execute a joint election with the Company and/or the Employer (the “Election”), the form of such Election being formally approved by HM Revenue and Customs (“HMRC”), and any other consent or elections required to accomplish the transfer of the Employer NICs to Participant. Participant further agrees to execute such other joint elections as may be required between Participant and any successor to the Company and/or the Employer. Participant agrees to enter into an Election prior


 
29 to the vesting of the RSUs. Participant further agrees that the Company and/or the Employer may collect the Employer NICs by any of the means set forth in paragraph 11 of the Agreement. Tax Withholding Obligations. The following supplements paragraph 11 of the Agreement: Without limitation to paragraph 11 of the Agreement, Participant agrees that he or she is liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company or the Employer or by HMRC (or any other tax authority or any other relevant authority). Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on Participant’s behalf (or any other tax authority or any other relevant authority). If Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the Exchange Act), the terms of the immediately foregoing provision will not apply. In the event that Participant is a director or executive officer and income tax due is not collected from or paid by Participant, the amount of any income tax due but not collected from or paid by Participant may constitute an additional benefit to Participant on which additional income tax and National Insurance Contributions (“NICs”) may be payable. Participant will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying the Company and/or the Employer the amount of any employee NICs due on this additional benefit, which the Company and/or the Employer may recover at any time thereafter by any of the means referred to in this Agreement.


 
Dolby Laboratories, Inc. Executive Severance Policy Effective as of November 9, 2026 (the “Effective Date”) This Executive Severance Policy (the “Policy”) is designed to provide certain benefits to certain key executives of Dolby Laboratories, Inc., a California corporation (the “Company”) or any of its subsidiaries in connection with the involuntary termination of their employment under the circumstances described in the Policy, including in connection with a change in control of the Company. The Policy is designed to be an “employee welfare benefit plan” (as defined in Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”)), and this document is both the formal plan document and the required summary plan description for the Policy. Eligible Executive: An individual is only eligible for benefits under the Policy if they are an Eligible Executive and comply with its terms (including any terms in the individual’s Participation Agreement). To be an “Eligible Executive,” an individual must (a) have been designated by the Compensation Committee of the Board (the “Compensation Committee”) as eligible to participate in the Policy, and (b) have executed a participation agreement in the form attached hereto as Exhibit A (a “Participation Agreement”). Policy Benefits: An Eligible Executive will be eligible to receive the payments and benefits set forth in the Policy and their Participation Agreement upon such Eligible Executive’s Qualified Termination. The amount and terms of any Salary Severance, Cash Incentive Severance, COBRA Benefits and Equity Benefits that an Eligible Executive may receive upon a Qualified Termination will depend on whether the Qualified Termination is a CIC Qualified Termination or a Non-CIC Qualified Termination. All benefits under the Policy payable on a Qualified Termination will be subject to the Eligible Executive’s compliance with (a) the Release Requirement and any timing modifications required to avoid adverse taxation under Section 409A, and (b) restrictive covenants applicable to an Eligible Executive. Qualified Termination Benefits: Subject to the terms of the Policy, including the provisions below related to the Release Requirement and Section 409A, an Eligible Executive will be eligible to receive the following severance benefits upon the occurrence of a Qualified Termination: • Salary Severance: Salary severance payment(s) equal to the applicable percentage (set forth in their Participation Agreement) of their Base Salary paid in cash at the time(s) specified in their Participation Agreement. • Cash Incentive Severance: Cash incentive severance payment(s) with respect to their annual incentive compensation in the amount set forth in their Participation Agreement paid in cash at the time(s) specified in their Participation Agreement. • COBRA Benefits: If an Eligible Executive makes a valid election under COBRA to continue their health coverage, the Company will pay or reimburse the Eligible Executive for the cost of such continuation coverage for the Eligible Executive and any eligible dependents that were covered under the Company’s health care plans immediately prior to the date of their eligible termination until the earliest of (i) the end of the applicable period set forth in the Eligible Executive’s Participation Agreement; (ii) the date upon which the Eligible Executive and/or the


 
-2- Eligible Executive’s eligible dependents become covered under similar plans; or (iii) the date upon which the Eligible Executive ceases to be eligible for coverage under COBRA. • Equity Benefits: Any then-unvested shares subject to each of the Eligible Executive’s then- outstanding time-based equity awards multiplied by the applicable percentage (set forth in their Participation Agreement) or to the extent provided for in the Participation Agreement will immediately vest and, in the case of options and stock appreciation rights, will become exercisable. For avoidance of doubt, no more than 100% of the shares subject to the outstanding portion of an equity award may vest and become exercisable under this provision. In the case of equity awards that are or remain subject to performance-based vesting (including, without limitation, equity awards granted under Dolby’s long-term equity incentive plan), the treatment of such awards upon a termination of employment shall be set forth in the Participation Agreement, or if the Participation Agreement is silent, in the individual performance-based award agreement; provided, for the avoidance of doubt, the Equity Benefits shall apply to equity awards that are eligible to vest based on both time and service-based condition (including, without limitation, equity awards initially granted subject to performance-based conditions which have or are deemed to have been achieved, including equity awards granted under Dolby’s long-term equity incentive plan). In the event of the Eligible Executive’s Non-CIC Qualified Termination, any unvested portion of the Eligible Executive’s then-outstanding equity awards will remain outstanding until the earlier of (a) 60 days following the Non-CIC Qualified Termination, or (b) the occurrence of a Change in Control, solely so that any benefits due to such Eligible Executive on a CIC Qualified Termination can be provided if a Change in Control occurs within the 60-day period following the Non-CIC Qualified Termination (provided that in no event will the Eligible Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). If no Change in Control occurs within the 60-day period following a Non-CIC Qualified Termination, any unvested portion of the Eligible Executive’s equity awards will be automatically and permanently forfeited on the 60-day anniversary following the date of the Non-CIC Qualified Termination without having vested (for the avoidance of doubt, after first applying any benefit (including accelerated vesting, if applicable) Eligible Executive was entitled to receive upon a Non-CIC Qualified Termination). COBRA Benefits Limitations. Notwithstanding anything to the contrary set forth in the Policy, if the Company determines in its sole discretion that it cannot provide the COBRA Benefits without potentially violating applicable laws (including, without limitation, Section 2716 of the Public Health Service Act and ERISA, then in lieu of such COBRA Benefits, and subject to any delay required under the paragraph below entitled “Section 409A,” the Company will provide to an Eligible Executive a taxable lump sum cash payment in an amount equal to the product of (a) the number of months of COBRA Benefits specified in an Eligible Executive’s Participation Agreement, as applicable, multiplied by (b) the monthly COBRA premium that they otherwise would be required to pay to continue the group health, dental and vision coverage for themself and their eligible dependents, as applicable, as in effect on the date of termination of such Eligible Executive’s employment (which amount will be based on the premium for the first month of COBRA coverage for themself and their eligible dependents), which payment will be made regardless of whether such Eligible Executive elects COBRA continuation coverage (the “Taxable Payment”). The Taxable Payment may be used for any purpose, including, but not limited to continuation coverage under COBRA, and will be subject to all applicable tax withholdings. Notwithstanding anything to the contrary under the Policy, if the Company determines in its sole discretion at any time that it cannot provide the


 
-3- COBRA Benefits or the Taxable Payment without violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act and ERISA), an Eligible Executive will not receive any COBRA Benefits or Taxable Payment under the Policy. Non-Duplication of Payment or Benefits: If (a) an Eligible Executive’s Qualified Termination occurring prior to a Change in Control qualifies them for severance payments and benefits payable on a Non-CIC Qualified Termination under the Policy, and (b) a Change in Control occurs within the 60-day period following their Qualified Termination that qualifies them for superior severance payments and benefits payable on a CIC Qualified Termination under the Policy, if any, then such Eligible Executive (i) will cease receiving any further payments or benefits under the Policy in connection with their Non-CIC Qualified Termination, and (ii) will receive payments and benefits under the Policy in connection with such CIC Qualified Termination; provided that each of the Salary Severance, Cash Incentive Severance, COBRA Benefits and Equity Benefits, as applicable, otherwise payable upon such CIC Qualified Termination under the Policy will be offset and reduced by the corresponding payments or benefits such Eligible Executive already received under the Policy in connection with their Non-CIC Qualified Termination. Death of Eligible Executive: If the Eligible Executive dies before all payments or benefits they are entitled to receive under the Policy have been paid, then (a) COBRA Benefits will cease, and (b) other unpaid cash amounts will be paid to their designated beneficiary, if living, or otherwise to their personal representative in a lump-sum payment as soon as possible following their death. Recoupment: All payments or benefits under the Policy shall be subject to reduction, cancellation, forfeiture, recoupment, reimbursement or reacquisition under Dolby’s or the Company’s clawback policies in place at the time the Eligible Executive signs their Participation Agreement and any other clawback policy of Dolby or the Company established and/or amended from time to time to comply with applicable laws (including, without limitation, pursuant to the listing standards of any national securities exchange or association on which Dolby’s securities are listed or as is otherwise required by the Dodd- Frank Wall Street Reform and Consumer Protection Act or other applicable laws) (in each case, a “Clawback Policy”). The Administrator may require an Eligible Executive to forfeit, return or reimburse Dolby or the Company all or a portion of benefits or any amounts paid hereunder pursuant to the terms of any applicable Clawback Policy or as necessary or appropriate to comply with applicable laws. Release: The Eligible Executive’s receipt of any severance payments or benefits upon their Qualified Termination under the Policy is subject to the Eligible Executive signing and not revoking the Company’s then-standard separation agreement and release of claims (the “Release” and such requirement, the “Release Requirement”), which must become effective and irrevocable no later than the 60th day following their Qualified Termination (the “Release Deadline”). If the Release does not become effective and irrevocable by the Release Deadline, the Eligible Executive will forfeit any right to severance payments or benefits under the Policy. In no event will severance payments or benefits under the Policy be paid or provided until the Release actually becomes effective and irrevocable. In the event a Qualified Termination occurs at a time during the calendar year where the Release could become effective in the calendar year following the calendar year in which an Eligible Executive’s Qualified Termination occurs, then any severance payments or benefits under the Policy that would be considered Deferred Payments (as defined below) will be paid on the first payroll date to occur during the calendar year following the calendar year in which such termination occurs, or, if later, (a) the Release Deadline, or (b) such time as required by the payment schedule applicable to each payment or benefit as set forth in an applicable Participation Agreement, provided that, except as otherwise set forth in their Participation Agreement or


 
-4- to the extent that payments are delayed under the paragraph below entitled “Section 409A,” on the first regular payroll pay day following the 60th day following their Qualified Termination, the Company will pay or provide them the severance payments and benefits that they would otherwise have received under the Policy on or prior to such date, with the balance of such severance payments and benefits being paid or provided as originally scheduled. Section 409A: Dolby and the Company intend that all payments and benefits under the Policy or otherwise are exempt from, or comply with, the requirements of Section 409A of the Code and any guidance promulgated thereunder (collectively, “Section 409A”) so that none of the payments or benefits will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted in accordance with this intent. No payment or benefits to be paid to an Eligible Executive, if any, under the Policy or otherwise, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A (together, the “Deferred Payments”) will be paid or otherwise provided until they have a “separation from service” within the meaning of Section 409A. If, at the time of the Eligible Executive’s termination of employment, they are a “specified employee” within the meaning of Section 409A, then the payment of the Deferred Payments will be delayed to the extent necessary to avoid the imposition of the additional tax imposed under Section 409A, which generally means that they will receive payment on the first payroll date that occurs on or after the date that is 6 months and 1 day following their termination of employment. The Company reserves the right to amend the Policy as it deems necessary or advisable, in its sole discretion and without the consent of such Eligible Executive or any other individual, to comply with any provision required to avoid the imposition of the additional tax imposed under Section 409A or to otherwise avoid income recognition under Section 409A prior to the actual payment of any benefits or imposition of any additional tax. Each payment, installment and benefit payable under the Policy is intended to constitute a separate payment for purposes of U.S. Treasury Regulation Section 1.409A-2(b)(2). In no event will Dolby or the Company reimburse any Eligible Executive for any taxes that may be imposed on an Eligible Executive as a result of Section 409A. Parachute Payments: Reduction of Severance Benefits. Notwithstanding anything set forth herein to the contrary, if any payment or benefit that an Eligible Executive would receive from Dolby, the Company or any other party whether in connection with the provisions herein or otherwise (the “Payment”) would (a) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (b) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal to the Best Results Amount. The “Best Results Amount” will be either (x) the full amount of such Payment, or (y) such lesser amount as would result in no portion of the Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local employment taxes, income taxes and the Excise Tax, results in the Eligible Executive’s receipt, on an after-tax basis, of the greater amount notwithstanding that all or some portion of the Payment may be subject to the Excise Tax. If a reduction in payments or benefits constituting parachute payments is necessary so that the Payment equals the Best Results Amount, reduction will occur in the following order with each payment or benefit fully reduced or cancelled, as applicable, before moving to the next type of payment or benefit: (i) reduction of cash payments, which will occur in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first cash payment to be reduced; (ii) cancellation of equity awards that were granted “contingent on a change in ownership or


 
-5- control” within the meaning of Section 280G of the Code in the reverse order of date of grant of the equity awards (i.e., the most recently granted equity awards will be cancelled first); (iii) reduction of vesting acceleration of equity awards, which will occur in the reverse order of the date of grant for such equity awards (i.e., the vesting of the most recently granted equity awards will be reduced first); and (iv) reduction of other benefits paid or provided to Eligible Executive, which will occur in reverse chronological order such that the benefit owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first benefit to be reduced. If more than one equity award was made to Eligible Executive on the same date of grant, all such awards will have their acceleration of vesting reduced pro rata. The Eligible Executive will be solely responsible for the payment of all personal tax liability that they incur as a result of the payments and benefits under the Policy, and they will not be reimbursed by Dolby or the Company for any such payments. Determination of Excise Tax Liability. Dolby will select a professional services firm to make all of the determinations required to be made under these paragraphs relating to parachute payments. Dolby will request that firm provide detailed supporting calculations both to Dolby and the Eligible Executive prior to the date on which the event that triggers the Payment occurs if administratively feasible, or subsequent to such date if events occur that result in parachute payments to them at that time. For purposes of making the calculations required under these paragraphs relating to parachute payments, the firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith determinations concerning the application of the Code. Dolby, the Company and the Eligible Executive will furnish to the firm such information and documents as the firm may reasonably request in order to make a determination under these paragraphs relating to parachute payments. Dolby will bear all costs the firm may reasonably incur in connection with any calculations contemplated by these paragraphs relating to parachute payments. Any such determination by the firm will be binding upon Dolby and the Eligible Executive, and Dolby and the Company will have no liability to the Eligible Executive for the determinations of the firm. Arbitration: Any and all disputes arising from Eligible Executive’s employment, including the termination thereof, or Eligible Executive’s compensation or benefits which are not resolved by the Policy’s claims and appeals procedures contained herein will be subject to arbitration in San Francisco County, before Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Employment Arbitration Rules & Procedures (“JAMS Rules”), unless Eligible Executive primarily works in a state outside of California, in which case the arbitration shall take place in the state where Eligible Executive primarily works and the arbitration shall be conducted in accordance with the laws of such state. The arbitrator may grant injunctions and other relief in such disputes. If the arbitration is conducted in California, the arbitrator shall administer and conduct the arbitration in accordance with California law, including the California Code of Civil Procedure, and the arbitrator shall apply substantive and procedural California law to any dispute or claim, without reference to any conflict-of-law provisions of any jurisdiction. To the extent that the JAMS Rules conflict with California law, California law shall take precedence. The decision of the arbitrator shall be final, conclusive, and binding on the parties to the arbitration. The parties agree that the prevailing party in any arbitration shall be entitled to injunctive relief in any court of competent jurisdiction to enforce the arbitration award. Dolby or the Company will pay for any administrative or hearing fees charged by the arbitrator or JAMS except that Eligible Executive shall pay any filing fees associated with any arbitration that Eligible Executive initiates, but only so much of the filing fees as Eligible Executive would have instead paid had Eligible Executive filed a complaint in a court of law. Each party shall separately pay for its respective counsel fees and expenses; provided, however, that the arbitrator shall award attorneys’ fees and costs to the prevailing party, except as


 
-6- prohibited by law. The parties hereby agree to waive their right to have any dispute between them resolved in a court of law by a judge or jury. Notwithstanding the foregoing, this paragraph will not prevent either party from seeking injunctive relief (or any other provisional remedy) from any court having jurisdiction over the parties and the subject matter of their dispute relating to the Policy and the agreements incorporated herein by reference. Should any part of the arbitration agreement contained in this paragraph conflict with any other arbitration agreement between the parties, the parties agree that this arbitration agreement shall govern. Administration: The Policy will be administered by the Compensation Committee or its delegate (in each case, an “Administrator”). The Administrator will have full discretion to administer and interpret the Policy. Any decision made or other action taken by the Administrator with respect to the Policy and any interpretation by the Administrator of any term or condition of the Policy, or any related document, will be conclusive and binding on all persons and be given the maximum possible deference allowed by law. The Administrator is the “plan administrator” of the Policy for purposes of ERISA and will be subject to the fiduciary standards of ERISA when acting in such capacity. Attorneys Fees: Except as otherwise provided herein, Dolby, the Company and each Eligible Executive will bear their own attorneys’ fees incurred in connection with any disputes between them. Exclusive Benefits: Except as may be set forth in an Eligible Executive’s Participation Agreement or as otherwise specifically set forth in Dolby’s long-term equity incentive plan, and/or an applicable equity award agreement (including, without limitation, with respect to equity awards granted under Dolby’s 2020 Stock Plan or other long-term equity incentive plan) (together, a “Superseding Equity Agreement”), the Policy is intended to be the only agreement between them and Dolby and the Company regarding any severance payments or benefits, including any acceleration of equity, to be paid to them on account of a termination of employment. Accordingly, by executing a Participation Agreement, an Eligible Executive hereby forfeits and waives any rights to any severance benefits set forth in any employment agreement, offer letter, and/or equity award agreement, except as set forth in the Policy and in their Participation Agreement or in a Superseding Equity Agreement. Tax Withholding: All payments and benefits under the Policy will be paid less applicable withholding taxes. The Company is authorized to withhold from any payments or benefits all federal, state, local and/or foreign taxes required to be withheld therefrom and any other required payroll deductions. Dolby and the Company will not pay any Eligible Executive’s taxes arising from or relating to any payments or benefits under the Policy. Amendment or Termination: The Board or the Compensation Committee may amend or terminate the Policy at any time, without advance notice to any Eligible Executive or other individual and without regard to the effect of the amendment or termination on any Eligible Executive or on any other individual. Notwithstanding the preceding, no amendment or termination of the Policy will be made if such amendment or reduction would reduce the benefits provided hereunder or impair an Eligible Executive’s eligibility under the Policy (unless the affected Eligible Executive consents to such amendment or termination), except that the Board or the Compensation Committee may unilaterally and without consent of any Eligible Executive make any such amendments that are necessary or appropriate to comply with applicable laws. For clarity, an action by the Administrator not to continue or renew the Policy will not be an action that requires an Eligible Executive’s consent. Any action to amend or terminate the Policy will be taken in a non-fiduciary capacity.


 
-7- Claims Procedure: Any Eligible Executive who believes they are entitled to any payment under the Policy may submit a claim in writing to the Administrator. If the claim is denied (in full or in part), the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Policy on which the denial is based. The notice will also describe any additional information needed to support the claim and the Policy’s procedures for appealing the denial. The denial notice will be provided within 90 days after the claim is received. If special circumstances require an extension of time (up to 90 days), written notice of the extension will be given within the initial 90-day period. This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the Administrator expects to render its decision on the claim. Appeal Procedure: If the claimant’s claim is denied, the claimant (or their authorized representative) may apply in writing to the Administrator for a review of the decision denying the claim. Review must be requested within 60 days following the date the claimant received the written notice of their claim denial or else the claimant loses the right to review. The claimant (or representative) then has the right to review and obtain copies of all documents and other information relevant to the claim, upon request and at no charge, and to submit issues and comments in writing. The Administrator will provide written notice of the decision on review within 60 days after it receives a review request. If additional time (up to 60 days) is needed to review the request, the claimant (or representative) will be given written notice of the reason for the delay. This notice of extension will indicate the special circumstances requiring the extension of time and the date by which the Administrator expects to render its decision. If the claim is denied (in full or in part), the claimant will be provided a written notice explaining the specific reasons for the denial and referring to the provisions of the Policy on which the denial is based. The notice will also include a statement that the claimant will be provided, upon request and free of charge, reasonable access to, and copies of, all documents and other information relevant to the claim and a statement regarding the claimant’s right to bring an action under Section 502(a) of ERISA. Successors: Any successor to Dolby of all or substantially all of Dolby’s or the Company’s business and/or assets (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or other transaction) will assume the obligations under the Policy and agree expressly to perform the obligations under the Policy in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under the Policy, the term “Company” will include any successor to Dolby’s or the Company’s business and/or assets which becomes bound by the terms of the Policy by operation of law, or otherwise. Applicable Law: The provisions of the Policy will be construed, administered and enforced in accordance with ERISA and, to the extent applicable, the internal substantive laws of the state of California (but not its conflict of laws provisions). Definitions: Unless otherwise defined in an Eligible Executive’s Participation Agreement, the following terms will have the following meanings for purposes of the Policy and the Eligible Executive’s Participation Agreement: “Base Salary” means the Eligible Executive’s annual base salary as in effect immediately prior to their Qualified Termination (or if the termination is due to a resignation for Good Reason based on a reduction of the Eligible Executive’s base salary, then their annual base salary in effect immediately prior to such reduction) or, if their Qualified Termination is a CIC Qualified Termination and such amount is greater, at the level in effect immediately prior to the Change in Control.


 
-8- “Board” means the Board of Directors of Dolby. “Cause” means any of the following: (i) an Eligible Executive’s willful, material and continued failure to perform the duties and responsibilities of Eligible Executive’s position (other than as a result of Eligible Executive’s illness or injury) after there has been delivered to Eligible Executive a written demand for performance from the CEO or the Board which describes the basis for the CEO’s or the Board’s belief that Eligible Executive has not substantially performed Eligible Executive’s duties and provides Eligible Executive with 30 days to take corrective action, and within such period the applicable corrective actions have not been taken; (ii) any willful and material act of personal dishonesty taken by Eligible Executive in connection with Eligible Executive’s responsibilities as an employee of the Company with the intention that such action may result in the substantial personal enrichment of Eligible Executive; (iii) Eligible Executive’s conviction of, or plea of guilty or nolo contendere to, a felony that the Board in good faith believes has or will have a material detrimental effect on Dolby’s or the Company’s financial condition or reputation; (iv) a willful breach of any fiduciary duty owed to Dolby or the Company by Eligible Executive that has a material detrimental effect on Dolby’s financial condition or reputation or of the Confidentiality Agreement or any other improper disclosure of confidential or proprietary information of Dolby or the Company; (v) Eligible Executive being found liable in any Securities and Exchange Commission or other civil or criminal securities law action (regardless of whether or not Eligible Executive admits or denies liability), which the Board in good faith determines will have a material detrimental effect on Dolby’s financial condition or reputation; (vi) Eligible Executive entering into any cease and desist order with respect to any action which would bar Eligible Executive from service as an executive officer or member of a board of directors of any publicly-traded company (regardless of whether or not Eligible Executive admits or denies liability); (vii) Eligible Executive (A) obstructing or impeding; (B) endeavoring to obstruct or impede, or (C) failing to materially cooperate with, any investigation authorized by the Board or any governmental or self-regulatory entity (an “Investigation”), provided that Eligible Executive’s failure to waive attorney-client privilege relating to communications with Eligible Executive’s own attorney in connection with an Investigation will not constitute “Cause”; (viii) a material breach by Eligible Executive of Dolby’s Code of Business Conduct and Ethics, Insider Trading Policy, and any other written Dolby or Company policy applicable to Eligible Executive that have been made available to Eligible Executive prior to such breach; (ix) Eligible Executive’s failure (other than as a result of Eligible Executive’s illness or injury) to follow a written directive of the CEO or the Board after there has been delivered to Eligible Executive a written demand for performance from the CEO or the Board which describes the basis for the CEO’s or the Board’s belief that Eligible Executive has not followed such written directive and provides Eligible Executive with 30 days to take corrective action, and within such period the applicable corrective actions have not been taken; or (x) Eligible Executive’s disqualification or bar by any governmental or self-regulatory authority from serving in the capacity contemplated by Eligible Executive’s then current role with the Company, if (A) the disqualification or bar continues for more than 30 days, and (B) during that period, the Company uses its commercially reasonable efforts to cause the disqualification or bar to be lifted. While any disqualification or bar continues during Eligible Executive’s employment, Eligible Executive will serve in the capacity contemplated by their then current role with the Company to whatever extent legally permissible and, if Eligible Executive’s employment is not permissible, Eligible Executive will be placed on administrative leave (which will be paid to the extent legally permissible). Eligible Executive shall receive notice and an opportunity to be heard before the Board with Eligible Executive’s own attorney before any termination for Cause is deemed effective. Notwithstanding anything to the contrary, the Board may immediately place Eligible Executive on


 
-9- administrative leave (with full pay and benefits to the extent legally permissible) and suspend all access to information of Dolby or the Company, employees and business should Eligible Executive wish to avail themself of Eligible Executive’s opportunity to be heard before the Board prior to a termination for Cause. If Eligible Executive avails themself of Eligible Executive’s opportunity to be heard before the Board, and then fails to make themself available to the Board within five business days of such request to be heard, the Board may thereafter cancel the administrative leave and terminate Eligible Executive for Cause. “CEO” means Dolby’s Chief Executive Officer. “Change in Control” will have the same meaning as “Change in Control” is defined in Dolby’s 2020 Stock Plan or any successor plan. “Change in Control Period” means the period beginning 60 days prior to a Change in Control and ending 12 months following a Change in Control. “CIC Qualified Termination” means a Qualified Termination that occurs during the Change in Control Period. “COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended. “Code” means the Internal Revenue Code of 1986, as amended. “Disability” will have the same meaning as “Disability” is defined in Dolby’s 2020 Stock Plan. “Dolby” means Dolby Laboratories, Inc., a Delaware corporation. “Good Reason” means Eligible Executive’s resignation of employment following the expiration of any Company cure period (discussed below) following the occurrence of any of the following, without Eligible Executive’s express written consent: (i) the assignment to or removal from Eligible Executive of duties or responsibilities that results in a material reduction of Eligible Executive’s duties, authority, title, or scope of responsibilities, whether occurring before or after a Change in Control; (ii) a material reduction in Eligible Executive’s base salary or target annual incentive as in effect immediately prior to such reduction (other than pursuant to a reduction that also is applied to substantially all other executive officers of the Company and which reduction reduces the base salary and/or target annual incentive by a percentage reduction that is no greater than 10%); (iii) a material change in the geographic location of Eligible Executive’s primary work facility or location; provided, that a relocation of 50 miles or less from Eligible Executive’s then present work location or to Eligible Executive’s home as Eligible Executive’s primary work location will not be considered a material change in geographic location; (iv) the material breach by the Company or Dolby of any provision of this Policy or any award agreement governing Eligible Executive’s equity awards; or (v) the failure of the Company or Dolby to obtain the assumption of this Policy by a successor. The notification and placement of Eligible Executive on administrative leave of not more than 60 calendar days pending a potential determination by the Board that Eligible Executive may be terminated for Cause shall not constitute Good Reason for purposes of this Policy. Eligible Executive will not resign for Good Reason without first providing the Company with written notice of the acts or omissions constituting the grounds for “Good Reason” within 90 days of the initial existence of the grounds for “Good Reason” and, if such grounds are susceptible to cure, a reasonable cure period of up to 30 days following the


 
-10- date of such notice. Any resignation for Good Reason must occur within one year of the initial existence of the grounds constituting Good Reason. “Non-CIC Qualified Termination” means a Qualified Termination that occurs outside of the Change in Control Period. “Qualified Termination” means a termination of the Eligible Executive’s employment either (a) by the Company other than for Cause, death, or Disability, or (b) by the Eligible Executive for Good Reason. Additional Information: Plan Name: Dolby Laboratories, Inc. Executive Severance Policy Plan Sponsor: Dolby Laboratories, Inc. 1275 Market Street San Francisco, California 94103 Identification Numbers: [--] Plan Year: Company’s Fiscal Year Plan Administrator: Dolby Laboratories, Inc. Attention: Plan Administrator of the Dolby Laboratories, Inc. Executive Severance Policy 1275 Market Street San Francisco, California 94103 Agent for Service of Legal Process: Dolby Laboratories, Inc. Attention: General Counsel 1275 Market Street San Francisco, California 94103 Service of process may also be made upon the Plan Administrator. Type of Plan: Severance Plan/Employee Welfare Benefit Plan Plan Costs: The cost of the Policy is paid by the Company. Statement of ERISA Rights: Eligible Executives have certain rights and protections under ERISA: They may examine (without charge) all Policy documents, including any amendments and copies of all documents filed with the U.S. Department of Labor, such as the Policy’s annual report (Internal Revenue Service Form 5500). These documents are available for review in the Company’s Human Resources Department. They may obtain copies of all Policy documents and other Policy information upon written request to the Plan Administrator. A reasonable charge may be made for such copies.


 
-11- In addition to creating rights for Eligible Executives, ERISA imposes duties upon the people who are responsible for the operation of the Policy. The people who operate the Policy (called “fiduciaries”) have a duty to do so prudently and in the interests of Eligible Executives. No one, including the Company or any other person, may fire or otherwise discriminate against an Eligible Executive in any way to prevent them from obtaining a benefit under the Policy or exercising rights under ERISA. If an Eligible Executive’s claim for a severance benefit is denied, in whole or in part, they must receive a written explanation of the reason for the denial. An Eligible Executive has the right to have the denial of their claim reviewed. (The claim review procedure is explained above.) Under ERISA, there are steps Eligible Executives can take to enforce the above rights. For instance, if an Eligible Executive requests materials and does not receive them within 30 days, they may file suit in a federal court. In such a case, the court may require the Administrator to provide the materials and to pay the Eligible Executive up to $110 a day until they receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan Administrator. If an Eligible Executive has a claim which is denied or ignored, in whole or in part, they may file suit in a state or federal court. If it should happen that an Eligible Executive is discriminated against for asserting their rights, they may seek assistance from the U.S. Department of Labor, or may file suit in a federal court. In any case, the court will decide who will pay court costs and legal fees. If the Eligible Executive is successful, the court may order the person sued to pay these costs and fees. If the Eligible Executive loses, the court may order the Eligible Executive to pay these costs and fees, for example, if it finds that the claim is frivolous. If an Eligible Executive has any questions regarding the Policy, please contact the Plan Administrator. If an Eligible Executive has any questions about this statement or about their rights under ERISA, they may contact the nearest area office of the Employee Benefits Security Administration (formerly the Pension and Welfare Benefits Administration), U.S. Department of Labor, listed in the telephone directory, or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, N.W. Washington, D.C. 20210. An Eligible Executive may also obtain certain publications about their rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration.


 
-12- EXHIBIT A Executive Severance Policy Participation Agreement This Participation Agreement (“Agreement”) is made and entered into by and between the undersigned, Dolby Laboratories, Inc., a California corporation (the “Company”) and Dolby Laboratories, Inc., a Delaware corporation (“Dolby”). You have been designated as eligible to participate in the Company’s Executive Severance Policy (the “Policy”), a copy of which is attached hereto, under which you are eligible to receive the following severance payments and benefits upon a Qualified Termination, subject to the terms and conditions of the Policy. Capitalized terms which are not otherwise defined in this Agreement shall have the meaning ascribed to such terms in the Policy. Non-CIC Qualified Termination If your Qualified Termination is a Non-CIC Qualified Termination, you will be entitled to the following benefits, subject to your compliance with the Policy: • Salary Severance: Your percentage of Base Salary will be 100%, payable in a lump-sum. • Cash Incentive Severance: You will receive a lump-sum payment equal to (i) 100% of your target annual incentive compensation amount as in effect for the fiscal year in which your Qualified Termination occurs, plus (ii) your annual incentive compensation payment as in effect for the fiscal year in which your Qualified Termination occurs based on actual achievement, prorated based on the number of days elapsed in such fiscal year prior to such Qualified Termination, payable when annual incentive compensation amounts are generally paid to similarly-situated executives. • COBRA Benefits: The Company shall pay or reimburse you for your COBRA continuation coverage for up to 12 months. • Equity Benefits: Vesting acceleration as to any then-outstanding time-based equity awards that otherwise would have vested solely based on continued service during the 12-month period following the date of the Non-CIC Qualified Termination (and for time-based equity awards that vest less frequently than on an annual schedule, pro-rata vesting of such awards calculated as if such awards had a monthly vesting schedule). [Notwithstanding the foregoing, for any restricted stock unit award granted on September 15, 2026, the vesting acceleration benefit as to such award will be as set forth in the award agreement governing such award.] In the case of (i) equity awards that are or remain subject to performance-based vesting (including, without limitation, equity awards granted under Dolby’s long-term equity incentive plan) as of the Effective Date (the “Current PSUs”), or (ii) equity awards that are subject to performance-based vesting (including, without limitation, equity awards granted under Dolby’s long-term equity incentive plan) granted after the Effective Date with substantially


 
-13- similar performance-based vesting terms as the Current PSUs, you will remain eligible to vest in such equity awards based on actual achievement of the applicable performance conditions, but with the number of target units or shares subject to such equity award equal to the product (rounded to the nearest whole unit or share) of: (i) the original target number of units or shares subject to such equity award, multiplied by (ii) the quotient derived from (x) the number of full months you remained in continuous service from the beginning of the performance period through the termination date, plus 12, over (y) the total months from the beginning of the performance period through the end of the applicable performance period for such portion (with such quotient not to exceed 1), and this Agreement acts as an amendment to your Current PSUs. In the case of performance-based equity awards granted after the Effective Date with performance-based vesting terms substantially different than those applicable to the Current PSUs, the treatment of such awards upon a termination of employment shall be set forth in the individual performance-based award agreement. CIC Qualified Termination If your Qualified Termination is a CIC Qualified Termination, you will be entitled to the following benefits, subject to your compliance with the Policy: • Salary Severance: Your percentage of Base Salary will be 150%, payable in a lump-sum. • Cash Incentive Severance: You will receive a lump-sum payment equal to (i) 150% of your target annual incentive compensation amount as in effect for the fiscal year in which your Qualified Termination occurs, plus (ii) your target annual incentive compensation payment as in effect for the fiscal year in which your Qualified Termination occurs, prorated based on the number of days elapsed in such fiscal year prior to such Qualified Termination, payable in a lump sum. • COBRA Benefits: The Company shall pay or reimburse you for your COBRA continuation coverage for up to 18 months. • Equity Benefits: 100% vesting as to any then-outstanding time-based equity awards (including time-based vesting applicable after the satisfaction of any performance conditions applicable to the equity awards) and for stock options or similar equity awards that are assumed or otherwise continue following the Change in Control, the ability to exercise such equity awards for 12 months following the date of the CIC Qualified Termination (provided that in no event will the Eligible Executive’s stock options or similar equity awards remain outstanding beyond the equity award’s maximum term to expiration). In the case of equity awards that are or remain subject to performance-based vesting, 100% vesting as to the target number of shares subject to such equity award, unless provided otherwise in the award agreement related to such equity award. Other Provisions


 
-14- You agree that the Policy and this Agreement constitute the entire agreement of the parties hereto and supersede in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties, and will specifically supersede any severance and/or change in control provisions of any offer letter, employment agreement, or equity award agreement entered into between you and Dolby or the Company, other than as set forth in a Superseding Equity Agreement (including equity awards granted under Dolby’s long-term incentive plan). For purposes of clarification, you will remain eligible to receive any accelerated vesting set forth in Dolby’s 2020 Stock Plan, subject to the terms and conditions of Dolby’s 2020 Stock Plan[, and any accelerated vesting set forth in your restricted stock unit award agreement governing your restricted stock unit award granted on September 15, 2026]. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. By its signature below, each of the parties signifies its acceptance of the terms of this Agreement, in the case of the Company and Dolby by its duly authorized officer effective as of the last date set forth below. Signature page follows


 
-15- ELIGIBLE EXECUTIVE DOLBY LABORATORIES, INC., A CALIFORNIA CORPORATION Signature: By: Name: Date: Date: DOLBY LABORATORIES, INC., A DELAWARE CORPORATION By: Date: [Signature Page of the Participation Agreement]


 

Exhibit 21.1
SIGNIFICANT SUBSIDIARIES OF DOLBY LABORATORIES, INC.

As of September 25, 2026
Name
Jurisdiction of Incorporation/Organization
Dolby Laboratories, Inc.
California
Dolby Laboratories Licensing Corporation
New York
Dolby International AB
Sweden
Via Licensing Alliance LLCDelaware
DI Holding BVNetherlands



Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-122908, 333-150804, 333-174319, 333-188602, 333-202012, 333-216058, 333-236622, 333-270271, and 333-298890) on Form S-8 of our report dated November 17, 2026, with respect to the consolidated financial statements of Dolby Laboratories, Inc. and subsidiaries and the effectiveness of internal control over financial reporting.

/s/ KPMG LLP

San Francisco, California
November 17, 2026


Exhibit 31.1
CERTIFICATION
I, Marc Whitten, certify that:
 
1.I have reviewed this Annual Report on Form 10-K of Dolby Laboratories, Inc.;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
 
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 17, 2026
 
/s/    MARC WHITTEN
Marc Whitten
President and Chief Executive Officer
(Principal Executive Officer)



Exhibit 31.2
CERTIFICATION
I, Robert Park, certify that:
 
1.I have reviewed this Annual Report on Form 10-K of Dolby Laboratories, Inc.;
 
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors (or persons performing the equivalent functions):
 
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
 
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 17, 2026
 
/s/    ROBERT PARK
Robert Park
Senior Vice President and Chief Financial Officer
(Principal Financial Officer)



Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Dolby Laboratories, Inc. (the “Company”), on Form 10-K for the fiscal year ended September 25, 2026, as filed with the Securities and Exchange Commission (the “Report”), Marc Whitten, President and Chief Executive Officer of the Company and Robert Park, Senior Vice President and Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
•The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
•The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 17, 2026
 
/s/    MARC WHITTEN
Marc Whitten
President and Chief Executive Officer (Principal Executive Officer)
/s/    ROBERT PARK
Robert Park
Senior Vice President and Chief Financial Officer (Principal Financial Officer)